{
  "meta": {
    "title": "37_Neetpg_June_2024_Mock_Test-1_-_10-06-2024",
    "url": "https://brainandscalpel.vercel.app/37-neetpg-june-2024-mock-test-1-10-06-2024-636e1287.html",
    "scrapedAt": "2025-11-29T17:23:38.956Z"
  },
  "questions": [
    {
      "id": 47825,
      "choices": [
        {
          "id": 190899,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Increased length of telomere</span></span></span></p>"
        },
        {
          "id": 190900,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Short telomere with damaged DNA and loss of helicase</span></span></span></p>"
        },
        {
          "id": 190901,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Increased advanced glycation end products</span></span></span></p>"
        },
        {
          "id": 190902,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Decreased lipid peroxidation</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 45-year-old individual presents with signs of premature aging, including graying hair, wrinkled skin, and cataracts. Genetic testing reveals a condition known as Werner syndrome. What is the underlying cause of Werner syndrome with premature aging? </span></span></p>",
      "unique_key": "Q6577975",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans.&nbsp;</span></strong><strong><span style=\"font-size:14.0pt\">B) Short telomere with damaged DNA and loss of helicase</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Werner syndrome is a rare genetic disorder characterized by premature aging. The etiology of Werner syndrome involves mutations in the WRN gene, which encodes a RecQ helicase protein. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This helicase is essential for maintaining the stability of DNA and proper telomere maintenance. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The loss of helicase activity leads to DNA damage and the shortening of telomeres, contributing to the accelerated aging observed in Werner syndrome.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Increased length of telomere:</span></strong><span style=\"font-size:14.0pt\"> Increased telomere length is typically associated with enhanced cellular longevity and is not a cause of Werner syndrome.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Increased advanced glycation end products:</span></strong><span style=\"font-size:14.0pt\"> While these products are associated with aging and diabetes complications, they are not the primary cause of Werner syndrome.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Decreased lipid peroxidation:</span></strong><span style=\"font-size:14.0pt\"> This is not related to the pathogenesis of Werner syndrome. Lipid peroxidation refers to oxidative degradation of lipids, which is more associated with oxidative stress.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Werner syndrome, characterized by premature aging, is caused by mutations in the WRN gene leading to short telomeres, damaged DNA, and loss of helicase activity.</span></span></li>\r\n</ul>",
      "correct_choice_id": 190900,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        1
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47794,
      "choices": [
        {
          "id": 190779,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Cavernous Sinus</span></span></span></p>"
        },
        {
          "id": 190780,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Sigmoid Sinus</span></span></span></p>"
        },
        {
          "id": 190781,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Straight Sinus</span></span></span></p>"
        },
        {
          "id": 190782,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Superior Sagittal Sinus</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 35-year-old woman presents to the neurology clinic with headaches and symptoms suggestive of increased intracranial pressure. Imaging studies reveal impaired cerebrospinal fluid (CSF) drainage. Which venous sinus is most involved in the reabsorption of CSF due to the presence of the greatest number of arachnoid granulations?</span></span></p>",
      "unique_key": "Q5801915",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. D) Superior Sagittal Sinus</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">The superior sagittal sinus runs along the midline at the top of the brain within the falx cerebri. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">It is the primary site for the drainage of cerebrospinal fluid (CSF) via numerous arachnoid granulations. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">These granulations protrude into the sinus, facilitating the reabsorption of CSF into the venous system, which is essential for maintaining normal intracranial pressure.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/07/screenshot-2024-06-07-093830.png\" style=\"height:249px; width:400px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Cavernous Sinus:</span></strong><span style=\"font-size:14.0pt\"> Located on either side of the sella turcica, the cavernous sinus receives venous blood from the ophthalmic veins and other small veins but is not the primary site for drainage of arachnoid granulations.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Sigmoid Sinus:</span></strong><span style=\"font-size:14.0pt\"> This sinus is a continuation of the transverse sinus and drains blood from the brain into the internal jugular vein. It does not receive significant drainage from arachnoid granulations.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Straight Sinus:</span></strong><span style=\"font-size:14.0pt\"> Found at the junction of the falx cerebri and tentorium cerebelli, the straight sinus receives blood from the inferior sagittal sinus and the great cerebral vein (vein of Galen). While it participates in venous drainage, it does not have the highest number of arachnoid granulations.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">The superior sagittal sinus is the major site of cerebrospinal fluid (CSF) reabsorption due to the presence of numerous arachnoid granulations, playing a crucial role in regulating intracranial pressure.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 190782,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        3
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47573,
      "choices": [
        {
          "id": 189903,
          "text": "<p><span style=\"font-size:14.0pt;\">Genotyping/karyotyping</span></p>"
        },
        {
          "id": 189904,
          "text": "<p><span style=\"font-size:14.0pt;\">Immunophenotyping</span></p>"
        },
        {
          "id": 189905,
          "text": "<p><span style=\"font-size:14.0pt;\">Bone marrow</span></p>"
        },
        {
          "id": 189906,
          "text": "<p><span style=\"font-size:14.0pt;\">Peripheral smear study</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">An adult patient presents with generalized lymphadenopathy, and a blood film shows 70% immature-looking lymphocytes. What should be the next best investigation?</span></p>",
      "unique_key": "Q4965627",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Immunophenotyping</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">Immunophenotyping is the next best investigation in a patient with generalized lymphadenopathy and a high percentage of immature lymphocytes on blood film.</span></li><li><span style=\"font-size:14.0pt;\">This test involves using flow cytometry to analyze the expression of specific cell surface markers on the lymphocytes.</span></li><li><span style=\"font-size:14.0pt;\">It helps in differentiating between different types of lymphoid malignancies, such as acute lymphoblastic leukaemia (ALL), chronic lymphocytic leukaemia (CLL), and other lymphoproliferative disorders.</span></li><li><span style=\"font-size:14.0pt;\">By determining the specific immunophenotype, clinicians can make an accurate diagnosis and guide appropriate treatment.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Genotyping/karyotyping:</strong> While genotyping and karyotyping are important for identifying specific genetic abnormalities associated with certain leukaemiaâ€™s and lymphomas, they are typically performed after the initial diagnosis is established by immunophenotyping.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Bone marrow:</strong> A bone marrow examination can provide valuable information about the extent of disease involvement and help in staging the disease. However, it is usually performed after immunophenotyping has suggested a specific diagnosis that requires further confirmation and staging.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Peripheral smear study:</strong> A peripheral smear has already been performed, revealing 70% immature lymphocytes. While the smear provides important initial information, it cannot differentiate between different types of lymphoid malignancies. Therefore, further investigation with immunophenotyping is necessary.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">In the evaluation of a patient with generalized lymphadenopathy and a high percentage of immature lymphocytes on blood film, immunophenotyping is the next best investigation to accurately diagnose the specific type of lymphoid malignancy and guide appropriate treatment.</span></li><li><span style=\"font-size:14.0pt;\">It identifies cell surface markers (CD markers) to:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Distinguish between B-cell and T-cell lineage</span></li><li><span style=\"font-size:14.0pt;\">Differentiate CLL vs. ALL vs. lymphoma spillover</span></li><li><span style=\"font-size:14.0pt;\">Confirm whether the cells are monoclonal (malignant) or polyclonal (reactive)</span></li><li><span style=\"font-size:14.0pt;\">Immunophenotyping is the gold standard for classifying lymphoid malignancies</span></li></ul></li></ul>",
      "correct_choice_id": 189904,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        5
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47686,
      "choices": [
        {
          "id": 190355,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Organism typically affects the colon</span></span></span></p>"
        },
        {
          "id": 190356,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The life cycle is partly in sheep and partly in man</span></span></span></p>"
        },
        {
          "id": 190357,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The treatment of choice is metronidazole </span></span></span></p>"
        },
        {
          "id": 190358,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The aspirate shows &ldquo;sterile pus&rdquo; on microscopy</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 42-year-old male had visited Mumbai a few months back. He had a history of bloody diarrhea for a few days on returning, which subsided on its own. He now presents with right upper abdominal pain, low grade fever, and weight loss. On examination, the patient shows pallor and tender hepatomegaly. Ultrasound shows fluid collection in liver with necrotic debris. What is incorrect about this disease?</span></span></p>",
      "unique_key": "Q5017265",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. B) The life cycle is partly in sheep and partly in man.</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The above clinical scenario is suggestive of amoebic liver abscess. It&#39;s caused by the parasite Entamoeba Histolytica. Its entire life cycle is in man. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">The life cycle is partly in sheep and partly in man:&nbsp; </span></strong><span style=\"font-size:14.0pt\">This statement is incorrect. Entamoeba histolytica&#39;s life cycle is entirely within humans, who are the definitive hosts. Sheep are not involved in the life cycle of this organism.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Organism typically affects the colon: </span></strong><span style=\"font-size:14.0pt\">This is correct. Entamoeba histolytica primarily infects the colon and can cause amebic dysentery, but it can also spread to the liver to form an abscess.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. The treatment of choice is metronidazole:&nbsp; </span></strong><span style=\"font-size:14.0pt\">This is correct. Metronidazole is the drug of choice for invasive amoebiasis, and diloxanide furoate is used as a luminal agent to eliminate intraluminal cysts. Chloroquine may be used adjunctively for the treatment of amebic liver abscesses, particularly when metronidazole alone is insufficient.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. The aspirate shows &ldquo;sterile pus&rdquo; on microscopy:&nbsp; </span></strong><span style=\"font-size:14.0pt\">This is correct. Aspirates from an amebic liver abscess typically do not show bacteria when cultured, hence the term &quot;sterile pus.&quot; The aspirate is often described as looking like &quot;anchovy sauce&quot; due to the presence of necrotic liver tissue and blood.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Entamoeba histolytica is the causative agent of amebic liver abscess, with a life cycle that occurs exclusively in humans, not sheep. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The treatment includes metronidazole, often combined with other agents like chloroquine and diloxanide furoate, and the condition is characterized by &quot;sterile pus&quot; in the liver abscess aspirate.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 190356,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        12
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47679,
      "choices": [
        {
          "id": 190327,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Leuprolide</span></span></span></p>"
        },
        {
          "id": 190328,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Goserelin</span></span></span></p>"
        },
        {
          "id": 190329,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Nafarelin</span></span></span></p>"
        },
        {
          "id": 190330,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Octreotide</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient underwent surgical resection for a pituitary tumor that overproduced growth hormone, but the surgery did not fully remove the tumor. What is the first-line treatment to manage the residual disease?</span></span></p>",
      "unique_key": "Q9370156",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. </span></strong><strong><span style=\"font-size:14.0pt\">D) Octreotide</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Octreotide</span></strong><span style=\"font-size:14.0pt\"> is a synthetic somatostatin analog that inhibits the secretion of several hormones, including growth hormone (GH). </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">It is particularly effective in the management of acromegaly, a condition resulting from excess GH, typically due to a pituitary adenoma. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Octreotide reduces the levels of GH and is often used when surgical treatment is inadequate or in patients who cannot undergo surgery.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Leuprolide: </span></strong><span style=\"font-size:14.0pt\">&nbsp;This is a gonadotropin-releasing hormone (GnRH) agonist, primarily used in the treatment of hormone-responsive cancers such as prostate cancer and in conditions like endometriosis. It is not effective in reducing GH levels.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Goserelin</span></strong><strong><span style=\"font-size:14.0pt\">:</span></strong><span style=\"font-size:14.0pt\">&nbsp; Another GnRH agonist similar to leuprolide, used for the same indications and also not suitable for treating excess GH production.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Nafarelin</span></strong><strong><span style=\"font-size:14.0pt\">:</span></strong><span style=\"font-size:14.0pt\"> Also a GnRH agonist, used for endometriosis and central precocious puberty, not for acromegaly or GH excess.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Octreotide is used for the treatment of the following conditions: </span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Mnemonic &ndash; SOMATostatin</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">S: S</span></strong><span style=\"font-size:14.0pt\">ecretory diarrhea due to carcinoid tumor, VIPoms, following cancer chemotherapy, AIDS etc.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">O: O</span></strong><span style=\"font-size:14.0pt\">esophageal varices (Acute Variceal bleeding)</span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">M: M</span></strong><span style=\"font-size:14.0pt\">alignancy like Insulinoma and Glucagonoma</span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">A: A</span></strong><span style=\"font-size:14.0pt\">cromegaly due to GH secreting pituitary adenoma</span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">T: T</span></strong><span style=\"font-size:14.0pt\">hyrotrope adenoma</span></span></span></p>",
      "correct_choice_id": 190330,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47719,
      "choices": [
        {
          "id": 190487,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Left optic tract</span></span></span></p>"
        },
        {
          "id": 190488,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Right visual cortex</span></span></span></p>"
        },
        {
          "id": 190489,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Optic chiasma</span></span></span></p>"
        },
        {
          "id": 190490,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Right optic nerve</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 60-year-old patient presents to the ophthalmology clinic with complaints of progressive loss of vision in the right halves of both eyes. On examination, visual field testing confirms right homonymous hemianopia. Where is the lesion likely located in the optic pathway? </span></span></p>",
      "unique_key": "Q5882196",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. A) Left optic tract</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">A lesion in the left optic tract results in right homonymous hemianopia, which is the loss of vision in the right halves of the visual fields of both eyes. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">This occurs because the optic tract contains fibers from the contralateral visual field.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Right visual cortex:</span></strong><span style=\"font-size:14.0pt\"> A lesion in the right visual cortex would cause left homonymous hemianopia, affecting the left halves of the visual fields of both eyes. This does not match the patient&#39;s symptoms.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Optic chiasma:</span></strong><span style=\"font-size:14.0pt\"> A lesion at the optic chiasma typically causes bitemporal hemianopia, characterized by loss of the outer visual fields in both eyes, due to the crossing fibers from the nasal retinas.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Right optic nerve:</span></strong><span style=\"font-size:14.0pt\"> A lesion in the right optic nerve would cause vision loss in the right eye only, not affecting the left eye. This would not present as right homonymous hemianopia.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/06/screenshot-2024-06-06-151112.png\" style=\"height:408px; width:500px\" /></span></strong></span></span></p>",
      "correct_choice_id": 190487,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        8
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47692,
      "choices": [
        {
          "id": 190379,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">1-a, 2-b, 3-c, 4-d</span></span></span></p>"
        },
        {
          "id": 190380,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">1-d, 2-a, 3-b 4-c</span></span></span></p>"
        },
        {
          "id": 190381,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">1-d, 2-a, 3-c, 4-b</span></span></span></p>"
        },
        {
          "id": 190382,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1-d, 2-c, 3-a, 4-b</span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Match the following: Mapleson circuits </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Column A</span></strong></span></span></p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Mapleson circuit of choice for controlled ventilation in adults</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Mapleson circuit of choice for controlled ventilation in children</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Mapleson circuit of choice for spontaneous ventilation in adults</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Water&rsquo;s to and fro circuit</span></span></span></li>\r\n</ol>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Column B</span></strong></span></span></p>\r\n\r\n<ol style=\"list-style-type:lower-alpha\">\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Mapleson F</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Mapleson C </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Mapleson A</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Mapleson D</span></span></span></li>\r\n</ol>",
      "unique_key": "Q4494088",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Ans. C) 1-d, 2-a, 3-c, 4-b</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">1-d The Mapleson D circuit is preferred for controlled ventilation in adults. </span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">2-a The Mapleson F circuit (also known as the Jackson-Rees modification) is used for controlled ventilation in children. </span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">3-c The Mapleson A circuit is the best for spontaneous ventilation in adults. </span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">4-b The Water&rsquo;s to-and-fro circuit corresponds to the Mapleson C circuit.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The Mapleson D circuit is preferred for controlled ventilation in adults, Mapleson F for controlled ventilation in children, Mapleson A for spontaneous ventilation in adults, and Mapleson C corresponds to the Water&rsquo;s to-and-fro circuit.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 190381,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        19
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47761,
      "choices": [
        {
          "id": 190651,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Acute hepatitis B</span></span></span></p>"
        },
        {
          "id": 190652,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Chronic hepatitis B</span></span></span></p>"
        },
        {
          "id": 190653,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Acute Hepatitis C</span></span></span></p>"
        },
        {
          "id": 190654,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Hepatitis B Window period </span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 45-year-old male patient presents with fever, jaundice, and malaise. What is the most likely diagnosis based on the serology reports given below?</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Anti-HBc (Total): Positive</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Anti-HBc (IgM): Negative</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">HBsAg: Negative</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Anti-HBs: Positive</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Anti-HCV: Positive</span></span></span></li>\r\n</ul>",
      "unique_key": "Q8460583",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Ans.&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">C) Acute Hepatitis C</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">The patient&#39;s serology reports show positive Anti-HCV, indicating exposure to hepatitis C virus (HCV). </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Additionally, the absence of HBsAg (hepatitis B surface antigen) and positive Anti-HBs (hepatitis B surface antibody) suggest no evidence of current or past hepatitis B virus (HBV) infection. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">The negative Anti-HBc IgM further supports the absence of acute hepatitis B. Based on these findings, the most likely diagnosis is acute hepatitis. Anti-HBc (Total): Positive and Anti-HBc (IgM): Negative indicate that it is a resolved Hepatitis B.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">This is the correct option. The positive Anti-HCV indicates exposure to HCV, and the absence of markers for hepatitis B infection supports the diagnosis of acute hepatitis C.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Option A. Acute hepatitis B:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"> This option is incorrect because the serology findings do not support acute hepatitis B. The absence of HBsAg and the presence of Anti-HBs indicate no active HBV infection, and the negative Anti-HBc IgM further suggests the absence of acute HBV infection.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Option B. Chronic hepatitis B:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"> This option is incorrect as the serology reports do not indicate chronic hepatitis B. The absence of HBsAg and the presence of Anti-HBs suggest resolved or past HBV infection, rather than chronic infection.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Option D. Hepatitis B Window period:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"> This option is incorrect. The serology findings do not suggest the hepatitis B window period. The presence of Anti-HBs and absence of HBsAg and Anti-HBc IgM indicate either resolved HBV infection or immunity to HBV, rather than the window period.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">In a patient presenting with fever, jaundice, and malaise, serological testing plays a crucial role in determining the etiology of hepatitis. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">In this case, the presence of positive Anti-HCV, absence of HBsAg, and positive Anti-HBs suggest acute hepatitis C as the most likely diagnosis. </span></span></span></li>\r\n</ul>",
      "correct_choice_id": 190653,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47681,
      "choices": [
        {
          "id": 190335,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Pretracheal fascia</span></span></span></p>"
        },
        {
          "id": 190336,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Sternothyroid</span></span></span></p>"
        },
        {
          "id": 190337,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Thyrohyoid membrane</span></span></span></p>"
        },
        {
          "id": 190338,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Ligament of Berry</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 45-year-old woman presents with a swelling in her neck, which has been progressively enlarging over the past few months. On examination, the swelling is found to be located in the region of the thyroid gland. Which of the following structures prevents the upward extension of thyroid swelling through its attachment to the thyroid cartilage? </span></span></p>",
      "unique_key": "Q1699643",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. B) Sternothyroid</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">The sternothyroid muscle plays a crucial role in preventing the upward extension of a thyroid swelling. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">This muscle attaches to the thyroid cartilage, creating a physical barrier that limits the upward movement of the thyroid gland. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">When the thyroid gland enlarges, such as in goiter or other thyroid pathologies, its superior extension is restricted by the sternothyroid muscle&#39;s attachment to the thyroid cartilage.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Pretracheal fascia</span></strong><span style=\"font-size:14.0pt\">: The pretracheal fascia encloses the thyroid gland and other structures in the anterior part of the neck, but it does not specifically prevent the upward extension of thyroid swelling.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Thyrohyoid membrane</span></strong><span style=\"font-size:14.0pt\">: The thyrohyoid membrane connects the thyroid cartilage to the hyoid bone. While it is involved in the movement and stability of these structures, it does not directly prevent the upward extension of thyroid swelling.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Ligament of Berry</span></strong><span style=\"font-size:14.0pt\">: The Ligament of Berry attaches the thyroid gland to the trachea and helps maintain its position in the neck. It is not primarily responsible for preventing the upward extension of thyroid swelling.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The sternothyroid muscle prevents the upward extension of a thyroid swelling due to its attachment to the thyroid cartilage, creating a physical barrier that limits the superior movement of the thyroid gland.</span></span></li>\r\n</ul>",
      "correct_choice_id": 190336,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        3
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47920,
      "choices": [
        {
          "id": 191275,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Acute Type 2 respiratory failure</span></span></span></p>"
        },
        {
          "id": 191276,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Chronic Type 2 respiratory failure</span></span></span></p>"
        },
        {
          "id": 191277,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Acute on chronic Type 2 respiratory failure</span></span></span></p>"
        },
        {
          "id": 191278,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Acute Type 1 respiratory failure</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 60-year-old man with a history of chronic obstructive pulmonary disease (COPD) presents to the emergency department with increasing shortness of breath and lethargy over the past three days. He reports a productive cough with yellow sputum. On examination, he is found to have diminished breath sounds and wheezing. His arterial blood gas (ABG) results are as follows. What is the most likely diagnosis?<strong> </strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">pH: 7.28 </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">pCO<sub>2</sub>: 50 mmHg </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">HCO<sub>3</sub>-: 32 mEq/L </span></span></span></li>\r\n</ul>",
      "unique_key": "Q2219992",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>C) Acute on chronic Type 2 respiratory failure</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">The patient&#39;s presentation and arterial blood gas (ABG) results indicate that he is experiencing an acute exacerbation of chronic obstructive pulmonary disease (COPD). </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">COPD can lead to chronic Type 2 respiratory failure, characterized by chronic hypercapnia (elevated pCO<sub>2</sub>) and compensated metabolic alkalosis (elevated HCO<sub>3</sub>-). In this case:</span></span></span></li>\r\n</ul>\r\n\r\n<ol style=\"margin-left:40px\">\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">pH: 7.28</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"> - This indicates acidemia.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">pCO<sub>2</sub>: 50 mmHg</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"> - Elevated pCO<sub>2</sub>, indicating hypercapnia.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">HCO<sub>3</sub>-: 32 mEq/L</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"> - Elevated bicarbonate, suggesting chronic compensation.</span></span></span></li>\r\n</ol>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">The combination of an elevated pCO<sub>2</sub> and elevated HCO<sub>3</sub>- with a low pH suggests that this patient has chronic Type 2 respiratory failure with an acute exacerbation. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Chronic Type 2 respiratory failure is characterized by chronically elevated pCO<sub>2</sub> with compensatory metabolic alkalosis. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">The current acidemia (low pH) indicates that the patient is experiencing an acute worsening of his chronic condition, leading to &quot;acute on chronic Type 2 respiratory failure.&quot;</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">A. Acute Type 2 respiratory failure</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">: Acute Type 2 respiratory failure is characterized by sudden onset hypercapnia (elevated pCO<sub>2</sub>) with acidemia (low pH). There would be no time for metabolic compensation (elevated HCO<sub>3</sub>-) in an acute setting, so bicarbonate levels would remain normal. This does not match the patient&#39;s presentation with elevated HCO<sub>3</sub>-.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">B. Chronic Type 2 respiratory failure</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">: Chronic Type 2 respiratory failure is characterized by chronic hypercapnia (elevated pCO<sub>2</sub>) with compensatory metabolic alkalosis (elevated HCO<sub>3</sub>-), maintaining a near-normal pH. The patient&#39;s current low pH indicates an acute exacerbation rather than a stable chronic condition.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14pt\"><strong>D.</strong>&nbsp;</span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><strong>Acute Type 1 respiratory failure</strong>: Acute Type 1 respiratory failure is characterized by hypoxemia (low PaO<sub>2</sub>) without hypercapnia (normal or low pCO<sub>2</sub>). This does not fit the patient&#39;s ABG results showing elevated pCO<sub>2</sub>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Educational objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">&quot;Acute on chronic Type 2 respiratory failure&quot; is characterized by a patient with chronic hypercapnia and compensatory metabolic alkalosis experiencing an acute exacerbation leading to a drop in pH (acidemia), as seen in the elevated pCO<sub>2</sub> and HCO<sub>3</sub>- levels with a low pH in the ABG results.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 191277,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47722,
      "choices": [
        {
          "id": 190499,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Post-transplant lymphoproliferative disorder (PTLD) </span></span></span></p>"
        },
        {
          "id": 190500,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Squamous cell carcinoma of the skin </span></span></span></p>"
        },
        {
          "id": 190501,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Leukaemia </span></span></span></p>"
        },
        {
          "id": 190502,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Kaposi&rsquo;s sarcoma</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 63-year-old male, who received a kidney transplant 2 years ago and has been on chronic immunosuppressive therapy, presents with multiple hyperkeratotic lesions on sun-exposed areas of the skin. Biopsy of one lesion confirms malignancy. Which of the following is the most likely diagnosis? </span></span></p>",
      "unique_key": "Q1498661",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. B) Squamous cell carcinoma of the skin </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Squamous cell carcinoma of the skin is the most common malignancy seen in post-transplant patients due to chronic immunosuppression, particularly in sun-exposed areas, matching the presentation described.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Option A.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>PTLD</strong>: Refers to a range of lymphoid proliferations that can occur following transplantation due to immunosuppression. However, it does not present with hyperkeratotic skin lesions.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C.&nbsp;</span></strong><strong><span style=\"font-size:14.0pt\">Leukaemia:</span></strong><span style=\"font-size:14.0pt\"> It can occur in the post-transplant setting but would not present with localized skin lesions.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D.&nbsp;</span></strong><strong><span style=\"font-size:14.0pt\">Kaposi&rsquo;s sarcoma:</span></strong><span style=\"font-size:14.0pt\"> It can occur in transplant patients but typically presents as violaceous plaques or nodules and is less common than squamous cell carcinoma in these patients.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The most common malignancy seen post-transplant in patients on immunosuppressive therapy is squamous cell carcinoma of the skin, often occurring on sun-exposed areas.</span></span></p>",
      "correct_choice_id": 190500,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        12
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47883,
      "choices": [
        {
          "id": 191127,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Chronic renal disease</span></span></span></p>"
        },
        {
          "id": 191128,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">History of amenorrhea</span></span></span></p>"
        },
        {
          "id": 191129,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Thromboembolism</span></span></span></p>"
        },
        {
          "id": 191130,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Diabetes mellitus</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 32-year-old woman is considering using oral contraceptive pills (OCPs) for birth control. During her medical evaluation, the healthcare provider needs to identify any absolute contraindications to OCP use. Which of the following is an absolute contraindication to the use of OCPs? </span></span></p>",
      "unique_key": "Q8403888",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. C) Thromboembolism</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Oral contraceptive pills (OCPs) are widely used for birth control but have certain absolute contraindications due to the risk of severe adverse effects. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Thromboembolism is a condition in which blood clots form in blood vessels and can travel to vital organs, causing serious complications. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">OCPs, particularly those containing estrogen, increase the risk of thromboembolic events. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Therefore, a history of thromboembolism is an absolute contraindication to the use of OCPs because of the significant risk of recurrence.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Chronic renal disease:</span></strong><span style=\"font-size:14.0pt\"> While chronic renal disease requires careful management and monitoring when using OCPs, it is not an absolute contraindication. Patients with renal disease should be evaluated on a case-by-case basis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. History of amenorrhea:</span></strong><span style=\"font-size:14.0pt\"> Amenorrhea, or the absence of menstruation, is not an absolute contraindication for the use of OCPs. In some cases, OCPs are even used to help regulate menstrual cycles in women with amenorrhea.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Diabetes mellitus:</span></strong><span style=\"font-size:14.0pt\"> Diabetes mellitus is not an absolute contraindication for OCP use. However, women with diabetes, especially those with vascular complications, should be carefully monitored while using OCPs due to potential risks.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Thromboembolism is an absolute contraindication to the use of oral contraceptive pills due to the increased risk of blood clot formation associated with these medications.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 191129,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47726,
      "choices": [
        {
          "id": 190515,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Measurement of blood glucose</span></span></span></p>"
        },
        {
          "id": 190516,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Measurement of blood pressure (BP)</span></span></span></p>"
        },
        {
          "id": 190517,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Measurement of hip circumference</span></span></span></p>"
        },
        {
          "id": 190518,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Measurement of height and weight</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The STEPwise approach to surveillance (STEPS) utilized by the World Health Organization includes various measurements to assess chronic disease risk factors. Which of the following is included only in the EXPANDED component of the STEPS approach?</span></span></p>",
      "unique_key": "Q3051107",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans.</span></strong><span style=\"font-size:14.0pt\"> <strong>C) Measurement of hip circumference</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Measurement of hip circumference, is correct as it is included only in the EXPANDED component of the STEPwise approach to surveillance. The expanded component involves additional measurements that provide a broader understanding of risk factors, which include hip circumference and heart rate, not typically measured in the core component.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">STEPwise approach to surveillance (STEPS) is a simple, standardized method by WHO for surveillance. It is of two types:</span></span></span></li>\r\n</ul>\r\n\r\n<ul style=\"list-style-type:circle\">\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">STEPwise approach to chronic disease risk factor surveillance</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">STEPwise approach to Stroke surveillance</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Measurement of blood glucose:</span></strong><span style=\"font-size:14.0pt\"> Incorrect<strong> </strong>because blood glucose is measured in both the CORE and EXPANDED components of the STEPS approach.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Measurement of blood pressure (BP):</span></strong><span style=\"font-size:14.0pt\"> Incorrect<strong> </strong>as blood pressure is also measured in both the CORE and EXPANDED components.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Measurement of height and weight:</span></strong><span style=\"font-size:14.0pt\"> Incorrect<strong> </strong>because these measurements are part of the CORE component and are fundamental to the initial risk factor assessment in STEPS.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/06/screenshot-2024-06-06-152535.png\" style=\"height:776px; width:1000px\" /></p>",
      "correct_choice_id": 190517,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47711,
      "choices": [
        {
          "id": 190455,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Alpha methyldopa</span></span></span></p>"
        },
        {
          "id": 190456,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Hydralazine</span></span></span></p>"
        },
        {
          "id": 190457,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Propranolol</span></span></span></p>"
        },
        {
          "id": 190458,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Labetalol</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 28-year-old pregnant woman with a history of hypertension is being evaluated for safe antihypertensive treatment options during her pregnancy. Which of the following antihypertensives is generally not recommended for use during pregnancy? </span></span></p>",
      "unique_key": "Q2774581",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans.&nbsp;</span></strong><strong><span style=\"font-size:14.0pt\">C) Propranolol</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Propranolol is a non-selective beta-blocker that is generally not recommended during pregnancy due to its potential adverse effects on both the mother and fetus. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Non-selective beta-blockers can restrict fetal growth and cause fetal bradycardia, hypoglycemia, and respiratory depression at birth.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Alpha methyldopa</span></strong><span style=\"font-size:14.0pt\">: Often considered the first-line treatment for hypertension in pregnancy due to its long track record of safety and efficacy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Hydralazine</span></strong><span style=\"font-size:14.0pt\">: Commonly used as a direct vasodilator in the management of hypertension during pregnancy, especially in acute settings.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Labetalol</span></strong><span style=\"font-size:14.0pt\">: A mixed alpha/beta-blocker, it is preferred over pure beta-blockers like propranolol due to its additional vasodilatory properties that make it safer and more effective during pregnancy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Antihypertensive to be avoided in pregnancy:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">ACE inhibitors, ARBS</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Diuretics</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Nonselective beta-blockers</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Nitroprusside</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 190457,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47876,
      "choices": [
        {
          "id": 191099,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Blood vessel penetration by tumor cells</span></span></span></p>"
        },
        {
          "id": 191100,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Lymphocyte infiltration</span></span></span></p>"
        },
        {
          "id": 191101,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Tumor cells in lymphatic channels</span></span></span></p>"
        },
        {
          "id": 191102,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The number of mitoses per high power field</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 55-year-old woman presents with a rapidly enlarging mass in her thigh. A biopsy confirms the diagnosis of leiomyosarcoma. To determine the malignant potential and prognosis of this tumor, which of the following histological criteria is most important? </span></span></p>",
      "unique_key": "Q9812851",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. D) The number of mitoses per high power field</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The mitotic rate, measured as the number of mitoses per high power field (HPF), is the most important histological criterion for assessing the malignant potential of leiomyosarcomas. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">A high mitotic rate is directly correlated with aggressive tumor behavior, higher grade, and worse prognosis. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">It reflects the proliferative activity of the tumor cells, which is a key factor in determining the aggressiveness of the sarcoma.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Blood vessel penetration by tumor cells:</span></strong><span style=\"font-size:14.0pt\"> Although invasion into blood vessels can indicate potential for metastasis and aggressive behavior, it is not the primary criterion used to assess the malignancy of leiomyosarcomas.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Lymphocyte infiltration:</span></strong><span style=\"font-size:14.0pt\"> Lymphocyte infiltration can be a response to the tumor but does not directly correlate with the malignant potential or grading of leiomyosarcomas. It is more indicative of an immune response to the tumor.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Tumor cells in lymphatic channels:</span></strong><span style=\"font-size:14.0pt\"> The presence of tumor cells in lymphatic channels can indicate lymphatic spread, but this is less common in leiomyosarcomas compared to other cancers and is not the main criterion for assessing malignancy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The mitotic rate, or the number of mitoses per high power field, is the most important histological criterion for determining the malignant behavior and prognosis of leiomyosarcomas. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">A higher mitotic rate indicates a more aggressive and malignant tumor.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 191102,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        5
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47821,
      "choices": [
        {
          "id": 190883,
          "text": "<p><span style=\"font-size:14.0pt;\">Ependymoma</span></p>"
        },
        {
          "id": 190884,
          "text": "<p><span style=\"font-size:14.0pt;\">Medulloblastoma</span></p>"
        },
        {
          "id": 190885,
          "text": "<p><span style=\"font-size:14.0pt;\">Astrocytoma</span></p>"
        },
        {
          "id": 190886,
          "text": "<p><span style=\"font-size:14.0pt;\">All of the above</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 47-year-old man presents with headaches and seizures. MRI reveals a mass in the brain. A biopsy of the mass shows the presence of glial fibrillary acidic protein (GFAP). Which of the following tumors is most likely to be diagnosed?</span></p>",
      "unique_key": "Q7625907",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Astrocytoma</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">Glial fibrillary acidic protein (GFAP) is an intermediate filament protein that is specifically expressed in astrocytes.</span></li><li><span style=\"font-size:14.0pt;\">Astrocytomas are glial tumors derived from astrocytes, and they characteristically express GFAP.</span></li><li><span style=\"font-size:14.0pt;\">The presence of GFAP in a brain tumor biopsy is highly indicative of an astrocytoma.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Ependymoma:</strong> Ependymomas are tumors arising from ependymal cells lining the ventricles and central canal of the spinal cord. While they may occasionally express GFAP, it is not as characteristic or definitive as it is for astrocytoma.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Medulloblastoma:</strong> Medulloblastomas are primitive neuroectodermal tumors that primarily occur in the cerebellum. They do not typically express GFAP, as they are derived from neuronal progenitor cells rather than glial cells.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. All of the above:</strong> While some ependymomas may express GFAP, medulloblastomas do not, making this option incorrect.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">Glial fibrillary acidic protein (GFAP) is specifically expressed in astrocytes, and its presence in a brain tumor biopsy is most indicative of an astrocytoma.</span></li><li><span style=\"font-size:14.0pt;\">Glial Fibrillary Acidic Protein (GFAP) is:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">An intermediate filament protein</span></li><li><span style=\"font-size:14.0pt;\">Specifically expressed in astrocytes, a type of glial cell</span></li><li><span style=\"font-size:14.0pt;\">Used as a marker to identify tumors of astrocytic lineage</span></li></ul></li></ul>",
      "correct_choice_id": 190885,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        5
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47725,
      "choices": [
        {
          "id": 190511,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">CuT200</span></span></span></p>"
        },
        {
          "id": 190512,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Danazol</span></span></span></p>"
        },
        {
          "id": 190513,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">RU486 (Mifepristone)</span></span></span></p>"
        },
        {
          "id": 190514,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Combined high dose estrogen-progestin pills</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 27-year-old woman comes to the clinic and is seeking advice on contraceptive methods that can be used after unprotected intercourse. Which of the following is NOT used as a post-coital contraceptive method?</span></span></p>",
      "unique_key": "Q4503238",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">&nbsp;Ans. B) Danazol</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Post-coital contraceptive methods, also known as emergency contraceptives, are used to prevent pregnancy after unprotected intercourse or contraceptive failure. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">These methods include hormonal pills and intrauterine devices.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Danazol is not used as a post-coital contraceptive. It is a synthetic steroid used primarily in the treatment of endometriosis and fibrocystic breast disease. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">It does not have the necessary properties to prevent pregnancy when taken after intercourse.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. CuT200:</span></strong><span style=\"font-size:14.0pt\"> The CuT200 is a copper intrauterine device (IUD) that can be inserted up to five days after unprotected intercourse. It is highly effective as an emergency contraceptive by creating a hostile environment for sperm and preventing fertilization.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. RU486 (Mifepristone):</span></strong><span style=\"font-size:14.0pt\"> RU486, also known as Mifepristone, can be used as an emergency contraceptive. It works by blocking progesterone receptors, thus preventing the continuation of a pregnancy. It is effective when used within a few days after unprotected intercourse.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Combined high dose estrogen-progestin pills:</span></strong><span style=\"font-size:14.0pt\"> These are also known as the Yuzpe regimen. When taken in high doses shortly after unprotected intercourse, they can prevent pregnancy by delaying ovulation, inhibiting fertilization, or preventing implantation.</span></span></span></p>\r\n\r\n<p><br />\r\n&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Danazol is not used as a post-coital contraceptive. Emergency contraceptive methods include copper IUDs, Mifepristone, and combined high dose estrogen-progestin pills.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 190512,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47479,
      "choices": [
        {
          "id": 189527,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Focal laser photocoagulation</span></span></span></p>"
        },
        {
          "id": 189528,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Pan-retinal photocoagulation</span></span></span></p>"
        },
        {
          "id": 189529,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Grid laser photocoagulation</span></span></span></p>"
        },
        {
          "id": 189530,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Scleral buckling</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 55-year-old diabetic patient presents to the ophthalmology clinic with complaints of decreased vision in the right eye. The visual acuity in the affected eye is 6/9. Fundoscopic examination reveals pre-retinal hemorrhages and neovascularization at the optic disc. What is the next step in management? </span></span></p>",
      "unique_key": "Q4092129",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. B) Pan-retinal photocoagulation</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Pan-retinal photocoagulation (PRP) is the standard treatment for proliferative diabetic retinopathy (PDR), especially with high-risk characteristics such as pre-retinal hemorrhages and neovascularization at the optic disc. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">PRP works by reducing the ischemic drive for neovascularization by ablating peripheral retinal tissue, thereby preserving central vision.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/05/screenshot-2024-06-05-115703.png\" style=\"height:283px; width:400px\" /></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;Pan-retinal Photocoagulation</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Diabetic retinopathy is used to describe retinal changes seen in diabetic patients. It is classified into the following types:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Non-proliferative diabetic retinopathy (NPDR)</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:14.0pt\">Proliferative diabetic retinopathy (PDR)</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:14.0pt\">Diabetic maculopathy</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Advanced diabetic eye disease</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/05/screenshot-2024-06-05-115738.png\" style=\"height:300px; width:700px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Focal laser photocoagulation:</span></strong><span style=\"font-size:14.0pt\"> Focal laser photocoagulation is typically used to treat macular edema by targeting specific areas of leakage, rather than the widespread retinal ischemia seen in proliferative diabetic retinopathy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Grid laser photocoagulation:</span></strong><span style=\"font-size:14.0pt\"> Grid laser photocoagulation is used for treating diffuse macular edema, not for managing proliferative diabetic retinopathy with neovascularization at the optic disc.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Scleral buckling:</span></strong><span style=\"font-size:14.0pt\"> Scleral buckling is a surgical procedure used to treat retinal detachment, not proliferative diabetic retinopathy. It involves placing a silicone band around the eye to indent the sclera and relieve traction on the retina.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">In cases of proliferative diabetic retinopathy with high-risk characteristics, such as pre-retinal hemorrhages and neovascularization at the optic disc, the next step in management is pan-retinal photocoagulation.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Indications for PRP are: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Proliferative Diabetic Retinopathy with high-risk characteristics</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Neovascularization of iris (NVI) </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Severe NPDR associated with:</span></span></span></li>\r\n</ol>\r\n\r\n<ul style=\"list-style-type:circle; margin-left:40px\">\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Poor compliance for follow up</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Before cataract surgery/YAG capsulotomy</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Renal failure</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">One-eyed patient</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Pregnancy</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is done using Yellow &ndash; Green spectrum laser - double frequency Nd YAG (532) laser or argon or diode laser.</span></span></li>\r\n</ul>",
      "correct_choice_id": 189528,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        8
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47914,
      "choices": [
        {
          "id": 191251,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Exploratory laparotomy</span></span></span></p>"
        },
        {
          "id": 191252,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Intubation</span></span></span></p>"
        },
        {
          "id": 191253,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">eFAST </span></span></span></p>"
        },
        {
          "id": 191254,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">CECT </span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 35-year-old male is brought to the emergency department following a motor vehicle accident. His blood pressure is 90/60 mm Hg. On examination, he is stable with a Glasgow Coma Scale (GCS) score of 15/15. His pupils are reactive to light. There is tenderness and bruising over the left lower chest wall with petechiae. What is the next step in management? </span></span></p>",
      "unique_key": "Q7426171",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. C) eFAST</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The eFAST (Extended Focused Assessment with Sonography for Trauma) examination is a rapid bedside ultrasound scan used in trauma settings to assess for the presence of free fluid (hemoperitoneum) in the abdomen, hemothorax, pneumothorax, and cardiac tamponade. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Given the patient&#39;s vital signs and physical findings, which include hypotension and signs of potential chest and abdominal trauma, an eFAST scan is the most appropriate immediate next step. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">It can quickly identify life-threatening injuries that require urgent intervention.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Exploratory Laparotomy:</span></strong><span style=\"font-size:14.0pt\"> This invasive procedure is indicated if there is strong evidence of intra-abdominal injury requiring surgical intervention. However, without further diagnostic imaging to confirm such injuries, it is not the first step.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Intubation:</span></strong><span style=\"font-size:14.0pt\"> The patient is currently stable with a GCS score of 15/15, indicating that he is fully conscious and has a patent airway. Intubation is not immediately necessary.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. CECT (Contrast-Enhanced Computed Tomography):</span></strong><span style=\"font-size:14.0pt\"> While a CECT scan is useful for detailed imaging of injuries, it requires a more stable hemodynamic status and is typically performed after an initial assessment with eFAST. Given the patient&#39;s hypotension, a rapid bedside assessment is prioritized.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">In the context of trauma with hypotension and signs of potential thoracoabdominal injury, an eFAST scan is a critical initial step to quickly identify life-threatening injuries and guide further management.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 191253,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        17
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47812,
      "choices": [
        {
          "id": 190847,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Receptor Phosphorylation</span></span></span></p>"
        },
        {
          "id": 190848,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">ATP Sensitive K+ Channels</span></span></span></p>"
        },
        {
          "id": 190849,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">cAMP</span></span></span></p>"
        },
        {
          "id": 190850,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Carrier Modulators</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 52-year-old woman presents to the clinic with symptoms of increased thirst, frequent urination, and fatigue. She is being evaluated for possible insulin secretion dysfunction. Blood tests confirm elevated blood glucose levels. Which of the following plays a crucial role in the release of insulin when blood glucose levels are elevated?</span></span></p>",
      "unique_key": "Q5729317",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. </span></strong><strong><span style=\"font-size:14.0pt\">B) ATP Sensitive K+ Channels</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The release of insulin in response to elevated blood glucose levels is a complex and tightly regulated process. When blood glucose levels rise, glucose enters pancreatic beta cells through the GLUT2 transporter. The subsequent steps are as follows:</span></span></span></li>\r\n</ul>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Glycolysis and ATP Production:</span></strong><span style=\"font-size:14.0pt\"> Inside the beta cells, glucose undergoes glycolysis and subsequent metabolic processes, leading to an increase in intracellular ATP.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">ATP Sensitive K+ Channels:</span></strong><span style=\"font-size:14.0pt\"> The increase in the ATP/ADP ratio causes ATP-sensitive potassium (Kâº) channels to close. This closure depolarizes the beta cell membrane.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Calcium Influx:</span></strong><span style=\"font-size:14.0pt\"> Depolarization opens voltage-gated calcium channels, allowing Ca&sup2;âº to enter the cell.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Insulin Secretion:</span></strong><span style=\"font-size:14.0pt\"> The influx of Ca&sup2;âº triggers the exocytosis of insulin-containing granules, releasing insulin into the bloodstream.</span></span></span></li>\r\n</ol>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option&nbsp;</span></strong><span style=\"font-size:14pt\"><strong>A.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>Receptor Phosphorylation:</strong> While important in many signaling pathways, receptor phosphorylation is not directly involved in the primary mechanism of glucose-mediated insulin release. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option&nbsp;</span></strong><span style=\"font-size:14pt\"><strong>C.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>cAMP:</strong> cAMP is involved in various signaling pathways but does not play a primary role in glucose-mediated insulin release. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option&nbsp;</span></strong><span style=\"font-size:14pt\"><strong>D.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>Carrier Modulators:</strong> These proteins do not play a central role in the direct mechanism of insulin release in response to elevated glucose levels.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The ATP-sensitive Kâº channels are crucial in the process of glucose-mediated insulin release. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The closure of these channels in response to increased intracellular ATP leads to cell membrane depolarization, calcium influx, and subsequent insulin secretion.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 190848,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        2
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47752,
      "choices": [
        {
          "id": 190615,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Diabetic Ketoacidosis (DKA)</span></span></span></p>"
        },
        {
          "id": 190616,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Hyperosmolar Hyperglycemic State (HHS)</span></span></span></p>"
        },
        {
          "id": 190617,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Normal Metabolic State</span></span></span></p>"
        },
        {
          "id": 190618,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Lactic Acidosis</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 15-year-old boy with a known history of diabetes mellitus presents to the emergency department with severe abdominal pain, deep rapid breathing, and a fruity odor on his breath. Laboratory investigations reveal the following results. What is the most likely diagnosis? </span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Glucose: 550 mg/dL</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Sodium: 122 mEq/L</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Osmolality: 310 mOsm/kg</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Plasma ketones: ++++</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Serum bicarbonate: 10 mEq/L</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Arterial pH: 7.1</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Arterial pCO2: 25 mmHg</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Anion gap: Elevated</span></span></span></li>\r\n</ul>",
      "unique_key": "Q4671301",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. A) Diabetic Ketoacidosis (DKA)</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">DKA is characterized by the presence of hyperglycemia (glucose levels typically between 250-600 mg/dL), low serum bicarbonate (&lt;15 mEq/L), low arterial pH (6.8-7.3), elevated anion gap, and the presence of significant ketones in the blood and urine. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Clinical features often include abdominal pain, Kussmaul respirations, and a fruity odor on the breath due to acetone.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Hyperosmolar Hyperglycemic State (HHS):</span></strong><span style=\"font-size:14.0pt\"> HHS typically occurs in patients with Type 2 diabetes mellitus and is characterized by severe hyperglycemia (glucose levels of 600-1200 mg/dL), normal to slightly low serum bicarbonate, normal arterial pH (&gt;7.3), high osmolality (330-380 mOsm/kg), and the absence or low levels of ketones. Patients often present with altered sensorium and coma.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Normal Metabolic State: </span></strong><span style=\"font-size:14.0pt\">The laboratory values and clinical presentation in this case are not consistent with a normal state.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Lactic Acidosis: </span></strong><span style=\"font-size:14.0pt\">Lactic acidosis is characterized by an elevated lactate level and often presents with metabolic acidosis. However, it typically does not present with significant hyperglycemia or elevated ketones unless it is secondary to another condition like DKA. The primary indicators in this case point towards DKA.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Diabetic Ketoacidosis (DKA) is identified by high blood glucose, low serum bicarbonate, low arterial pH, elevated anion gap, and significant ketonemia. </span></span></span></li>\r\n\t<li><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It often presents with symptoms such as abdominal pain, deep rapid breathing (Kussmaul respirations), and a fruity odor on the breath.</span></span></li>\r\n</ul>",
      "correct_choice_id": 190615,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47476,
      "choices": [
        {
          "id": 189515,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Neck holding &ndash; 3 months</span></span></span></p>"
        },
        {
          "id": 189516,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Sits with support &ndash; 6 months</span></span></span></p>"
        },
        {
          "id": 189517,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Stands with support &ndash; 12 months</span></span></span></p>"
        },
        {
          "id": 189518,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Runs &ndash; 18 months</span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Find the incorrect match with respect to milestones achieved:</span></span></p>",
      "unique_key": "Q3456491",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Ans. C) Stands with support &ndash; 12 months</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Gross Motor milestones table:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/05/screenshot-2024-06-05-115256.png\" style=\"height:1161px; width:1000px\" /></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">A child can stand with support at 9 months of age.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 189517,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        13
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47480,
      "choices": [
        {
          "id": 189531,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Nasopharyngeal stenosis</span></span></span></p>"
        },
        {
          "id": 189532,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Velopharyngeal insufficiency</span></span></span></p>"
        },
        {
          "id": 189533,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Eustachian tube dysfunction</span></span></span></p>"
        },
        {
          "id": 189534,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Middle ear effusion recurrence</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 6-year-old girl with a history of recurrent otitis media with effusion is scheduled for an adenoidectomy with grommet insertion. Postoperatively, she develops nasal regurgitation of fluids and hypernasal speech. Which of the following is the most likely complication responsible for these symptoms? </span></span></p>",
      "unique_key": "Q5685914",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. B) Velopharyngeal insufficiency</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Velopharyngeal insufficiency (VPI) is a condition where there is an inadequate closure of the velopharyngeal sphincter (the soft palate muscle that closes off the nasopharynx during speech and swallowing). </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This results in nasal regurgitation of fluids and hypernasal speech due to air escaping through the nose during phonation. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This complication can occur after adenoidectomy, particularly in patients with a predisposing anatomical weakness or submucous cleft palate.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Nasopharyngeal stenosis:</span></strong><span style=\"font-size:14.0pt\"> Nasopharyngeal stenosis involves the narrowing of the nasopharyngeal space, which can cause nasal obstruction and difficulty breathing through the nose, but it is unlikely to cause nasal regurgitation of fluids and hypernasal speech.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Eustachian tube dysfunction:</span></strong><span style=\"font-size:14.0pt\"> Eustachian tube dysfunction can lead to middle ear problems, such as otitis media with effusion or hearing loss. However, it does not cause nasal regurgitation of fluids and hypernasal speech.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Middle ear effusion recurrence:</span></strong><span style=\"font-size:14.0pt\"> While recurrence of middle ear effusion can occur postoperatively, it primarily causes hearing issues and discomfort but does not lead to nasal regurgitation of fluids and hypernasal speech.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Velopharyngeal insufficiency (VPI) is the most likely complication responsible for nasal regurgitation of fluids and hypernasal speech following an adenoidectomy, due to inadequate closure of the velopharyngeal sphincter during swallowing and speaking.</span></span></li>\r\n</ul>",
      "correct_choice_id": 189532,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        9
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47698,
      "choices": [
        {
          "id": 190403,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Odorless</span></span></span></p>"
        },
        {
          "id": 190404,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Pungent</span></span></span></p>"
        },
        {
          "id": 190405,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Putrid</span></span></span></p>"
        },
        {
          "id": 190406,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Offensive</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A forensic expert is examining a body found in an ancient tomb (located in a very hot and dry place) that is remarkably preserved. Considering the state of preservation, which characteristic best describes the odor of the body? </span></span></p>",
      "unique_key": "Q9692148",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans.&nbsp;</span></strong><strong><span style=\"font-size:14.0pt\">A) Odorless</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">A preserved body in hot and dry environment is likely to be due to mummification.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">&nbsp;A mummified body is typically odorless because the process of mummification involves dehydration or drying out of tissues, which prevents the typical decay processes that cause odors. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This lack of moisture inhibits bacterial growth, which is responsible for the generation of foul smells in decomposing bodies.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span><br />\r\n&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Pungent</span></strong><span style=\"font-size:14.0pt\">: Incorrect because pungent smells are usually strong and sharp, associated with chemical reactions, not typical of dry, mummified remains.</span></span></span><br />\r\n&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Putrid</span></strong><span style=\"font-size:14.0pt\">: Incorrect as putrid smells are associated with the decomposition of organic matter under moist conditions, which does not apply to mummified bodies.</span></span></span><br />\r\n&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Offensive:</span></strong><span style=\"font-size:14.0pt\"> Incorrect since offensive odors generally arise from decaying tissue in the presence of moisture, which is not a condition found in mummification.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mummified bodies are odorless due to the absence of moisture and bacterial activity, contrasting with the odors associated with different stages of body decomposition under more typical environmental conditions.</span></span></p>",
      "correct_choice_id": 190403,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        10
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47796,
      "choices": [
        {
          "id": 190787,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Remifentanil</span></span></span></p>"
        },
        {
          "id": 190788,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Propofol</span></span></span></p>"
        },
        {
          "id": 190789,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Fentanyl</span></span></span></p>"
        },
        {
          "id": 190790,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Remimazolam</span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of these is a common opioid used in TIVA due to its short duration of action?</span></span></p>",
      "unique_key": "Q2580150",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Ans. A) Remifentanil</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Remifentanil is a potent, ultra-short-acting opioid commonly used in Total Intravenous Anesthesia (TIVA) due to its rapid onset and quick offset, allowing for precise control over sedation levels.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Propofol: </span></strong><span style=\"font-size:14.0pt\">&nbsp;Propofol is a short-acting sedative-hypnotic agent used for induction and maintenance of anesthesia, but it is not an opioid. It provides rapid onset and recovery but lacks analgesic properties.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Fentanyl:</span></strong><span style=\"font-size:14.0pt\"> Fentanyl is a potent opioid used in anesthesia and pain management. It has a relatively longer duration of action compared to remifentanil, making it less ideal for TIVA where rapid titration is needed.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Remimazolam:&nbsp;</span></strong><span style=\"font-size:14.0pt\">Remimazolam is a benzodiazepine used for sedation and procedural anesthesia, not an opioid. It offers quick onset and recovery but lacks the analgesic effects provided by opioids.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Remifentanil is the opioid of choice for TIVA due to its ultra-short duration of action, enabling fine-tuned control over anesthesia depth and rapid recovery post-procedure.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 190787,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        19
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47715,
      "choices": [
        {
          "id": 190471,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Contraction of right atrium</span></span></span></p>"
        },
        {
          "id": 190472,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Passive filling of right atrium</span></span></span></p>"
        },
        {
          "id": 190473,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tricuspid bulge into right atrium </span></span></p>"
        },
        {
          "id": 190474,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Passive emptying of right atrium</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 58-year-old man with a history of congestive heart failure presents with worsening dyspnea and lower extremity edema. On physical examination, his jugular venous pressure (JVP) is elevated, and you observe a prominent &#39;c&#39; wave. What does the &#39;c&#39; wave of the JVP represent? </span></span></p>",
      "unique_key": "Q3309430",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. C) Tricuspid bulge into right atrium </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The &#39;c&#39; wave of the jugular venous pulse (JVP) corresponds to the bulging of the tricuspid valve into the right atrium during isovolumetric ventricular contraction. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">During this phase of the cardiac cycle, the right ventricle contracts while all the heart valves are closed, leading to an increase in intraventricular pressure. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This pressure causes the tricuspid valve to bulge slightly into the right atrium, creating the &#39;c&#39; wave observed in the JVP. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The &#39;c&#39; wave is a transient event and is part of the complex waveform seen in jugular venous pressure tracing.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/06/screenshot-2024-06-06-150430.png\" style=\"height:551px; width:700px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Option A.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>Contraction of right atrium:</strong> This event is represented by the &#39;a&#39; wave of the JVP, which occurs just before the &#39;c&#39; wave. The &#39;a&#39; wave reflects atrial contraction, leading to a brief increase in atrial pressure.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Option B.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>Passive filling of right atrium:</strong> This occurs during ventricular systole when the tricuspid valve is closed and venous blood returns to the right atrium, creating the &#39;v&#39; wave. It is not related to the &#39;c&#39; wave.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Option D.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>Passive emptying of right atrium:</strong> This occurs when the tricuspid valve opens during ventricular diastole, allowing blood to flow passively from the right atrium to the right ventricle. This phase is represented by the &#39;y&#39; descent in the JVP and is not related to the &#39;c&#39; wave.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The &#39;c&#39; wave of the jugular venous pulse (JVP) represents the bulging of the tricuspid valve into the right atrium during isovolumetric ventricular contraction.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/06/screenshot-2024-06-06-150549.png\" style=\"height:217px; width:700px\" /></span></span></span></p>",
      "correct_choice_id": 190473,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        2
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47478,
      "choices": [
        {
          "id": 189523,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Trigeminal nerve</span></span></span></p>"
        },
        {
          "id": 189524,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Glossopharyngeal nerve</span></span></span></p>"
        },
        {
          "id": 189525,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:14.0pt\">Facial nerve</span></span></span></p>"
        },
        {
          "id": 189526,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:14.0pt\">Vagal nerve</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 32-year-old woman presents with a complaint of facial muscle weakness on one side of her face. She has a history of recurrent ear infections and mild hearing loss. On examination, you note paralysis of the muscles of facial expression on the affected side. Which of the following nerves, associated with the second pharyngeal (branchial) arch, is most likely involved in this patient&rsquo;s condition? </span></span></p>",
      "unique_key": "Q2486011",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. C) Facial nerve</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">The second pharyngeal arch, also known as the hyoid arch, gives rise to several structures in the head and neck. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">One of the key components derived from the second pharyngeal arch is the facial nerve (cranial nerve VII). </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">The facial nerve is responsible for innervating the muscles of facial expression, the stapedius muscle in the middle ear, and providing taste sensation to the anterior two-thirds of the tongue. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Additionally, the second pharyngeal arch contributes to the formation of the stapes bone in the middle ear, the styloid process, and part of the hyoid bone.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/05/screenshot-2024-06-05-115310.png\" style=\"height:299px; width:500px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Trigeminal nerve</span></strong><span style=\"font-size:14.0pt\">: The trigeminal nerve (cranial nerve V) is associated with the first pharyngeal arch. It innervates the muscles of mastication and provides sensory innervation to the face, oral cavity, and nasal cavity.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Glossopharyngeal nerve</span></strong><span style=\"font-size:14.0pt\">: The glossopharyngeal nerve (cranial nerve IX) is associated with the third pharyngeal arch, not the second. It provides motor innervation to the stylopharyngeus muscle and sensory innervation to the posterior third of the tongue and the pharynx.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Vagal nerve</span></strong><span style=\"font-size:14.0pt\">: The vagus nerve (cranial nerve X) is associated with the fourth and sixth pharyngeal arches. It provides extensive innervation to structures in the neck, thorax, and abdomen, including the laryngeal muscles and the muscles involved in swallowing and phonation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">The facial nerve (cranial nerve VII) is derived from the second pharyngeal arch and is responsible for innervating the muscles of facial expression, as well as providing taste sensation to the anterior two-thirds of the tongue.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 189525,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        3
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47730,
      "choices": [
        {
          "id": 190531,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">600 INR to ASHA and 1000 INR to mother in rural areas in high performing states</span></span></span></p>"
        },
        {
          "id": 190532,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">600 INR to ASHA and 1400 INR to mother in rural areas in low performing states</span></span></span></p>"
        },
        {
          "id": 190533,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">400 INR to ASHA and 1000 INR to mother in urban areas in high performing states</span></span></span></p>"
        },
        {
          "id": 190534,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">400 INR to ASHA and 600 INR to mother in urban areas in low performing states</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In the context of the Janani Suraksha Yojana, a program aimed at enhancing maternal health services in India, which of the following statements correctly describes the incentive distribution between ASHA workers and mothers?</span></span></p>",
      "unique_key": "Q6182738",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans.</span></strong><span style=\"font-size:14.0pt\"> <strong>B) 600 INR to ASHA and 1400 INR to mother in rural areas in low performing states</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">This is correct.</span></strong><span style=\"font-size:14.0pt\"> Under the Janani Suraksha Yojana, ASHA workers in rural areas of low performing states receive an incentive of 600 INR, and the mothers receive 1400 INR. This incentive structure is designed to encourage the use of health services for childbirth in regions that require significant improvements in maternal and infant health outcomes.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Janani Suraksha Yojana Incentives&nbsp; </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/06/screenshot-2024-06-06-153100.png\" style=\"height:280px; width:1000px\" /></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">(LPS: Low performing states; HPS: High performing states)</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">(LPS include UP, Uttarakhand, MP, Jharkhand, Bihar, Chhattisgarh, Odisha, Assam, Jammu &amp; Kashmir, Rajasthan)</span></span></span></p>",
      "correct_choice_id": 190532,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47802,
      "choices": [
        {
          "id": 190811,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Hyper IgM syndrome</span></span></span></p>"
        },
        {
          "id": 190812,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Wiskott-Aldrich syndrome</span></span></span></p>"
        },
        {
          "id": 190813,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Hyper IgE syndrome</span></span></span></p>"
        },
        {
          "id": 190814,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Carcinoid syndrome</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 10-year-old girl is brought to the pediatric clinic by her guardian because of recurrent skin lesions and frequent episodes of bronchitis. The girl has been suffering from these issues since she was very young. During the examination, the physician notices several eczematous patches on her skin and a few healed abscesses. She also reports experiencing itching and discomfort due to the skin condition. Given the patient&#39;s history, what is the most likely diagnosis? </span></span></p>",
      "unique_key": "Q3785897",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. C) Hyper IgE syndrome</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Job&rsquo;s syndrome or Hyper-IgE syndrome: Rare, characterized by eczema, recurrent staphylococcal skin abscesses, recurrent lung infections (pneumatocele), eosinophilia and high serum levels of IgE.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/07/screenshot-2024-06-07-100508.png\" style=\"height:276px; width:400px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Mechanism: Due to a defect in neutrophil chemotaxis. Most cases are sporadic, but some familial cases have also been reported which may be:</span></span></span></li>\r\n</ul>\r\n\r\n<ul style=\"list-style-type:circle\">\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Autosomal dominant cases: Linked to mutations in the STAT3 gene</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Autosomal recessive cases: Due to mutations in DOCK8 gene.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Hyper IgM syndrome:</span></strong><span style=\"font-size:14.0pt\"> This condition involves high levels of IgM with low levels of other immunoglobulins and lacks the typical skin manifestations and elevated IgE seen in Hyper IgE syndrome.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Wiskott-Aldrich syndrome:</span></strong><span style=\"font-size:14.0pt\"> Characterized by eczema, thrombocytopenia, and immunodeficiency. While it shares some symptoms with Hyper IgE syndrome, it does not typically present with high levels of IgE.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Carcinoid syndrome:</span></strong><span style=\"font-size:14.0pt\"> Primarily involves symptoms related to hormone secretion by carcinoid tumors, such as flushing and diarrhea, which are not observed in this patient.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">In cases presenting with eczema, recurrent bacterial infections, and elevated levels of IgE and eosinophils, consider Hyper IgE syndrome as a differential diagnosis. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Early diagnosis and management are crucial for preventing severe complications associated with infections and for improving the quality of life.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 190813,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        6
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47587,
      "choices": [
        {
          "id": 189959,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Preterm labor</span></span></span></p>"
        },
        {
          "id": 189960,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Menorrhagia</span></span></span></p>"
        },
        {
          "id": 189961,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Transverse lie</span></span></span></p>"
        },
        {
          "id": 189962,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Abortion</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 28-year-old woman is diagnosed with uterus didelphys during a routine pelvic examination. Which of the following is NOT likely to be a complication of this uterine anomaly?</span></span></p>",
      "unique_key": "Q7315118",
      "difficulty_level": "difficult",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. B) Menorrhagia</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Uterus didelphys is a congenital uterine anomaly where there is a complete duplication of the uterus, cervix, and sometimes the vagina. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This anomaly can lead to several complications related to pregnancy and childbirth due to the abnormal uterine structure.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Option A.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>Preterm labor:</strong> Women with uterus didelphys are at increased risk of preterm labor due to the limited space for fetal growth and potential cervical incompetence.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Option C.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>Transverse lie:</strong> The abnormal shape and division of the uterus can prevent the fetus from aligning correctly for vaginal delivery, leading to malpresentations like transverse lie.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Option D.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>Abortion:</strong> The structural abnormalities of the uterus can interfere with normal implantation and pregnancy maintenance, increasing the risk of spontaneous abortion.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Menorrhagia (heavy menstrual bleeding) is not typically associated with uterus didelphys, which is more likely to cause complications related to pregnancy and fetal positioning rather than menstrual abnormalities.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 189960,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47713,
      "choices": [
        {
          "id": 190463,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">6-Mercaptopurine</span></span></span></p>"
        },
        {
          "id": 190464,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Mitomycin</span></span></span></p>"
        },
        {
          "id": 190465,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Actinomycin</span></span></span></p>"
        },
        {
          "id": 190466,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Asparaginase</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A clinical oncologist is considering various chemotherapeutic agents for a patient diagnosed with acute lymphoblastic leukaemia. Which of the following drugs is known to specifically inhibit DNA synthesis, impacting the proliferation of cancer cells? </span></span></p>",
      "unique_key": "Q1759350",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans.&nbsp;</span></strong><strong><span style=\"font-size:14.0pt\">A) 6-Mercaptopurine</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">6-Mercaptopurine</span></strong><span style=\"font-size:14.0pt\"> is a purine analog that inhibits DNA synthesis by interfering with purine nucleotide biosynthesis. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">It is particularly effective during the S phase of the cell cycle, where DNA synthesis occurs, making it a critical agent in the treatment of certain leukemias.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Mitomycin</span></strong><span style=\"font-size:14.0pt\">: This drug functions as an alkylating agent, leading to DNA damage through cross-linking of DNA strands, which is different from direct inhibition of DNA synthesis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Actinomycin</span></strong><span style=\"font-size:14.0pt\">: Known also as dactinomycin, this drug binds to DNA and inhibits RNA polymerase, which affects RNA synthesis more directly, though it can cause DNA damage by creating single-strand breaks.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Asparaginase</span></strong><span style=\"font-size:14.0pt\">: Works by depleting asparagine, an amino acid necessary for protein synthesis in certain cancer cells, thus indirectly affecting cell growth and survival without directly inhibiting DNA synthesis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">6-Mercaptopurine is a critical drug in the management of certain types of leukaemia due to its specific mechanism of inhibiting DNA synthesis, making it essential in protocols designed to control rapid cell proliferation associated with cancer.</span></span></li>\r\n</ul>",
      "correct_choice_id": 190463,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47826,
      "choices": [
        {
          "id": 190903,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Refractive esotropia; fully correctable by use of spectacles</span></span></span></p>"
        },
        {
          "id": 190904,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Non-refractive esotropia; fully corrected by adding +3 DS for near vision</span></span></span></p>"
        },
        {
          "id": 190905,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Mixed esotropia; esotropia for distance corrected by hypermetropia correction and residual esotropia for near corrected by +3 DS lens</span></span></span></p>"
        },
        {
          "id": 190906,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Refractive esotropia; fully correctable by surgery</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 4-year-old child presents with esotropia that is more pronounced when looking at near objects than when looking at distant objects. The child has no significant refractive error. Which of the following is the most likely diagnosis and appropriate treatment?</span></span></p>",
      "unique_key": "Q3254555",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. B) Non-refractive esotropia; fully corrected by adding +3 DS for near vision</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Non-refractive esotropia is caused by an abnormally high accommodative convergence/accommodation (AC/A) ratio and may occur even in patients with no refractive error. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">It is characterized by greater esotropia for near than for distance (with minimal or no deviation for distance). </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">This condition is fully corrected by adding +3 DS for near vision, which matches the patient&#39;s presentation.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Refractive esotropia; fully correctable by use of spectacles:</span></strong><span style=\"font-size:14.0pt\"> Refractive esotropia develops at the age of 2 to 3 years and is associated with high hypermetropia (+4 to +7 D). It affects both near and distance vision and is fully correctable by the use of spectacles.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Mixed esotropia; esotropia for distance corrected by hypermetropia correction and residual esotropia for near corrected by +3 DS lens:</span></strong><span style=\"font-size:14.0pt\"> Mixed esotropia is caused by a combination of hypermetropia and a high AC/A ratio. Esotropia for distance is corrected by the correction of hypermetropia, and the residual esotropia for near is corrected by an additional +3 DS lens. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Refractive esotropia; fully correctable by surgery:</span></strong><span style=\"font-size:14.0pt\"> Refractive esotropia is not typically treated with surgery but with spectacles. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">&nbsp;<strong>Educational Objective:</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Types of esotropia</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/07/screenshot-2024-06-07-104954.png\" style=\"height:1233px; width:1000px\" /></span></strong></span></span></p>",
      "correct_choice_id": 190904,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        8
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47743,
      "choices": [
        {
          "id": 190579,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Decreased Forced Vital Capacity (FVC)</span></span></span></p>"
        },
        {
          "id": 190580,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Decreased Forced Expiratory Volume in 1 second (FEV1)</span></span></span></p>"
        },
        {
          "id": 190581,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Normal/ Increased Total Lung Capacity (TLC)</span></span></span></p>"
        },
        {
          "id": 190582,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Decreased Residual Volume (RV)</span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">All of the following features are seen in Chronic Obstructive Pulmonary Disease (COPD) except:<strong> </strong></span></span></p>",
      "unique_key": "Q1720884",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Ans. </span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">D) Decreased Residual Volume (RV)</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">This is incorrect for COPD. Residual Volume is typically increased, not decreased, in COPD due to air trapping.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Option A. Decreased Forced Vital Capacity (FVC):</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"> In COPD, there is a reduction in FVC due to the obstruction of airflow, which makes it difficult to completely expel air from the lungs.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Option B. Decreased Forced Expiratory Volume in 1 second (FEV1):</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"> FEV1 is significantly reduced in COPD due to the narrowed airways, which slow down the flow of air out of the lungs.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Option C. Normal/ Increased Total Lung Capacity (TLC):</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"> In COPD, TLC can be normal or increased due to hyperinflation of the lungs. This occurs because of air trapping in the alveoli.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">In COPD, pulmonary function tests typically show decreased FVC, decreased FEV1, a reduced FEV1/FVC ratio, increased Residual Volume (RV), and normal or increased Total Lung Capacity (TLC) due to air trapping and hyperinflation. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Understanding these characteristic changes helps in diagnosing and differentiating COPD from restrictive lung diseases.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 190582,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47683,
      "choices": [
        {
          "id": 190343,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Decreased FVC, Decreased FEV1/FVC</span></span></span></p>"
        },
        {
          "id": 190344,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Increased FVC, Increased FEV1/FVC</span></span></span></p>"
        },
        {
          "id": 190345,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Decreased FVC, increased FEV1/FVC</span></span></span></p>"
        },
        {
          "id": 190346,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Increased FVC, Normal FEV1/FVC</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 60-year-old man presents to the pulmonology clinic with complaints of a persistent dry cough, progressive shortness of breath, and recent unintentional weight loss. He reports a history of working in construction and significant exposure to dust and other environmental pollutants. A thorough workup, including imaging and lung biopsy, confirms the diagnosis of pulmonary fibrosis. Which of the following pulmonary function test findings is most likely to be observed in this patient?</span></span></p>",
      "unique_key": "Q8808633",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. </span></strong><strong><span style=\"font-size:14.0pt\">C) Decreased FVC, increased FEV1/FVC</span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Pulmonary fibrosis is a restrictive lung disease characterized by scarring and stiffening of the lung tissue, which restricts lung expansion and reduces lung volumes. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This condition typically leads to a decrease in both forced vital capacity (FVC) and forced expiratory volume in one second (FEV1). </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">However, because FVC decreases more significantly than FEV1, the FEV1/FVC ratio is often increased or remains normal in restrictive lung diseases.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The forced expiratory volume in one second (FEV1) is also typically reduced in restrictive lung disease, but the reduction is proportional to the decrease in FVC, resulting in a normal or increased FEV1/FVC ratio. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This distinguishes restrictive lung diseases like pulmonary fibrosis from obstructive lung diseases, where the FEV1/FVC ratio is decreased due to a disproportionate reduction in FEV1.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/06/screenshot-2024-06-06-130558.png\" style=\"height:365px; width:1000px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A.</span></strong><span style=\"font-size:14.0pt\"> <strong>Decreased FVC, Decreased FEV1/FVC:</strong> This pattern is characteristic of obstructive lung diseases, such as chronic obstructive pulmonary disease (COPD), where the airflow limitation leads to a reduced FEV1/FVC ratio. It is not seen in restrictive lung diseases like pulmonary fibrosis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B.</span></strong><span style=\"font-size:14.0pt\"> <strong>Increased FVC, Increased FEV1/FVC:</strong> This finding is inconsistent with pulmonary fibrosis, as it suggests an improvement in lung volumes and function, which does not occur in restrictive lung diseases.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D.</span></strong><span style=\"font-size:14.0pt\"> <strong>Increased FVC, Normal FEV1/FVC:</strong> This pattern is also incorrect for pulmonary fibrosis because restrictive lung diseases result in decreased, not increased, FVC.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">In pulmonary fibrosis, pulmonary function tests typically show decreased FVC and an increased or normal FEV1/FVC ratio, reflecting the restrictive nature of the disease.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 190345,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        2
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47762,
      "choices": [
        {
          "id": 190655,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Congestive heart failure</span></span></span></p>"
        },
        {
          "id": 190656,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Hypertension</span></span></span></p>"
        },
        {
          "id": 190657,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">History of stroke</span></span></span></p>"
        },
        {
          "id": 190658,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Age &gt; 60 years</span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is NOT a part of the CHADS2-Vasc score?</span></span></p>",
      "unique_key": "Q7378342",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Ans.&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">D) Age &gt; 60 years</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">The CHADS2-Vasc score is a clinical prediction rule for estimating the risk of stroke in patients with atrial fibrillation. The components of the CHADS2-Vasc score include:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Congestive heart failure (C)</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"> - 1 point</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Hypertension (H)</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"> - 1 point</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Age &ge; 75 years (A)</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"> - 2 points</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Diabetes mellitus (D)</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"> - 1 point</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Stroke or transient ischemic attack (S2)</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"> - 2 points</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Vascular disease (V)</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"> - 1 point</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Age 65-74 years (A)</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"> - 1 point</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Sex category (female gender) (Sc)</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"> - 1 point</span></span></span></li>\r\n</ol>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Age &gt; 60 years is not a part of the CHADS2-Vasc score.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Option A.</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"> <strong>Congestive heart failure</strong>: Congestive heart failure is part of the CHADS2-Vasc score and is assigned 1 point.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Option B.</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"> <strong>Hypertension</strong>: Hypertension is included in the CHADS2-Vasc score and is assigned 1 point.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Option C.</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"> <strong>History of stroke</strong>: A history of stroke or transient ischemic attack is included in the CHADS2-Vasc score and is assigned 2 points.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">The CHADS2-Vasc score includes Congestive heart failure, Hypertension, Age &ge; 75 years, Diabetes mellitus, Stroke or transient ischemic attack, Vascular disease, Age 65-74 years, and Female gender. </span></span></span></li>\r\n\t<li><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Age &gt; 60 years is not included in this scoring system.</span></span></li>\r\n</ul>",
      "correct_choice_id": 190658,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47818,
      "choices": [
        {
          "id": 190871,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Serratus anterior</span></span></span></p>"
        },
        {
          "id": 190872,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Pectoralis major</span></span></span></p>"
        },
        {
          "id": 190873,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Latissimus dorsi </span></span></span></p>"
        },
        {
          "id": 190874,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">5th Intercostal space</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is not a boundary of the &lsquo;triangle of safety&rsquo; for chest tube insertion?</span></span></p>",
      "unique_key": "Q5041510",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. A) Serratus anterior</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The boundaries of the &lsquo;triangle of safety&rsquo; are as follows-</span></span></span></li>\r\n</ul>\r\n\r\n<ul style=\"list-style-type:circle\">\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Posteriorly- latissimus dorsi</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Anteriorly- lateral border of pectoralis major</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Inferiorly - 5th Intercostal space</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/07/screenshot-2024-06-07-103848.png\" style=\"height:236px; width:400px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Fig: Triangle of safety for Chest Tube placement</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The &quot;triangle of safety&quot; is a guideline used in medical procedures to locate a safe area for chest interventions like needle thoracostomy, bordered by the lateral edge of the pectoralis major, the lateral edge of the latissimus dorsi, and a horizontal line at the level of the nipple.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 190871,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        12
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47837,
      "choices": [
        {
          "id": 190947,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">ELISA</span></span></span></p>"
        },
        {
          "id": 190948,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Immunochromatography</span></span></span></p>"
        },
        {
          "id": 190949,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Immunofluorescence</span></span></span></p>"
        },
        {
          "id": 190950,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Chemiluminescence</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A research team is conducting a field study to assess the prevalence of hepatitis B in a remote rural area. The team uses the HBsAg test kit depicted in the image, appreciating its quick turnaround time and ease of use for immediate results. </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/07/screenshot-2024-06-07-111708.png\" style=\"height:183px; width:600px\" /></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">What is the principle of operation of the HBsAg test kit used in the field study? </span></span>â€‹â€‹â€‹â€‹â€‹â€‹â€‹</p>",
      "unique_key": "Q8360993",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans.&nbsp;</span></strong><span style=\"font-size:14.0pt\"><strong>B) Immunochromatography</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The HBsAg test kit functions on the principle of immunochromatography. This method is particularly suited for field applications due to its simplicity and rapid provision of results. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The test involves the capillary action of a fluid sample through a membrane strip that contains immobilized antibodies specific to the hepatitis B surface antigen. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">If HBsAg is present in the sample, it binds to these antibodies and a colored line appears, indicating a positive result. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This direct and visual confirmation is ideal for studies in remote locations where laboratory access is limited. The test also includes a control line to ensure the test is functioning correctly.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. ELISA:</span></strong><span style=\"font-size:14.0pt\"> Requires more sophisticated laboratory equipment and procedures, making it less ideal for rapid, field-based testing.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Immunofluorescence:</span></strong><span style=\"font-size:14.0pt\"> Involves the use of fluorescent dyes and a fluorescence microscope, which are not practical for field settings due to their complexity and equipment requirements.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Chemiluminescence:</span></strong><span style=\"font-size:14.0pt\"> Also requires specialized equipment for detecting light emissions, which is impractical in a field setting without proper laboratory facilities.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Immunochromatography is an excellent choice for rapid diagnostic tests in field research due to its ease of use, rapid turnaround, and minimal equipment requirements, making it invaluable for assessing disease prevalence in remote or resource-limited settings.</span></span></li>\r\n</ul>",
      "correct_choice_id": 190948,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        6
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47658,
      "choices": [
        {
          "id": 190243,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Basilic Vein</span></span></span></p>"
        },
        {
          "id": 190244,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Axillary Artery</span></span></span></p>"
        },
        {
          "id": 190245,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Cephalic Vein</span></span></span></p>"
        },
        {
          "id": 190246,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Radial Nerve</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 48-year-old male presents to the clinic concerned about a prominent structure on his right shoulder that becomes more noticeable during exercise or when lifting heavy objects. He denies any pain, redness, or swelling, and there is no history of trauma. On physical examination, a prominent, non-pulsatile linear structure is noted running along the deltopectoral groove. Which of the following structures is found in this area?</span></span></p>",
      "unique_key": "Q2786565",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. </span></strong><strong><span style=\"font-size:14.0pt\">C) Cephalic Vein</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">The cephalic vein is a superficial vein located in the upper limb, running along the deltopectoral groove between the deltoid and pectoralis major muscles. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">It becomes more prominent during activities that increase venous return, such as exercise or heavy lifting. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">The absence of symptoms like pain, redness, or swelling and its anatomical location supports the identification of this structure as the cephalic vein.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/06/screenshot-2024-06-06-123240.png\" style=\"height:181px; width:300px\" /></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Basilic Vein: Incorrect. </span></strong><span style=\"font-size:14.0pt\">The basilic vein runs along the medial aspect of the arm and does not pass through the deltopectoral groove, making it an unlikely candidate for the described presentation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Axillary Artery: Incorrect. </span></strong><span style=\"font-size:14.0pt\">The axillary artery is a deep structure that lies beneath the pectoralis major muscle and is not visible as a superficial vein in the deltopectoral groove.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Radial Nerve: Incorrect. </span></strong><span style=\"font-size:14.0pt\">The radial nerve is a deep structure that runs along the posterior aspect of the arm and does not traverse the deltopectoral groove.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">The cephalic vein is a prominent superficial vein visible in the deltopectoral groove, particularly noticeable during physical exertion or in individuals with low subcutaneous fat.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 190245,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        3
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47700,
      "choices": [
        {
          "id": 190411,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Wuchereria bancrofti</span></span></span></p>"
        },
        {
          "id": 190412,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Brugia malayi</span></span></span></p>"
        },
        {
          "id": 190413,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Loa loa</span></span></span></p>"
        },
        {
          "id": 190414,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Onchocerca volvulus</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 35-year-old male, recently returned from a trip to Southeast Asia, presents to the clinic with complaints of intermittent fever and localized swelling in his lower limbs. Blood samples are collected during the night to evaluate for possible parasitic infections, given his travel history and symptoms. Microscopic examination reveals microfilariae with a sheathed tail and two distinct nuclei at the tail tip. Which of the following species of microfilariae is suggested in the microscopic examination? </span></span></p>",
      "unique_key": "Q5246165",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. B) Brugia malayi</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Brugia malayi is a nematode that causes lymphatic filariasis and is characterized by microfilariae with a sheathed tail that contains two distinct nuclei at the tip&mdash;one terminal and one subterminal. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This structural feature distinguishes B. malayi from other filarial worms. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The organism exhibits a nocturnal periodicity, where microfilariae are present in peripheral blood mainly at night. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The sheathed nature of the microfilariae indicates that they retain their egg membranes.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Wuchereria bancrofti:</span></strong><span style=\"font-size:14.0pt\"> This microfilaria also exhibits a sheathed appearance but differs in that its tail tip has no nuclei and ends in a pointed tail.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Loa loa:</span></strong><span style=\"font-size:14.0pt\"> Exhibits a sheathed microfilaria with a column of nuclei extending into the blunt tail tip, not just two nuclei.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Onchocerca volvulus:</span></strong><span style=\"font-size:14.0pt\"> Identified by unsheathed microfilariae with a pointed tail tip that contains no nuclei, commonly found in the skin and eyes rather than blood.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Comparison of microfilariae of 3 important filarial worms </span></span></strong></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/06/screenshot-2024-06-06-134955.png\" style=\"height:497px; width:1000px\" /></span></span></strong></p>",
      "correct_choice_id": 190412,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        6
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47806,
      "choices": [
        {
          "id": 190827,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Quinolones</span></span></span></p>"
        },
        {
          "id": 190828,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Macrolides</span></span></span></p>"
        },
        {
          "id": 190829,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Beta-lactams</span></span></span></p>"
        },
        {
          "id": 190830,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Oxazolidinones</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Among the following options, which antimicrobial class is known for exhibiting a long post-antibiotic effect?</span></span></p>",
      "unique_key": "Q6493131",
      "difficulty_level": "difficult",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. </span></strong><strong><span style=\"font-size:14.0pt\">A) Quinolones</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Quinolones</span></strong><span style=\"font-size:14.0pt\">, such as ciprofloxacin and levofloxacin, are well known for their significant post-antibiotic effect (PAE). </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This effect refers to the persistent suppression of bacterial growth after the antibiotic levels have fallen below the minimum inhibitory concentration (MIC). </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The PAE of quinolones is attributed to their mechanism of action, which involves inhibiting DNA gyrase and topoisomerase IV, enzymes critical for bacterial DNA replication and cell division. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This mechanism leads to sustained effects on bacterial replication even after the drug is no longer present at active concentrations.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Macrolides</span></strong><span style=\"font-size:14.0pt\">: While macrolides do have a post-antibiotic effect, it is generally less pronounced than that observed with quinolones.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Beta-lactams</span></strong><span style=\"font-size:14.0pt\">: These antibiotics, including penicillins and cephalosporins, typically have a shorter PAE, especially against Gram-negative bacteria.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Oxazolidinones</span></strong><span style=\"font-size:14.0pt\">: This class, including linezolid, also has a post-antibiotic effect, but it is not as long as that seen with quinolones.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Quinolones are notable for their long post-antibiotic effect, which can be particularly beneficial in treatment strategies that aim to reduce the frequency of dosing while maintaining effective bacterial suppression. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This characteristic is crucial for designing dosing regimens and understanding the clinical implications of antibiotic therapy.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 190827,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47836,
      "choices": [
        {
          "id": 190943,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Decision making</span></span></span></p>"
        },
        {
          "id": 190944,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Systems analysis</span></span></span></p>"
        },
        {
          "id": 190945,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Network analysis</span></span></span></p>"
        },
        {
          "id": 190946,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Management by objective</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dr. Kapil, a healthcare administrator, is exploring various management strategies to enhance team performance and patient care in his hospital. He is particularly interested in incorporating a method that leverages behavioral sciences to motivate staff and align their personal goals with organizational objectives. Which management technique should Dr. Kapil implement to achieve this integration? </span></span></p>",
      "unique_key": "Q8317296",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans.&nbsp;</span></strong><strong><span style=\"font-size:14.0pt\">D) Management by objective</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This<strong> </strong></span><span style=\"font-size:14.0pt\">is correct. Management by Objective (MBO) is a strategic management model that relies heavily on the principles of behavioral sciences. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Developed by Peter Drucker in the 1950s, MBO involves setting specific measurable goals with each employee and then periodically reviewing the progress made. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The technique&#39;s effectiveness is rooted in its focus on aligning employees&#39; personal achievements with organizational goals, thereby fostering a participatory environment and enhancing motivation through clear, agreed-upon objectives.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Option A.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>Decision making:</strong><strong> Incorrect.</strong> While decision-making is a crucial aspect of management, it does not inherently rely on behavioral sciences as much as MBO. Decision making typically involves choosing between alternatives and does not necessarily focus on goal alignment or behavioral motivations.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Option B.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>Systems analysis:</strong> <strong>Incorrect.</strong> Systems analysis is more quantitative and focuses on the technical and procedural aspects of organizational operations, rather than on behavioral aspects and personal goal setting.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Option C.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>Network analysis:</strong> <strong>Incorrect.</strong> Network analysis deals with understanding relationships and flows between parts of a network, which can be used in organizational settings but does not specifically focus on behavioral science principles or individual goal alignment.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/07/screenshot-2024-06-07-111542.png\" style=\"height:592px; width:1000px\" /></span></strong></span></span></p>",
      "correct_choice_id": 190946,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47589,
      "choices": [
        {
          "id": 189967,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">1-e, 2-b, 3-d, 4-a, 5-c </span></span></span></p>"
        },
        {
          "id": 189968,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">1-c, 2-e, 3-a, 4-d, 5-b </span></span></span></p>"
        },
        {
          "id": 189969,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">1-b, 2-d, 3-e, 4-c, 5-a </span></span></span></p>"
        },
        {
          "id": 189970,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">1-a, 2-c, 3-b, 4-e, 5-d</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Accurately identify the specific toxins produced by various adulterants mentioned below.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Adulterants:</span></strong></span></span></p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Khesari Dal (Lathyrus sativus)</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Argemone mexicana (oil)</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Crotolaria seeds (Jhunjhunia)</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Aspergillus flavus/parasiticus</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Claviceps fusiformis</span></span></span><br />\r\n\t&nbsp;</li>\r\n</ol>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Toxins:</span></strong> </span></span></p>\r\n\r\n<ol style=\"list-style-type:lower-alpha\">\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Aflatoxin </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Sanguinarine </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Clavine alkaloids </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Pyrrolizidine alkaloids </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:14.0pt\">BOAA (Beta-N-Oxalyl-L-alpha,beta-diaminopropionic acid)</span></span></span></li>\r\n</ol>",
      "unique_key": "Q4454618",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. A) 1-e, 2-b, 3-d, 4-a, 5-c</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Khesari Dal (Lathyrus sativus)&nbsp;</span></strong><span style=\"font-size:14.0pt\">is known to contain <strong>BOAA (Beta-N-Oxalyl-L-alpha,beta-diaminopropionic acid)</strong>, a neurotoxin that can cause irreversible neurological disorders, known as neurolathyrism.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Argemone mexicana (oil)&nbsp;</span></strong><span style=\"font-size:14.0pt\">is contaminated with <strong>Sanguinarine</strong>, a toxic alkaloid that leads to epidemic dropsy, characterized by severe edema and cardiovascular complications.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Crotolaria seeds (Jhunjhunia)&nbsp;</span></strong><span style=\"font-size:14.0pt\">are a source of <strong>Pyrrolizidine alkaloids</strong>, which are hepatotoxic and can lead to hepatic veno-occlusive disease, potentially causing severe liver damage.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Aspergillus flavus/parasiticus</span></strong><span style=\"font-size:14.0pt\">, a fungus, produces <strong>Aflatoxin</strong>, one of the most potent natural carcinogens known, primarily affecting the liver and leading to liver cancer.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Claviceps fusiformis</span></strong><span style=\"font-size:14.0pt\">, a fungus that affects rye and other cereals, produces <strong>Clavine alkaloids</strong>, which are associated with ergotism that can cause severe vasoconstriction leading to gangrene.</span></span></span></li>\r\n</ol>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Food Adulteration Diseases</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/05/screenshot-2024-06-05-160112.JPG\" style=\"height:581px; width:1000px\" /></span></strong></span></span></p>",
      "correct_choice_id": 189967,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47662,
      "choices": [
        {
          "id": 190259,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Trichothiodystrophy</span></span></span></p>"
        },
        {
          "id": 190260,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Netherton syndrome</span></span></span></p>"
        },
        {
          "id": 190261,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Lamellar ichthyosis</span></span></span></p>"
        },
        {
          "id": 190262,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Atopic dermatitis</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A two-year-old boy was referred to the dermatology outpatient department (OPD) with lesions resistant to atopic dermatitis therapy. Parents reported that he received treatment for desquamative skin lesions. He had no family history of skin disorders. On physical examination, his skin on the abdomen, face, and extremities with classical hair disorders as shown in the below mentioned images. What is the diagnosis? </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/06/screenshot-2024-06-06-123817.png\" style=\"height:183px; width:300px\" /></span></span></p>",
      "unique_key": "Q8371589",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. B) Netherton syndrome</span></strong><span style=\"font-size:14.0pt\">.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Netherton syndrome is a rare autosomal recessive disorder characterized by a triad of symptoms: ichthyosis, hair shaft abnormalities (such as trichorrhexis invaginata, also known as &quot;bamboo hair&quot;), and atopic diathesis (including eczematous dermatitis, elevated IgE levels, and recurrent infections). The patient&#39;s symptoms of intractable pruritus, dry skin, eczematous lesions resistant to typical treatments, and the presence of distinctive hair abnormalities strongly suggest Netherton syndrome.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Trichothiodystrophy:</span></strong><span style=\"font-size:14.0pt\"> This condition involves brittle hair, intellectual disability, and ichthyosis but lacks the classical eczematous lesions and the specific hair abnormalities seen in Netherton syndrome.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Lamellar ichthyosis:</span></strong><span style=\"font-size:14.0pt\"> This condition presents with large, dark, plate-like scales over the entire body but does not typically include the eczematous dermatitis or the hair abnormalities associated with Netherton syndrome.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Atopic dermatitis:</span></strong><span style=\"font-size:14.0pt\"> While the boy has eczematous lesions, the presence of hair shaft abnormalities and the severity of symptoms make Netherton syndrome a more likely diagnosis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Netherton syndrome is characterized by the triad of ichthyosis, atopic diathesis, and hair shaft abnormalities (trichorrhexis invaginata). </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">It should be considered in children with severe eczema resistant to treatment, especially when hair abnormalities are present.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 190260,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        18
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47838,
      "choices": [
        {
          "id": 190951,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Chi-square test</span></span></span></p>"
        },
        {
          "id": 190952,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">T-test</span></span></span></p>"
        },
        {
          "id": 190953,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">ANOVA</span></span></span></p>"
        },
        {
          "id": 190954,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Pearson correlation</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dr. Radhika, a pediatrician and public health researcher, is conducting a study to assess the impact of different nutritional programs on the growth of school children in three distinct regions. She has collected height measurements from children in each region and plans to analyze the data to determine if there are statistically significant differences in average heights among the groups. Given this scenario, which statistical test should Dr. Radhika use to evaluate the differences in average heights among the three groups of school children? </span></span></p>",
      "unique_key": "Q1523429",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans.&nbsp;</span></strong><strong><span style=\"font-size:14.0pt\">C) ANOVA</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This<strong> </strong></span><span style=\"font-size:14.0pt\">is correct. One-way analysis of variance (ANOVA) is the appropriate statistical test to be use when comparing the average heights of school children across three different regions. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This test is designed to determine if there are any statistically significant differences between the means of three or more independent (unrelated) groups. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">ANOVA will allow her to assess whether the variations in nutritional programs across the regions have different impacts on the children&#39;s growth.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Option A.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>Chi-square test:</strong> <strong>Incorrect.</strong> The chi-square test is used for categorical data, such as frequency counts, and is not suitable for comparing means of continuous data like heights.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Option B.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>T-test:</strong> <strong>Incorrect.</strong> The T-test is generally used when comparing the means between two groups only, not suitable for three or more groups.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Option D.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>Pearson correlation: </strong><strong>Incorrect.</strong> The Pearson correlation is used to measure the strength of a linear association between two continuous variables.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">ANOVA test (F-test/F-ratio): Comparing <strong>means (+ SD)</strong> in more than two different group of individuals</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Chi-square test (&chi;<sup>2</sup> - test): Comparing <strong>percentage, proportions &amp; fractions</strong> in two or more different group of individuals</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Fischer&rsquo;s test: Is a variant of Chi-square test when sample size is &lt; 30</span></span></span></p>",
      "correct_choice_id": 190953,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47859,
      "choices": [
        {
          "id": 191031,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Anti-centromere antibodies</span></span></p>"
        },
        {
          "id": 191032,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Anti-histone antibodies</span></span></p>"
        },
        {
          "id": 191033,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Rheumatoid factor</span></span></p>"
        },
        {
          "id": 191034,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Anti-topoisomerase I antibodies (Anti-Scl-70)</span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 50-year-old woman presents with progressive skin thickening on her fingers extending to her trunk, accompanied by Raynaud&#39;s phenomenon and difficulty swallowing. She also complains of shortness of breath on exertion. High-resolution CT of the chest shows interstitial lung disease. Which of the following serological markers is most likely to be positive in this patient?<strong> </strong></span></span></p>",
      "unique_key": "Q3754777",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Ans.&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">D) Anti-topoisomerase I antibodies (Anti-Scl-70)</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Anti-topoisomerase I antibodies (Anti-Scl-70) are associated with diffuse cutaneous systemic sclerosis, which is characterized by widespread skin involvement and a higher likelihood of internal organ involvement, such as interstitial lung disease, as seen in this patient.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Other Options:</span></strong></span></span><br />\r\n&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><strong>Option A. Anti-centromere antibodies</strong> are more commonly associated with limited cutaneous systemic sclerosis, which primarily affects the hands and face.</span></span></span><br />\r\n&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><strong>Option B. Anti-histone antibodies</strong> are associated with drug-induced lupus and not specific to systemic sclerosis.</span></span></span><br />\r\n&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><strong>Option C. Rheumatoid factor</strong> can be positive in many autoimmune diseases, but it is not specifically associated with systemic sclerosis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Anti-topoisomerase I antibodies (Anti-Scl-70) is a serological marker associated with diffuse cutaneous systemic sclerosis and its relation to extensive skin involvement and internal organ manifestations.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 191034,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47483,
      "choices": [
        {
          "id": 189543,
          "text": "<p><span style=\"font-size:14.0pt;\">Its diameter is less than the left coronary artery</span></p>"
        },
        {
          "id": 189544,
          "text": "<p><span style=\"font-size:14.0pt;\">It arises from the anterior aortic sinus</span></p>"
        },
        {
          "id": 189545,
          "text": "<p><span style=\"font-size:14.0pt;\">It gives rise to the circumflex coronary branch</span></p>"
        },
        {
          "id": 189546,
          "text": "<p><span style=\"font-size:14.0pt;\">Right conus artery is its first branch</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 55-year-old woman presents with exertional chest pain and shortness of breath. She undergoes a coronary angiography to evaluate for coronary artery disease. During the procedure, the cardiologist examines the right coronary artery (RCA) in detail. Which of the following statements about the right coronary artery is incorrect?</span></p>",
      "unique_key": "Q8374523",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) It gives rise to the circumflex coronary branch</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">The right coronary artery (RCA) has several key anatomical features and branches, but it does not give rise to the circumflex coronary branch. The circumflex coronary artery is a branch of the left coronary artery (LCA).</span></li><li><span style=\"font-size:14.0pt;\">The RCA typically arises from the anterior (right) aortic sinus and supplies blood to the right atrium, right ventricle, and parts of the conduction system of the heart.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Its diameter is less than the left coronary artery</strong>: This statement is true. Generally, the right coronary artery has a smaller diameter compared to the left coronary artery.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. It arises from the anterior aortic sinus</strong>: This statement is true. The right coronary artery originates from the anterior (right) aortic sinus.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Right conus artery is its first branch</strong>: This statement is true. The first branch of the right coronary artery is typically the right conus artery, which supplies the conus arteriosus.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">The right coronary artery does not give rise to the circumflex coronary branch; instead, the circumflex coronary artery is a branch of the left coronary artery.</span></li></ul>",
      "correct_choice_id": 189545,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        3
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47886,
      "choices": [
        {
          "id": 191139,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Steroids</span></span></span></p>"
        },
        {
          "id": 191140,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Topical estrogen</span></span></span></p>"
        },
        {
          "id": 191141,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Antihistamines only</span></span></span></p>"
        },
        {
          "id": 191142,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">None of the above</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 55-year-old postmenopausal woman presents with complaints of vaginal itching and dryness. Upon examination, she is diagnosed with atrophic vaginitis. What is the treatment of choice for her condition? </span></span></p>",
      "unique_key": "Q9278090",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. B) Topical estrogen</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Atrophic vaginitis is a condition commonly seen in postmenopausal women due to decreased estrogen levels, leading to thinning and inflammation of the vaginal walls. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Symptoms include vaginal dryness, itching, and discomfort. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The treatment of choice for atrophic vaginitis is topical estrogen, which helps replenish local estrogen levels, thereby alleviating symptoms by promoting the regeneration of the vaginal epithelium and increasing vaginal moisture and elasticity. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Topical estrogen can be administered in various forms, including creams, tablets, or rings, and has been shown to be highly effective in managing the symptoms of atrophic vaginitis.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Steroids:</span></strong><span style=\"font-size:14.0pt\"> Steroids are not typically used for the treatment of atrophic vaginitis as they do not address the underlying cause, which is estrogen deficiency. Steroids may reduce inflammation but do not restore the vaginal epithelium or moisture.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Antihistamines only:</span></strong><span style=\"font-size:14.0pt\"> Antihistamines may relieve itching temporarily but do not treat the underlying cause of atrophic vaginitis. They are not suitable as a primary treatment for this condition.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Topical estrogen is the treatment of choice for atrophic vaginitis, addressing the underlying estrogen deficiency and effectively relieving symptoms such as vaginal dryness and itching.</span></span></p>",
      "correct_choice_id": 191140,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47663,
      "choices": [
        {
          "id": 190263,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Truth Serum</span></span></span></p>"
        },
        {
          "id": 190264,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Polygraph</span></span></span></p>"
        },
        {
          "id": 190265,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Hypnosis</span></span></span></p>"
        },
        {
          "id": 190266,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Brain mapping</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A Medical Officer is preparing to evaluate a suspect who may have prior knowledge of a crime scene, and the test to be used is based on the principle that this prior knowledge will influence the suspect&#39;s reactions. Which test is most suitable for detecting such influences based on the suspect&#39;s physiological responses?</span></span></p>",
      "unique_key": "Q4134979",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. </span></strong><strong><span style=\"font-size:14.0pt\">B) Polygraph</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The Polygraph test, also known as a lie detector test, measures and records several physiological indices such as blood pressure, pulse, respiration, and skin conductivity while the subject is asked and answers a series of questions. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The principle behind this test is that deceptive answers will produce physiological responses that can be differentiated from those associated with non-deceptive answers. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This is because knowing the truth about the crime may involuntarily trigger distinct physiological responses when questioned, which the polygraph aims to detect.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/06/screenshot-2024-06-06-124032.png\" style=\"height:244px; width:300px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span><br />\r\n&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Truth Serum</span></strong><span style=\"font-size:14.0pt\">: Incorrect because while truth serum (such as sodium thiopental) is used to make a person more likely to share information, it does not specifically measure reaction based on prior knowledge.</span></span></span><br />\r\n&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Hypnosis:</span></strong><span style=\"font-size:14.0pt\"> Incorrect as hypnosis is used to retrieve deeper or suppressed memories but does not directly measure physiological reactions to knowledge of specific events.</span></span></span><br />\r\n&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Brain mapping:</span></strong><span style=\"font-size:14.0pt\"> Incorrect because brain mapping (or functional MRI) observes brain activity patterns but is not specifically about the reaction to prior knowledge in the context mentioned.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The polygraph test is designed to capture changes in physiological responses that occur when a suspect with prior knowledge of the crime is questioned, leveraging the body&#39;s involuntary reactions to stress or deception related to their awareness of the crime details.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 190264,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        10
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47842,
      "choices": [
        {
          "id": 190967,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Reactive arthritis</span></span></span></p>"
        },
        {
          "id": 190968,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Osteoarthritis</span></span></span></p>"
        },
        {
          "id": 190969,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Rheumatoid arthritis</span></span></span></p>"
        },
        {
          "id": 190970,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Psoriatic arthritis</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient presented with skin lesions on his body as shown in the image. On evaluation, he has pain and swelling in the DIP joints. What is the diagnosis? </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/08/whatsapp-image-2024-06-08-at-183403.jpeg\" style=\"height:266px; width:400px\" /></p>",
      "unique_key": "Q7407184",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. D) Psoriatic arthritis</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Psoriatic arthritis is a chronic inflammatory arthritis that occurs in patients with psoriasis, a skin condition characterized by red, scaly patches of skin. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Psoriatic arthritis can affect any joint, including the DIP joints, and often presents with asymmetric arthritis, enthesitis (inflammation at sites where tendons or ligaments attach to bone), and dactylitis (swelling of an entire finger or toe).</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Psoriatic arthritis is strongly associated with psoriasis, and the presence of skin lesions in the image provided supports this diagnosis. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Additionally, involvement of the DIP joints, along with pain and swelling, is characteristic of psoriatic arthritis.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options</span></strong><span style=\"font-size:14.0pt\">: </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Reactive Arthritis: </span></strong><span style=\"font-size:14.0pt\">Reactive arthritis, also known as Reiter&#39;s syndrome, is a type of inflammatory arthritis that develops in response to an infection in another part of the body, typically the genitourinary or gastrointestinal tract. It is characterized by asymmetric arthritis, often affecting large joints such as the knees and ankles, as well as extra-articular manifestations such as uveitis and urethritis. Reactive arthritis is less commonly associated with involvement of the DIP joints. While it can present with joint pain and swelling, the presence of skin lesions (as shown in the image) and DIP joint involvement make other diagnoses more likely.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Osteoarthritis: </span></strong><span style=\"font-size:14.0pt\">Osteoarthritis is a degenerative joint disease characterized by the breakdown of joint cartilage and the formation of bone spurs. It typically affects weight-bearing joints such as the hips and knees, but can also involve the hands, including the DIP joints. Osteoarthritis is more common in older individuals and is associated with joint pain and stiffness that worsen over time. While osteoarthritis can affect the DIP joints, the presence of skin lesions and the relatively young age of the patient make other diagnoses, such as inflammatory arthritis, more likely.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Rheumatoid Arthritis: </span></strong><span style=\"font-size:14.0pt\">Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by symmetric polyarthritis, often involving the small joints of the hands and feet. RA typically presents with joint pain, swelling, and stiffness, as well as systemic symptoms such as fatigue and morning stiffness. It can lead to joint deformities and erosive changes on imaging. RA typically affects the proximal interphalangeal (PIP) joints rather than the DIP joints. Additionally, while skin manifestations can occur in RA, they are less common and typically different from those seen in the image provided.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The skin lesions seen in the given case are typical of psoriasis. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Psoriasis is associated with pain and swelling in the DIP joints, leading to psoriatic arthritis. </span></span></span></li>\r\n\t<li><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Thus, the given case is true for psoriatic arthritis.&nbsp; </span></span></li>\r\n</ul>",
      "correct_choice_id": 190970,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        15
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47758,
      "choices": [
        {
          "id": 190639,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">GBS typically presents with ascending paralysis.</span></span></span></p>"
        },
        {
          "id": 190640,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Deep tendon reflexes are exaggerated in the initial days of symptom onset.</span></span></span></p>"
        },
        {
          "id": 190641,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">GBS is associated with autonomic dysfunction.</span></span></span></p>"
        },
        {
          "id": 190642,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Campylobacter jejuni is a common preceding infection.</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">All of the following are true about Guillain-Barre Syndrome (GBS) except: </span></span></p>",
      "unique_key": "Q9771049",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. B) Deep tendon reflexes are exaggerated in the initial days of symptom onset.</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">In Guillain-Barre Syndrome (GBS), deep tendon reflexes actually diminish or disappear within the initial days of symptom onset. This is a key diagnostic feature of GBS.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. GBS typically presents with ascending paralysis:</span></strong><span style=\"font-size:14.0pt\"> GBS typically presents with symmetrical, ascending paralysis that begins in the lower limbs and progresses to involve the trunk and upper limbs. This characteristic pattern helps differentiate GBS from other neurological conditions.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. GBS is associated with autonomic dysfunction</span></strong><span style=\"font-size:14.0pt\">: GBS can involve autonomic dysfunction, with or without sensory involvement. This can include symptoms such as fluctuations in blood pressure and heart rate, indicating the involvement of the autonomic nervous system.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Campylobacter jejuni is a common preceding infection:</span></strong><span style=\"font-size:14.0pt\"> Campylobacter jejuni is a common preceding infection in cases of GBS. Other infections such as those caused by human herpes viruses and Mycoplasma pneumoniae can also be implicated.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Guillain-Barre Syndrome (GBS) is characterized by symmetrical, ascending paralysis and diminished or absent deep tendon reflexes.</span></span></p>",
      "correct_choice_id": 190640,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47764,
      "choices": [
        {
          "id": 190663,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Normal CSF</span></span></span></p>"
        },
        {
          "id": 190664,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Bacterial Meningitis</span></span></span></p>"
        },
        {
          "id": 190665,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Viral Meningitis</span></span></span></p>"
        },
        {
          "id": 190666,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Fungal Meningitis</span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 12-year-old girl presents with a headache and fever. A lumbar puncture is performed, and the cerebrospinal fluid (CSF) analysis reveals glucose 60 mg/dL, protein 25 mg/dL, and WBC 3 cells/&micro;L (70% lymphocytes, 30% monocytes/macrophages). What is the most likely diagnosis?</span></span></p>",
      "unique_key": "Q6354994",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Ans. A)&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Normal CSF</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">The normal CSF findings include glucose levels of 40-85 mg/dL, protein levels of 15-45 mg/dL, and a WBC count of less than 5 cells/&micro;L with 60-70% lymphocytes and 30% monocytes/macrophages. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">The patient&#39;s CSF analysis matches these normal parameters, indicating no infection.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Option B. Bacterial Meningitis:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"> Bacterial meningitis typically presents with CSF glucose levels less than 40 mg/dL, protein levels greater than 100 mg/dL, and a WBC count greater than 1000 cells/&micro;L, predominantly polymorphonuclear leukocytes (PMNs). These findings indicate a significant infection and inflammation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Option C. Viral Meningitis:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"> Viral meningitis usually shows normal glucose levels, protein levels of 20-80 mg/dL, and a WBC count of 25-500 cells/&micro;L, predominantly lymphocytes. It indicates a less severe infection compared to bacterial meningitis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Option D. Fungal Meningitis:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"> Fungal meningitis often presents with decreased to normal glucose levels, protein levels of 150-300 mg/dL, and a WBC count of 40-600 cells/&micro;L, with lymphocytes or PMNs depending on the specific organism. It indicates a chronic infection process.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Normal CSF findings include glucose 40-85 mg/dL, protein 15-45 mg/dL, and WBC less than 5 cells/&micro;L with a predominance of lymphocytes. </span></span></p>",
      "correct_choice_id": 190663,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47691,
      "choices": [
        {
          "id": 190375,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Nephrin</span></span></span></p>"
        },
        {
          "id": 190376,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Podocin</span></span></span></p>"
        },
        {
          "id": 190377,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Alpha actinin</span></span></span></p>"
        },
        {
          "id": 190378,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">CD2 activated protein</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 3-year-old child presents with generalized edema and proteinuria. Genetic testing reveals a mutation associated with Finnish-type nephrotic syndrome. Which of the following proteins is implicated in this condition?</span></span></p>",
      "unique_key": "Q8120130",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. A) Nephrin</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Finnish-type nephrotic syndrome, also known as congenital nephrotic syndrome of the Finnish type, is primarily caused by mutations in the NPHS1 gene that encodes the protein nephrin. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Nephrin is a crucial component of the slit diaphragm in the kidney glomeruli, which plays an essential role in maintaining the filtration barrier. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Mutations in nephrin lead to a defective slit diaphragm, resulting in significant proteinuria and the clinical manifestations of nephrotic syndrome.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Podocin:</span></strong><span style=\"font-size:14.0pt\"> Podocin is encoded by the NPHS2 gene and is also important for the structure and function of the slit diaphragm. However, mutations in podocin are associated with a different form of nephrotic syndrome called steroid-resistant nephrotic syndrome, not specifically the Finnish type.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Alpha actinin:</span></strong><span style=\"font-size:14.0pt\"> Alpha actinin is a cytoskeletal protein involved in the structural integrity of the cell&#39;s actin network. While it plays a role in kidney function, mutations in this protein are not typically associated with Finnish-type nephrotic syndrome.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. CD2 activated protein (CD2AP):</span></strong><span style=\"font-size:14.0pt\"> CD2AP is involved in the signaling and structural integrity of the slit diaphragm. Mutations in CD2AP can lead to focal segmental glomerulosclerosis (FSGS), but they are not specifically associated with Finnish-type nephrotic syndrome.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Finnish-type nephrotic syndrome is associated with mutations in the NPHS1 gene, leading to defects in the protein nephrin, which is crucial for the structural integrity of the kidney&#39;s filtration barrier. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This results in significant proteinuria and nephrotic syndrome.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 190375,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        5
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47925,
      "choices": [
        {
          "id": 191295,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Associated with EBV infection.</span></span></span></p>"
        },
        {
          "id": 191296,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Can present with peripheral lymphadenopathy and intrabdominal mass.</span></span></span></p>"
        },
        {
          "id": 191297,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Ki-67 of 40%</span></span></span></p>"
        },
        {
          "id": 191298,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Curable with chemotherapy</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">All of the following are true about Burkitt&#39;s lymphoma except:<strong> </strong></span></span></p>",
      "unique_key": "Q1055585",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. C)&nbsp;</span></strong><strong><span style=\"font-size:14.0pt\">Ki-67 of 40%</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">The Ki-67 index is a marker of proliferation. Burkitt&#39;s lymphoma is characterized by a very high proliferation rate, with a Ki-67 index approaching 100%. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">A Ki-67 index of 40% is not characteristic of Burkitt&#39;s lymphoma and would suggest a less aggressive malignancy.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14pt\"><strong>Option A.</strong>&nbsp;</span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><strong>Associated with EBV infection:</strong> This statement is true. Burkitt&#39;s lymphoma, particularly the endemic variant, is strongly associated with Epstein-Barr Virus (EBV) infection.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14pt\"><strong>Option B.</strong>&nbsp;</span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><strong>Can present with peripheral lymphadenopathy and intrabdominal mass:</strong> This statement is true. Burkitt&#39;s lymphoma can present with peripheral lymphadenopathy and commonly with abdominal masses, especially in the sporadic form.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14pt\"><strong>Option D.</strong>&nbsp;</span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><strong>Curable with chemotherapy:</strong> This statement is true. Burkitt&#39;s lymphoma is curable with aggressive chemotherapy regimens, despite its rapid growth and aggressive nature.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Burkitt&#39;s lymphoma is an aggressive but potentially curable B-cell non-Hodgkin lymphoma characterized by a very high proliferation rate (Ki-67 near 100%), association with EBV infection, and presentation with rapidly growing masses, including peripheral lymphadenopathy and abdominal involvement. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">A Ki-67 index of 40% is not typical for this disease.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 191297,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47680,
      "choices": [
        {
          "id": 190331,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Inhibits the release of acetylcholine</span></span></span></p>"
        },
        {
          "id": 190332,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Release of noradrenaline at the synaptic cleft</span></span></span></p>"
        },
        {
          "id": 190333,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Selectively and irreversibly inhibits nicotinic receptors</span></span></span></p>"
        },
        {
          "id": 190334,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Stimulates muscarinic and nicotinic receptors</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient being treated for muscle spasticity is prescribed a medication (Botox) known for its specific neuromuscular action. Which of the following best describes its mechanism of action?</span></span></p>",
      "unique_key": "Q9839780",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. </span></strong><strong><span style=\"font-size:14.0pt\">A) Inhibits the release of acetylcholine</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Botulinum toxin (Botox)</span></strong><span style=\"font-size:14.0pt\"> functions by inhibiting the release of acetylcholine, a neurotransmitter responsible for triggering muscle contractions. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">It achieves this by cleaving SNARE proteins, which are essential for the fusion of neurotransmitter-containing vesicles with the neuron&#39;s membrane. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This disruption prevents acetylcholine from being released into the neuromuscular junction, effectively reducing muscle activity and preventing contraction.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Release of noradrenaline at the synaptic cleft</span></strong><span style=\"font-size:14.0pt\">: This statement is incorrect as botulinum toxin does not affect noradrenaline release.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Selectively and irreversibly inhibits nicotinic receptors</span></strong><span style=\"font-size:14.0pt\">: Botulinum toxin does not directly interact with nicotinic receptors; its action is at the level of neurotransmitter release.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Stimulates muscarinic and nicotinic receptors</span></strong><span style=\"font-size:14.0pt\">: Incorrect, as botulinum toxin does not stimulate but rather inhibits the action at synapses by preventing acetylcholine release.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The primary mechanism of botulinum toxin is the inhibition of acetylcholine release at the neuromuscular junction, making it an effective treatment for reducing muscle activity and improving aesthetic concerns like wrinkles or for medical conditions associated with muscle spasticity.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 190331,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47839,
      "choices": [
        {
          "id": 190955,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Mean = Median = Mode</span></span></span></p>"
        },
        {
          "id": 190956,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Mean &gt; Median &gt; Mode</span></span></span></p>"
        },
        {
          "id": 190957,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Mode &gt; Median &gt; Mean</span></span></span></p>"
        },
        {
          "id": 190958,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Median &gt; Mode &gt; Mean</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dr. Lalit is examining a dataset to understand the distribution of cholesterol levels among patients in a longitudinal health study. The distribution of the data appears as shown in the image. Based on this distribution, how do the mean, median, and mode of the cholesterol levels compare?</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/07/screenshot-2024-06-07-112025.png\" style=\"height:187px; width:300px\" /></span></span></p>",
      "unique_key": "Q4648858",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans.&nbsp;</span></strong><strong><span style=\"font-size:14.0pt\">B) Mean &gt; Median &gt; Mode</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This<strong> </strong></span><span style=\"font-size:14.0pt\">is correct. In a right-skewed distribution, the tail of the distribution extends to the right, indicating that the mean is pulled in the direction of the tail. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This results in the mean being greater than the median, and the median being greater than the mode. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The mean is affected most by the outliers and high values typically found in the tail of the distribution, whereas the mode represents the highest frequency of data which is less affected by outliers and typically occurs before the peak of the median and mean.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Option A.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>Mean = Median = Mode:</strong> <strong>Incorrect.</strong> In a normal distribution (not skewed), the mean, median, and mode are equal, which is not the case here.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Mode &gt; Median &gt; Mean:</span></strong><span style=\"font-size:14.0pt\"> <strong>Incorrect.</strong> This arrangement would be more typical of a left-skewed (negatively skewed) distribution, where the tail extends to the left.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Option D.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>Median &gt; Mode &gt; Mean: </strong><strong>Incorrect.</strong> This order does not typically occur in any standard distribution format and reverses the relationship seen in a right-skewed distribution.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">In Right skew curve (Photograph): Mean &gt; Median &gt; Mode</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">In Left skew curve: Mean &lt; Median &lt; Mode</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">In Normal distribution: Mean = Median = Mode.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 190956,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        7
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47552,
      "choices": [
        {
          "id": 189819,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Cytomegalovirus</span></span></span></p>"
        },
        {
          "id": 189820,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Epstein-Barr virus</span></span></span></p>"
        },
        {
          "id": 189821,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Herpes simplex virus</span></span></span></p>"
        },
        {
          "id": 189822,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Toxoplasma gondii</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 5-year-old child presents to the pediatric clinic with a fever and a distinctive rash. Upon further examination, the pediatrician orders a urine test, which reveals cells displaying an &quot;owl&#39;s eye&quot; appearance. Based on these clinical findings, what is the most likely diagnosis?</span></span></p>",
      "unique_key": "Q1865284",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans.&nbsp;</span></strong><strong><span style=\"font-size:14.0pt\">A) Cytomegalovirus</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The &quot;owl&#39;s eye&quot; appearance in cells is characteristic of Cytomegalovirus (CMV) infection, typically seen in the urine or tissue biopsy under microscopy. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This viral inclusion shows a large, intranuclear inclusion body surrounded by a clear halo, giving it an owl&#39;s eye appearance. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">CMV can cause a range of symptoms in children, including fever and rash, particularly in immunocompromised individuals or congenitally infected infants.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/05/screenshot-2024-06-05-154236.JPG\" style=\"height:175px; width:500px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Additional Information:&nbsp; </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/05/screenshot-2024-06-05-154443.JPG\" style=\"height:522px; width:1000px\" /></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span><br />\r\n&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Epstein-Barr virus: </span></strong><span style=\"font-size:14.0pt\">Incorrect because Epstein-Barr virus (EBV) primarily causes infectious mononucleosis, which typically presents with fever, sore throat, and swollen lymph nodes, but does not feature the &quot;owl&#39;s eye&quot; appearance in cells.</span></span></span><br />\r\n&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Herpes simplex virus:</span></strong><span style=\"font-size:14.0pt\"> Incorrect as Herpes simplex virus (HSV) infections are characterized by vesicular lesions rather than cells with an &quot;owl&#39;s eye&quot; appearance.</span></span></span><br />\r\n&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Toxoplasma gondii: </span></strong><span style=\"font-size:14.0pt\">Incorrect because Toxoplasma gondii, a parasite, causes toxoplasmosis and does not produce the &quot;owl&#39;s eye&quot; appearance in cells; its diagnosis is typically confirmed through serological testing.</span></span></span></p>\r\n\r\n<p style=\"margin-left:24px\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The &quot;owl&#39;s eye&quot; appearance in cellular examinations is a diagnostic indicator of Cytomegalovirus infection, particularly relevant in pediatric cases presenting with symptoms like fever and rash. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Recognizing this key diagnostic feature can guide appropriate clinical management and treatment.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 189819,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        6
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47568,
      "choices": [
        {
          "id": 189883,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Thiersch&rsquo;s operation</span></span></span></p>"
        },
        {
          "id": 189884,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Mesh rectopexy</span></span></span></p>"
        },
        {
          "id": 189885,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Delorme&rsquo;s operation</span></span></span></p>"
        },
        {
          "id": 189886,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Altemeier procedure</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following procedures is preferred for strangulated rectal prolapse?</span></span></p>",
      "unique_key": "Q7063298",
      "difficulty_level": "difficult",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Ans. D)</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>Altemeier procedure</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">In the Altemeier procedure, the rectum is prolapsed through the anal canal and a <strong>full thickness resection performed</strong>, incorporating any associated colonic prolapse. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Restoration of colorectal continuity can be performed by either a handsewn or stapled anastomosis<strong>. </strong></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">This is the procedure of choice in patients presenting with incarcerated and strangulated prolapse.</span></strong></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Thiersch&rsquo;s operation:&nbsp;</span></strong><span style=\"font-size:14.0pt\">In this <strong>perineal approach</strong> <strong>procedure</strong>, a steel wire, or silastic or nylon tape, is placed around the anal canal. It has become largely obsolete owing to problems with chronic perineal sepsis, anal stenosis and obstructed defecation, but may be used to augment perineal repair in cases of severe pelvic floor weakness.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Mesh rectopexy:&nbsp;</span></strong><span style=\"font-size:14.0pt\">The principle of all abdominal operations for rectal prolapse is to fix the rectum in its normal anatomical position. Many variations have been described, including inserting a sheet of polypropylene mesh.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C</span></strong><span style=\"font-size:14.0pt\">. </span><strong><span style=\"font-size:14.0pt\">Delorme</span></strong><span style=\"font-size:14.0pt\"> <strong>procedure:</strong> The <strong>rectal mucosa is stripped</strong> circumferentially from the rectum over the length of the prolapse. The underlying muscle is plicated with a series of sutures, so that the rectal muscle is concave towards the anal canal. The excess rectal mucosa is excised and a mucosal anastomosis performed.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Altemeier procedure <strong>is the procedure of choice in patients presenting with incarcerated and strangulated prolapse.</strong></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 189886,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        12
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47592,
      "choices": [
        {
          "id": 189979,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Cross-sectional study</span></span></span></p>"
        },
        {
          "id": 189980,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Concurrent cohort</span></span></span></p>"
        },
        {
          "id": 189981,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Retrospective cohort</span></span></span></p>"
        },
        {
          "id": 189982,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Clinical trial</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In 1977, a research team analyzed the health records of the 1935 freshman cohort at a large academic institution to evaluate whether their heights and weights at university entry could predict the later occurrence of Coronary Heart Disease (CHD). What study design is exemplified by this investigation?</span></span></p>",
      "unique_key": "Q7101071",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>C) Retrospective cohort</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This is a retrospective cohort study because it involves looking back at historical data (physical examination records from 1935) to assess the relationship between certain exposures (height and weight at university admission) and subsequent outcomes (development of CHD by 1977). </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The study does not manipulate variables but observes existing data across different times, making it retrospective in nature.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Cross-sectional study:&nbsp;</span></strong><span style=\"font-size:14.0pt\">Incorrect<strong> </strong>because cross-sectional studies assess both exposure and outcome at a single point in time, which is not the case here.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Concurrent cohort:&nbsp;</span></strong><span style=\"font-size:14.0pt\">Incorrect<strong> </strong>as this study design would involve assessing the exposure and outcome during the same time period; however, in this scenario, the data spans several decades.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Clinical trial:&nbsp;</span></strong><span style=\"font-size:14.0pt\">Incorrect<strong> </strong>because clinical trials involve the intervention of the researchers to assign treatments, which does not occur in this study.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>&nbsp;</strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Exposure and outcome in analytical studies:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/05/screenshot-2024-06-05-160209.JPG\" style=\"height:733px; width:1000px\" /></span></strong></span></span></p>",
      "correct_choice_id": 189981,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47695,
      "choices": [
        {
          "id": 190391,
          "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Olanzapine&nbsp; </span></span></p>"
        },
        {
          "id": 190392,
          "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Clozapine&nbsp; </span></span></p>"
        },
        {
          "id": 190393,
          "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Risperidone&nbsp; </span></span></p>"
        },
        {
          "id": 190394,
          "text": "<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Aripiprazole</span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient with schizophrenia was started on drug A. After beginning treatment with drug A, the patient&#39;s psychotic symptoms improved; however, he developed gynecomastia, infertility, tremors and rigidity. Which drug is most likely to be &#39;drug A&rsquo;?</span></span></p>",
      "unique_key": "Q7356061",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:14.0pt\">Ans. C) Risperidone</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:14.0pt\">Risperidone is effective in managing psychotic symptoms but can lead to several side effects due to its dopamine antagonism. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:14.0pt\">These side effects include <strong>hyperprolactinemia</strong>, which can result in gynecomastia (breast enlargement in males) and infertility. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:14.0pt\">Additionally, risperidone can cause <strong>extrapyramidal symptoms (EPS) </strong>such as tremors and rigidity, particularly at higher doses.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:14.0pt\">Option A. Olanzapine: </span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:14.0pt\">Olanzapine is another atypical antipsychotic known for its efficacy in treating schizophrenia. It is associated more with weight gain, metabolic syndrome, and sedation. Olanzapine is less likely to cause hyperprolactinemia and EPS compared to risperidone.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:14.0pt\">Option B. Clozapine: </span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:14.0pt\">Clozapine is used primarily for treatment-resistant schizophrenia due to its superior efficacy but has a unique side effect profile, including agranulocytosis, seizures, and sialorrhea. It is not typically associated with hyperprolactinemia or EPS.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:14.0pt\">Option D. Aripiprazole: </span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:14.0pt\">Aripiprazole acts as a partial agonist at dopamine D2 receptors and has a lower risk of causing hyperprolactinemia and EPS compared to risperidone. It may cause akathisia but is less likely to cause gynecomastia and infertility.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:14.0pt\">Educational Objective:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:14.0pt\">Risperidone can improve psychotic symptoms in schizophrenia but may cause side effects such as gynecomastia, infertility, and extrapyramidal symptoms like tremors and rigidity.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 190393,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        16
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47844,
      "choices": [
        {
          "id": 190975,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Oprelvekin (IL-11)</span></span></span></p>"
        },
        {
          "id": 190976,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Filgrastim</span></span></span></p>"
        },
        {
          "id": 190977,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Erythropoietin</span></span></span></p>"
        },
        {
          "id": 190978,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Amifostine</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 52-year-old female patient undergoing chemotherapy for breast cancer has developed thrombocytopenia as a complication of her treatment. To manage this condition, which of the following drugs would be the most appropriate? </span></span></p>",
      "unique_key": "Q8820133",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans.&nbsp;</span></strong><strong><span style=\"font-size:14.0pt\">A) Oprelvekin (IL-11)</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Oprelvekin</span></strong><span style=\"font-size:14.0pt\">, an interleukin-11 analog, is specifically used to treat thrombocytopenia (a decrease in platelets) caused by chemotherapy. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Oprelvekin works by stimulating the bone marrow to produce more platelets, thereby reducing the risk of bleeding associated with low platelet counts.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Filgrastim</span></strong><span style=\"font-size:14.0pt\">: This medication is a granulocyte-colony stimulating factor (G-CSF) that is primarily used to treat neutropenia (low levels of neutrophils) rather than thrombocytopenia.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Erythropoietin</span></strong><span style=\"font-size:14.0pt\">: Commonly used to treat anemia, especially in patients with chronic kidney disease or those suffering from anemia due to chemotherapy, erythropoietin stimulates the production of red blood cells, not platelets.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Amifostine</span></strong><span style=\"font-size:14.0pt\">: This drug provides protection against the toxic effects of chemotherapy, particularly against cisplatin-induced renal toxicity, and is not used to treat low platelet counts.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">For patients experiencing thrombocytopenia as a result of chemotherapy, oprelvekin (IL-11) is a targeted and effective treatment option to increase platelet production and mitigate the associated risks of bleeding.</span></span></li>\r\n</ul>",
      "correct_choice_id": 190975,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47690,
      "choices": [
        {
          "id": 190371,
          "text": "<p><span style=\"font-size:14.0pt;\">Azygous vein</span></p>"
        },
        {
          "id": 190372,
          "text": "<p><span style=\"font-size:14.0pt;\">Thoracic duct</span></p>"
        },
        {
          "id": 190373,
          "text": "<p><span style=\"font-size:14.0pt;\">Vagal trunk</span></p>"
        },
        {
          "id": 190374,
          "text": "<p><span style=\"font-size:14.0pt;\">Aorta</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 50-year-old man presents with a pulsatile abdominal mass. An abdominal CT scan reveals an aneurysm of the abdominal aorta. The attending physician explains to medical students the anatomical structures passing through the aortic opening of the diaphragm. Which of the following structures does not pass through the aortic opening of the diaphragm?</span></p>",
      "unique_key": "Q6499491",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Vagal trunk</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">The vagal trunks (anterior and posterior) pass through the esophageal opening at the level of T10 vertebra, not the aortic opening of the diaphragm.</span></li><li><span style=\"font-size:14.0pt;\">The esophageal hiatus is an opening in the diaphragm that allows the esophagus and vagus nerves to pass through from the thoracic cavity to the abdominal cavity.</span></li><li><span style=\"font-size:14.0pt;\">Therefore, the vagal trunk does not pass through the aortic opening, making it the correct</span></li></ul><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/06/screenshot-2024-06-06-130651.png\" alt=\"\" width=\"800\" height=\"521\"></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Azygous Vein:</strong> The azygous vein is a major vein that drains blood from the thoracic wall and upper lumbar region into the superior vena cava. It passes through the aortic hiatus along with the aorta and thoracic duct.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Thoracic Duct:</strong> The thoracic duct is the largest lymphatic vessel in the body, responsible for draining lymph from the lower body, left upper limb, and left side of the head and neck into the venous system. It also passes through the aortic hiatus.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Aorta:</strong> The aorta is the main artery that carries oxygenated blood from the heart to the rest of the body. It passes through the aortic hiatus of the diaphragm at the level of the T12 vertebra.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">The vagal trunk passes through the esophageal hiatus, not the aortic opening of the diaphragm, which instead accommodates the aorta, azygous vein, and thoracic duct.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/06/screenshot-2024-06-06-131018.png\" alt=\"\" width=\"1000\" height=\"395\"></span></p>",
      "correct_choice_id": 190373,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        3
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47823,
      "choices": [
        {
          "id": 190891,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Has a good prognosis</span></span></span></p>"
        },
        {
          "id": 190892,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Not associated with liver cirrhosis&nbsp;&nbsp;&nbsp;&nbsp;</span></span></span></p>"
        },
        {
          "id": 190893,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Females have an equal incidence to males</span></span></span></p>"
        },
        {
          "id": 190894,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Serum AFP levels are usually &gt; 1000 mg/litre</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 28-year-old woman presents with a liver mass discovered during a routine ultrasound. She has no history of liver disease or cirrhosis. Further imaging and biopsy confirm the diagnosis of fibrolamellar carcinoma. Which of the following statements about fibrolamellar carcinoma is NOT true?</span></span></p>",
      "unique_key": "Q9217755",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. D) Serum AFP levels are usually &gt; 1000 mg/litre</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Serum AFP levels are usually &gt; 1000 mg/litre:</span></strong><span style=\"font-size:14.0pt\"> This statement is incorrect. Fibrolamellar carcinoma typically does not present with significantly elevated serum alpha-fetoprotein (AFP) levels. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Unlike conventional hepatocellular carcinoma (HCC), where AFP levels can be markedly elevated, AFP levels in fibrolamellar carcinoma are generally normal or only mildly elevated.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Has a good prognosis:</span></strong><span style=\"font-size:14.0pt\"> This statement is true. Fibrolamellar carcinoma generally has a better prognosis compared to conventional hepatocellular carcinoma, partly because it often occurs in younger patients without underlying liver disease and is more amenable to surgical resection.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Not associated with liver cirrhosis:</span></strong><span style=\"font-size:14.0pt\"> This statement is true. Unlike conventional hepatocellular carcinoma, fibrolamellar carcinoma is typically not associated with liver cirrhosis or significant underlying liver disease.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Females have an equal incidence to males:</span></strong><span style=\"font-size:14.0pt\"> This statement is true. The incidence of fibrolamellar carcinoma is roughly equal between males and females.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Fibrolamellar carcinoma of the liver is a distinct type of liver cancer that typically affects young individuals without cirrhosis, has a better prognosis than conventional hepatocellular carcinoma, and is not associated with significantly elevated serum AFP levels.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 190894,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        5
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47724,
      "choices": [
        {
          "id": 190507,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Glycine</span></span></span></p>"
        },
        {
          "id": 190508,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">70% dextrose</span></span></span></p>"
        },
        {
          "id": 190509,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Normal saline</span></span></span></p>"
        },
        {
          "id": 190510,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">CO2</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 35-year-old woman is scheduled for a hysteroscopic polypectomy to remove uterine polyps. This procedure will use bipolar electrocautery. Which of the following agents is ideal for uterine cavity distention during this procedure?</span></span></p>",
      "unique_key": "Q3017851",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. C) Normal saline</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Hysteroscopic procedures, such as polypectomy, require the uterine cavity to be distended to allow for better visualization and access. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">When bipolar electrocautery is used, it is crucial to choose an appropriate distending medium that is both safe and effective. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Normal saline is an ideal agent in this scenario because it is an isotonic, non-conductive fluid that does not interfere with the electrical conductivity of the bipolar electrocautery. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">It also reduces the risk of complications such as fluid overload and electrolyte imbalances.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Glycine:</span></strong><span style=\"font-size:14.0pt\"> Glycine is often used as a distention medium in monopolar electrocautery because it is non-conductive. However, it is not suitable for bipolar electrocautery due to its conductive properties, which can interfere with the procedure and increase the risk of complications.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. 70% dextrose:</span></strong><span style=\"font-size:14.0pt\"> 70% dextrose is not a common choice for uterine distention in hysteroscopic procedures. It can cause significant fluid shifts and hyperglycemia, making it unsuitable for this purpose.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. CO2:</span></strong><span style=\"font-size:14.0pt\"> CO2 is used for distention in laparoscopy but is not suitable for hysteroscopic procedures because it does not provide adequate distention of the uterine cavity and can cause gas embolism.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Normal saline is the ideal distention medium for hysteroscopic procedures using bipolar electrocautery due to its safety, isotonic nature, and non-conductive properties.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 190509,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47580,
      "choices": [
        {
          "id": 189931,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Fluorescein dye - visualized under cobalt blue filter</span></span></span></p>"
        },
        {
          "id": 189932,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Lissamine dye - visualized under green filter</span></span></span></p>"
        },
        {
          "id": 189933,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Lissamine dye - visualized under cobalt blue filter</span></span></span></p>"
        },
        {
          "id": 189934,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Fluorescein dye - visualized under green filter</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 35-year-old man presents to the ophthalmology clinic with complaints of eye irritation and blurred vision in his right eye. On examination, the ophthalmologist applies a specific dye to the patient&#39;s eye and visualizes it under a particular filter. The image is shown below. What is the dye and filter used as seen in the image?</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/05/screenshot-2024-06-05-155738.JPG\" style=\"height:197px; width:300px\" /></span></span></p>",
      "unique_key": "Q9812868",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. A) Fluorescein dye - visualized under cobalt blue filter</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">The most likely correct combination for fluorescein dye visualization is Fluorescein dye - visualized under cobalt blue filter. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Fluorescein is a yellow dye that, when applied to the eye, emits a bright green fluorescence when illuminated with blue light from a cobalt blue filter. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">It&#39;s commonly used in ophthalmology to detect corneal abrasions, ulcers, or foreign bodies and to assess contact lens fit.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Lissamine Green dye - visualized under a green filter:</span></strong><span style=\"font-size:14.0pt\"> Lissamine Green is a dye that stains devitalized cells and mucous filaments and is used to visualize damage to the conjunctiva and cornea, particularly in dry eye syndrome. It is typically observed under white light, not a green filter, so this combination is not standard.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Lissamine Green dye - visualized under a cobalt blue filter:</span></strong><span style=\"font-size:14.0pt\"> This is not the standard practice for visualizing Lissamine Green dye. This dye is usually observed under white light, as the cobalt blue filter is specifically used to excite fluorescence from fluorescein dye.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Fluorescein dye - visualized under a green filter:</span></strong><span style=\"font-size:14.0pt\"> Fluorescein dye is usually visualized under a blue light, not a green filter. When fluorescein is viewed under a green filter, the fluorescence is typically not visible because the green filter would block the green fluorescence emitted by the fluorescein dye.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Fluorescein dye is used in ophthalmology to detect corneal abrasions, ulcers, or foreign bodies and is visualized under a cobalt blue filter, which emits a bright green fluorescence.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 189931,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        8
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47731,
      "choices": [
        {
          "id": 190535,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Murine typhus</span></span></span></p>"
        },
        {
          "id": 190536,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Pneumonic plague</span></span></span></p>"
        },
        {
          "id": 190537,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Chiggerosis</span></span></span></p>"
        },
        {
          "id": 190538,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Hymenolepis diminuta</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following diseases is NOT transmitted by the rat flea, Xenopsylla cheopis?</span></span></p>",
      "unique_key": "Q2691559",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans.</span></strong><span style=\"font-size:14.0pt\"> <strong>D) Hymenolepis diminuta</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This<strong> </strong>is correct because Hymenolepis diminuta, commonly known as the rat tapeworm, is primarily transmitted through the ingestion of infected arthropods like beetles, not through rat fleas. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This tapeworm is often found in rodents but does not involve fleas in its lifecycle.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Rat flea </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/06/screenshot-2024-06-06-153336.png\" style=\"height:202px; width:300px\" /></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. &nbsp;Murine typhus:&nbsp;</span></strong></span></span><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Incorrect<strong> </strong>as Murine typhus, caused by Rickettsia typhi, is indeed transmitted by rat fleas, which act as vectors for this bacterial disease.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Pneumonic plague:&nbsp;</span></strong></span></span><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Incorrect<strong> </strong>regarding the mode of transmission. While rat fleas transmit the bacterium Yersinia pestis responsible for bubonic plague, pneumonic plague is a secondary form developed from bubonic or septicemic plague and is typically spread from person to person through respiratory droplets.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. &nbsp;Chiggerosis:&nbsp;</span></strong></span></span><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Incorrect<strong> since Chiggerosis,</strong> while typically associated with mite infestations, can also be linked to areas or vectors that involve rat fleas, though it is not the primary disease transmitted by rat fleas.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">RAT FLEA (XENOPSYLLA)</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/08/screenshot-2024-06-08-111013.JPG\" style=\"height:245px; width:1000px\" /></p>",
      "correct_choice_id": 190538,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47492,
      "choices": [
        {
          "id": 189579,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Free T3 level</span></span></span></p>"
        },
        {
          "id": 189580,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Free T4 level</span></span></span></p>"
        },
        {
          "id": 189581,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Total T3 level</span></span></span></p>"
        },
        {
          "id": 189582,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">TSH level</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 28-year-old pregnant woman comes in for routine prenatal care and the doctor advises for a thyroid profile test. Which of the following thyroid profile components is altered throughout pregnancy? </span></span></p>",
      "unique_key": "Q3649272",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. C) Total T3 level</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">During pregnancy, there is an increase in thyroid-binding globulin (TBG) due to elevated estrogen levels. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This leads to an increase in the total levels of thyroid hormones, including total T3 and total T4. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">However, the free (unbound) levels of T3 and T4 generally remain within the normal range due to homeostatic mechanisms. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The total T3 level is, therefore, altered throughout pregnancy, reflecting the increased production and binding capacity.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Free T3 level:</span></strong><span style=\"font-size:14.0pt\"> The free T3 level usually remains within the normal range during pregnancy because the body adjusts to maintain homeostasis despite the increased total thyroid hormone levels.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Free T4 level:</span></strong><span style=\"font-size:14.0pt\"> Similarly, the free T4 level generally stays within the normal range during pregnancy due to the regulatory mechanisms that balance thyroid hormone production and metabolism.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. TSH level:</span></strong><span style=\"font-size:14.0pt\"> TSH levels can fluctuate during pregnancy, especially in the first trimester, due to the influence of human chorionic gonadotropin (hCG), which can mildly stimulate the thyroid. However, overall, the TSH levels are maintained within the trimester-specific reference ranges and do not consistently remain altered throughout pregnancy like the total T3 levels.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">During pregnancy, total T3 and total T4 levels increase due to elevated thyroid-binding globulin (TBG) levels, while free T3 and free T4 levels generally remain stable. </span></span></span></li>\r\n\t<li><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Total T3 level is specifically altered throughout pregnancy.</span></span></li>\r\n</ul>",
      "correct_choice_id": 189581,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47815,
      "choices": [
        {
          "id": 190859,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">SGLT (Sodium-Glucose Linked Transporter 1)</span></span></span></p>"
        },
        {
          "id": 190860,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">SGLT2 (Sodium-Glucose Linked Transporter 2)</span></span></span></p>"
        },
        {
          "id": 190861,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">GLUT4 (Glucose Transporter Type 4)</span></span></span></p>"
        },
        {
          "id": 190862,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Na-Ca transporter (Sodium-Calcium Exchanger)</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 4-year-old child presents to the outpatient department with a one-day history of loose stools. On examination, signs of dehydration are present. The child is treated with oral rehydration solution (ORS). The administration of ORS facilitates glucose absorption through which of the following receptors? </span></span></p>",
      "unique_key": "Q9900691",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans.&nbsp; A)&nbsp; SGLT1 (Sodium-Glucose Linked Transporter 1):</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">SGLT1 is a transporter protein located in the brush border of the small intestine. It is responsible for the co-transport of glucose and sodium from the lumen of the intestine into the enterocytes. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">When ORS, which contains glucose and sodium, is administered to a dehydrated child, the glucose component is absorbed into the intestinal cells via SGLT1. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This absorption process is coupled with the uptake of sodium ions, creating an osmotic gradient that promotes water absorption. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This mechanism is crucial in rehydrating the patient effectively by replenishing both fluids and electrolytes lost due to diarrhoea.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/07/screenshot-2024-06-07-103244.png\" style=\"height:194px; width:500px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B.&nbsp; SGLT2 (Sodium-Glucose Linked Transporter 2):</span></strong><span style=\"font-size:14.0pt\"> This transporter is primarily found in the renal proximal tubules of the kidneys. Its main function is to reabsorb glucose from the glomerular filtrate back into the blood, preventing glucose loss in urine. It does not play a role in the intestinal absorption of glucose and is therefore not involved in the action of ORS in treating dehydration.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. GLUT4 (Glucose Transporter Type 4):</span></strong><span style=\"font-size:14.0pt\"> GLUT4 is an insulin-regulated glucose transporter found in adipose tissue and muscle cells. It facilitates the uptake of glucose into cells in response to insulin, playing a key role in glucose homeostasis. However, it is not involved in the absorption of glucose from the intestinal lumen, making it irrelevant to the mechanism of ORS.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Na-Ca Transporter (Sodium-Calcium Exchanger):</span></strong><span style=\"font-size:14.0pt\"> This transporter is involved in the exchange of sodium and calcium ions across cell membranes, primarily in cardiac and smooth muscle cells. It plays a role in cellular calcium homeostasis and cardiac contractility. It does not participate in glucose absorption in the intestines and therefore is not relevant to the action of ORS in rehydration therapy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The administration of oral rehydration solution (ORS) facilitates glucose absorption through the SGLT1 transporter in the small intestine, which is crucial for effective rehydration by enhancing the uptake of both sodium and water.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/07/screenshot-2024-06-07-103433.png\" style=\"height:1463px; width:1000px\" /></span></span></span></p>",
      "correct_choice_id": 190859,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        2
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47656,
      "choices": [
        {
          "id": 190235,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The RDA is established by a panel of experts based on scientific research.</span></span></span></p>"
        },
        {
          "id": 190236,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The RDA meets the dietary needs of every individual in the population.</span></span></span></p>"
        },
        {
          "id": 190237,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The RDA is typically set above the minimal nutritional requirement to cover variations in needs.</span></span></span></p>"
        },
        {
          "id": 190238,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The RDA is derived from the Estimated Average Requirement (EAR).</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following statements about the Recommended Dietary Allowance (RDA) is false? </span></span></p>",
      "unique_key": "Q1996290",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans.&nbsp;</span></strong><strong><span style=\"font-size:14.0pt\">B) The RDA meets the dietary needs of every individual in the population.</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This is false because while the Recommended Dietary Allowance (RDA) aims to cover the nutritional needs of nearly all (97-98%) healthy individuals in a particular age and gender group, it does not necessarily cater to every single individual, especially those with unique health conditions or exceptional nutritional requirements.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. The RDA is established by a panel of experts based on scientific research: </span></strong><strong><span style=\"font-size:14.0pt\">&nbsp;True, </span></strong><span style=\"font-size:14.0pt\">The RDA is determined by a panel of nutrition and health experts who base their recommendations on extensive scientific research.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. The RDA is typically set above the minimal nutritional requirement to cover variations in needs:</span></strong><strong><span style=\"font-size:14.0pt\"> True,</span></strong><span style=\"font-size:14.0pt\"> The RDA often includes a margin to ensure the nutritional sufficiency for different conditions, including periods of growth, illness, or higher metabolic demand, making it higher than the minimal nutritional requirements.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Option D.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>The RDA is derived from the Estimated Average Requirement (EAR):</strong><strong> True,</strong> The RDA is indeed based on the Estimated Average Requirement (EAR), which is the average daily nutrient intake level estimated to meet the requirement of half the healthy individuals in a particular life stage and gender group.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Recommended Dietary Allowance (RDA)</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Definition: Recommended Dietary Allowance (RDA): Is a level of intake corresponding to Mean + 2 Standard Deviation, which covers requirement of 97.5% of population</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">RDA is safe level of intake which is likely to be inadequate in not more than 2.5% population</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">RDA is decided by a panel of experts and is based on scientific research</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">RDA is often higher than the recommended minimum requirement: RDA includes both daily requirement and some additional requirement for periods of growth or illness </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">RDA is based on Estimated Average Requirement </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">RDA &lsquo;safe level approach&rsquo; is not used for energy since excess energy intake is undesirable</span></span></span></li>\r\n\t<li><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">For energy: only mean or average requirement is defined as RDA.</span></span></li>\r\n</ul>",
      "correct_choice_id": 190236,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47820,
      "choices": [
        {
          "id": 190879,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Spinal anesthesia </span></span></span></p>"
        },
        {
          "id": 190880,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Epidural anesthesia </span></span></span></p>"
        },
        {
          "id": 190881,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Lumbar puncture</span></span></span></p>"
        },
        {
          "id": 190882,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Both A and C</span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Identify the procedure for which the instrument given below is used:<strong> </strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/07/screenshot-2024-06-07-103841.png\" style=\"height:308px; width:400px\" /></p>",
      "unique_key": "Q8890488",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Ans. B) Epidural anesthesia</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The instrument shown is an epidural Tuohy needle, which is used specifically for administering epidural anesthesia. </span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. </span></strong><span style=\"font-size:14.0pt\">Spinal anesthesia and Option C. Lumbar puncture most commonly use Quincke babcock needle </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/07/screenshot-2024-06-07-103931.png\" style=\"height:89px; width:400px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/07/screenshot-2024-06-07-104036.png\" style=\"height:415px; width:1000px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The needle shown above is specifically designed for administering epidural anesthesia.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 190880,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        19
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47827,
      "choices": [
        {
          "id": 190907,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Constant Km and increased Vmax</span></span></span></p>"
        },
        {
          "id": 190908,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Constant Km and decreased Vmax</span></span></span></p>"
        },
        {
          "id": 190909,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Decreased Km and decreased Vmax</span></span></span></p>"
        },
        {
          "id": 190910,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Decreased Km and increased Vmax</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A biochemistry student is studying the effects of various types of enzyme inhibition on enzyme kinetics. She learns about non-competitive inhibition and its impact on enzyme activity. Which of the following statements is true regarding non-competitive inhibition? </span></span></p>",
      "unique_key": "Q5297306",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans.&nbsp;</span></strong><strong><span style=\"font-size:14.0pt\">B) Constant Km and decreased Vmax</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Non-competitive inhibition occurs when an inhibitor binds to an enzyme at a site other than the active site, which is known as an allosteric site. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This binding alters the enzyme&#39;s structure and function, reducing its catalytic activity. In non-competitive inhibition, the maximum reaction velocity (Vmax) is decreased because the inhibitor affects the enzyme regardless of the concentration of the substrate. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">However, the Km (Michaelis constant), which reflects the affinity of the enzyme for the substrate, remains unchanged because the inhibitor does not compete with the substrate for the active site.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/07/screenshot-2024-06-07-104953.png\" style=\"height:306px; width:1000px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Constant Km and increased Vmax:</span></strong><span style=\"font-size:14.0pt\"> Non-competitive inhibition does not increase Vmax; it decreases it.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Decreased Km and decreased Vmax:</span></strong><span style=\"font-size:14.0pt\"> Km remains constant in non-competitive inhibition.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Decreased Km and increased Vmax:</span></strong><span style=\"font-size:14.0pt\"> Neither Km decreases nor Vmax increases in non-competitive inhibition.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In non-competitive inhibition, the inhibitor binds to an allosteric site, leading to a constant Km and a decreased Vmax, reflecting reduced enzyme activity regardless of substrate concentration.</span></span></li>\r\n</ul>",
      "correct_choice_id": 190908,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        1
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47795,
      "choices": [
        {
          "id": 190783,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">It is a thickening of the lumbar fascia</span></span></span></p>"
        },
        {
          "id": 190784,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">It lies anterior to the Poupart&#39;s ligament</span></span></span></p>"
        },
        {
          "id": 190785,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">It inserts into the pubic tubercle in front of the conjoint tendon</span></span></span></p>"
        },
        {
          "id": 190786,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">The fibers fan out with fascia iliaca laterally</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 32-year-old male presents with groin pain after lifting heavy objects at work. On physical examination, tenderness is noted in the inguinal region. The attending physician discusses the anatomical structures related to inguinal hernias with the medical students, specifically the iliopubic tract. Which of the following statements is true about the iliopubic tract?</span></span></p>",
      "unique_key": "Q7196455",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. D) The fibers fan out with fascia iliaca laterally</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">The iliopubic tract is a fibrous band that extends from the iliac crest to the pubic tubercle. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">It is an important anatomical landmark in the inguinal region, especially in relation to inguinal hernias. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">The fibers of the iliopubic tract fan out laterally and blend with the fascia iliaca, which covers the iliacus muscle. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">This structure is significant in surgical procedures involving the inguinal region, as it helps delineate the boundaries of the inguinal canal and hernia repairs.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/07/screenshot-2024-06-07-094551.png\" style=\"height:252px; width:400px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. It is a thickening of the lumbar fascia:</span></strong><span style=\"font-size:14.0pt\"> This statement is incorrect. The iliopubic tract is not a thickening of the lumbar fascia but rather a distinct fibrous structure associated with the inguinal region.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. It lies anterior to the Poupart&#39;s ligament:&nbsp;</span></strong><span style=\"font-size:14.0pt\">This statement is incorrect. The iliopubic tract actually lies posterior to the inguinal ligament (Poupart&#39;s ligament), not anterior.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. It inserts into the pubic tubercle in front of the conjoint tendon:</span></strong><span style=\"font-size:14.0pt\"> This statement is incorrect. While the iliopubic tract is related to the pubic tubercle, it does not insert in front of the conjoint tendon. The conjoint tendon is a structure formed by the fusion of the transversus abdominis and internal oblique muscles, and it lies medially to the iliopubic tract.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">The iliopubic tract is a fibrous band in the inguinal region that fans out laterally and blends with the fascia iliaca. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">It is crucial in understanding the anatomy of the inguinal region, particularly in the context of inguinal hernias.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 190786,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        3
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47578,
      "choices": [
        {
          "id": 189923,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Choroidal hemangioma, iris heterochromia- Sturge Weber syndrome</span></span></span></p>"
        },
        {
          "id": 189924,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:14.0pt\">Retinal hemangiomas &ndash; Von hippel lindau syndrome</span></span></span></p>"
        },
        {
          "id": 189925,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">B/L Lisch nodules, eyelid plexiform neurofibroma- Neurofibromatosis &ndash; 2</span></span></span></p>"
        },
        {
          "id": 189926,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:14.0pt\">Iris coloboma, Retinal astrocytoma &ndash; Tuberous sclerosis</span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Choose the incorrect option:</span></span></p>",
      "unique_key": "Q8433332",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Ans. C) B/L Lisch nodules, eyelid plexiform neurofibroma- Neurofibromatosis &ndash; 2</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Bilateral Lisch nodules and eyelid plexiform neurofibromas are actually characteristic of Neurofibromatosis type 1 (NF1), not Neurofibromatosis type 2 (NF2). NF2 is more commonly associated with posterior subcapsular cataract and retinal hamartomas, but not Lisch nodules or eyelid plexiform neurofibromas.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Choroidal hemangioma, iris heterochromia - Sturge Weber syndrome</span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Sturge Weber syndrome is associated with ocular manifestations such as choroidal hemangioma and iris heterochromia. These features are typical and consistent with the syndrome.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Retinal hemangiomas &ndash; Von Hippel Lindau syndrome</span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Von Hippel Lindau syndrome commonly presents with retinal hemangiomas. This is a key ocular manifestation of the syndrome, making this option correct.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Iris coloboma, Retinal astrocytoma &ndash; Tuberous sclerosis</span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Tuberous sclerosis typically presents with ocular manifestations such as atypical iris coloboma and retinal astrocytoma. These features are indicative of the condition, confirming the accuracy of this option.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Choroidal hemangioma, iris heterochromia- Sturge Weber syndrome</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:14.0pt\">Retinal hemangiomas &ndash; Von hippel lindau syndrome</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">B/L Lisch nodules, eyelid plexiform neurofibroma- Neurofibromatosis &ndash; 1</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:14.0pt\">Iris coloboma, Retinal astrocytoma &ndash; Tuberous sclerosis</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 189925,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        13
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47716,
      "choices": [
        {
          "id": 190475,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">1-a, 2-b, 3-c, 4-d</span></span></span></p>"
        },
        {
          "id": 190476,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">1-b, 2-d, 3-a, 4-c</span></span></span></p>"
        },
        {
          "id": 190477,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">1-b, 2-c, 3-d, 4-a</span></span></span></p>"
        },
        {
          "id": 190478,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">1-b, 2-d, 3-c, 4-a</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Match the following diseases with the respective odor of urine</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Column A</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">1. Isovaleric acidemia</span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">2. Phenylketonuria</span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">3. Tyrosinemia</span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">4. MSUD</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Column B</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">a. Maple syrup</span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">b. Sweaty feet</span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">c. Boiled cabbage</span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">d. Mousy</span></span></span></p>",
      "unique_key": "Q2586405",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Ans. D)</span></strong><strong><span style=\"font-size:14.0pt\"> 1-b, 2-d, 3-c, 4-a</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">1-b: Isovaleric acidemia</span></strong><span style=\"font-size:14.0pt\"> is associated with a distinctive &quot;sweaty feet&quot; odor due to the accumulation of isovaleric acid.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">2-d: Phenylketonuria</span></strong><span style=\"font-size:14.0pt\"> often presents a &quot;mousy&quot; odor in the urine, which results from phenylalanine breakdown products.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">3-c: Tyrosinemia</span></strong><span style=\"font-size:14.0pt\"> can result in a urine odor resembling &quot;boiled cabbage&quot; due to the accumulation of tyrosine and its metabolites.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">4-a: Maple Syrup Urine Disease (MSUD)</span></strong><span style=\"font-size:14.0pt\"> is named after the characteristic &quot;maple syrup&quot; odor of the urine caused by the accumulation of certain amino acids.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Educational Objective </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/07/screenshot-2024-06-07-185446.JPG\" style=\"height:299px; width:1000px\" /></p>",
      "correct_choice_id": 190478,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        13
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47567,
      "choices": [
        {
          "id": 189879,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Gilbert</span></span></span></p>"
        },
        {
          "id": 189880,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Nyhus</span></span></span></p>"
        },
        {
          "id": 189881,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Rives-Stoppa</span></span></span></p>"
        },
        {
          "id": 189882,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">European Hernia Society</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Primary direct inguinal hernia with a 3 cm defect is labelled as PM2. This nomenclature is according to which classification system?</span></span></p>",
      "unique_key": "Q8122168",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. D) European Hernia Society</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The European Hernia Society&#39;s classification system is the most recent and is based on whether the hernia is primary or recurrent, the location (lateral, medial, or femoral), and the size of the defect measured in fingerbreadths.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The European Hernia Society has recently suggested a simplified system of:</span></span></span>\r\n\t<ul>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Primary or recurrent (P or R); </span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Lateral, medial or femoral (L, M or F);</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Defect size in fingerbreadths (assumed to be 1.5&nbsp;cm), with three sizes of one fingerbreadth or less, between one and three fingerbreadths and three or more fingerbreadths. </span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">E.g.,</span></strong><span style=\"font-size:14.0pt\"> A primary indirect inguinal hernia with a 3-cm defect size would be PL2.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Gilbert</span></strong><span style=\"font-size:14.0pt\">: Gilbert&#39;s classification is an older system that classifies inguinal hernias based on their anatomic position and the integrity of the inguinal canal floor.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Nyhus: </span></strong><span style=\"font-size:14.0pt\">&nbsp;The Nyhus classification, which is also one of the older systems, is based on the presence of a hernia sac, the condition of the internal ring, and the presence or absence of a posterior wall defect.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Rives-Stoppa</span></strong><span style=\"font-size:14.0pt\">:&nbsp; This is not a classification system for hernias but rather a technique for ventral hernia repair using a large sublay mesh.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The European Hernia Society&#39;s classification is the most recent system for classifying groin hernias, which includes primary or recurrent status, location of the hernia, and the size of the defect.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 189882,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        12
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47882,
      "choices": [
        {
          "id": 191123,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">0.25 mg</span></span></span></p>"
        },
        {
          "id": 191124,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">2 mg</span></span></span></p>"
        },
        {
          "id": 191125,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">20 mg</span></span></span></p>"
        },
        {
          "id": 191126,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">200 mg</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 30-year-old woman experiences postpartum hemorrhage following the delivery of her baby. To manage this condition, the healthcare provider considers administering PGF2 alpha. What is the maximum dose of PGF2 alpha used for treating postpartum hemorrhage? </span></span></p>",
      "unique_key": "Q3057528",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. B) 2 mg</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Postpartum hemorrhage (PPH) is a significant cause of maternal morbidity and mortality. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Prostaglandin F2 alpha (PGF2 alpha) is one of the medications used to manage this condition by stimulating uterine contractions and reducing bleeding. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The recommended dose of PGF2 alpha is 0.25 mg administered intramuscularly, and it can be repeated every 15 to 90 minutes if necessary. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">However, the total cumulative dose should not exceed 2 mg. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This limit is set to prevent potential side effects and ensure the safety of the patient.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The maximum cumulative dose of PGF2 alpha for the treatment of postpartum hemorrhage is 2 mg.</span></span></p>",
      "correct_choice_id": 191124,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47718,
      "choices": [
        {
          "id": 190483,
          "text": "<p><span style=\"font-size:14.0pt;\">Paralytic ileus - Put a NG tube</span></p>"
        },
        {
          "id": 190484,
          "text": "<p><span style=\"font-size:14.0pt;\">Paralytic ileus - CECT abdomen</span></p>"
        },
        {
          "id": 190485,
          "text": "<p><span style=\"font-size:14.0pt;\">Adhesive obstruction - CECT abdomen</span></p>"
        },
        {
          "id": 190486,
          "text": "<p><span style=\"font-size:14.0pt;\">Adhesive obstruction - laparotomy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 20-year-old male presents with colicky abdominal pain and bilious vomiting 3 years following an open appendectomy. Abdominal examination reveals hyper-peristalsis. X ray abdomen showed the following. What is the likely pathology and the next step?</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/06/screenshot-2024-06-06-150837.png\" alt=\"\" width=\"400\" height=\"331\"></p>",
      "unique_key": "Q4760861",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Adhesive obstruction - CECT abdomen</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">Adhesive obstruction is the <strong>MC complication (late)</strong> of appendicectomy. X ray shows mechanical obstruction- step ladder pattern of air fluid levels.</span></li><li><span style=\"font-size:14.0pt;\">Next step in mechanical obstruction is CECT abdomen to identify etiology/site of obstruction and presence of bowel ischemia.</span></li><li><span style=\"font-size:14.0pt;\">Adhesive obstruction occurs as a late complication of abdominal surgery, such as appendectomy, due to the formation of scar tissue (adhesions) that cause mechanical obstruction of the intestine.</span></li><li><span style=\"font-size:14.0pt;\">Patients typically present with colicky abdominal pain, vomiting, and abdominal distension.</span></li><li><span style=\"font-size:14.0pt;\">The presence of a step ladder pattern of air-fluid levels on X-ray suggests a mechanical obstruction, consistent with adhesive obstruction.</span></li><li><span style=\"font-size:14.0pt;\">Therefore, obtaining a CECT abdomen is the next step in management to further evaluate the etiology, site, and severity of the obstruction, as well as to assess for signs of bowel ischemia or other complications.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Paralytic ileus - Put a NG tube: </strong>Paralytic ileus is characterized by decreased bowel motility without mechanical obstruction. Patients typically present with decreased or absent bowel sounds and lack of peristalsis. Inserting a nasogastric (NG) tube for decompression may be indicated to relieve abdominal distension and vomiting. However, in this case, the presence of a step ladder pattern of air-fluid levels on X-ray suggests a mechanical obstruction rather than paralytic ileus.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Paralytic ileus - CECT abdomen: </strong>Paralytic ileus is characterized by generalized decreased bowel motility due to various causes such as surgery, inflammation, or neurological dysfunction. It typically presents with diffuse abdominal distension, absence of peristalsis, and lack of bowel sounds. In this scenario, however, the X-ray findings indicate a mechanical obstruction with a step ladder pattern of air-fluid levels, which is not consistent with paralytic ileus. Therefore, obtaining a contrast-enhanced computed tomography (CECT) abdomen, while useful in certain clinical scenarios to assess for complications or underlying pathology, may not be the most appropriate next step given the suggestive findings of mechanical obstruction.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Adhesive obstruction â€“ laparotomy: </strong>While adhesive obstruction may ultimately require surgical intervention, such as laparotomy, for definitive management, it is essential to first obtain imaging studies to confirm the diagnosis and evaluate the extent of the obstruction. A CECT abdomen provides valuable information about the underlying pathology, location of obstruction, and presence of complications such as bowel ischemia. Therefore, proceeding directly to laparotomy without prior imaging may not be warranted and could potentially lead to unnecessary surgery.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective</strong>:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">While all options involve aspects of management for bowel obstruction, the presence of a step ladder pattern of air-fluid levels on X-ray suggests mechanical obstruction, likely due to adhesive obstruction.</span></li><li><span style=\"font-size:14.0pt;\">The next appropriate step is to obtain a CECT abdomen to further evaluate the etiology and extent of the obstruction before considering surgical intervention.</span></li></ul>",
      "correct_choice_id": 190485,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        12
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47699,
      "choices": [
        {
          "id": 190407,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">IgM in CSF</span></span></span></p>"
        },
        {
          "id": 190408,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Tzanck smear of CSF</span></span></span></p>"
        },
        {
          "id": 190409,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">CSF PCR for viral DNA</span></span></span></p>"
        },
        {
          "id": 190410,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">CSF culture on chick embryo lines</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 40-year-old male presents to the emergency department with a one-day history of high fever, altered mental status, severe headache, neck rigidity, and new-onset seizures. He also reports having had oral herpes flare-ups in the past. Given the clinical presentation and history, HSV encephalitis is suspected, and a lumbar puncture is performed to obtain CSF for definitive diagnostic testing. Which of the following tests is most appropriate to confirm the diagnosis of HSV encephalitis in this patient? </span></span></p>",
      "unique_key": "Q3609134",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. C) CSF PCR for viral DNA</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The gold standard for diagnosing HSV encephalitis is the demonstration of HSV DNA in the CSF by PCR. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This method is highly specific and provides rapid results, which are essential for the timely initiation of antiviral therapy. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">HSV-1, the typical cause of encephalitis, has properties like latency in the trigeminal ganglia and a transmission mode through direct contact with mucosa or abraded skin.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. IgM in CSF:</span></strong><span style=\"font-size:14.0pt\"> Serological tests to detect antibodies are used for primary herpes infections.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Tzanck smear of CSF:</span></strong><span style=\"font-size:14.0pt\"> Rapid, fairly sensitive and inexpensive diagnostic method, but prepared from the lesions, preferably from the base of vesicles and stained with 1% aqueous solution of toluidine blue &lsquo;0&rsquo; for 15 seconds, not CSF.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. CSF culture on chick embryo lines:</span></strong><span style=\"font-size:14.0pt\"> HSV-1 does not grow well in chick embryo fibroblast cultures, making this method inefficient for the confirmation of HSV encephalitis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">For suspected HSV encephalitis, CSF PCR for viral DNA is the diagnostic test of choice due to its high specificity and sensitivity. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Other investigations that can help include:</span></span></span></li>\r\n</ul>\r\n\r\n<ul style=\"list-style-type:circle; margin-left:40px\">\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">CSF examination&nbsp;&nbsp;&nbsp;&nbsp;</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">CSF culture</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Serological studies</span></span></span></li>\r\n\t<li><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">MRI, CT, EEG, and brain biopsy.</span></span></li>\r\n</ul>",
      "correct_choice_id": 190409,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        6
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47485,
      "choices": [
        {
          "id": 189551,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Acyclovir and induction of labor</span></span></span></p>"
        },
        {
          "id": 189552,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Antiviral and normal vaginal delivery</span></span></span></p>"
        },
        {
          "id": 189553,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Spontaneous delivery</span></span></span></p>"
        },
        {
          "id": 189554,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Acyclovir and elective Cesarean section</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 29-year-old primigravida presents at 36 weeks of gestation with painful vulvar ulcers. She has no history of similar lesions in the past. On examination, there are multiple painful vesicular lesions. What is the best treatment option? </span></span></p>",
      "unique_key": "Q4799329",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. D) Acyclovir and elective Cesarean section</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The presence of multiple painful vesicular lesions at 36 weeks&rsquo; gestation is highly suggestive of a primary herpes simplex virus (HSV) infection. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">HSV infection in late pregnancy, especially with active lesions, poses a significant risk of neonatal herpes, which can be severe or even fatal. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The best management in this scenario includes administering acyclovir to help reduce viral load and performing an elective Cesarean section to prevent the transmission of the virus to the newborn during vaginal delivery.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Acyclovir and induction of labor:</span></strong><span style=\"font-size:14.0pt\"> While acyclovir is appropriate, induction of labor would still pose a high risk of neonatal herpes transmission if active lesions are present at the time of delivery.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Antiviral and normal vaginal delivery:</span></strong><span style=\"font-size:14.0pt\"> Administering antivirals is important, but allowing a normal vaginal delivery with active HSV lesions would significantly increase the risk of neonatal herpes.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Spontaneous delivery:</span></strong><span style=\"font-size:14.0pt\"> Allowing spontaneous vaginal delivery in the presence of active HSV lesions carries a high risk of transmitting the virus to the newborn, leading to potentially severe neonatal herpes infection.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In the case of a primary herpes simplex virus (HSV) infection with active lesions in late pregnancy, the best treatment option is to administer antiviral therapy such as acyclovir and to plan an elective Cesarean section to reduce the risk of neonatal herpes transmission.</span></span></li>\r\n</ul>",
      "correct_choice_id": 189554,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47739,
      "choices": [
        {
          "id": 190563,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Primary sclerosing cholangitis </span></span></p>"
        },
        {
          "id": 190564,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Erythema nodosum</span></span></p>"
        },
        {
          "id": 190565,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Uveitis </span></span></p>"
        },
        {
          "id": 190566,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hemolytic anemia</span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 30-year-old female with a history of Crohn&#39;s disease presents with fatigue, jaundice, and pruritus. Liver function tests reveal elevated alkaline phosphatase and gamma-glutamyl transferase levels. Which of the following is NOT a common extraintestinal manifestation of Crohn&#39;s disease?</span></span></p>",
      "unique_key": "Q7223383",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Ans. </span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">D) Hemolytic anemia</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Crohn&#39;s disease, an inflammatory bowel disease (IBD), is often associated with a variety of extraintestinal manifestations, affecting various organs outside the gastrointestinal tract.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">However, Hemolytic anemia</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"> is not typically associated with Crohn&#39;s disease. </span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Option A.</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"> <strong>Primary sclerosing cholangitis (PSC)</strong>: PSC is a known, though less common, extraintestinal manifestation of Crohn&#39;s disease, particularly in cases with extensive colonic involvement.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Option B.</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"> <strong>Erythema nodosum</strong>: Erythema nodosum is a common dermatologic manifestation in Crohn&#39;s disease, often presenting as painful, red nodules on the legs.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Option C.</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"> <strong>Uveitis</strong>: Uveitis is an inflammatory condition affecting the eyes and is a recognized extraintestinal manifestation of Crohn&#39;s disease.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Primary sclerosing cholangitis, erythema nodosum, and uveitis are common extraintestinal manifestations of Crohn&#39;s disease. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Hemolytic anemia, however, is not typically associated with Crohn&#39;s disease.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 190566,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47593,
      "choices": [
        {
          "id": 189983,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Grey kit for scrotal swelling with Azithromycin and Cefixime</span></span></span></p>"
        },
        {
          "id": 189984,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Green kit for vaginal discharge with Secnidazole and Fluconazole</span></span></span></p>"
        },
        {
          "id": 189985,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Red kit for herpetic genito-ulcerative disease with Acyclovir</span></span></span></p>"
        },
        {
          "id": 189986,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Blue kit for non-herpetic genito-ulcerative disease with Azithromycin and Benzathine penicillin</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Identify the mismatched option out of the following option of the color-coded STI kit and its intended syndrome or treatment contents:</span></span></p>",
      "unique_key": "Q6350699",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>D) Blue kit for non-herpetic genito-ulcerative disease with Azithromycin and Benzathine penicillin</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This i</span><span style=\"font-size:14.0pt\">s incorrect<strong> </strong>as the blue kit for non-herpetic genito-ulcerative disease in a patient allergic to penicillin should contain Azithromycin and Doxycycline, not Benzathine penicillin. Benzathine penicillin is inappropriate for patients allergic to penicillin.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options</span></strong><span style=\"font-size:14.0pt\">:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A.&nbsp;</span></strong><span style=\"font-size:14.0pt\"><strong>Grey kit for scrotal swelling with Azithromycin and Cefixime:&nbsp;</strong>Grey kit contains Azithromycin and Cefixime, appropriate for treating urethral, anorectal, cervical discharge, or scrotal swelling.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B.&nbsp;</span></strong><strong><span style=\"font-size:14.0pt\">Green kit for vaginal discharge with Secnidazole and Fluconazole:&nbsp;</span></strong><span style=\"font-size:14.0pt\">Green kit includes Secnidazole and Fluconazole,<strong> </strong>suitable for treating vaginal discharge due to causes like trichomoniasis, candidiasis, or bacterial vaginosis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Red kit for herpetic genito-ulcerative disease with Acyclovir:</span></strong><strong> </strong><span style=\"font-size:14.0pt\">Red kit with Acyclovir is used for managing herpetic genito-ulcerative disease, focusing on herpes simplex virus infections.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">STI color coded kits are as follows:</span></span></strong></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/05/screenshot-2024-06-05-160541.JPG\" style=\"height:459px; width:1000px\" /></span></span></strong></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/05/screenshot-2024-06-05-160555.JPG\" style=\"height:364px; width:500px\" /></span></span></strong><br />\r\n&nbsp;</p>",
      "correct_choice_id": 189986,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47843,
      "choices": [
        {
          "id": 190971,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Clotrimazole</span></span></span></p>"
        },
        {
          "id": 190972,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Griseofulvin</span></span></span></p>"
        },
        {
          "id": 190973,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Terbinafine</span></span></span></p>"
        },
        {
          "id": 190974,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Flucytosine</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 45-year-old male with bronchial asthma, regularly using inhalational steroids, reports to his physician complaining of white patchy lesions on his tongue and inside his cheeks. He is concerned about these symptoms, which appeared shortly after starting his new medication regimen. Given these symptoms, what is the most appropriate antifungal medication to prescribe? </span></span></p>",
      "unique_key": "Q3443549",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans.&nbsp;</span></strong><strong><span style=\"font-size:14.0pt\">A) Clotrimazole</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The patient&#39;s symptoms are indicative of <strong>oral candidiasis</strong>, a common complication in individuals using inhalational steroids due to the immunosuppressive effect of steroids and their tendency to alter normal oral flora. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Clotrimazole, an antifungal medication from the azole group, is effective for treating this condition as it inhibits ergosterol synthesis, a crucial component of the fungal cell membrane. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">It is commonly used topically for the treatment of oral candidiasis and is available in lozenge form, which is suitable for oral infections.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Griseofulvin</span></strong><span style=\"font-size:14.0pt\">: This drug targets dermatophytes by disrupting microtubule function and is primarily used for tinea infections of the scalp, skin, and nails but is ineffective against Candida species.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Terbinafine</span></strong><span style=\"font-size:14.0pt\">: Acts by inhibiting squalene epoxidase in the fungal cell, disrupting ergosterol biosynthesis. It is primarily used for nail onychomycosis and dermatophyte infections, not for oral candidiasis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Flucytosine</span></strong><span style=\"font-size:14.0pt\">: A systemic antifungal that inhibits fungal DNA and RNA synthesis. It is typically used in severe systemic fungal infections and is not indicated for oral candidiasis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">For asthma patients experiencing oral candidiasis due to inhalational steroid use, clotrimazole is the recommended treatment. </span></span></span></li>\r\n\t<li><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is effective, easy to use, and targets the pathogenic yeast directly in the oral cavity, relieving symptoms and eradicating the infection.</span></span></li>\r\n</ul>",
      "correct_choice_id": 190971,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47563,
      "choices": [
        {
          "id": 189863,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Enfuviritide</span></span></span></p>"
        },
        {
          "id": 189864,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Abacavir</span></span></span></p>"
        },
        {
          "id": 189865,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Emtricitabine</span></span></span></p>"
        },
        {
          "id": 189866,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Ritonavir</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 35-year-old male patient, diagnosed with both HIV and chronic hepatitis B, is being evaluated for antiviral therapy options. Which antiviral drug, known to have dual activity against both HIV and hepatitis B, would be most appropriate for this patient? </span></span></p>",
      "unique_key": "Q8010436",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans.&nbsp;</span></strong><strong><span style=\"font-size:14.0pt\">C) Emtricitabine</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Emtricitabine is a nucleoside reverse transcriptase inhibitor (NRTI) that is effective against both HIV and hepatitis B virus (HBV). </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This dual antiviral activity makes it particularly valuable in treating patients co-infected with both viruses. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Emtricitabine is often used in combination with other antiretrovirals to provide a potent antiviral regimen for HIV, while also managing HBV replication.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Enfuviritide</span></strong><span style=\"font-size:14.0pt\">: This drug is a fusion inhibitor specific to HIV and does not have efficacy against HBV.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Abacavir</span></strong><span style=\"font-size:14.0pt\">: Another NRTI effective against HIV but does not have activity against HBV.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Ritonavir</span></strong><span style=\"font-size:14.0pt\">: Primarily used as a booster for other protease inhibitors in the treatment of HIV; it does not have activity against HBV.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Emtricitabine is effective in the treatment of both HIV and chronic hepatitis B, making it a crucial option for patients co-infected with these viruses. </span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Mnemonic</span></strong><span style=\"font-size:14.0pt\"> for the drug have dual activity against HIV and HBV &ndash; </span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:14.0pt\">L: L</span></strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:14.0pt\">amivudine</span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:14.0pt\">E: E</span></strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:14.0pt\">mtricitabine</span></span></span></p>\r\n\r\n<p><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">T: T</span></span></strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">enofovir</span></span></p>",
      "correct_choice_id": 189865,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47482,
      "choices": [
        {
          "id": 189539,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Hysteroscopy and septoplasty</span></span></span></p>"
        },
        {
          "id": 189540,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Laparoscopy and metroplasty</span></span></span></p>"
        },
        {
          "id": 189541,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Laparotomy and metroplasty</span></span></span></p>"
        },
        {
          "id": 189542,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hysterectomy</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 33-year-old woman presents for evaluation of infertility. Imaging studies reveal a septum in her uterine cavity. What is the most appropriate management for this condition? </span></span></p>",
      "unique_key": "Q1595154",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. A) Hysteroscopy and septoplasty</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Hysteroscopic and septoplasty is the preferred method for managing a uterine septum in a patient with infertility. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This minimally invasive procedure allows direct visualization and precise resection of the septum within the uterine cavity. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">It has the advantage of a shorter recovery time and lower complication rates compared to open surgical procedures. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The goal of septoplasty is to restore the normal uterine cavity shape, which can improve reproductive outcomes.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Laparoscopy and Metroplasty:</span></strong><span style=\"font-size:14.0pt\"> While laparoscopy is a minimally invasive procedure, it is not typically used for the resection of a uterine septum. Metroplasty via laparoscopy is more commonly associated with the correction of other uterine anomalies, such as a bicornuate uterus.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Laparotomy and Metroplasty:</span></strong><span style=\"font-size:14.0pt\"> Laparotomy, an open surgical procedure, and metroplasty are more invasive and are generally reserved for more complex uterine anomalies. They are not first-line treatments for a uterine septum due to the increased morbidity compared to hysteroscopic approaches.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Hysterectomy:</span></strong><span style=\"font-size:14.0pt\"> Hysterectomy, the removal of the uterus, is not indicated for a uterine septum, especially in a patient desiring future fertility. This option would eliminate the possibility of pregnancy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The most appropriate management for a uterine septum in a patient with infertility is hysteroscopic septoplasty. </span></span></span></li>\r\n\t<li><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This minimally invasive procedure effectively corrects the uterine anomaly with lower risks and a quicker recovery, improving the chances of a successful pregnancy.</span></span></li>\r\n</ul>",
      "correct_choice_id": 189539,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47585,
      "choices": [
        {
          "id": 189951,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Ectopic pregnancy</span></span></span></p>"
        },
        {
          "id": 189952,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Endometriosis</span></span></span></p>"
        },
        {
          "id": 189953,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">&nbsp;Menstrual irregularities</span></span></span></p>"
        },
        {
          "id": 189954,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">&nbsp;Pelvic inflammatory disease</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following conditions is a contraindication for performing a dilatation and curettage (D&amp;C) in the patient?</span></span></p>",
      "unique_key": "Q7057702",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">&nbsp;Ans. D) Pelvic inflammatory disease</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Dilatation and curettage (D&amp;C) is contraindicated in the presence of active pelvic inflammatory disease. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Performing a D&amp;C in a patient with PID can exacerbate the infection, potentially leading to severe complications such as sepsis, spread of the infection, or damage to the reproductive organs. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">PID needs to be treated and resolved before considering D&amp;C.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Ectopic pregnancy:</span></strong><span style=\"font-size:14.0pt\"> While D&amp;C is not used to treat ectopic pregnancy, the presence of an ectopic pregnancy is not a direct contraindication for the procedure. Ectopic pregnancy requires specific management, typically with methotrexate or surgical intervention.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Endometriosis:</span></strong><span style=\"font-size:14.0pt\"> Endometriosis is not a contraindication for D&amp;C. The procedure can be performed if indicated for other reasons, such as abnormal uterine bleeding.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Menstrual irregularities:</span></strong><span style=\"font-size:14.0pt\"> Menstrual irregularities themselves are not a contraindication for D&amp;C. In fact, D&amp;C can be performed as a diagnostic or therapeutic procedure for menstrual irregularities.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Dilatation and curettage (D&amp;C) is contraindicated in patients with active pelvic inflammatory disease (PID) due to the risk of exacerbating the infection and causing severe complications. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">PID should be treated and resolved before considering D&amp;C.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 189954,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47805,
      "choices": [
        {
          "id": 190823,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Closed reduction and assessment of hip stability</span></span></span></p>"
        },
        {
          "id": 190824,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">CT and 3D reconstruction</span></span></span></p>"
        },
        {
          "id": 190825,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">High weight skeletal traction</span></span></span></p>"
        },
        {
          "id": 190826,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Open reduction and posterior pillar of acetabulum reconstruction</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 15-year-old boy was brought to ER following a motor vehicle collision complaining of pain over the hip. The x-ray is given below. What is the next step of management?</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/07/screenshot-2024-06-07-102107.png\" style=\"height:161px; width:300px\" /></span></span></p>",
      "unique_key": "Q8336199",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. A) Closed reduction and assessment of hip stability</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Closed reduction involves manipulating the displaced hip joint back into its normal position without surgery. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Once reduction is achieved, the stability of the hip joint is assessed through physical examination and imaging studies. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Closed reduction may be considered as the initial management step for traumatic hip dislocations, especially in the acute setting. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">However, the decision to proceed with closed reduction depends on various factors, including the stability of the reduction, the presence of associated injuries, and the patient&#39;s overall condition.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options</span></strong><span style=\"font-size:14.0pt\">: </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. CT and 3D Reconstruction:&nbsp;</span></strong><span style=\"font-size:14.0pt\">Computed tomography (CT) imaging, often with three-dimensional (3D) reconstruction, provides detailed anatomical information about the hip joint and surrounding structures. It can help assess the extent of injury, including associated fractures, displacement, and involvement of intra-articular structures. CT with 3D reconstruction is commonly performed in patients with traumatic hip injuries to further evaluate the extent of the injury and guide treatment planning. It can provide valuable information for surgical decision-making, especially in cases where closed reduction may not be feasible or sufficient.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. High Weight Skeletal Traction:&nbsp;</span></strong><span style=\"font-size:14.0pt\">High weight skeletal traction involves applying traction to the injured limb using a system of pulleys and weights to stabilize the fracture or dislocation and temporarily relieve pain.&nbsp; High weight skeletal traction may be used as a temporary measure to stabilize the hip joint and provide pain relief while awaiting definitive management, such as surgery or closed reduction. However, it is typically not the next step in management following a traumatic hip dislocation without further evaluation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Open Reduction and Posterior Pillar of Acetabulum Reconstruction:&nbsp;</span></strong><span style=\"font-size:14.0pt\">Open reduction involves surgically accessing the hip joint to manipulate the displaced bones back into their normal position. In cases of acetabular fractures involving the posterior pillar, surgical reconstruction may be necessary to restore the normal anatomy of the hip joint. Open reduction with posterior pillar reconstruction is indicated in cases of complex acetabular fractures associated with hip dislocation or instability. However, the decision to proceed with this surgical intervention would typically be based on the findings of thorough imaging studies, including CT scans, and a comprehensive assessment of the patient&#39;s condition.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The given case is a traumatic posterior dislocation of the hip. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The initial treatment of choice is the closed reduction of the dislocation followed by investigation and assessment of the reduction and the surrounding tissues for deciding on the further treatment process. </span></span></span></li>\r\n</ul>",
      "correct_choice_id": 190823,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        15
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47475,
      "choices": [
        {
          "id": 189511,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:14.0pt\">Disorder of sleep arousal&nbsp; </span></span></span></p>"
        },
        {
          "id": 189512,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:14.0pt\">Person will have full consciousness&nbsp; </span></span></span></p>"
        },
        {
          "id": 189513,
          "text": "<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Usually, terminates in awakening followed by confusion&nbsp; </span></span></p>"
        },
        {
          "id": 189514,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:14.0pt\">There may be neurological conditions associated</span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 10-year-old boy is brought to the clinic by his parents because they are concerned about his sleep behavior. They report that over the past few months, he has been getting out of bed during the night and walking around the house, and unresponsive to their attempts to communicate with him.&nbsp; What is the false statement regarding this condition? </span></span></p>",
      "unique_key": "Q7825760",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:14.0pt\">Ans. B) Person will have full consciousness</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:14.0pt\">The child&#39;s symptoms suggest sleepwalking (somnambulism), a type of parasomnia, which is a disorder of sleep arousal. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:14.0pt\">Sleepwalking involves getting out of bed and walking around during sleep, and the person is usually unresponsive to attempts to communicate and has no memory of the event. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:14.0pt\">We arrived at this answer because one key characteristic of sleepwalking is the lack of full consciousness during the episodes.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:14.0pt\">Option A. Disorder of sleep arousal:</span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:14.0pt\"> This is true. Sleepwalking is classified as a disorder of sleep arousal, occurring during the transition from deep sleep to lighter stages of sleep.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:14.0pt\">Option C. Usually, terminates in awakening followed by confusion:</span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:14.0pt\"> This is true. Episodes often end with the person awakening in a state of confusion or simply returning to bed without full awareness of the episode.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:14.0pt\">Option D. There may be neurological conditions associated:</span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:14.0pt\"> This is true. Sleepwalking can be associated with various neurological or developmental conditions, though it can also occur in otherwise healthy individuals.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:14.0pt\">Sleepwalking (somnambulism) is an arousal disorder originating from deep, non-REM stage 4 sleep. </span></span></span></li>\r\n\t<li><span dir=\"ltr\" lang=\"EN\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Individuals who sleepwalk typically act without conscious awareness and have no memory of the episode upon awakening. The person who is having sleep walking is <strong>difficult to awake</strong>. </span></span></li>\r\n</ul>",
      "correct_choice_id": 189512,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        16
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47471,
      "choices": [
        {
          "id": 189495,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Fc and C3b</span></span></span></p>"
        },
        {
          "id": 189496,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Pseudopod extension</span></span></span></p>"
        },
        {
          "id": 189497,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Respiratory burst</span></span></span></p>"
        },
        {
          "id": 189498,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Receptor-mediated endocytosis</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 45-year-old man with a history of recurrent bacterial infections is evaluated for possible immunodeficiency. Laboratory tests reveal normal immunoglobulin levels but an abnormality in the phagocytosis process of his polymorphonuclear leukocytes (PMNs). After the complement and antibody bind to the surface of encapsulated bacteria, which of the following components is crucial for the effective phagocytosis by PMNs? </span></span></p>",
      "unique_key": "Q2668706",
      "difficulty_level": "difficult",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. B) Pseudopod extension</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">After opsonization, which involves the binding of antibodies and complement to the surface of encapsulated bacteria, the phagocytosis process by polymorphonuclear leukocytes (PMNs) involves the extension of pseudopods. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Pseudopods are protrusions of the cell membrane that extend around the bacteria to engulf and internalize them into phagosomes. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This process is critical for the ingestion of the bacteria following the initial binding and recognition steps.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Fc and C3b:</span></strong><span style=\"font-size:14.0pt\"> While the binding of Fc receptors to the Fc portion of antibodies and complement receptors to C3b is crucial for opsonization, it is the subsequent pseudopod extension that physically engulfs the bacteria, leading to phagocytosis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Respiratory Burst:</span></strong><span style=\"font-size:14.0pt\"> The respiratory burst is an antimicrobial mechanism that occurs after the bacteria have been engulfed, where reactive oxygen species are produced to kill the ingested pathogens. It does not play a direct role in the initial engulfment process.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Receptor-mediated Endocytosis:</span></strong><span style=\"font-size:14.0pt\"> This process involves the uptake of specific molecules via receptors on the cell surface. While related to the internalization of substances, it is not specific to the phagocytosis of opsonized bacteria by PMNs in the context described.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">After opsonization by antibodies and complement, the effective phagocytosis of encapsulated bacteria by polymorphonuclear leukocytes (PMNs) involves the extension of pseudopods, which are cellular protrusions that engulf and internalize the bacteria.</span></span></li>\r\n</ul>",
      "correct_choice_id": 189496,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        5
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47864,
      "choices": [
        {
          "id": 191051,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Choledochojejunostomy</span></span></span></p>"
        },
        {
          "id": 191052,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Resection of proximal jejunum</span></span></span></p>"
        },
        {
          "id": 191053,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Caudate lobectomy</span></span></span></p>"
        },
        {
          "id": 191054,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Cholecystectomy</span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient with carcinoma of pancreatic head underwent surgery. All of the following are done in the procedure shown below except? </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/07/screenshot-2024-06-07-124318.png\" style=\"height:328px; width:600px\" /></span></span></p>",
      "unique_key": "Q1716450",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Ans. C) Caudate lobectomy</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">The procedure shown is Whipple&rsquo;s procedure.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">The operation has three distinct phases:</span></span></span></li>\r\n</ul>\r\n\r\n<ul style=\"list-style-type:circle; margin-left:40px\">\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">exploration and assessment;</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"FR\" style=\"font-size:14.0pt\">Resection</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"FR\" style=\"font-size:14.0pt\">Reconstruction.</span></span></span></li>\r\n</ul>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Structures removed-</span></span></span></li>\r\n</ul>\r\n\r\n<ul style=\"list-style-type:circle; margin-left:40px\">\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Head of pancreas</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">D</span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">uodenum, proximal jejunum <strong>(Option B)</strong></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Common bile duct</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Gallbladder (Option D)</span></strong></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Distal stomach (removed in original Whipple&rsquo;s but can be preserved in surgeries done these days)</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Lymph nodes</span></span></span></li>\r\n</ul>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Reconstruction- in this order-</span></span></span></li>\r\n</ul>\r\n\r\n<ul style=\"list-style-type:circle; margin-left:40px\">\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Pancreaticojejunostomy</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Choledochojejunostomy/hepaticejejunostomy (Option A)</span></strong></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Duodenojejunostomy / Gastrojejunostomy</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The Whipple&rsquo;s procedure involves the removal of the head of the pancreas, duodenum, proximal jejunum, common bile duct, gallbladder, and sometimes part of the stomach. </span></span></span></li>\r\n\t<li><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Reconstruction involves pancreaticojejunostomy, choledochojejunostomy, and gastrojejunostomy or duodenojejunostomy.</span></span></li>\r\n</ul>",
      "correct_choice_id": 191053,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        12
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47899,
      "choices": [
        {
          "id": 191191,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Infant mortality rate</span></span></span></p>"
        },
        {
          "id": 191192,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Under-5 mortality rate</span></span></span></p>"
        },
        {
          "id": 191193,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Percentage of undernourished population</span></span></span></p>"
        },
        {
          "id": 191194,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Percentage of children under 5 suffering from malnutrition</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dr Ishan is analyzing global health data to prepare a policy brief on nutritional interventions. In reviewing the Global Hunger Index (GHI), he notes several indicators that measure hunger&#39;s impact on populations. Dr. Ishan seeks to clarify which indicator does not contribute to the GHI calculations. Which of the following is not used in compiling the Global Hunger Index? </span></span></p>",
      "unique_key": "Q2802577",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans.&nbsp;</span></strong><strong><span style=\"font-size:14.0pt\">A) Infant mortality rate</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The Global Hunger Index does not include the infant mortality rate as part of its indicators. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The GHI specifically uses the under-5 mortality rate, which encompasses the broader category of child deaths under five years old, not just infants. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This wider scope helps provide a more comprehensive measure of the health impacts of malnutrition and hunger in young children.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">To capture the multidimensional nature of hunger, GHI scores are based on the following indicators:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/07/screenshot-2024-06-07-151226.png\" style=\"height:208px; width:1000px\" /></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Option B.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>Under-5 mortality rate:</strong><strong> Incorrect. </strong>The under-5 mortality rate<strong> </strong>is indeed a part of the GHI reflecting the mortality among children under five years of age due to nutritional and other health-related factors.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Option C.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>Percentage of undernourished population:</strong><strong> Incorrect. </strong>The percentage of the undernourished population is a key component of the GHI, indicating the breadth of hunger within a community or nation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Option D.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>Percentage of children under 5 suffering from malnutrition:</strong> <strong>Incorrect. </strong>The percentage of children under 5 suffering from malnutrition including indicators such as wasting and stunting, is crucial for the GHI&#39;s assessment of the depth of hunger&#39;s impact on the most vulnerable populations.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/07/screenshot-2024-06-07-151403.png\" style=\"height:560px; width:600px\" /></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Note - India, Global Hunger Index GHI 2021: Score 27.5, Serious level of hunger (Rank 101<sup>st</sup> out of the 116 countries)</span></span></span></p>",
      "correct_choice_id": 191191,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47694,
      "choices": [
        {
          "id": 190387,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Ferrochelatase</span></span></span></p>"
        },
        {
          "id": 190388,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Uroporphyrinogen III synthase</span></span></span></p>"
        },
        {
          "id": 190389,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">ALA synthase</span></span></span></p>"
        },
        {
          "id": 190390,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Uroporphyrinogen I Synthase</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 55-year-old male, who has been employed at a paint manufacturing factory for the past two decades, presents with complaints of persistent joint pain, difficulty sleeping, chronic fatigue, constipation, and recurrent headaches. Laboratory findings reveal that he has anemia. Which enzyme is most likely affected in this patient? </span></span></p>",
      "unique_key": "Q6205334",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. A)&nbsp;</span></strong><strong><span style=\"font-size:14.0pt\">Ferrochelatase</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This patient&rsquo;s clinical presentation is indicative of chronic lead poisoning, commonly seen in individuals with prolonged exposure to lead-based paints. Lead poisoning interferes with several enzymes in the heme synthesis pathway, with ferrochelatase being one of the most notably affected enzymes. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Ferrochelatase catalyzes the final step in heme synthesis, where iron is inserted into protoporphyrin IX to form heme. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Lead inhibits this enzyme, leading to the accumulation of protoporphyrin and subsequent anemia due to defective heme synthesis. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The symptoms such as joint pain, insomnia, fatigue, constipation, and headache, alongside anemia, align with chronic lead exposure.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Uroporphyrinogen III synthase:</span></strong><span style=\"font-size:14.0pt\"> This enzyme is involved in the conversion of hydroxymethylbilane to uroporphyrinogen III in the heme synthesis pathway. Deficiency in this enzyme leads to congenital erythropoietic porphyria, which presents differently with photosensitivity and disfiguring skin lesions, not the symptoms seen in this patient.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. ALA synthase:</span></strong><span style=\"font-size:14.0pt\"> This enzyme catalyzes the first step in heme synthesis, converting glycine and succinyl-CoA to delta-aminolevulinic acid (ALA). Mutations or deficiencies in ALA synthase lead to X-linked sideroblastic anemia, presenting with microcytic anemia, which is not consistent with the patient&#39;s history and symptoms related to chronic lead exposure.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Uroporphyrinogen I Synthase:</span></strong><span style=\"font-size:14.0pt\"> Also known as hydroxymethylbilane synthase, this enzyme is involved in the conversion of porphobilinogen to hydroxymethylbilane. Deficiency in this enzyme results in acute intermittent porphyria, characterized by abdominal pain, neuropathies, and psychiatric symptoms, which do not align with this patient&rsquo;s chronic presentation of lead poisoning symptoms.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chronic lead exposure in industrial settings, such as paint manufacturing, can inhibit ferrochelatase, leading to anemia and a constellation of symptoms including joint pain, insomnia, fatigue, constipation, and headache.</span></span></li>\r\n</ul>",
      "correct_choice_id": 190387,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        1
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47721,
      "choices": [
        {
          "id": 190495,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Submucous fibroid</span></span></span></p>"
        },
        {
          "id": 190496,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Tuberculosis with tubo-ovarian mass</span></span></span></p>"
        },
        {
          "id": 190497,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Ectopic pregnancy</span></span></span></p>"
        },
        {
          "id": 190498,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Ovarian malignancy</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 19-year-old Girl presents with a six-month history of low-grade fever, weight loss, abdominal pain, and amenorrhea. On examination, she has a palpable pelvic mass on the left side and signs of ascites. What is the most likely diagnosis? </span></span></p>",
      "unique_key": "Q1340545",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">&nbsp;Ans. B) Tuberculosis with tubo-ovarian mass</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The clinical presentation of prolonged low-grade fever, weight loss, abdominal pain, and amenorrhea, along with the physical findings of a pelvic mass and ascites, strongly suggest a diagnosis of genital tuberculosis. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Tuberculosis can involve the fallopian tubes and ovaries, forming a tubo-ovarian mass. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The systemic symptoms of fever and weight loss are also consistent with tuberculosis.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Submucous fibroid:</span></strong><span style=\"font-size:14.0pt\"> Submucous fibroids typically cause heavy menstrual bleeding and pelvic pain but are less likely to present with systemic symptoms such as fever, weight loss, and ascites.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Ectopic pregnancy:</span></strong><span style=\"font-size:14.0pt\"> Ectopic pregnancy usually presents with acute abdominal pain and vaginal bleeding, rather than chronic systemic symptoms like low-grade fever and weight loss. It typically results in an adnexal mass, not ascites.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Ovarian malignancy:</span></strong><span style=\"font-size:14.0pt\"> While ovarian malignancy can present with a pelvic mass and ascites, it is less common in an 18-year-old. Additionally, the systemic symptoms of low-grade fever and weight loss are more suggestive of an infectious process like tuberculosis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The combination of prolonged systemic symptoms (low-grade fever, weight loss), abdominal pain, amenorrhea, a pelvic mass, and ascites in an 18-year-old girl strongly suggests tuberculosis with a tubo-ovarian mass. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This diagnosis is supported by the characteristic clinical presentation and findings.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 190496,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47564,
      "choices": [
        {
          "id": 189867,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Increased Capillary Permeability due to Inflammation or Injury</span></span></span></p>"
        },
        {
          "id": 189868,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Elevated Hydrostatic Pressure within the Capillaries</span></span></span></p>"
        },
        {
          "id": 189869,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Impaired Lymphatic Drainage leading to Inadequate Lymph Flow</span></span></span></p>"
        },
        {
          "id": 189870,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Enhanced Levels of Plasma Proteins exerting Increased Oncotic Pressure</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 52-year-old male was admitted to the general medicine inpatient ward with severe breathlessness and generalized body swelling. Considering the multifactorial aspects of edema development, which of the following factors is LEAST likely to significantly contribute to the pathogenesis of edema in this patient?</span></span></p>",
      "unique_key": "Q2731322",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans.&nbsp;</span></strong><strong><span style=\"font-size:14.0pt\">D) Enhanced Levels of Plasma Proteins exerting Increased Oncotic Pressure</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Enhanced levels of plasma proteins exerting increased oncotic pressure is the least likely factor to contribute to the development of edema. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Oncotic pressure is primarily generated by plasma proteins, mainly albumin, which draw water into the capillaries from the interstitial spaces, helping to maintain fluid balance. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Increased oncotic pressure would actually counteract the formation of edema by reducing fluid leakage from the capillaries. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Therefore, in the context of edema development, increased plasma protein levels are protective rather than contributory.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Option A.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>Increased Capillary Permeability due to Inflammation or Injury:</strong> This factor significantly contributes to the development of edema. When capillary permeability is increased, proteins and fluids can leak into the interstitial space, causing swelling. Conditions such as infections, allergic reactions, and injuries can increase capillary permeability, leading to edema.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Option</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>B.</strong>&nbsp;<strong>Elevated Hydrostatic Pressure within the Capillaries:</strong> This factor is a major contributor to edema. Elevated hydrostatic pressure forces fluid out of the capillaries and into the interstitial space. This can occur in conditions like congestive heart failure, where increased venous pressure raises capillary hydrostatic pressure, promoting fluid leakage and swelling.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Option</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>C.</strong> <strong>Impaired Lymphatic Drainage leading to Inadequate Lymph Flow:</strong> This factor also significantly contributes to edema. The lymphatic system is responsible for draining excess fluid from the interstitial space. Impaired lymphatic drainage, due to conditions such as lymphatic obstruction or damage, leads to fluid accumulation and edema. This can be seen in lymphedema, often resulting from surgical removal of lymph nodes or radiation therapy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Enhanced levels of plasma proteins exerting increased oncotic pressure are least likely to significantly contribute to the pathogenesis of edema, as they help to draw fluid back into the capillaries and maintain fluid balance, opposing the development of edema.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 189870,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        2
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47822,
      "choices": [
        {
          "id": 190887,
          "text": "<p><span style=\"font-size:14.0pt;\">Pheochromocytoma</span></p>"
        },
        {
          "id": 190888,
          "text": "<p><span style=\"font-size:14.0pt;\">Medullary carcinoma</span></p>"
        },
        {
          "id": 190889,
          "text": "<p><span style=\"font-size:14.0pt;\">Hyperthyroidism</span></p>"
        },
        {
          "id": 190890,
          "text": "<p><span style=\"font-size:14.0pt;\">Hyperparathyroidism</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 43-year-old woman presents with a history of hypertension, episodes of palpitations, and neck swelling. Genetic testing reveals a mutation consistent with Sipple Syndrome. Which of the following is NOT a feature of Sipple Syndrome?</span></p>",
      "unique_key": "Q7594624",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Hyperthyroidism</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">Sipple Syndrome, also known as Multiple Endocrine Neoplasia Type 2 (MEN2), typically includes medullary thyroid carcinoma, pheochromocytoma, and primary hyperparathyroidism.</span></li><li><span style=\"font-size:14.0pt;\">Hyperthyroidism is not a characteristic feature of this syndrome.</span></li><li><span style=\"font-size:14.0pt;\">Medullary thyroid carcinoma, which arises from the parafollicular C cells of the thyroid, is a hallmark of MEN2 but does not cause hyperthyroidism.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Pheochromocytoma:</strong> This adrenal gland tumor is a common feature of MEN2 and can cause episodic hypertension due to catecholamine secretion.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Medullary carcinoma:</strong> Medullary thyroid carcinoma is a key component of MEN2 and arises from the calcitonin-secreting C cells of the thyroid.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Hyperparathyroidism:</strong> Primary hyperparathyroidism, often due to hyperplasia or adenomas of the parathyroid glands, is another feature of MEN2.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">Sipple Syndrome (MEN2) is characterized by the presence of medullary thyroid carcinoma, pheochromocytoma, and hyperparathyroidism.</span></li><li><span style=\"font-size:14.0pt;\">Hyperthyroidism is not a feature of this syndrome.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Mutation:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">MEN 2A is associated with a <strong>germline mutation in the RET proto-oncogene</strong></span></li><li><span style=\"font-size:14.0pt;\">Screening and prophylactic thyroidectomy may be done in relatives with the mutation</span></li></ul>",
      "correct_choice_id": 190889,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        5
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47553,
      "choices": [
        {
          "id": 189823,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Widal test</span></span></span></p>"
        },
        {
          "id": 189824,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Microscopic agglutination test</span></span></span></p>"
        },
        {
          "id": 189825,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Weil-Felix reaction</span></span></span></p>"
        },
        {
          "id": 189826,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Paul-Bunnell test</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 34-year-old male, working in flood relief efforts, develops severe abdominal cramps, noticeable yellowing of the skin, redness in the eyes, and notices blood in his urine, which started about a week ago. Given his environmental exposure to potentially contaminated water and the clinical presentation, which diagnostic test would be most appropriate to confirm the suspected condition? </span></span></p>",
      "unique_key": "Q2606087",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>B) Microscopic agglutination test</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The Microscopic Agglutination Test (MAT) is the preferred diagnostic tool for leptospirosis, particularly relevant in this scenario where the patient has been exposed to potentially contaminated water during flood relief activities. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Leptospirosis, caused by the bacterium Leptospira interrogans, can present with symptoms such as jaundice, conjunctival suffusion, and hematuria, matching the patient&#39;s symptoms. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">MAT detects antibodies against Leptospira in the patient&#39;s serum, providing a definitive diagnosis.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\"><strong>Option A. Widal test</strong>:&nbsp; Incorrect, as it is specifically used for identifying typhoid fever, which is characterized by a slow-onset fever and gastrointestinal disturbances, not primarily by the symptoms described.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Weil-Felix reaction</span></strong><span style=\"font-size:14.0pt\">:&nbsp; Incorrect, it tests for rickettsial infections, presenting with symptoms like fever, rash, and headaches, but not typically jaundice or hematuria.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Paul-Bunnell test</span></strong><span style=\"font-size:14.0pt\">:&nbsp; Incorrect, this tests for infectious mononucleosis caused by Epstein-Barr virus, characterized by fever, pharyngitis, and lymphadenopathy, which does not align with the symptoms presented in this case.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The Microscopic Agglutination Test is crucial for diagnosing leptospirosis in individuals exposed to water contaminated with the Leptospira bacteria. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Recognizing and confirming leptospirosis early allows for timely treatment, which is vital in preventing severe complications like Weil&#39;s disease.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 189824,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        6
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47689,
      "choices": [
        {
          "id": 190367,
          "text": "<p><span style=\"font-size:14.0pt;\">Increased neutrophil proteases</span></p>"
        },
        {
          "id": 190368,
          "text": "<p><span style=\"font-size:14.0pt;\">Prior infection with TB</span></p>"
        },
        {
          "id": 190369,
          "text": "<p><span style=\"font-size:14.0pt;\">Reduced anti-elastase activity</span></p>"
        },
        {
          "id": 190370,
          "text": "<p><span style=\"font-size:14.0pt;\">CFTR gene mutation</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 30-year-old male presents with a 5-year history of increasing dyspnea. On physical examination, breath sounds are decreased in all lung fields. A chest X-ray reveals a flattened diaphragm and increased lucency in all lung fields. Pulmonary function tests show a markedly decreased FEV1 and mildly reduced FVC. His younger brother has similar symptoms. What is the likely mechanism of his pulmonary pathology?</span></p>",
      "unique_key": "Q8595961",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Reduced anti-elastase activity</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">The presentation of dyspnea, decreased breath sounds, flattened diaphragm, and increased lung lucency on X-ray, along with markedly decreased FEV1 and mildly reduced FVC on pulmonary function tests, is indicative of emphysema.</span></li><li><span style=\"font-size:14.0pt;\">The familial occurrence suggests a genetic cause, such as alpha-1 antitrypsin (AAT) deficiency.</span></li><li><span style=\"font-size:14.0pt;\">AAT deficiency leads to reduced anti-elastase activity, allowing unopposed elastase to break down elastic fibers in the lungs, causing emphysema.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Increased Neutrophil Proteases:</strong> While increased neutrophil proteases can damage lung tissue, the primary issue in this case is the lack of inhibition due to AAT deficiency. The reduced anti-elastase activity allows these proteases to cause significant damage.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Prior Infection with TB:</strong> Tuberculosis can cause chronic lung damage, but it typically results in fibrosis and granulomas rather than diffuse emphysematous changes seen in this patient.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. CFTR Gene Mutation:</strong> Cystic fibrosis (CF) results from CFTR gene mutations and typically presents with recurrent respiratory infections, bronchiectasis, and pancreatic insufficiency. The findings in this case are more consistent with emphysema due to AAT deficiency.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">Alpha-1 antitrypsin deficiency leads to reduced anti-elastase activity, causing unopposed elastase activity and resulting in early-onset emphysema.</span></li><li><span style=\"font-size:14.0pt;\">This genetic disorder should be considered in patients with early-onset emphysema and a family history of similar symptoms.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Mechanism:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Î±1-antitrypsin</strong> is a <strong>serine protease inhibitor</strong> made in the liver.</span></li><li><span style=\"font-size:14.0pt;\">Its role is to <strong>inhibit neutrophil elastase</strong>, an enzyme that digests <strong>elastin</strong> in alveolar walls.</span></li><li><span style=\"font-size:14.0pt;\">In <strong>AAT deficiency</strong>, there's <strong>reduced anti-elastase activity</strong>, leading to <strong>uncontrolled elastin breakdown</strong> â†’ <strong>alveolar wall destruction</strong> â†’ <strong>panacinar emphysema</strong>, especially in the <strong>lower lobes</strong>.</span></li></ul>",
      "correct_choice_id": 190369,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        5
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47575,
      "choices": [
        {
          "id": 189911,
          "text": "<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Thought insertion</span></span></p>"
        },
        {
          "id": 189912,
          "text": "<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Thought withdrawal</span></span></p>"
        },
        {
          "id": 189913,
          "text": "<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Thought broadcasting</span></span></p>"
        },
        {
          "id": 189914,
          "text": "<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Thought echo</span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 30-year-old man presents to the psychiatric clinic complaining that others can hear what he is thinking. He is distressed and believes this is happening constantly. Which of the following best fits the above description? </span></span></p>",
      "unique_key": "Q1459453",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:14.0pt\">Ans. C) Thought broadcasting</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:14.0pt\">The patient&#39;s complaint that others can hear his thoughts fits the description of <strong>thought broadcasting</strong>, a type of disorder of possession of thought, where an individual believes their thoughts are being broadcasted or transmitted to others. </span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:14.0pt\">Option A. Thought insertion:&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:14.0pt\">This is another type of disorder of possession of thought, where an individual believes that thoughts are being placed into one&#39;s mind by an external force. The patient believes the thoughts are not his own but are inserted by someone else.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:14.0pt\">Option B. Thought withdrawal:&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:14.0pt\">This refers to another type of disorder of possession of thought, where an individual believes that thoughts are being removed from one&rsquo;s mind by an external force. The patient feels that his thoughts are being taken away.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:14.0pt\">Option D. Thought echo:&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:14.0pt\">Also known as &quot;audible thoughts,&quot; this involves hearing one&#39;s thoughts spoken aloud shortly after thinking them. It&rsquo;s an auditory hallucination where the person hears their own thoughts repeated.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:14.0pt\">Thought broadcasting is a type of disorder of possession of thought where an individual believes their thoughts are accessible to others without their consent.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 189913,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        16
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47556,
      "choices": [
        {
          "id": 189835,
          "text": "<p><span style=\"font-size:14.0pt;\">Triple arthrodesis</span></p>"
        },
        {
          "id": 189836,
          "text": "<p><span style=\"font-size:14.0pt;\">Osteotomy</span></p>"
        },
        {
          "id": 189837,
          "text": "<p><span style=\"font-size:14.0pt;\">Postero-medial soft tissue procedure</span></p>"
        },
        {
          "id": 189838,
          "text": "<p><span style=\"font-size:14.0pt;\">Manipulation &amp; cast</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">What will be the management in the case of a 6-month-old baby with the following presentation?</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/05/screenshot-2024-06-05-154650.JPG\" alt=\"\" width=\"300\" height=\"228\"></span></p>",
      "unique_key": "Q6225384",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans</strong>. <strong>D) Manipulation &amp; cast</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The image provided shows the feet of a baby, and they appear to be in a position consistent with <strong>clubfoot (talipes equinovarus)</strong>.</span></li><li><span style=\"font-size:14.0pt;\">For a 6-month-old baby with clubfoot, the most appropriate initial management is non-surgical, involving manipulation and casting. This is typically done using the <strong>Ponseti method</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Manipulation and casting involve manually manipulating the affected limb to correct alignment followed by immobilization in a cast to maintain the corrected position.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This approach is generally preferred in infants due to their rapid growth and development, as it allows for gradual correction of the deformity without the need for invasive surgery.</span></li><li><span style=\"font-size:14.0pt;\">Gentle manipulations are performed to gradually correct the deformities, followed by the application of a cast to hold the correction. This is repeated weekly.&nbsp;</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options</strong>:</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Triple Arthrodesis</strong>: Triple arthrodesis is a surgical procedure that involves fusing three joints in the foot: the subtalar joint, the talonavicular joint, and the calcaneocuboid joint. It is typically performed to correct severe deformities or instability in the foot and ankle, such as those associated with severe flatfoot deformity or certain types of arthritis. Triple arthrodesis is a complex surgical procedure that is generally reserved for older children or adults with significant&nbsp;severe, rigid, and painful foot&nbsp;deformities or functional impairments&nbsp;that haven't responded to other treatments. It is not typically considered as a primary treatment option for infants, especially at 6 months of age, unless there are exceptionally severe deformities or abnormalities present, which would be rare at this age.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Osteotomy</strong>: Osteotomy is a surgical procedure that involves cutting and reshaping bones to correct deformities, improve alignment, or alleviate pressure on affected joints. Osteotomy may be considered in older children or adolescents with bone deformities or growth abnormalities that require surgical correction. However, it is less commonly performed in infants, especially at 6 months of age, due to the immaturity of the skeletal system and the potential risks associated with surgery in such young patients.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Postero-medial soft tissue procedure:&nbsp;</strong>Postero-medial soft tissue procedures involve surgical techniques aimed at addressing soft tissue abnormalities or contractures in the posterior and medial aspects of a joint, such as the ankle or foot. These procedures may include tendon lengthening, tendon transfers, or release of tight ligaments or fascia.&nbsp;Some babies with clubfoot may eventually require a limited posterior release (especially a percutaneous Achilles tenotomy) as part of the Ponseti method, or a more extensive soft tissue release if Ponseti fails, but it is not the initial management for a 6-month-old. The initial approach is always non-surgical manipulation and casting.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">For a child of 6 months of age with clubfoot deformity, the treatment of choice is the manipulation of the foot followed by cast application.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The other options are used for older children or adolescents.&nbsp;</span></li></ul>",
      "correct_choice_id": 189838,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        15
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47895,
      "choices": [
        {
          "id": 191175,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Inactivated polio vaccine (IPV)</span></span></span></p>"
        },
        {
          "id": 191176,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Measles, Mumps, Rubella (MMR) vaccine</span></span></span></p>"
        },
        {
          "id": 191177,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Diphtheria, Tetanus, acellular Pertussis (DTaP)</span></span></span></p>"
        },
        {
          "id": 191178,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Tetanus toxoid vaccine</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A pediatrician is evaluating a 4-year-old boy with a medical history of recurrent fungal skin infections and frequent upper respiratory tract infections starting from early infancy. The child&#39;s immune response is suspected to be compromised. Which vaccine is contraindicated in this patient due to his medical condition? </span></span></p>",
      "unique_key": "Q6024542",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans.&nbsp;</span></strong><strong><span style=\"font-size:14.0pt\">B) Measles, Mumps, Rubella (MMR) vaccine</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This<strong> </strong>is correct<strong> </strong>because the MMR vaccine is a live attenuated vaccine, which poses a risk to immunocompromised individuals like this child. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">His history of recurrent infections suggests an underlying immunodeficiency, making live vaccines potentially dangerous as they may cause the diseases they are designed to prevent.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Inactivated polio vaccine: </span></strong><strong><span style=\"font-size:14.0pt\">Incorrect-</span></strong><span style=\"font-size:14.0pt\"> IPV is an inactivated vaccine which does not contain live organisms and is therefore safe for immunocompromised patients.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Option C.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>Diphtheria, Tetanus, acellular Pertussis: </strong><strong>Incorrect-</strong> <strong>The DTaP vaccine contains diphtheria and tetanus toxoids and acellular pertussis: </strong>&nbsp;all of which are either inactivated or acellular, making them safe for use in patients with compromised immune systems.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Tetanus toxoid vaccine:</span></strong><span style=\"font-size:14.0pt\"> <strong>Incorrect-</strong> <strong>The tetanus toxoid vaccine:</strong> containing inactivated toxin, is also safe for immunocompromised individuals as it does not contain live bacteria.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">CONTRAINDICATIONS OF LIVE VACCINES</span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Immunodeficient individuals (Symptomatic HIV infection) except BCG vaccine</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Immunosuppressed individuals (patient with leukemia or patients on antimetabolites, steroids or radiation)</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Pregnancy (except Yellow fever)</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/07/screenshot-2024-06-07-150256.png\" style=\"height:610px; width:1000px\" /></span></span></span></p>",
      "correct_choice_id": 191176,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47835,
      "choices": [
        {
          "id": 190939,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Null hypothesis</span></span></span></p>"
        },
        {
          "id": 190940,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Degrees of freedom</span></span></span></p>"
        },
        {
          "id": 190941,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Means in different groups</span></span></span></p>"
        },
        {
          "id": 190942,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Proportions in different groups</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dr. Roma is conducting a research study to analyze the association between different treatment methods and patient recovery rates. She decides to use the chi-square test to evaluate the data collected from various patient groups. As she prepares her analysis plan, she reviews the essentials required for the chi-square test. Which of the following is NOT required for performing a chi-square test?</span></span></p>",
      "unique_key": "Q5933572",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans.&nbsp;</span></strong><strong><span style=\"font-size:14.0pt\">C) Means in different groups</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This<strong> </strong></span><span style=\"font-size:14.0pt\">is correct. The chi-square test is used to compare categorical variables and assess whether differences between observed and expected frequencies are statistically significant. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">It primarily deals with proportions or frequencies within categories, not means. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Therefore, calculating means in different groups is not necessary when using the chi-square test.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Option A.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>Null hypothesis:</strong> <strong>Incorrect. </strong>A null hypothesis is essential for the chi-square test, as it typically states that there is no association between the variables being studied, which the test then seeks to either reject or fail to reject.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Option B.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>Degrees of freedom:</strong> <strong>Incorrect. </strong>Degrees of freedom are crucial in determining the chi-square test&#39;s critical value from the chi-square distribution table, which is necessary to interpret the test&#39;s results.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Option D.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>Proportions in different groups:</strong> <strong>Incorrect. </strong>Proportions in different groups are fundamental to the chi-square test, as it analyzes the differences between observed and expected proportions (or frequencies) across categorical groups.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Chi-square test (</span></strong><span style=\"font-size:14.0pt\">&chi;<strong><sup>2</sup> &ndash; TEST):</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Is a &lsquo;non-parametric test&rsquo; of significance</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Is used to &lsquo;test significance of association between 2 or</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">more QUALITATIVE characteristics&rsquo;</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Is used for non &ndash; Normal (non&ndash;Gaussian) distributions</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Applications of Chi-square test:</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">1. Test of proportions</span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">2. Test of association</span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">3. Test of goodness of fit.</span></span></span></p>",
      "correct_choice_id": 190941,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47684,
      "choices": [
        {
          "id": 190347,
          "text": "<p><span style=\"font-size:14.0pt;\">Tension pneumothorax</span></p>"
        },
        {
          "id": 190348,
          "text": "<p><span style=\"font-size:14.0pt;\">Hollow viscous perforation</span></p>"
        },
        {
          "id": 190349,
          "text": "<p><span style=\"font-size:14.0pt;\">Normal findings</span></p>"
        },
        {
          "id": 190350,
          "text": "<p><span style=\"font-size:14.0pt;\">Pyloric stenosis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 30-year-old male patient presented with abdominal pain, fever, nausea, vomiting and respiratory distress. His BP was found to be 80/40 mm Hg and pulse rate of 115/min. The following chest X-ray was recorded in ER. What is the diagnosis?&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_nI6Xz8C.png\" width=\"333\" height=\"327\"></span></p>",
      "unique_key": "Q5968219",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Hollow viscous perforation</strong></span></p><p>&nbsp;</p><p style=\"margin-left:0cm;\"><span style=\"font-size:14.0pt;\"><strong>Management of Peritonitis&nbsp;</strong></span></p><p style=\"margin-left:0cm;\">&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"color:windowtext;font-size:14.0pt;\">General care of patient&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Correction of fluid &amp; electrolyte imbalance&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Insertion of nasogastric drainage tube &amp; urinary catheter&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Broad-spectrum antibiotic therapy&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Analgesia&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Vital system support&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Operative (laparotomy) treatment of cause&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Remove or divert cause&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Peritoneal lavage Â± drainage&nbsp;</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Tension pneumothorax:&nbsp;</strong>This would manifest as absent lung markings on the affected side, tracheal deviation, and mediastinal shift on the chest X-ray. The current X-ray <strong>does not</strong> show these signs.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Normal findings:&nbsp;</strong>The presence of free air under the diaphragm is an <strong>abnormal and significant finding</strong>, indicating pathology.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Pyloric stenosis:&nbsp;</strong>This is a condition typically seen in infants causing projectile vomiting and is not associated with free air under the diaphragm on a chest X-ray.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The presence of pneumoperitoneum on the chest X-ray, combined with the patient's severe abdominal symptoms and signs of shock, strongly indicates a <strong>hollow viscous perforation</strong>.</span></p>",
      "correct_choice_id": 190348,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        12
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47594,
      "choices": [
        {
          "id": 189987,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Total life years lost</span></span></span></p>"
        },
        {
          "id": 189988,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Average life span at birth</span></span></span></p>"
        },
        {
          "id": 189989,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Death rate in infants</span></span></span></p>"
        },
        {
          "id": 189990,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Disease frequency at a single point in time</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A public health researcher is analyzing various health statistics to evaluate the burden of disease in a community. Which of the following metrics is not used to assess mortality rates directly?</span></span></p>",
      "unique_key": "Q2747072",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>D) Disease frequency at a single point in time</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Disease frequency at a single point in time, also known as prevalence, is not a direct indicator of mortality. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">It measures the total number of cases of a disease within a population at a specific time, encompassing both new and existing cases, and does not directly relate to death statistics.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Total life years lost (YPLL):</span></strong><span style=\"font-size:14.0pt\"> This indicator focuses on the years that are lost due to premature mortality, emphasizing the impact of diseases that cause early death and is a direct measure of mortality.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Average life span at birth (Life expectancy):</span></strong><span style=\"font-size:14.0pt\"> This is a primary mortality indicator that estimates the average number of years a newborn is expected to live if current mortality rates continue to apply. It is used globally to assess the overall health status of populations.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Death rate in infants (Infant Mortality Rate):</span></strong><span style=\"font-size:14.0pt\"> This rate measures the number of infant deaths per 1,000 live births within their first year of life, directly reflecting the effectiveness of healthcare during and after pregnancy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">MORTALITY INDICATORS</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Crude Death Rate, Age specific death rates, Disease-specific Mortality Rate</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Expectation of Life</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">IMR, MMR, U5MR, Child Mortality Rate</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Case fatality rate, Proportional Mortality Rate</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Years of potential life years lost</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 189990,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47576,
      "choices": [
        {
          "id": 189915,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Sensorineural hearing loss, salt and pepper retinopathy &ndash; Rubella</span></span></span></p>"
        },
        {
          "id": 189916,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Periventricular calcifications, microcephaly- Toxoplasmosis</span></span></span></p>"
        },
        {
          "id": 189917,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Vesicular lesions, microcephaly &ndash; Herpes simplex virus</span></span></span></p>"
        },
        {
          "id": 189918,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Chorioretinitis, periventricular calcifications &ndash; CMV</span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Choose the incorrect option:</span></span></p>",
      "unique_key": "Q4536753",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Ans. B) Periventricular calcifications, microcephaly- Toxoplasmosis</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Toxoplasmosis</span></strong><span style=\"font-size:14.0pt\"> typically presents with:</span></span></span>\r\n\r\n\t<ul>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Chorioretinitis</span></strong></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Diffuse intracranial calcifications</span></strong><span style=\"font-size:14.0pt\">: Unlike periventricular calcifications seen in CMV, toxoplasmosis affects the entire brain.</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Hydrocephalus</span></strong></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Incorrect Feature</span></strong><span style=\"font-size:14.0pt\">:</span></span></span>\r\n\t<ul>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Periventricular calcifications and microcephaly</span></strong><span style=\"font-size:14.0pt\"> are not typically seen in toxoplasmosis but are characteristic of CMV.</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A: Sensorineural hearing loss, salt and pepper retinopathy &ndash; Rubella</span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Rubella</span></strong><span style=\"font-size:14.0pt\"> is known for causing a variety of congenital anomalies, particularly affecting the sensory organs. The most characteristic features include:</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Sensorineural hearing loss</span></strong><span style=\"font-size:14.0pt\"> and <strong>Salt and pepper retinopathy</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C: Vesicular lesions, microcephaly &ndash; Herpes simplex virus</span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Herpes simplex virus (HSV)</span></strong><span style=\"font-size:14.0pt\"> infections in neonates often present with:</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Vesicular lesions</span></strong><span style=\"font-size:14.0pt\"> and <strong>Microcephaly</strong> from severe CNS involvement by HSV.</span></span></span><br />\r\n\t&nbsp;</li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D: Chorioretinitis, periventricular calcifications &ndash; CMV</span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Cytomegalovirus (CMV)</span></strong><span style=\"font-size:14.0pt\"> is well-known for causing:</span></span></span>\r\n\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Periventricular calcifications</span></strong></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Chorioretinitis</span></strong></span></span><br />\r\n\t\t&nbsp;</li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Rubella</span></strong><span style=\"font-size:14.0pt\">: Sensorineural hearing loss and salt-and-pepper retinopathy.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Toxoplasmosis</span></strong><span style=\"font-size:14.0pt\">: Chorioretinitis and diffuse intracranial calcifications.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">HSV</span></strong><span style=\"font-size:14.0pt\">: Vesicular lesions and microcephaly.</span></span></span></li>\r\n\t<li><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">CMV</span></span></strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Periventricular calcifications and microcephaly.</span></span></li>\r\n</ul>",
      "correct_choice_id": 189916,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        13
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47902,
      "choices": [
        {
          "id": 191203,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Performing a cervical Pap smear on a 40-year-old woman during a routine health visit. </span></span></span></p>"
        },
        {
          "id": 191204,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Conducting neonatal screening for hypothyroidism immediately after birth. </span></span></p>"
        },
        {
          "id": 191205,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Screening immigrants for infectious diseases upon entry to a new country. </span></span></span></p>"
        },
        {
          "id": 191206,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Checking a 40-year-old man for diabetes through a routine urine sugar test.</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dr. Mehta is consulting with a public health team on the implementation of various screening programs aimed at improving community health outcomes. She emphasizes the differences between prescriptive and prospective screening strategies to ensure the team understands when each approach is applicable. Which of the following scenarios exemplifies prospective screening, where the primary aim is disease control for the benefit of the broader community? </span></span></p>",
      "unique_key": "Q3202008",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans.&nbsp;</span></strong><strong><span style=\"font-size:14.0pt\">C) Screening immigrants for infectious diseases upon entry to a new country.</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This </span><span style=\"font-size:14.0pt\">is correct. Prospective screening, such as screening immigrants for infectious diseases, is conducted primarily for public health benefits, aiming to control disease spread within the community. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This form of screening is typically mandated or requested by public health authorities to maintain the health security of the population.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Option A.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>Performing a cervical Pap smear on a 40-year-old woman during a routine health visit:</strong><strong> Incorrect. </strong>A cervical Pap smear is an example of prescriptive screening<strong> </strong>aimed at the individual&#39;s benefit by detecting early signs of cervical cancer.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Option B.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>Conducting neonatal screening for hypothyroidism immediately after birth:</strong> <strong>Incorrect. Neonatal screening for conditions like hypothyroidism is also prescriptive:</strong> focusing on early detection and treatment to benefit the screened newborn.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Option D.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>Checking a 40-year-old man for diabetes through a routine urine sugar test:</strong> <strong>Incorrect. Urine sugar screening in adults:&nbsp; </strong>is another form of prescriptive screening intended for individual diabetes management rather than broader public health control.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/07/screenshot-2024-06-07-151839.png\" style=\"height:330px; width:1000px\" /></span></strong></span></span></p>",
      "correct_choice_id": 191205,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47846,
      "choices": [
        {
          "id": 190979,
          "text": "<p><span style=\"font-size:14.0pt;\">CD 25</span></p>"
        },
        {
          "id": 190980,
          "text": "<p><span style=\"font-size:14.0pt;\">CD 11a</span></p>"
        },
        {
          "id": 190981,
          "text": "<p><span style=\"font-size:14.0pt;\">TNF (Tumor necrosis factor)</span></p>"
        },
        {
          "id": 190982,
          "text": "<p><span style=\"font-size:14.0pt;\">IL-2</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A transplant specialist is selecting an immunosuppressive agent for a patient undergoing renal transplantation to prevent organ rejection. The drug of choice targets a specific immune cell receptor. Which of the following is the target of basiliximab used in this clinical scenario?</span></p>",
      "unique_key": "Q2822407",
      "difficulty_level": "difficult",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.&nbsp;A) CD 25</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\"><strong>Basiliximab</strong> is a monoclonal antibody that specifically targets the alpha subunit of the IL-2 receptor on activated T lymphocytes, known as CD 25.</span></li><li><span style=\"font-size:14.0pt;\">By binding to CD 25, Basiliximab blocks the IL-2 mediated activation of lymphocytes, which is a critical pathway in the immune response leading to organ rejection.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. CD 11a</strong>: This is not the correct ans as CD 11a pertains to another molecule involved in leukocyte adhesion and migration, targeted by drugs like efalizumab.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. TNF</strong>: Tumor necrosis factor (TNF) is targeted by drugs such as infliximab and adalimumab, which are used primarily in inflammatory and autoimmune conditions, not in the context of organ transplant immunosuppression.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. IL-2</strong>: While basiliximab indirectly affects IL-2 signaling by targeting its receptor, it does not directly antagonize IL-2 itself.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">Basiliximab is used in the perioperative period of organ transplantation to prevent acute rejection. It works by inhibiting IL-2 signaling, crucial for the proliferation and activity of immune cells that can cause graft rejection.</span></li><li><span style=\"font-size:14.0pt;\">This targeted approach helps in maintaining the viability and function of the transplanted organ while minimizing the overall immunosuppressive burden on the patient.</span></li></ul>",
      "correct_choice_id": 190979,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47569,
      "choices": [
        {
          "id": 189887,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Early dumping</span></span></span></p>"
        },
        {
          "id": 189888,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Late dumping</span></span></span></p>"
        },
        {
          "id": 189889,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Post vagotomy diarrhoea</span></span></span></p>"
        },
        {
          "id": 189890,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Gastrojejunal (G-J) ulceration</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 55-year-old man presents with light-headedness, bloating and diarrhea occurring 15 minutes after meals. He had a Billroth II reconstruction two months ago. What is the most likely diagnosis?</span></span></p>",
      "unique_key": "Q9246453",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. A) Early dumping</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Occurs shortly after eating, usually within 15 to 30 minutes. It is caused by rapid emptying of the stomach contents into the small intestine, leading to symptoms like lightheadedness, abdominal fullness, nausea, diarrhea, and tachycardia. This matches the scenario described, where the patient experiences symptoms soon after meals.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Late dumping:&nbsp;</span></strong><span style=\"font-size:14.0pt\">Happens 1 to 3 hours after eating and is associated with hypoglycemia due to an exaggerated insulin response. Symptoms include weakness, sweating, and palpitations. It does not match the immediate post-meal timeframe mentioned.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Post vagotomy diarrhea</span></strong><span style=\"font-size:14.0pt\">: This can occur after gastric surgery like vagotomy and not Billroth 2, due to altered motility but typically does not cause lightheadedness or is related to meal timing.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. G-J ulceration</span></strong><span style=\"font-size:14.0pt\">: Gastrojejunal ulceration can cause symptoms like pain, but it is less likely to cause immediate postprandial symptoms like lightheadedness or diarrhea unless there is significant bleeding or obstruction, which is not described here.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Early dumping syndrome is a complication that can occur after gastric surgery, such as a Billroth II reconstruction, and is characterized by symptoms of lightheadedness, bloating, tachycardia, diaphoresis, and diarrhea shortly after eating. These symptoms are due to the rapid transit of food into the small intestine, causing fluid shifts and autonomic reactions.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/05/screenshot-2024-06-05-155445.JPG\" style=\"height:685px; width:968px\" /></span></span></span></p>",
      "correct_choice_id": 189887,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        12
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47798,
      "choices": [
        {
          "id": 190795,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Type IV hyperlipoproteinemia</span></span></span></p>"
        },
        {
          "id": 190796,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Type IIb hyperlipoproteinemia</span></span></span></p>"
        },
        {
          "id": 190797,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Type I hyperlipoproteinemia</span></span></span></p>"
        },
        {
          "id": 190798,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Type V hyperlipoproteinemia</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 25-year-old woman presents with recurrent episodes of abdominal pain. On physical examination, she has eruptive xanthomas on her skin. Laboratory studies reveal elevated plasma concentrations of chylomicrons and triacylglycerols. Which of the following conditions is most likely associated with these findings? </span></span></p>",
      "unique_key": "Q5376961",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. </span></strong><strong><span style=\"font-size:14.0pt\">C) Type I hyperlipoproteinemia</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C:</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">&nbsp;</span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Type I hyperlipoproteinemia, also known as familial lipoprotein lipase deficiency or familial hyperchylomicronemia, is a rare genetic disorder characterized by an inability to properly metabolize chylomicrons due to a deficiency in lipoprotein lipase or its cofactor, apolipoprotein C-II. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This results in elevated plasma concentrations of chylomicrons and triacylglycerols. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Patients often present with recurrent episodes of pancreatitis, abdominal pain, and eruptive xanthomas. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The condition is typically diagnosed in childhood but can present later in life with these characteristic symptoms and laboratory findings.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option&nbsp;</span></strong><strong><span style=\"font-size:14.0pt\">A.</span></strong><span style=\"font-size:14.0pt\"> <strong>Type IV hyperlipoproteinemia:</strong> This condition, also known as familial hypertriglyceridemia, is characterized by elevated levels of very low-density lipoproteins (VLDL) and triacylglycerols but not chylomicrons. It typically presents with mild to moderate hypertriglyceridemia and is not associated with the severe symptoms seen in Type I hyperlipoproteinemia.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>&nbsp;</strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option&nbsp;</span></strong><strong><span style=\"font-size:14.0pt\">B.</span></strong><span style=\"font-size:14.0pt\"> <strong>Type IIb hyperlipoproteinemia:</strong> This condition, also known as familial combined hyperlipidemia, involves elevated levels of low-density lipoprotein (LDL) and VLDL. It is associated with an increased risk of cardiovascular disease but does not typically present with elevated chylomicrons or the specific symptoms of pancreatitis and eruptive xanthomas.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D.</span></strong><span style=\"font-size:14.0pt\"> <strong>Type V hyperlipoproteinemia:</strong> This condition is characterized by elevated levels of both chylomicrons and VLDL. While it does present with elevated triacylglycerols, it differs from Type I hyperlipoproteinemia in its broader lipid profile. Patients may have similar symptoms but the primary distinguishing feature is the simultaneous elevation of VLDL.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Type I hyperlipoproteinemia, or familial lipoprotein lipase deficiency, is characterized by elevated plasma concentrations of chylomicrons and triacylglycerols, leading to recurrent pancreatitis, abdominal pain, and eruptive xanthomas.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 190797,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        1
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47703,
      "choices": [
        {
          "id": 190423,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Lithium</span></span></span></p>"
        },
        {
          "id": 190424,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Quinidine</span></span></span></p>"
        },
        {
          "id": 190425,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Adenosine</span></span></span></p>"
        },
        {
          "id": 190426,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Magnesium</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 47-year-old female patient with a history of cardiac arrhythmia is being evaluated for medication-induced QT prolongation, a condition that increases the risk of torsades de pointes. Which of the following medications is most likely to cause QT prolongation in this patient?</span></span></p>",
      "unique_key": "Q9502995",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans.&nbsp;</span></strong><strong><span style=\"font-size:14.0pt\">B) Quinidine</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Quinidine is a class IA antiarrhythmic drug known for its potential to prolong the QT interval on an electrocardiogram (ECG). </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This effect can increase the risk of developing torsades de pointes, a type of life-threatening ventricular tachycardia. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The mechanism involves the inhibition of potassium channels, which delays repolarization of the cardiac action potential.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Lithium</span></strong><span style=\"font-size:14.0pt\">: Mainly affects the central nervous system and is used for bipolar disorder. It does not typically cause QT prolongation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Adenosine</span></strong><span style=\"font-size:14.0pt\">: This is a short-acting drug used to manage supraventricular tachycardias. It primarily acts by slowing conduction through the AV node and does not prolong the QT interval.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Magnesium</span></strong><span style=\"font-size:14.0pt\">: Often used as a treatment rather than a cause of prolonged QT intervals, magnesium can help stabilize cardiac membranes and is used therapeutically in cases of torsades de pointes associated with magnesium deficiency.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Quinidine is significant for its ability to prolong the QT interval, necessitating careful monitoring when used in patients with or at risk of arrhythmias. </span></span></span></li>\r\n\t<li><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Always consider the impact of antiarrhythmic drugs on the ECG and monitor accordingly to prevent arrhythmogenic side effects.</span></span></li>\r\n</ul>",
      "correct_choice_id": 190424,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47677,
      "choices": [
        {
          "id": 190319,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Warfarin</span></span></span></p>"
        },
        {
          "id": 190320,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Heparin</span></span></span></p>"
        },
        {
          "id": 190321,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Dabigatran</span></span></span></p>"
        },
        {
          "id": 190322,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Rivaroxaban</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 58-year-old male patient with a history of deep vein thrombosis (DVT) was prescribed a new anticoagulant. Two days following the initiation of the therapy, he presented with painful skin lesions on his toes, as depicted in the image. </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/06/screenshot-2024-06-06-130130.png\" style=\"height:306px; width:300px\" /></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following drugs is most likely responsible for this complication? </span></span></p>",
      "unique_key": "Q7163557",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. </span></strong><strong><span style=\"font-size:14.0pt\">A) Warfarin</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The patient&#39;s symptoms are indicative of <strong>Warfarin-induced skin necrosis</strong>, a rare but serious complication known as &quot;purple toe syndrome.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">&quot; This condition is characterized by painful, necrotic lesions that typically occur early in the course of warfarin treatment. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">It is thought to be caused by a rapid depletion of protein C, which creates a transient hypercoagulable state, particularly in patients with protein C deficiency.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Heparin</span></strong><span style=\"font-size:14.0pt\">: Not typically associated with skin necrosis as an initial adverse effect; more commonly linked to heparin-induced thrombocytopenia.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Dabigatran</span></strong><span style=\"font-size:14.0pt\">: A direct thrombin inhibitor that does not typically cause skin necrosis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Rivaroxaban</span></strong><span style=\"font-size:14.0pt\">: Part of the new oral anticoagulants (NOACs) that also do not commonly cause skin necrosis as seen with warfarin.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Warfarin-induced skin necrosis, although rare, should be promptly recognized as a potential early complication of warfarin therapy. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">It necessitates immediate discontinuation of warfarin and switching to an alternative anticoagulation treatment to prevent further progression of necrotic lesions. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This complication underscores the importance of careful monitoring during the initiation of warfarin therapy, especially in patients with known or suspected protein C deficiency.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 190319,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        4
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47875,
      "choices": [
        {
          "id": 191095,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">WT-1</span></span></span></p>"
        },
        {
          "id": 191096,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">APC</span></span></span></p>"
        },
        {
          "id": 191097,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">MSH2</span></span></span></p>"
        },
        {
          "id": 191098,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">p53</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 40-year-old woman presents with endometrial carcinoma. Her mother died of endometrial cancer at age 50, and her 42-year-old brother was recently diagnosed with colon cancer. You suspect a familial cancer syndrome. Which gene in this family is most likely to be mutated? </span></span></p>",
      "unique_key": "Q3386575",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. C) MSH2</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The history of endometrial carcinoma in the patient, endometrial cancer in her mother, and colon cancer in her brother is suggestive of Lynch syndrome (hereditary nonpolyposis colorectal cancer, HNPCC). </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Lynch syndrome is caused by mutations in mismatch repair (MMR) genes, most commonly MLH1, MSH2, MSH6, and PMS2. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">MSH2 is one of the key genes associated with this syndrome. Individuals with Lynch syndrome have an increased risk of various cancers, including colorectal, endometrial, ovarian, gastric, and others.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. WT-1:</span></strong><span style=\"font-size:14.0pt\"> The WT-1 gene is associated with Wilms&#39; tumor, a pediatric kidney cancer. It is not linked to Lynch syndrome or the familial pattern of endometrial and colon cancer seen in this case.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. APC:</span></strong><span style=\"font-size:14.0pt\"> The APC gene is associated with familial adenomatous polyposis (FAP), another hereditary colorectal cancer syndrome. FAP is characterized by the development of hundreds to thousands of colorectal polyps and an increased risk of colorectal cancer. It is not typically associated with endometrial cancer.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. p53:</span></strong><span style=\"font-size:14.0pt\"> The p53 gene is a tumor suppressor gene associated with Li-Fraumeni syndrome. This syndrome increases the risk of various cancers, including breast cancer, sarcomas, brain tumors, and adrenocortical carcinoma. While p53 mutations can lead to a wide range of cancers, the combination of colon and endometrial cancer is more characteristic of Lynch syndrome.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Lynch syndrome (hereditary nonpolyposis colorectal cancer, HNPCC) is associated with mutations in mismatch repair genes, most commonly MLH1 and MSH2. </span></span></span></li>\r\n\t<li><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The presence of endometrial and colon cancer in the same family strongly suggests a mutation in one of these genes, such as MSH2.</span></span></li>\r\n</ul>",
      "correct_choice_id": 191097,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        5
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47799,
      "choices": [
        {
          "id": 190799,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Multidrug therapy for leprosy</span></span></p>"
        },
        {
          "id": 190800,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Amphotericin B</span></span></p>"
        },
        {
          "id": 190801,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sodium stibogluconate</span></span></p>"
        },
        {
          "id": 190802,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Miltefosine</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 36-year-old male from Bihar comes with complaints of hypopigmented macules over the trunk and face. The nerves and sensations are tested to be normal, and no scaling is visible in the lesions. The patient gives a history of prolonged fever 2 years back for which he was treated. What is the drug of choice for this condition? </span></span></p>",
      "unique_key": "Q5280666",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. </span></strong><span style=\"font-size:14.0pt\">&nbsp;<strong>D) Miltefosine</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The presentation of hypopigmented macules without nerve involvement, combined with a history of prolonged fever, is suggestive of post-kala-azar dermal leishmaniasis (PKDL). </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This condition occurs as a sequela of visceral leishmaniasis (kala-azar), which is endemic in regions like Bihar, India.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">PKDL typically presents with macular, papular, or nodular skin lesions that develop months to years after the successful treatment of visceral leishmaniasis. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The absence of nerve involvement and scaling helps differentiate it from leprosy.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Option</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>A.</strong> <strong>Multidrug therapy for leprosy</strong>: Leprosy often presents with hypopigmented or erythematous patches with loss of sensation and may include nerve thickening, which is not described in this case.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Option</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>B.</strong> <strong>Amphotericin B</strong>: This is an antifungal and also used for treating visceral leishmaniosis but not for PKDL.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Option</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>C. </strong>&nbsp;<strong>Sodium stibogluconate</strong>: This is an antimonial used for treating leishmaniasis but is not the drug of choice for PKDL in regions where miltefosine is available and effective.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Post-kala-azar dermal leishmaniasis (PKDL) can occur after treatment of visceral leishmaniasis, particularly in endemic areas. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Miltefosine is the drug of choice for treating PKDL.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 190802,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        18
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47879,
      "choices": [
        {
          "id": 191111,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">4</span></span></span></p>"
        },
        {
          "id": 191112,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">5</span></span></span></p>"
        },
        {
          "id": 191113,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">6</span></span></span></p>"
        },
        {
          "id": 191114,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">7</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A neonate is born at 38 weeks of gestation with clear amniotic fluid. At 1 minute after birth, the infant is observed to have a heart rate of 90 bpm, slow and irregular breathing, some flexion of the extremities, a grimace response to suction, and a blue body with pink extremities. What is the APGAR score for this infant? </span></span></p>",
      "unique_key": "Q9130714",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. B) 5</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Heart Rate (Pulse):</span></strong><span style=\"font-size:14.0pt\"> A heart rate of less than 100 bpm scores 1 point.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Respiratory Effort:</span></strong><span style=\"font-size:14.0pt\"> Slow and irregular breathing scores 1 point.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Muscle Tone:</span></strong><span style=\"font-size:14.0pt\"> Some flexion of extremities scores 1 point.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Reflex Irritability:</span></strong><span style=\"font-size:14.0pt\"> A grimace response to suction scores 1 point.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Color:</span></strong><span style=\"font-size:14.0pt\"> A blue body with pink extremities scores 1 point.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The total APGAR score is calculated as follows:<br />\r\n1 (Heart Rate) + 1 (Respiratory Effort) + 1 (Muscle Tone) + 1 (Reflex Irritability) + 1 (Color) = 5.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The APGAR score is a quick assessment of a newborn&#39;s condition at 1 and 5 minutes after birth, evaluating five criteria: heart rate, respiratory effort, muscle tone, reflex irritability, and color.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Each criterion is scored from 0 to 2, with a maximum total score of 10.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/07/screenshot-2024-06-07-134336.png\" style=\"height:451px; width:700px\" /></span></span></span></p>",
      "correct_choice_id": 191112,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        13
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47870,
      "choices": [
        {
          "id": 191075,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Testicular torsion</span></span></span></p>"
        },
        {
          "id": 191076,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Increased risk of trauma</span></span></span></p>"
        },
        {
          "id": 191077,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Direct inguinal hernia</span></span></span></p>"
        },
        {
          "id": 191078,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Seminoma</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 2-year-old boy is brought to the pediatrician for a wellness visit. The mother reports that the child&#39;s right testicle cannot be felt within the scrotum. On examination, the right testicle is palpable in the inguinal canal and does not descend into the scrotum with gentle pressure. Which of these is not a usual complication of undescended testes? </span></span></p>",
      "unique_key": "Q8920565",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. C) Direct inguinal hernia</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Direct inguinal hernia</span></strong><span style=\"font-size:14.0pt\"> is not a typical complication associated with undescended testes. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">These patients are more likely to have an associated indirect inguinal hernia due to a patent processus vaginalis.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Testicular torsion:</span></strong><span style=\"font-size:14.0pt\"> It is a potential complication of undescended testes due to the abnormal position of the testis, which may predispose it to rotate on the spermatic cord.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Increased risk of trauma:</span></strong><span style=\"font-size:14.0pt\"> to the testis is observed when the testis is located in the inguinal canal where it can be more susceptible to injury.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Seminoma:</span></strong><span style=\"font-size:14.0pt\"> is a type of testicular cancer that can occur with greater frequency in men with a history of undescended testes.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">A direct inguinal hernia is not a usual complication of undescended testes, whereas an indirect inguinal hernia, associated with a patent processus vaginalis, is frequently observed in these patients.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 191077,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        12
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47488,
      "choices": [
        {
          "id": 189563,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Decreased NADH/NAD+ ratio</span></span></span></p>"
        },
        {
          "id": 189564,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Increased urea and urate levels</span></span></span></p>"
        },
        {
          "id": 189565,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Increased urate and lactate levels</span></span></span></p>"
        },
        {
          "id": 189566,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Increased level of alkaline phosphatase</span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 50-year-old chronic alcoholic man presents with joint pain and swelling,</span></span><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> and is diagnosed with gouty arthritis. Which of the following biochemical changes is most likely to be seen in this patient?</span></span></p>",
      "unique_key": "Q6977552",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. C) Increased urate and lactate levels</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Chronic alcohol consumption can lead to increased levels of urate and lactate in the blood. Alcohol metabolism increases the NADH/NAD+ ratio, leading to increased conversion of pyruvate to lactate and decreased excretion of uric acid. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The elevated lactate levels contribute to lactic acidosis, which competes with uric acid for excretion in the kidneys, resulting in hyperuricemia. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This biochemical environment promotes the formation of urate crystals, leading to gouty arthritis.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Decreased NADH/NAD+ ratio: </span></strong><span style=\"font-size:14.0pt\">This statement is incorrect because chronic alcohol consumption actually increases the NADH/NAD+ ratio due to the metabolism of alcohol in the liver.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Increased urea and urate levels: </span></strong><span style=\"font-size:14.0pt\">While urate levels are increased, urea levels are not typically elevated in gout. Urea levels are more closely related to protein metabolism and renal function, and are not directly influenced by the mechanisms causing gout.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Increased level of alkaline phosphatase: </span></strong><span style=\"font-size:14.0pt\">Increased levels of alkaline phosphatase are usually associated with liver or bone disease, not specifically with gout or alcohol consumption.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Chronic alcohol consumption increases the NADH/NAD+ ratio, leading to elevated levels of urate and lactate, which can contribute to the development of gouty arthritis.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 189565,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        1
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47660,
      "choices": [
        {
          "id": 190251,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Muscle glycogenolysis</span></span></span></p>"
        },
        {
          "id": 190252,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Dietary glucose</span></span></span></p>"
        },
        {
          "id": 190253,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Hepatic gluconeogenesis</span></span></span></p>"
        },
        {
          "id": 190254,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Hepatic glycogenolysis</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 50-year-old man presents to the clinic with a history of persistently high blood glucose levels. He mentions that he had his last meal at 8 pm the previous night and recorded his blood glucose at 7 am the next morning, which was 180 mg/dL. Which metabolic process is the most likely source of his elevated blood glucose levels?</span></span></p>",
      "unique_key": "Q3362009",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. </span></strong><strong><span style=\"font-size:14.0pt\">D) Hepatic glycogenolysis</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The elevated blood glucose level in this patient the morning after a meal suggests that the glucose is being sourced from internal metabolic processes rather than dietary intake, given the overnight fast. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Hepatic glycogenolysis is the process by which glycogen stored in the liver is broken down into glucose, which is then released into the bloodstream. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This process is particularly active during fasting states to maintain blood glucose levels. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Since the patient has not eaten for approximately 11 hours, hepatic glycogenolysis is the primary source of glucose.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Muscle glycogenolysis:</span></strong><span style=\"font-size:14.0pt\"> Muscle glycogenolysis also involves the breakdown of glycogen, but the glucose produced is used locally within muscle cells for energy and not released into the bloodstream.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Dietary glucose:</span></strong><span style=\"font-size:14.0pt\"> Dietary glucose would have been utilized or stored shortly after the meal. Given the time elapsed since the last meal, it is unlikely to be the source of the elevated glucose levels observed the next morning.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Hepatic gluconeogenesis:</span></strong><span style=\"font-size:14.0pt\"> While hepatic gluconeogenesis (the production of glucose from non-carbohydrate sources) does contribute to blood glucose, it typically becomes more significant after prolonged fasting when glycogen stores are depleted. In an overnight fast, hepatic glycogenolysis is the predominant source of glucose.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">After an overnight fast, elevated blood glucose levels are primarily maintained by hepatic glycogenolysis, which breaks down stored liver glycogen to release glucose into the bloodstream.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 190254,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        1
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47804,
      "choices": [
        {
          "id": 190819,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Diphtheria</span></span></span></p>"
        },
        {
          "id": 190820,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">MRSA&nbsp;(Methicillin-Resistant Staphylococcus Aureus)</span></span></span></p>"
        },
        {
          "id": 190821,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">&nbsp;Mumps</span></span></span></p>"
        },
        {
          "id": 190822,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">&nbsp;Asthma</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A healthcare provider is reviewing infection control procedures at a hospital training session. The discussion includes various diseases and the appropriate isolation precautions required to prevent their transmission in a healthcare setting. The provider emphasizes the importance of correctly categorizing the diseases based on their transmission routes to ensure patient and staff safety. Contact-based isolation is primarily employed for which of the following diseases? </span></span></p>",
      "unique_key": "Q7356507",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. B) MRSA&nbsp;(Methicillin-Resistant Staphylococcus Aureus)</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Contact-based isolation is used for patients who are infected with or are carriers of organisms that can be transmitted by direct contact with the patient or by contact with items in the patient&#39;s environment. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">MRSA (Methicillin-Resistant Staphylococcus Aureus) is a prime example of an organism requiring contact precautions due to its ability to spread via direct contact and its resistance to standard antibiotic treatments. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This makes stringent hygiene and isolation practices essential to control its spread within healthcare facilities.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Diphtheria:</span></strong><span style=\"font-size:14.0pt\"> Employed under droplet-based isolation when it is the respiratory type, due to the potential for droplet spread during coughing or sneezing.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Mumps:</span></strong><span style=\"font-size:14.0pt\"> Also managed under droplet precautions because the virus can be transmitted through respiratory droplets from an infected person.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Asthma:</span></strong><span style=\"font-size:14.0pt\"> This is not infectious and does not require transmission-based precautions, as it is a chronic lung condition triggered by various environmental factors.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The three categories of transmission-based precautions include:</span></span></span></li>\r\n</ul>\r\n\r\n<ul style=\"list-style-type:circle\">\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Contact- based isolation is used for infections, diseases, or germs that are spread by touching the patient or items in the room. Examples include MRSA, VRE, diarrheal illnesses, open wounds, and RSV.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Droplet-based isolation is employed for diphtheria and mumps.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Airborne precautions are required to protect against conditions like measles, severe acute respiratory syndrome (SARS), varicella (chickenpox), and Mycobacterium tuberculosis.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 190820,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        6
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47571,
      "choices": [
        {
          "id": 189895,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">GPCR (G Protein-Coupled Receptors)</span></span></span></p>"
        },
        {
          "id": 189896,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">C type of lectin receptor</span></span></span></p>"
        },
        {
          "id": 189897,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">NOD like receptor</span></span></span></p>"
        },
        {
          "id": 189898,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Toll like receptor</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 55-year-old male presents to the clinic with severe pain and swelling in his big toe. He has a history of hyperuricemia and is diagnosed with gout. The inflammation in gout is mediated by pattern recognition receptors that detect uric acid crystals. Which of the following receptors is responsible for detecting uric acid crystals in this patient?</span></span></p>",
      "unique_key": "Q7529437",
      "difficulty_level": "difficult",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. C) NOD like receptor</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">NOD-like receptors are a family of intracellular pattern recognition receptors that play a critical role in the innate immune response. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">In gout, NLRs, specifically NLRP3, are involved in detecting uric acid crystals. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The activation of NLRP3 leads to the formation of the inflammasome, which subsequently activates caspase-1 and results in the production of pro-inflammatory cytokines like IL-1&beta;. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This inflammatory cascade contributes to the intense inflammation and pain experienced in gout.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. GPCR (G Protein-Coupled Receptors):</span></strong><span style=\"font-size:14.0pt\"> GPCRs are a large family of cell surface receptors that detect molecules outside the cell and activate internal signal transduction pathways. They are not directly involved in the detection of uric acid crystals or the inflammatory response in gout.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. C type of lectin receptor:</span></strong><span style=\"font-size:14.0pt\"> These receptors are primarily involved in recognizing carbohydrate structures on pathogens and are important in the immune response to fungal and bacterial infections. They do not play a significant role in the detection of uric acid crystals.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Toll like receptor (TLR):</span></strong><span style=\"font-size:14.0pt\"> TLRs are another family of pattern recognition receptors that detect microbial components such as lipopolysaccharides, flagellin, and nucleic acids. Although TLRs play a role in the innate immune response, they are not directly responsible for the detection of uric acid crystals in gout.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">In gout, NOD-like receptors, particularly NLRP3, are responsible for detecting uric acid crystals. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Activation of NLRP3 leads to the formation of the inflammation&nbsp;&nbsp;resulting in the production of pro-inflammatory cytokines and the characteristic inflammation and pain of gout.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 189897,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        5
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47668,
      "choices": [
        {
          "id": 190283,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Robertson cooked meat broth</span></span></span></p>"
        },
        {
          "id": 190284,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Alkaline peptone water</span></span></span></p>"
        },
        {
          "id": 190285,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">&nbsp;Selenite F broth</span></span></span></p>"
        },
        {
          "id": 190286,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">&nbsp;Brain heart infusion broth</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 4-year-old boy is brought to the emergency department with symptoms of high fever and diarrhea containing streaks of blood. The symptoms began abruptly two days ago, and his parents are concerned about dehydration due to frequent bowel movements. The pediatrician decides to send a stool sample to the laboratory to identify the potential bacterial pathogen causing these symptoms. Which enrichment medium should be used to isolate the causative organism from this child&#39;s stool sample? </span></span></p>",
      "unique_key": "Q9627525",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans.</span></strong><span style=\"font-size:14.0pt\"> <strong>C) Selenite F broth</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The clinical presentation of fever, bloody stools, and abdominal pain in a child is suggestive of bacillary dysentery, likely caused by Shigella. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Selenite F broth is specifically used as an enrichment medium for the isolation of dysentery-causing bacteria such as Shigella and Salmonella.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This medium helps suppress the growth of commensal gut flora while allowing the pathogenic bacteria to survive and proliferate, facilitating their subsequent identification.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Robertson cooked meat broth:</span></strong><span style=\"font-size:14.0pt\"> Primarily used for the culture of anaerobic bacteria, which is not typically implicated in dysentery.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Alkaline peptone water:</span></strong><span style=\"font-size:14.0pt\"> Used for the enrichment of Vibrio species, particularly in cases of cholera, which presents with watery rather than bloody diarrhea.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Brain heart infusion broth:</span></strong><span style=\"font-size:14.0pt\"> A general enriched medium used for cultivating a wide range of fastidious organisms, but not specific for the selective enrichment of dysentery-causing bacteria.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Selenite F broth is the preferred choice for enriching stool cultures suspected of containing dysentery-causing organisms like Shigella, due to its ability to suppress normal flora while promoting the growth of pathogens. </span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Enrichment media:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">It is used to suppress commensal bacteria while allowing the pathogen to remain viable and grow. <strong>Common examples include:</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">&bull; <u>Tetrathionate broth</u> - It inhibits coliforms and <u>allows typhoid and paratyphoid</u> bacilli to grow.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">&bull; <u>Selenite F broth - used for dysentery causing bacteria</u>.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">&bull; <u>Alkaline peptone water - used for vibrio cholera</u> causing watery diarrhea.</span></span></span></p>",
      "correct_choice_id": 190285,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        6
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47551,
      "choices": [
        {
          "id": 189815,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Viper</span></span></span></p>"
        },
        {
          "id": 189816,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Cobra</span></span></span></p>"
        },
        {
          "id": 189817,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Wasp bite</span></span></span></p>"
        },
        {
          "id": 189818,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Scorpion</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 28-year-old man presents to a regional healthcare center with a history of being bitten while hiking in a forest area. He developed pain around the site and continued to bleed profusely from the wound site. The wound has now become red with the appearance of blisters. The casualty medical officer is considering the type of creature responsible based on the clinical presentation. Which of the following is the most likely cause of these symptoms?</span></span></p>",
      "unique_key": "Q9417092",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans.&nbsp;</span></strong><strong><span style=\"font-size:14.0pt\">A) Viper</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Vipers are known for their hemotoxic venom, which can cause extensive swelling, pain, bleeding, and blistering at the wound site. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The venom affects the blood&#39;s ability to clot, leading to continued bleeding, which is consistent with the patient&#39;s symptoms.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span><br />\r\n&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Cobra:</span></strong><span style=\"font-size:14.0pt\"> Cobra venom is primarily neurotoxic, not hemotoxic. It affects the nervous system, leading to paralysis, respiratory failure, and other neurologic symptoms, rather than causing bleeding and blistering.</span></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\"><strong>Option C. Wasp bite:</strong> Wasp bites can cause pain, swelling, and redness but are unlikely to cause profuse bleeding or blister formation unless there is an allergic reaction, which presents differently.</span></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\"><strong>Option D. Scorpion:</strong> Scorpion stings can lead to severe pain, numbness, and sometimes convulsions or cardiac effects, depending on the species, but they do not typically cause bleeding or blistering as described.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">When a patient present with pain, prolonged bleeding, and blistering at a bite site, a viper bite should be considered due to the hemotoxic nature of the venom, which disrupts blood clotting and damages tissues at the site of the bite.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/05/screenshot-2024-06-05-154218.JPG\" style=\"height:235px; width:1000px\" /></span></span></span></p>",
      "correct_choice_id": 189815,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        10
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47829,
      "choices": [
        {
          "id": 190915,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Fetal growth restriction</span></span></span></p>"
        },
        {
          "id": 190916,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Early-onset preeclampsia</span></span></span></p>"
        },
        {
          "id": 190917,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Placenta accreta</span></span></span></p>"
        },
        {
          "id": 190918,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Late-onset preeclampsia</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 29-year-old woman, gravida 2 para 1, is at 14 weeks of gestation and comes for her routine antenatal checkup. The obstetrician recommends a uterine artery Doppler ultrasound. What is the primary purpose of this test?</span></span></p>",
      "unique_key": "Q2254081",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. B) Early-onset preeclampsia</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">A uterine artery Doppler ultrasound is an important diagnostic tool used in early pregnancy to assess the blood flow in the uterine arteries. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Abnormal blood flow patterns, such as high resistance or the presence of notching, can indicate poor placental perfusion. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This is strongly associated with the development of early-onset preeclampsia, a condition characterized by high blood pressure and signs of damage to another organ system, often the kidneys, occurring before 34 weeks of gestation. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Identifying abnormal uterine artery blood flow early allows for closer monitoring and management to prevent severe complications.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Fetal growth restriction:</span></strong><span style=\"font-size:14.0pt\"> While uterine artery Doppler can help identify pregnancies at risk for fetal growth restriction, its primary role is in the early detection of placental insufficiency leading to conditions like preeclampsia. Fetal growth restriction is often a consequence of such insufficiency, but the Doppler is not primarily used to diagnose this condition directly.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Placenta accreta:</span></strong><span style=\"font-size:14.0pt\"> Placenta accreta is a condition where the placenta attaches too deeply into the uterine wall. This condition is usually diagnosed through ultrasound and MRI rather than a uterine artery Doppler. The Doppler ultrasound focuses on blood flow and is not the appropriate tool for diagnosing placenta accreta.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Late-onset preeclampsia:</span></strong><span style=\"font-size:14.0pt\"> Late-onset preeclampsia occurs after 34 weeks of gestation. While uterine artery Doppler can be suggestive of future preeclampsia risk, its primary utility is in predicting early-onset preeclampsia. Late-onset preeclampsia has different etiological factors and might not show the same early Doppler abnormalities as early-onset preeclampsia.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The primary purpose of a uterine artery Doppler ultrasound at 14 weeks of gestation is to detect early-onset preeclampsia by assessing placental blood flow and identifying high resistance or notching in the uterine arteries.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 190916,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47723,
      "choices": [
        {
          "id": 190503,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Ischiocavernosus</span></span></span></p>"
        },
        {
          "id": 190504,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Bulbospongiosus</span></span></span></p>"
        },
        {
          "id": 190505,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Urethral sphincter</span></span></span></p>"
        },
        {
          "id": 190506,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">External anal sphincter</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 28-year-old woman undergoes a successful vaginal delivery. Following the delivery, the obstetrician notices that the episiotomy, intended to facilitate the delivery, has extended posteriorly beyond the perineal body. Which of the following structures is most likely to be injured in this scenario?</span></span></p>",
      "unique_key": "Q2166837",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. D) External anal sphincter</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">An episiotomy is a surgical incision made in the perineum&mdash;the area between the vaginal opening and the anus&mdash;to enlarge the vaginal opening for childbirth. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Sometimes, despite careful incision, the episiotomy can extend inadvertently, causing further injury to surrounding structures. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">In this case, the extension of the episiotomy beyond the perineal body likely affects the external anal sphincter, as it lies posterior to the perineal body. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Damage to the external anal sphincter can result in significant complications, including fecal incontinence. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Therefore, the external anal sphincter is the structure most at risk of injury when the episiotomy extends posteriorly beyond the perineal body.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Ischiocavernosus:</span></strong><span style=\"font-size:14.0pt\"> The ischiocavernosus muscle is located in the perineal region but is more lateral, associated with the clitoral crura in females. It is less likely to be injured in a posterior extension of an episiotomy, as it is not in the direct line of extension.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Bulbospongiosus:</span></strong><span style=\"font-size:14.0pt\"> The bulbospongiosus muscle surrounds the vaginal orifice and the vestibule, contributing to the constriction of the vaginal opening. While it is part of the perineal muscles, it lies anterior to the perineal body and is therefore less likely to be affected by a posterior extension of the episiotomy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Urethral sphincter:</span></strong><span style=\"font-size:14.0pt\"> The urethral sphincter encircles the urethra and is located anteriorly in the perineum. An injury to the urethral sphincter from an episiotomy would be unusual unless the episiotomy extends anteriorly, which is not the case in this scenario.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">An episiotomy that extends beyond the perineal body posteriorly is most likely to injure the external anal sphincter, posing risks for fecal incontinence.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 190506,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47884,
      "choices": [
        {
          "id": 191131,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"IT\" style=\"font-size:14.0pt\">Suboccipito-frontal diameter</span></span></span></p>"
        },
        {
          "id": 191132,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"IT\" style=\"font-size:14.0pt\">Occipito-frontal diameter</span></span></span></p>"
        },
        {
          "id": 191133,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"IT\" style=\"font-size:14.0pt\">Suboccipito-bregmatic diameter</span></span></span></p>"
        },
        {
          "id": 191134,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"IT\" style=\"font-size:14.0pt\">Occipito-posterior position</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 28-year-old primigravida is in active labor. The fetus is in vertex presentation with complete flexion of the head. Which of the following diameters is engaged in this presentation? </span></span></p>",
      "unique_key": "Q1168590",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. C) Suboccipito-bregmatic diameter</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">In the vertex presentation with complete flexion of the fetal head, the chin is tucked towards the chest, and the smallest diameter of the head presents to the birth canal. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The suboccipito-bregmatic diameter, measuring approximately 9.5 cm, is the diameter engaged in this presentation. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This allows for the most favorable passage through the maternal pelvis, facilitating a smoother delivery.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/07/screenshot-2024-06-07-144814.png\" style=\"height:579px; width:800px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Suboccipito-frontal diameter:</span></strong><span style=\"font-size:14.0pt\"> The suboccipito-frontal diameter measures approximately 10.5 cm and is seen when the head is moderately flexed, not completely flexed. This diameter is larger than the suboccipito-bregmatic diameter and presents when the fetal head is slightly extended.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Occipito-frontal diameter:</span></strong><span style=\"font-size:14.0pt\"> The occipito-frontal diameter measures approximately 11.5 cm and is present when the fetal head is in a military or neutral position. This diameter is larger than both the suboccipito-bregmatic and suboccipito-frontal diameters and is not engaged in the vertex presentation with complete flexion.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Occipito-posterior position:</span></strong><span style=\"font-size:14.0pt\"> Occipito-posterior position refers to the orientation of the fetal head in the maternal pelvis, with the back of the fetal head towards the maternal sacrum. It is a positional term and not a description of the presenting diameter.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">In a vertex presentation with complete flexion of the fetal head, the suboccipito-bregmatic diameter, measuring approximately 9.5 cm, is the engaged diameter, facilitating the most favorable passage through the birth canal.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 191133,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47809,
      "choices": [
        {
          "id": 190839,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">50 mg/L</span></span></span></p>"
        },
        {
          "id": 190840,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">25 mg/L</span></span></span></p>"
        },
        {
          "id": 190841,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">12.5 mg/L</span></span></span></p>"
        },
        {
          "id": 190842,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">6.25 mg/L</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A clinician administers an intravenous drug to a patient at 8 AM with an initial plasma concentration of 200 mg/L. The drug has a half-life of 4 hours and follows first-order kinetics. What will be the plasma concentration of the drug at 8 PM on the same day?</span></span></p>",
      "unique_key": "Q9656713",
      "difficulty_level": "beginner",
      "solution": "<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. B) </span></strong><strong><span style=\"font-size:14.0pt\">25 mg/L</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Explanation</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Given:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Initial concentration (Câ‚€)</span></strong><span style=\"font-size:14.0pt\">: 200 mg/L</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Half-life (t&frac12;)</span></strong><span style=\"font-size:14.0pt\">: 4 hours</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Duration from 8 AM to 8 PM</span></strong><span style=\"font-size:14.0pt\">: 12 hours</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">To calculate the plasma concentration at 8 PM after 12 hours, we use the property of half-lives in first-order kinetics, where the drug concentration decreases by half with each half-life. Here&#39;s the calculation:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">After 1 half-life (4 hours, 12 PM)</span></strong><span style=\"font-size:14.0pt\">: 200&thinsp;/2=100 mg/L</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">After 2 half-lives (8 hours, 4 PM)</span></strong><span style=\"font-size:14.0pt\">: 100&thinsp;/2=50&thinsp;mg/L</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">After 3 half-lives (12 hours, 8 PM)</span></strong><span style=\"font-size:14.0pt\">: 50/2=25&thinsp;mg/L</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The drug follows first-order kinetics where the rate of drug elimination is proportional to the drug concentration in the plasma; here the drug concentration decreases by half with each half-life. </span></span></span></li>\r\n</ul>",
      "correct_choice_id": 190840,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47847,
      "choices": [
        {
          "id": 190983,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">A</span></span></span></p>"
        },
        {
          "id": 190984,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">B</span></span></span></p>"
        },
        {
          "id": 190985,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">C</span></span></span></p>"
        },
        {
          "id": 190986,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">D</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">An infectious disease specialist is evaluating the mechanism of action of various antiviral drugs (as shown below). Based on the known mechanisms of antiviral drugs, which part of the diagram is most likely to represent the action of baloxavir marboxil? </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/07/screenshot-2024-06-07-115031.png\" style=\"height:385px; width:600px\" /></span></span></p>",
      "unique_key": "Q6749763",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans.&nbsp;</span></strong><strong><span style=\"font-size:14.0pt\">C) C</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Baloxavir marboxil</span></strong><span style=\"font-size:14.0pt\"> functions by inhibiting cap-dependent endonuclease, an enzyme critical for the initiation of viral mRNA synthesis. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This mechanism is pivotal for the replication of influenza viruses, as it hampers the virus&#39;s ability to hijack the host&#39;s cellular machinery to begin synthesis of its own proteins.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Option A.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>A:</strong> might represent entry inhibitors or fusion inhibitors, affecting the virus&rsquo;s ability to enter the host cell.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. B:</span></strong><span style=\"font-size:14.0pt\"> could be indicative of processes interfering with the virus&#39;s ability to uncoat or replicate its genome inside the host cell.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. D:</span></strong><span style=\"font-size:14.0pt\"> likely involves the release phase of the virus lifecycle, possibly related to neuraminidase inhibitors or other mechanisms that prevent virus budding and release.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Baloxavir marboxil is a novel antiviral drug that targets the cap-dependent endonuclease activity of influenza viruses, offering a unique approach to inhibiting viral replication by preventing the proper processing of viral mRNA necessary for protein synthesis. </span></span></span></li>\r\n\t<li><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This mechanism is distinct from those of other common antivirals, making it a valuable tool in the treatment of influenza.</span></span></li>\r\n</ul>",
      "correct_choice_id": 190985,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        4
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47673,
      "choices": [
        {
          "id": 190303,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Osteochondroma</span></span></span></p>"
        },
        {
          "id": 190304,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Osteosarcoma</span></span></span></p>"
        },
        {
          "id": 190305,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Multiple Myeloma</span></span></span></p>"
        },
        {
          "id": 190306,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Ewing&rsquo;s sarcoma</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 16-year-old patient complains of a painless mass above his left knee, which is gradually growing in size. X-ray reveals the following. What is the diagnosis? </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/06/screenshot-2024-06-06-125849.png\" style=\"height:608px; width:300px\" /></span></span></p>",
      "unique_key": "Q7695390",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. A) Osteochondroma</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Osteochondromas are the most common benign bone tumors. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">They typically present as painless, slow-growing masses near the ends of long bones, such as the knee, and are often detected in adolescents or young adults. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">They consist of bony projections covered by cartilage and usually arise from the growth plate (epiphyseal cartilage) during bone growth.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Given the patient&#39;s age, the location of the mass above the knee, and the slow-growing nature of the lesion, osteochondroma is a likely diagnosis.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">X-rays typically show a bony outgrowth with a distinct bony stalk (pedicle) arising from the surface of the affected bone.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options</span></strong><span style=\"font-size:14.0pt\">: </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Osteosarcoma: </span></strong><span style=\"font-size:14.0pt\">Osteosarcoma is the most common primary malignant bone tumor in adolescents and young adults. It typically presents as a painful mass, often with associated swelling and decreased range of motion. Osteosarcomas usually arise in the metaphyseal region of long bones, such as the distal femur or proximal tibia. While osteosarcoma is an important consideration in a young patient with a bone mass, the fact that the mass is painless and slowly growing makes osteochondroma a more likely diagnosis. However, further evaluation with imaging studies and possibly a biopsy may be warranted to rule out osteosarcoma definitively.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Multiple Myeloma: </span></strong><span style=\"font-size:14.0pt\">Multiple myeloma is a malignant plasma cell disorder characterized by the proliferation of abnormal plasma cells within the bone marrow, leading to lytic bone lesions and the production of monoclonal proteins. It typically presents with symptoms such as bone pain, anemia, kidney dysfunction, and hypercalcemia. Multiple myeloma is uncommon in adolescents and is more commonly seen in older adults. While it can present with lytic bone lesions, the clinical presentation and age of the patient make it less likely in this scenario.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Ewing&#39;s Sarcoma: </span></strong><span style=\"font-size:14.0pt\">Ewing&#39;s sarcoma is a highly aggressive malignant bone tumor that primarily affects children and young adults. It often presents with bone pain, swelling, and a palpable mass. Ewing&#39;s sarcoma commonly arises in the diaphysis (shaft) of long bones, such as the femur or tibia. While Ewing&#39;s sarcoma is a consideration in a young patient with a bone mass, the painless nature of the mass and the gradual growth make osteochondroma a more likely diagnosis. However, further evaluation with imaging studies and possibly a biopsy may be needed to differentiate between the two.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The given case and x-ray image of the 16-year-old patient describes the presence of osteochondroma. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Since the mass is painless, it confirms it to be an osteochondroma. </span></span></span></li>\r\n</ul>",
      "correct_choice_id": 190303,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        15
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47807,
      "choices": [
        {
          "id": 190831,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Phenytoin</span></span></span></p>"
        },
        {
          "id": 190832,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Valproate</span></span></span></p>"
        },
        {
          "id": 190833,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Levetiracetam</span></span></span></p>"
        },
        {
          "id": 190834,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Lamotrigine</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A neurologist is reviewing a case of a patient who has developed unusual hair growth on the face and neck after starting a new medication for epilepsy. Based on the pattern of hair growth seen in the patient, which of the following drugs is most likely responsible?</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/07/screenshot-2024-06-07-102423.png\" style=\"height:183px; width:300px\" /></span></span></p>",
      "unique_key": "Q6189695",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. A) </span></strong><strong><span style=\"font-size:14.0pt\">Phenytoin</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Phenytoin</span></strong><span style=\"font-size:14.0pt\"> is well-documented for causing hypertrichosis, which is an increase in hair growth, particularly on the face and neck, as seen in the image provided. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This side effect is one of the more cosmetic, yet distressing effects associated with this medication, which is used primarily in the management of epilepsy.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Valproate</span></strong><span style=\"font-size:14.0pt\">: While valproate can cause weight gain and hair loss, it is not typically associated with increased facial hair growth.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Levetiracetam</span></strong><span style=\"font-size:14.0pt\">: Known for its neurological side effects, such as mood changes and irritability, levetiracetam does not commonly cause changes in hair growth.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Lamotrigine</span></strong><span style=\"font-size:14.0pt\">: This drug can cause skin rash and other serious skin reactions but does not typically affect hair growth.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Hirsutism is caused by:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Phenytoin</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Cyclosporine</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Minoxidol</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 190831,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        4
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47880,
      "choices": [
        {
          "id": 191115,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Timolol</span></span></span></p>"
        },
        {
          "id": 191116,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Latanoprost</span></span></span></p>"
        },
        {
          "id": 191117,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Pilocarpine</span></span></span></p>"
        },
        {
          "id": 191118,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Carbonic anhydrase inhibitor</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 45-year-old patient with a history of glaucoma presents to the clinic for follow-up. The ophthalmologist decides to adjust the patient&#39;s medication to better control intraocular pressure. Which of the following drugs decreases intraocular pressure by increasing uveoscleral flow? </span></span></p>",
      "unique_key": "Q5475618",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. B) Latanoprost</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Latanoprost is a prostaglandin analog used to lower intraocular pressure. It works by increasing uveoscleral outflow. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Latanoprost is a prodrug activated during its passage through the cornea, where it stimulates prostanoid receptors on ciliary muscles, leading to the release of matrix metalloproteinases. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">These enzymes increase uveoscleral outflow, thereby reducing intraocular pressure.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Timolol:</span></strong><span style=\"font-size:14.0pt\"> Timolol is a beta-blocker that decreases intraocular pressure by reducing aqueous humor production. It does not primarily increase uveoscleral outflow.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Pilocarpine:</span></strong><span style=\"font-size:14.0pt\"> Pilocarpine is a miotic agent that reduces intraocular pressure by increasing trabecular meshwork outflow. It does not significantly affect uveoscleral outflow.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Carbonic anhydrase inhibitor:</span></strong><span style=\"font-size:14.0pt\"> Carbonic anhydrase inhibitors decrease intraocular pressure by reducing aqueous humor production, not by increasing uveoscleral outflow.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/07/screenshot-2024-06-07-135106.png\" style=\"height:642px; width:800px\" /></span></span></strong></p>",
      "correct_choice_id": 191116,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        8
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47861,
      "choices": [
        {
          "id": 191039,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Botzinger Complex</span></span></span></p>"
        },
        {
          "id": 191040,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Cells of Ito</span></span></span></p>"
        },
        {
          "id": 191041,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Brunner&rsquo;s Cells</span></span></span></p>"
        },
        {
          "id": 191042,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Cajal&rsquo;s Cells</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 35-year-old woman presents with complaints of chronic nausea, vomiting, and intermittent abdominal pain. She is diagnosed with a disorder affecting gastrointestinal motility. During her hospital stay, she undergoes several tests to determine the underlying cause of her symptoms. The results point towards an abnormality in the cells responsible for initiating the Basal Electrical Rhythm (BER) in the gastrointestinal tract. Which of the following cells is primarily responsible for the initiation of the BER? </span></span></p>",
      "unique_key": "Q7835103",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans.&nbsp;</span></strong><strong><span style=\"font-size:14.0pt\">D) Cajal&rsquo;s Cells</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The Basal Electrical Rhythm (BER) is crucial for coordinating the contractions of the smooth muscle in the gastrointestinal tract. These rhythmic electrical impulses are generated by specific pacemaker cells.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Cajal&rsquo;s cells are specialized pacemaker cells located in the smooth muscle layers of the gastrointestinal tract. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">They generate and propagate the slow waves that form the BER, which are essential for the coordination of smooth muscle contractions and effective gastrointestinal motility.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Option A.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>Botzinger Complex:</strong> This is a cluster of neurons in the medulla oblongata involved in respiratory rhythm generation, not in the motility of the gastrointestinal tract.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Option B.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>Cells of Ito:</strong> These hepatic stellate cells are found in the liver and are involved in liver function and fibrosis, but they do not play a role in the BER of the gastrointestinal tract. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Option C.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>Brunner&rsquo;s Cells:</strong> These are glands located in the duodenum that secrete an alkaline mucus to protect the duodenal lining, but they are not involved in initiating the BER.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The Interstitial Cells of Cajal (Cajal&rsquo;s Cells) are responsible for the initiation and propagation of the Basal Electrical Rhythm (BER) in the gastrointestinal tract, coordinating the smooth muscle contractions necessary for proper gastrointestinal motility.</span></span></li>\r\n</ul>",
      "correct_choice_id": 191042,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        2
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47570,
      "choices": [
        {
          "id": 189891,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Accumulation of lipid in the cytoplasm of hepatocytes</span></span></span></p>"
        },
        {
          "id": 189892,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Accumulation of glycogen in the cytoplasm of hepatocytes</span></span></span></p>"
        },
        {
          "id": 189893,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Accumulation of iron in the hepatic parenchyma</span></span></span></p>"
        },
        {
          "id": 189894,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Accumulation of iron in the Kupffer cells</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 41-year-old obese, non-alcoholic woman presents with mild right-sided abdominal pain. Physical examination is normal. Blood tests reveal mildly elevated liver enzymes (SGOT and SGPT) with normal total and direct bilirubin levels. An ultrasound shows a few hyperechoic regions in the liver. If a liver biopsy is performed, which finding is most likely?</span></span></p>",
      "unique_key": "Q4179593",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. A) Accumulation of lipid in the cytoplasm of hepatocytes</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The clinical presentation and laboratory findings are suggestive of non-alcoholic fatty liver disease (NAFLD), a condition commonly associated with obesity. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">NAFLD is characterized by the accumulation of fat within the liver cells (hepatocytes). </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The mild elevation in liver enzymes and the presence of hyperechoic regions on ultrasonography are indicative of fatty infiltration in the liver. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">If a liver biopsy were performed, it would most likely show the presence of lipid droplets within the cytoplasm of hepatocytes.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Accumulation of glycogen in the cytoplasm of hepatocytes:</span></strong><span style=\"font-size:14.0pt\"> While glycogen storage diseases can lead to the accumulation of glycogen in hepatocytes, this condition is less likely given the patient&rsquo;s obesity and typical presentation suggestive of fatty liver disease.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Accumulation of iron in the hepatic parenchyma:</span></strong><span style=\"font-size:14.0pt\"> This finding is characteristic of hemochromatosis, a condition involving excessive iron deposition in the liver and other tissues. Hemochromatosis typically presents with a different clinical picture, including signs of iron overload rather than obesity and fatty liver.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Accumulation of iron in the Kupffer cells:</span></strong><span style=\"font-size:14.0pt\"> This occurs in conditions such as hemosiderosis, which involves iron storage in macrophages (Kupffer cells) and can be secondary to frequent blood transfusions or certain anemia&rsquo;s. The patient&rsquo;s presentation is more consistent with NAFLD rather than iron overload conditions.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Non-alcoholic fatty liver disease (NAFLD) is characterized by the accumulation of lipid in the cytoplasm of hepatocytes, often associated with obesity and mild elevations in liver enzymes. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This condition can be identified through imaging and confirmed by liver biopsy showing lipid infiltration in hepatocytes.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 189891,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        5
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47491,
      "choices": [
        {
          "id": 189575,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Patent ductus arteriosus</span></span></span></p>"
        },
        {
          "id": 189576,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Premature closure of the ductus arteriosus</span></span></span></p>"
        },
        {
          "id": 189577,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Premature closure of the ductus venosus</span></span></p>"
        },
        {
          "id": 189578,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Flap closure of foramen ovale</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 25-year-old primigravida at 35 weeks of gestation has been taking indomethacin (25 mg TDS) for the management of polyhydramnios. If she goes into labor now, what fetal abnormality is most likely to be observed? </span></span></p>",
      "unique_key": "Q8442849",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. B) Premature closure of the ductus arteriosus</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Indomethacin, a nonsteroidal anti-inflammatory drug (NSAID), is used to manage polyhydramnios by reducing fetal urine production. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">However, one of the potential adverse effects of indomethacin on the fetus is the premature closure or constriction of the ductus arteriosus. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The ductus arteriosus is a vital fetal blood vessel that allows blood to bypass the fetal lungs. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Its premature closure can result in significant fetal cardiovascular complications, including right ventricular hypertrophy, pulmonary hypertension, and heart failure.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Patent ductus arteriosus:</span></strong><span style=\"font-size:14.0pt\"> Indomethacin is actually used to treat patent ductus arteriosus (PDA) in premature infants because it promotes the closure of the ductus arteriosus. Therefore, indomethacin is not associated with causing PDA.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Premature closure of the ductus venosus:</span></strong><span style=\"font-size:14.0pt\"> Indomethacin does not affect the ductus venosus, which shunts blood from the umbilical vein to the inferior vena cava, bypassing the liver. Premature closure of the ductus venosus is not a known complication of indomethacin use.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Flap closure of foramen ovale:</span></strong><span style=\"font-size:14.0pt\"> The foramen ovale is an opening between the right and left atria that normally closes after birth. Indomethacin does not typically affect the foramen ovale during fetal life.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Indomethacin use in pregnancy, especially in the third trimester, can lead to premature closure of the ductus arteriosus in the fetus, which can cause significant cardiovascular complications such as right ventricular hypertrophy and pulmonary hypertension.</span></span></li>\r\n</ul>",
      "correct_choice_id": 189576,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47493,
      "choices": [
        {
          "id": 189583,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Administer both human tetanus immunoglobulin and restart the tetanus vaccine series</span></span></span></p>"
        },
        {
          "id": 189584,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Administer human tetanus immunoglobulin only</span></span></span></p>"
        },
        {
          "id": 189585,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Administer a single booster dose of tetanus toxoid</span></span></span></p>"
        },
        {
          "id": 189586,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Restart the full tetanus toxoid vaccination series</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 24-year-old male visits the clinic with a clean, non-bleeding laceration on his arm. He reports that his last tetanus vaccine was administered 7-8 years ago, following a complete vaccination schedule. What is the most appropriate next step in managing this patient&rsquo;s wound? </span></span></p>",
      "unique_key": "Q1008214",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">&nbsp;</span></strong></span></span><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans.&nbsp;</span></strong><strong><span style=\"font-size:14.0pt\">C) Administer a single booster dose of tetanus toxoid</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">For a patient who has a clean, non-bleeding wound and whose last tetanus vaccine was administered 7-8 years ago following a complete vaccination schedule, the most appropriate management is to administer a single booster dose of tetanus toxoid. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This recommendation is based on guidelines that suggest a tetanus booster should be given if the last dose was administered more than 5 years ago for a clean, minor wound.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Option A.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>Administering both human tetanus immunoglobulin and restarting the tetanus vaccine series:</strong> This is not indicated for patients with clean wounds who have received a full vaccination series within the past 10 years. This approach is more suited for patients with either unknown vaccination status or severe, contaminated wounds.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B.&nbsp;</span></strong><strong><span style=\"font-size:14.0pt\">Administering human tetanus immunoglobulin only</span></strong><span style=\"font-size:14.0pt\">: This is not necessary for patients with a complete vaccination history and a clean wound, as the risk of tetanus infection is low.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D.&nbsp;</span></strong><strong><span style=\"font-size:14.0pt\">Restarting the full tetanus toxoid vaccination series</span></strong><span style=\"font-size:14.0pt\">: This is not required for patients who have received their full course within the last 10 years. A booster is sufficient to extend protection.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></span></strong></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/06/screenshot-2024-06-06-121202.png\" style=\"height:246px; width:1000px\" /></span></span></strong></p>",
      "correct_choice_id": 189585,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47801,
      "choices": [
        {
          "id": 190807,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Datura, Pralidoxime</span></span></span></p>"
        },
        {
          "id": 190808,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Datura, Physostigmine</span></span></span></p>"
        },
        {
          "id": 190809,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Yellow oleander, Digoxin</span></span></span></p>"
        },
        {
          "id": 190810,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Yellow oleander, Physostigmine</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 30-year-old man presents to the emergency department with symptoms of irritability, restlessness, dry hot skin, and an inability to pass urine or stools. These symptoms are indicative of poisoning, and the medical officer needs to identify the likely poison and its appropriate antidote based on the clinical presentation. Which of the following combinations of poison and antidote is most appropriate? </span></span></p>",
      "unique_key": "Q1575063",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. </span></strong><strong><span style=\"font-size:14.0pt\">B) Datura, Physostigmine</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Datura poisoning typically presents with symptoms characteristic of anticholinergic toxicity, such as irritability, restlessness, dry and hot skin, and urinary retention. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The appropriate antidote for anticholinergic poisoning is Physostigmine, an acetylcholinesterase inhibitor that can cross the blood-brain barrier and counteract the effects of anticholinergic agents like Datura by increasing the level of acetylcholine.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Note - Trumpet shape flower &ndash; Datura</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/07/screenshot-2024-06-07-100318.png\" style=\"height:238px; width:400px\" /></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Datura, Pralidoxime:</span></strong><span style=\"font-size:14.0pt\"> Incorrect because Pralidoxime is used to treat organophosphate poisoning, not anticholinergic poisoning.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Yellow oleander, Digoxin:</span></strong><span style=\"font-size:14.0pt\"> Incorrect as Digoxin is a cardiac glycoside itself and not an antidote. Yellow oleander toxicity mimics that of digoxin and requires different management strategies, such as activated charcoal and possibly Digoxin-specific antibody fragments, not Digoxin itself.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Yellow oleander, Physostigmine:</span></strong><span style=\"font-size:14.0pt\"> Incorrect because Physostigmine is used for anticholinergic poisoning, not for poisoning by cardiac glycosides like those found in yellow oleander.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective</span></strong><span style=\"font-size:14.0pt\">:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Datura poisoning:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Common names </span></strong><span style=\"font-size:14.0pt\">- thorn apple, Jimson weed, and Devil&#39;s trumpet.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Active principle</span></strong><span style=\"font-size:14.0pt\"> - Atropine, Scopolamine, and Hyoscyamine.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Features of Datura poisoning (D&#39;s of Datura): </span></strong><span style=\"font-size:14.0pt\">Dry hot skin, Dilatation of pupils<strong>, </strong>Diplopia<strong>, </strong>Dry mouth<strong>, </strong>Dysphagia<strong>, </strong>Dysarthria<strong>, </strong>Drunken gait<strong>, </strong>Delirium<strong>, </strong>Drowsiness<strong>, </strong>Death.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Datura causes constipation, not diarrhoea</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Treatment of Datura Poisoning: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Datura is an anticholinergic plant poison and antidote is a cholinergic drug.</span></span></span></li>\r\n\t<li><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Physostigmine&nbsp;</span></span><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">is the antidote of choice</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Neostigmine isn&rsquo;t preferred as it doesn&rsquo;t cross blood brain barrier, and hence does not reverse atropine induced CNS toxicity </span></span></span></li>\r\n</ul>",
      "correct_choice_id": 190808,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        10
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47841,
      "choices": [
        {
          "id": 190963,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Subgaleal hematoma</span></span></span></p>"
        },
        {
          "id": 190964,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Caput Succedaneum</span></span></span></p>"
        },
        {
          "id": 190965,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Cephalhematoma</span></span></span></p>"
        },
        {
          "id": 190966,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Encephalocele</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 2-month-old infant is brought to the pediatric clinic for evaluation of a swelling on the right side of the head, present since birth. The swelling has not increased in size and is firm to the touch. An X-ray of the skull is obtained and shown below. What is the likely diagnosis?</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/07/screenshot-2024-06-07-112228.png\" style=\"height:296px; width:300px\" /></span></span></p>",
      "unique_key": "Q4792240",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. C) Cephalhematoma</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Cephalhematoma is a subperiosteal hemorrhage that occurs due to birth trauma. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">It is characterized by a collection of blood between the periosteum and the skull bone, usually appearing as a firm swelling that is confined to one bone and does not cross suture lines. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This is because the periosteum is tightly bound to the edges of the bones, limiting the spread of blood. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The X-ray will show a localized swelling on the skull, which matches the description and imaging in this case.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Subgaleal Hematoma:</span></strong><span style=\"font-size:14.0pt\"> This condition involves bleeding between the galea aponeurotica and the periosteum of the skull. It can spread widely and cross suture lines, often leading to a diffuse swelling of the scalp. This is more serious due to potential for significant blood loss, which is not consistent with the localized, firm swelling described and seen in the X-ray.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/07/screenshot-2024-06-07-112302.png\" style=\"height:507px; width:400px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Caput Succedaneum:</span></strong><span style=\"font-size:14.0pt\"> This is a diffuse, edematous swelling of the scalp tissue caused by pressure during birth. It crosses suture lines and typically resolves within a few days postpartum. The swelling in caput succedaneum is soft and not confined to one bone, unlike the case described.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/07/screenshot-2024-06-07-112314.png\" style=\"height:457px; width:400px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Encephalocele:</span></strong><span style=\"font-size:14.0pt\"> Encephalocele is a congenital condition where brain tissue herniates through a defect in the skull. It would present as a bony defect with protruding brain tissue on imaging, which is not seen in this X-ray.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/07/screenshot-2024-06-07-112321.png\" style=\"height:441px; width:400px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Cephalhematoma is a subperiosteal hemorrhage typically caused by birth trauma, presenting as a firm, localized swelling that does not cross suture lines and is confined to a single bone.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 190965,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        17
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47657,
      "choices": [
        {
          "id": 190239,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Dorsalis Pedis Artery lies beneath the Deep Fascia along the Lateral Border of Dorsum of Foot</span></span></span></p>"
        },
        {
          "id": 190240,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Close to its Termination it is crossed by the Tendon of Extensor Hallucis Longus</span></span></span></p>"
        },
        {
          "id": 190241,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">It gives rise to the First Dorsal Metatarsal Artery before Termination</span></span></span></p>"
        },
        {
          "id": 190242,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">It lies Medial to Tendon of Extensor Hallucis Longus</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 60-year-old male, known hypertensive, diabetic, and a smoker for the past 30 years, visited the surgery OPD with an ulcer on the dorsum of the foot close to the great toe. The unit chief asked one of the students to look for dorsalis pedis artery pulsation in this patient. Which of the following statements pertaining to this case is correct? </span></span></p>",
      "unique_key": "Q1546656",
      "difficulty_level": "difficult",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. C) It gives rise to the First Dorsal Metatarsal Artery before Termination</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">The dorsalis pedis artery is a continuation of the anterior tibial artery on the dorsum of the foot. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">It runs along the dorsum of the foot towards the space between the first and second toes. Before its termination, it gives off the first dorsal metatarsal artery, which supplies the adjacent sides of the first and second toes.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/06/screenshot-2024-06-06-123034.png\" style=\"height:365px; width:300px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Dorsalis Pedis Artery lies beneath the Deep Fascia along the Lateral Border of Dorsum of Foot:</span></strong><span style=\"font-size:14.0pt\"> This statement is incorrect. The dorsalis pedis artery lies superficial to the deep fascia and runs along the medial aspect of the dorsum of the foot.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Close to its Termination it is crossed by the Tendon of Extensor Hallucis Longus:</span></strong><span style=\"font-size:14.0pt\"> This statement is incorrect. The dorsalis pedis artery runs alongside the tendon of the extensor hallucis longus and is not crossed by it.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. It lies Medial to Tendon of Extensor Hallucis Longus:</span></strong><span style=\"font-size:14.0pt\"> This statement is incorrect. The dorsalis pedis artery actually lies lateral to the tendon of the extensor hallucis longus on the dorsum of the foot.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">The dorsalis pedis artery gives rise to the first dorsal metatarsal artery before its termination, which is an important landmark in the anatomical identification of this artery.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 190241,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        3
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47737,
      "choices": [
        {
          "id": 190555,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Hypokalemia</span></span></span></p>"
        },
        {
          "id": 190556,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Hyperkalemia</span></span></span></p>"
        },
        {
          "id": 190557,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Hypercalcemia</span></span></span></p>"
        },
        {
          "id": 190558,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Hypocalcemia</span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 50-year-old patient presents to the emergency department with weakness and palpitations. An ECG is performed and is shown below. Identify the electrolyte abnormality associated with the ECG findings.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/06/screenshot-2024-06-06-154103.png\" style=\"height:145px; width:300px\" /></span></span></p>",
      "unique_key": "Q1484571",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Ans. </span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">B) Hyperkalemia</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Hyperkalemia causes characteristic ECG changes which include tall, peaked T waves, a prolonged PR interval, widening of the QRS complex, and in severe cases, a sine wave pattern due to the merging of the QRS and T waves. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">The ECG provided shows these specific findings, which are indicative of elevated potassium levels in the blood.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Option A. Hypokalemia:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"> Hypokalemia typically presents with flattened or inverted T waves, the presence of U waves, ST depression, and a prolonged QT interval. These features are not observed in the provided ECG.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Option C. Hypercalcemia:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"> Hypercalcemia is characterized by a shortened QT interval and a decrease in the ST segment duration. The ECG changes in hypercalcemia do not match the findings in the provided ECG.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Option D. Hypocalcemia:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"> Hypocalcemia leads to a prolonged QT interval due to lengthening of the ST segment. These changes are not consistent with the ECG shown.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Hyperkalemia is an important electrolyte disturbance to recognize on an ECG. Key features include tall, peaked T waves, prolonged PR intervals, widening of the QRS complex, and in severe cases, a sine wave pattern. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Prompt recognition and treatment are critical to prevent potentially fatal arrhythmias.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 190556,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        11
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47676,
      "choices": [
        {
          "id": 190315,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Search, rescue, and first aid</span></span></span></p>"
        },
        {
          "id": 190316,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Triage</span></span></span></p>"
        },
        {
          "id": 190317,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Tagging</span></span></span></p>"
        },
        {
          "id": 190318,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Disaster mitigation</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In a disaster setting, a medical team utilizes a method to rapidly evaluate injured individuals to prioritize those who need urgent care based on their potential for survival and the severity of their injuries. This process is known as: </span></span></p>",
      "unique_key": "Q6162724",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans.&nbsp;</span></strong><strong><span style=\"font-size:14.0pt\">B) Triage</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This<strong> </strong></span><span style=\"font-size:14.0pt\">is the correct<strong> </strong>answer. Triage is the systematic process used during disasters to assess and categorize injured individuals based on the urgency of their medical needs and the likelihood of survival with immediate intervention. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This method helps in optimizing resource allocation when resources are limited, ensuring that those who are most likely to benefit from immediate care receive it first.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Search, rescue, and first aid:</span></strong><span style=\"font-size:14.0pt\"> This involves the initial steps in a disaster response, including locating, rescuing, and providing basic first aid to victims. While essential, it does not involve the systematic prioritization of care based on the likelihood of survival.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Tagging:</span></strong><span style=\"font-size:14.0pt\"> This is a component of triage where each patient is given a tag that indicates their triage status, which helps in further management and tracking. Tagging itself is not the process of prioritizing care based on medical need.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Disaster mitigation:</span></strong><span style=\"font-size:14.0pt\"> Refers to measures designed to reduce or prevent the risk of disasters and to mitigate their impacts on communities. It is not related to the immediate medical assessment of injured individuals.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Triage system: Most commonly uses FOUR color code system:</span></span></span>\r\n\r\n\t<ul>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Red (Highest Priority): Immediate resuscitation or limb/lifesaving surgery in next 6 hours</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Yellow (High Priority): Possible resuscitation or limb/lifesaving surgery in next 24 hours</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Green (Low Priority): Minor illness/ambulatory patients</span></span></span></li>\r\n\t\t<li><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Black (Least Priority): Dead and moribund patients</span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>",
      "correct_choice_id": 190316,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47863,
      "choices": [
        {
          "id": 191047,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Oral candidiasis &amp; WHO stage 2</span></span></span></p>"
        },
        {
          "id": 191048,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Oral candidiasis &amp; WHO stage 3</span></span></span></p>"
        },
        {
          "id": 191049,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Oral hairy leukoplakia &amp; WHO stage 3</span></span></span></p>"
        },
        {
          "id": 191050,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Oral hairy leukoplakia &amp; WHO stage 2</span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">An HIV-positive individual with CD 4 count &lt; 300 / microlitre presents with the following finding. What is the diagnosis &amp; WHO staging?</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/07/screenshot-2024-06-07-124155.png\" style=\"height:198px; width:300px\" /></span></span></p>",
      "unique_key": "Q8277728",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Ans. C)&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Oral hairy leukoplakia &amp; WHO stage 3</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">This is correct. Oral hairy leukoplakia presents as white, corrugated plaques on the lateral aspects of the tongue and is associated with Epstein-Barr virus infection in HIV-positive individuals. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">It is classified under WHO stage 3.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Option A. Oral candidiasis &amp; WHO stage 2</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">: This is incorrect. Oral candidiasis is characterized by white, creamy plaques that can be scraped off, and it is classified under WHO stage 2 in HIV.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Option B. Oral candidiasis &amp; WHO stage 3</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">: This is incorrect. While oral candidiasis can progress to WHO stage 3 if persistent and untreated, the image shows features more consistent with oral hairy leukoplakia.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Option D. Oral hairy leukoplakia &amp; WHO stage 2</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">: This is incorrect. Oral hairy leukoplakia is not classified under WHO stage 2. It is a stage 3 condition due to its association with significant immunosuppression in HIV patients.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/07/screenshot-2024-06-07-124350.png\" style=\"height:683px; width:1000px\" /></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Oral hairy leukoplakia is a white, corrugated lesion commonly seen on the lateral tongue in HIV-positive patients and is classified as a WHO stage 3 condition. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">It is an indicator of significant immunosuppression and often requires prompt management.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 191049,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        11
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47917,
      "choices": [
        {
          "id": 191263,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Primary hyperparathyroidism</span></span></span></p>"
        },
        {
          "id": 191264,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Secondary hyperparathyroidism</span></span></span></p>"
        },
        {
          "id": 191265,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Tertiary hyperparathyroidism</span></span></span></p>"
        },
        {
          "id": 191266,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Vitamin D deficiency</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 65-year-old woman presents with Diabetes Mellitus, Hypertension, Obesity and end stage renal disease. Her laboratory results show the following. Which of the following is the most likely diagnosis?<strong> </strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Calcium: Increased</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">PTH: Increased</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Phosphate: Increased</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Alkaline Phosphatase (ALP): Increased</span></span></span></li>\r\n</ul>",
      "unique_key": "Q6471199",
      "difficulty_level": "difficult",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>C) Tertiary hyperparathyroidism</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Tertiary hyperparathyroidism occurs in the context of long-standing secondary hyperparathyroidism, typically in patients with chronic kidney disease (CKD) or end-stage renal disease (ESRD). </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">In these patients, prolonged stimulation of the parathyroid glands due to chronic hypocalcemia (secondary hyperparathyroidism) eventually leads to autonomous parathyroid hyperplasia and hyperfunction, resulting in tertiary hyperparathyroidism. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">The laboratory findings in tertiary hyperparathyroidism include:</span></span></span></li>\r\n</ul>\r\n\r\n<ol style=\"margin-left:40px\">\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Increased Calcium</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">: The parathyroid glands secrete excess parathyroid hormone (PTH) autonomously, leading to hypercalcemia.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Increased PTH</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">: The parathyroid glands are hyperplastic and continue to secrete high levels of PTH despite elevated calcium levels.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Increased Phosphate</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">: In CKD and ESRD, phosphate excretion is impaired, leading to hyperphosphatemia.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Increased Alkaline Phosphatase (ALP)</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">: Elevated ALP levels are indicative of increased bone turnover and activity, often seen in hyperparathyroidism.</span></span></span></li>\r\n</ol>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Given the patient&#39;s history of end-stage renal disease (ESRD), the presence of increased calcium, increased PTH, increased phosphate, and increased ALP is consistent with tertiary hyperparathyroidism.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">A. Primary hyperparathyroidism</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">: Primary hyperparathyroidism is characterized by autonomous overproduction of PTH due to a parathyroid adenoma or hyperplasia. This condition typically presents with increased calcium and PTH but usually has normal or decreased phosphate levels, not increased phosphate as seen in this patient.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option </span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">B.</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"> <strong>Secondary hyperparathyroidism</strong>: Secondary hyperparathyroidism occurs due to chronic hypocalcemia, often secondary to CKD. It is characterized by increased PTH and phosphate with normal or low calcium levels. This patient&#39;s hypercalcemia is not consistent with secondary hyperparathyroidism.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14pt\"><strong>D.</strong>&nbsp;</span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><strong>Vitamin D deficiency</strong>: Vitamin D deficiency typically leads to low calcium and phosphate levels, with secondary increases in PTH. This patient&#39;s laboratory findings of increased calcium, phosphate, and PTH are not consistent with vitamin D deficiency.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Tertiary hyperparathyroidism develops in patients with chronic kidney disease or end-stage renal disease who have had prolonged secondary hyperparathyroidism. </span></span></span></li>\r\n\t<li><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is characterized by autonomous overproduction of PTH, resulting in hypercalcemia, increased phosphate, and elevated alkaline phosphatase levels.</span></span></li>\r\n</ul>",
      "correct_choice_id": 191265,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47555,
      "choices": [
        {
          "id": 189831,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Erythromycin</span></span></span></p>"
        },
        {
          "id": 189832,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Azithromycin</span></span></span></p>"
        },
        {
          "id": 189833,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Ceftriaxone</span></span></span></p>"
        },
        {
          "id": 189834,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Penicillin G</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 25-year-old male presents to the clinic complaining of painful urination and a yellowish discharge from the urethra. He admits to having unprotected sexual intercourse with a new partner two weeks ago. A Gram stain of the urethral discharge is seen in the following image. What is the treatment of choice for this patient&#39;s condition?</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/05/screenshot-2024-06-05-154605.JPG\" style=\"height:200px; width:300px\" /></span></span></p>",
      "unique_key": "Q8472384",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>C) Ceftriaxone</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The presence of gram-negative intracellular diplococci in the urethral discharge strongly suggests an infection with <em>Neisseria gonorrhoeae</em>, commonly known as gonorrhea. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Ceftriaxone, a third-generation cephalosporin, is the recommended first-line treatment for uncomplicated gonococcal infections due to its efficacy in eradicating the pathogen. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">It is typically administered as a single intramuscular dose of 250 mg.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Erythromycin:</span></strong><span style=\"font-size:14.0pt\"> Not effective against gonorrhea; primarily used for chlamydial infections and other bacterial infections.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Azithromycin:</span></strong><span style=\"font-size:14.0pt\"> Often used as a co-treatment for chlamydial infections in the setting of gonorrhea but not as effective as monotherapy for gonorrhea.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Penicillin G:</span></strong><span style=\"font-size:14.0pt\"> Historically used for treating gonorrhea, but widespread resistance has made it an ineffective option in most geographical areas.</span></span></span></p>\r\n\r\n<p style=\"margin-left:24px\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Treatment of Gonorrhoea</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Third generation cephalosporins &ndash; DOC for uncomplicated gonococcal infection - both the sexual partners should be treated.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Ceftriaxone (250 mg given IM, single dose)</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Cefixime (400 mg given orally, single dose)</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">If coexisting chlamydial infection &ndash; azithromycin or doxycycline added.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 189833,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        6
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47720,
      "choices": [
        {
          "id": 190491,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">a-4, b-1, c-3, d-2</span></span></span></p>"
        },
        {
          "id": 190492,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">a-3, b-2, c-4, d-1</span></span></span></p>"
        },
        {
          "id": 190493,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">a-2, b-4, c-1, d-3</span></span></span></p>"
        },
        {
          "id": 190494,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">a-1, b-3, -2, d-4</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Match the descriptions in Column A with the appropriate type of rhinitis in Column B.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/08/screenshot-2024-06-08-150823.JPG\" style=\"height:442px; width:700px\" /></p>",
      "unique_key": "Q9730859",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. A) a-4, b-1, c-3, d-2</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">A) Describes rhinitis medicamentosa, characterized by the prolonged use of nasal decongestants (a-4).</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">B) Describes allergic rhinitis, an IgE-mediated response to allergens (b-1).</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">C) Describes atrophic rhinitis, characterized by pale mucosa, crusting, and anosmia (c-3).</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">D) Describes vasomotor rhinitis, which results from autonomic imbalance and parasympathetic overactivity (d-2).</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Understand the different types of rhinitis and their distinguishing clinical features to accurately diagnose and manage conditions such as rhinitis medicamentosa, allergic rhinitis, atrophic rhinitis, and vasomotor rhinitis.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 190491,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        9
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47561,
      "choices": [
        {
          "id": 189855,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Bran </span></span></span></p>"
        },
        {
          "id": 189856,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Psyllium </span></span></span></p>"
        },
        {
          "id": 189857,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Senna </span></span></span></p>"
        },
        {
          "id": 189858,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Methylcellulose</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 58-year-old female patient presents with a history of chronic constipation for which she has used various over-the-counter laxatives. She undergoes a colonoscopy, and the images show distinctive mucosal changes. Based on the colonoscopy images shown, which laxative is most likely to have caused the observed mucosal changes?</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/05/screenshot-2024-06-05-154939.JPG\" style=\"height:279px; width:400px\" /></span></span></p>",
      "unique_key": "Q4937682",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans.&nbsp;</span></strong><strong><span style=\"font-size:14.0pt\">C) Senna</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The colonoscopy images provided display characteristics of melanosis coli, a condition often associated with the chronic use of stimulant laxatives such as senna. Melanosis coli is characterized by a dark pigmentation of the colon mucosa, which is evident in some of the images. This condition is harmless and usually reversible, but it distinctly points to the use of certain types of laxatives.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This is a stimulant laxative that increases the motility of the colon by irritating the mucosa and enhancing intestinal peristalsis. Chronic use of senna is well-known to cause melanosis coli, which is what the images suggest.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Bran</span></strong><span style=\"font-size:14.0pt\">: This is a bulk-forming laxative and generally does not cause mucosal changes. It aids in constipation by increasing fecal mass and stimulating bowel movements naturally.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Psyllium</span></strong><span style=\"font-size:14.0pt\">: Also a bulk-forming laxative, psyllium increases stool bulk and facilitates passage without causing significant mucosal changes.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Methylcellulose</span></strong><span style=\"font-size:14.0pt\">: Another bulk-forming agent, methylcellulose works similarly to psyllium and bran and does not typically lead to changes in colon mucosa appearance.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Melanosis coli is a benign condition associated with the prolonged use of stimulant laxatives like senna, Cascara Sagrada and Bisacodyl. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">It presents with characteristic dark pigmentation of the colon mucosa and is reversible upon cessation of the causative agent. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Also they should not be used for more than 10 days due to the risk of developing atonic colon.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 189857,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        4
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47797,
      "choices": [
        {
          "id": 190791,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Albinism</span></span></span></p>"
        },
        {
          "id": 190792,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Phenylketonuria</span></span></span></p>"
        },
        {
          "id": 190793,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Carcinoid syndrome</span></span></span></p>"
        },
        {
          "id": 190794,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Alkaptonuria</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 50-year-old man presents to the clinic with flushing, diarrhea, and wheezing. He has a history of intermittent abdominal pain. Physical examination reveals a right-sided heart murmur. Laboratory tests are ordered, and results show elevated levels of urinary 5-hydroxyindoleacetic acid (5-HIAA). Which of the following conditions is most likely associated with these findings?</span></span></p>",
      "unique_key": "Q1281564",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. </span></strong><strong><span style=\"font-size:14.0pt\">C) Carcinoid syndrome</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Carcinoid syndrome is a paraneoplastic syndrome caused by the release of serotonin and other vasoactive substances from carcinoid tumors, which are most commonly found in the gastrointestinal tract. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The hallmark of carcinoid syndrome includes symptoms such as flushing, diarrhea, and wheezing. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">These symptoms result from the secretion of serotonin and other substances by the tumor. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Serotonin is metabolized into 5-hydroxyindoleacetic acid (5-HIAA), which is then excreted in the urine. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Therefore, elevated urinary 5-HIAA is a key diagnostic marker for carcinoid syndrome. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The presence of a right-sided heart murmur is also indicative of carcinoid heart disease, which occurs due to the fibrotic effects of serotonin on the heart valves.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option&nbsp;</span></strong><span style=\"font-size:14pt\"><strong>A.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>Albinism:</strong> Albinism is a genetic condition characterized by a deficiency in melanin production, leading to hypopigmentation of the skin, hair, and eyes. It does not involve abnormalities in serotonin metabolism or elevated urinary 5-HIAA levels.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option&nbsp;</span></strong><span style=\"font-size:14pt\"><strong>B.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>Phenylketonuria (PKU):</strong> PKU is an inherited metabolic disorder resulting from a deficiency in the enzyme phenylalanine hydroxylase. This enzyme is crucial for the conversion of phenylalanine to tyrosine. Patients with PKU accumulate phenylalanine, leading to intellectual disability if untreated. PKU is diagnosed by elevated phenylalanine levels in the blood and does not cause elevated urinary 5-HIAA.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Option D.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>Alkaptonuria:</strong> Alkaptonuria is a rare genetic disorder caused by a deficiency in the enzyme homogentisate 1,2-dioxygenase, leading to the accumulation of homogentisic acid. This acid is deposited in connective tissues, causing ochronosis and urine that darkens upon standing. Elevated urinary 5-HIAA is not a feature of alkaptonuria.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Elevated urinary 5-hydroxyindoleacetic acid (5-HIAA) is a key diagnostic marker for carcinoid syndrome, which presents with symptoms such as flushing, diarrhea, and wheezing due to excessive serotonin production.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 190793,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        1
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47817,
      "choices": [
        {
          "id": 190867,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">a, b, d</span></span></span></p>"
        },
        {
          "id": 190868,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">a, d, e</span></span></span></p>"
        },
        {
          "id": 190869,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">b, d, e</span></span></span></p>"
        },
        {
          "id": 190870,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">b, c, e</span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Identify the components of Revised Trauma Score? </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol style=\"list-style-type:lower-alpha\">\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Pulse rate</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Respiratory rate</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Patient age</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Glasgow coma scale</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Systolic BP</span></span></span></li>\r\n</ol>",
      "unique_key": "Q5449593",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Ans. C) b, d, e</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The Revised Trauma Score (RTS) is a physiological scoring system, with the intent to provide an assessment of the severity of a trauma patient&#39;s condition. </span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>b. Respiratory rate</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>d. Glasgow Coma Scale</strong> <strong>e. Systolic BP</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">These three parameters are used to calculate the RTS, which can help to predict the patient&#39;s chances of survival. Each component is given a score, and the sum of these scores is used to determine the overall RTS.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Other trauma scoring systems include:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Abbreviated Injury Scale (AIS)</span></strong><span style=\"font-size:14.0pt\">: Codes injuries on a scale from 1 (minimally severe) to 6 (presumably fatal).</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Injury Severity Score (ISS)</span></strong><span style=\"font-size:14.0pt\">: Ranges from 3-75, and is the summation of the squares of the highest AIS severity codes for the three most severely injured body regions.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Mangled Extremity Severity Score (MESS)</span></strong><span style=\"font-size:14.0pt\">: Includes factors like the energy causing injury, limb ischemia, shock, and patient age.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">TRISS (Trauma and Injury Severity Score)</span></strong><span style=\"font-size:14.0pt\">: Combines the ISS, RTS, the mechanism of injury, and the patient&#39;s age to estimate survival.</span></span></span></li>\r\n</ol>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This means that the correct components of the Revised Trauma Score are the respiratory rate, Glasgow Coma Scale, and systolic blood pressure.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Understand the components of the Revised Trauma Score (RTS) as a tool for assessing the severity of trauma, which includes the patient&#39;s respiratory rate, Glasgow Coma Scale score, and systolic blood pressure. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Lower RTS scores correlate with higher injury severity and potentially lower chances of survival.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 190869,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        12
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47473,
      "choices": [
        {
          "id": 189503,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Crypt hyperplasia</span></span></span></p>"
        },
        {
          "id": 189504,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Increase in thickness of the mucosa</span></span></span></p>"
        },
        {
          "id": 189505,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Increase in intraepithelial lymphocytes</span></span></span></p>"
        },
        {
          "id": 189506,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Increase in inflammatory cells in lamina propria</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 34-year-old woman presents with chronic diarrhea, weight loss, and fatigue. She is suspected of having celiac disease, and a duodenal biopsy is performed. The histological features of celiac disease include all of the following, except: </span></span></p>",
      "unique_key": "Q8672211",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. B) Increase in thickness of the mucosa</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">In celiac disease, the mucosa does not increase in thickness. In fact, the mucosa often appears thinner due to villous atrophy, which is a hallmark of the disease. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The villi in the small intestine are blunted or completely flattened, reducing the overall surface area and resulting in a thinner mucosal layer.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Crypt hyperplasia:</span></strong><span style=\"font-size:14.0pt\"> This is a common histological feature of celiac disease. The crypts of Lieberk&uuml;hn become elongated and hyperplastic as a response to the chronic inflammatory process.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Increase in intraepithelial lymphocytes:</span></strong><span style=\"font-size:14.0pt\"> An increase in the number of intraepithelial lymphocytes (IELs) is one of the characteristic histological findings in celiac disease. These lymphocytes are part of the immune response to gluten.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Increase in inflammatory cells in lamina propria:</span></strong><span style=\"font-size:14.0pt\"> The lamina propria in patients with celiac disease often shows an increase in inflammatory cells, including lymphocytes, plasma cells, and macrophages. This inflammation contributes to the damage and atrophy of the villi.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Celiac disease is characterized by villous atrophy, crypt hyperplasia, an increase in intraepithelial lymphocytes, and increased inflammatory cells in the lamina propria, but not by an increase in the thickness of the mucosa.</span></span></li>\r\n</ul>",
      "correct_choice_id": 189504,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        5
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47816,
      "choices": [
        {
          "id": 190863,
          "text": "<p><span style=\"font-size:14.0pt;\">Retrograde dissection from distal branch</span></p>"
        },
        {
          "id": 190864,
          "text": "<p><span style=\"font-size:14.0pt;\">Tragal pointer</span></p>"
        },
        {
          "id": 190865,
          "text": "<p><span style=\"font-size:14.0pt;\">Inferior belly of omohyoid muscle</span></p>"
        },
        {
          "id": 190866,
          "text": "<p><span style=\"font-size:14.0pt;\">Posterior belly of digastric</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 52-year-old man undergoes parotid gland surgery for the removal of a benign tumor. The surgeon needs to identify the facial nerve trunk to avoid damaging it during the procedure. Which of the following anatomical landmark or technique is NOT used for the identification of the facial nerve trunk?</span></p>",
      "unique_key": "Q2559923",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Inferior belly of omohyoid muscle</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">The inferior belly of the omohyoid muscle is located in the neck and is not used as a landmark for identifying the facial nerve trunk during parotid gland surgery.</span></li><li><span style=\"font-size:14.0pt;\">The omohyoid muscle is more relevant in neck dissection procedures and is not anatomically close to the facial nerve trunk, which lies in the parotid region.</span></li></ul><p style=\"margin-left:24px;\">&nbsp;</p><p><span style=\"font-size:14.0pt;\">Methods to identify the facial nerve trunk during parotid surgeries:</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/07/screenshot-2024-06-07-103437.png\" alt=\"\" width=\"800\" height=\"428\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/07/screenshot-2024-06-07-103457.png\" alt=\"\" width=\"800\" height=\"589\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Retrograde Dissection from Distal Branch: </strong>This technique involves identifying the distal branches of the facial nerve and tracing them back to the main trunk. It is a common technique used in parotid surgeries to ensure the preservation of the facial nerve.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Tragal Pointer: </strong>The tragal pointer is an important landmark used in parotid surgery. It is a cartilaginous projection anterior to the tragus of the ear and points towards the location of the facial nerve trunk.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Posterior Belly of Digastric: </strong>The posterior belly of the digastric muscle is another anatomical landmark used in the identification of the facial nerve trunk. The facial nerve trunk is located just superior to this muscle in the parotid region.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">The inferior belly of the omohyoid muscle is not used as a landmark for the identification of the facial nerve trunk during parotid gland surgery, while the tragal pointer, retrograde dissection from distal branches, and the posterior belly of the digastric muscle are key landmarks and techniques utilized in this context.</span></li></ul>",
      "correct_choice_id": 190865,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        3
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47868,
      "choices": [
        {
          "id": 191067,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">1.5 to 3.5 ng/ml</span></span></span></p>"
        },
        {
          "id": 191068,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">3.5 to 10 ng/ml</span></span></span></p>"
        },
        {
          "id": 191069,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">10 to 35 ng/ml</span></span></span></p>"
        },
        {
          "id": 191070,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">35 to 100 ng/ml</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 68-year-old man with a history of lower backache undergoes a health screening. His digital rectal examination is notable for a hard, nodular prostate. Which of these levels of Serum PSA is suggestive of advanced Ca Prostate? </span></span></p>",
      "unique_key": "Q2863666",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. D) 35 to 100 ng/ml</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The finding of a PSA &gt;10&nbsp;ng/mL is suggestive of cancer and &gt;35&nbsp;ng/mL is almost diagnostic of advanced prostate cancer, in the absence of active urinary tract infection. A decrease in PSA to the normal range following hormonal ablation is a good prognostic sign.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Serum PSA level is not significantly altered by DRE:</span></span></span></li>\r\n</ul>\r\n\r\n<ul style=\"list-style-type:circle; margin-left:40px\">\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Can be significantly altered by a UTI </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">After an infective episode, takes 6 weeks to return to baseline values </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Is artificially lowered, up to two times, in men taking 5&alpha;-reductase inhibitors (finasteride, dutasteride)</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">PSA level greater than 35 ng/mL is highly suggestive of advanced prostate cancer in the absence of an active urinary tract infection or other causes of PSA elevation. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Further investigation, including biopsy, is usually warranted to confirm the diagnosis and stage the disease.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 191070,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        12
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47735,
      "choices": [
        {
          "id": 190547,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Barium swallow</span></span></span></p>"
        },
        {
          "id": 190548,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Barium meal</span></span></span></p>"
        },
        {
          "id": 190549,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Barium meal follow through</span></span></span></p>"
        },
        {
          "id": 190550,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Barium enema</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 45-year-old man presents with a history of chronic dyspepsia and postprandial fullness. The radiograph shown below was taken as part of his diagnostic workup. Which of the following investigations is shown in the radiograph? </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/06/screenshot-2024-06-06-153641_CKLlm7t.png\" style=\"height:348px; width:300px\" /></p>",
      "unique_key": "Q1285844",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans.&nbsp; B) Barium meal</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The radiograph shows a barium study where the stomach and duodenum are outlined with barium contrast. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">A barium meal is an imaging procedure where the patient ingests a barium sulfate solution, which coats the lining of the upper gastrointestinal tract, including the esophagus, stomach, and duodenum. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This allows for detailed radiographic examination of these structures. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The image clearly shows the stomach and the beginning of the small intestine (duodenum), characteristic of a barium meal study.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Barium Swallow:</span></strong><span style=\"font-size:14.0pt\"> This procedure specifically examines the esophagus. The radiograph in question shows the stomach and duodenum, indicating that the investigation goes beyond the esophagus.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Barium Meal Follow Through:</span></strong><span style=\"font-size:14.0pt\"> This is a continuation of the barium meal study that follows the passage of barium through the entire small intestine. The radiograph provided does not show the complete small intestine, but rather focuses on the stomach and duodenum, typical of a barium meal study.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Barium Enema:</span></strong><span style=\"font-size:14.0pt\"> This procedure involves the introduction of barium sulfate into the colon via the rectum to visualize the large intestine. The radiograph does not show the large intestine, thus ruling out this option.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">A barium meal study involves ingesting barium sulfate to visualize the upper gastrointestinal tract, including the stomach and duodenum, which is demonstrated in the radiograph provided.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 190548,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        17
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47470,
      "choices": [
        {
          "id": 189491,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"IT\" style=\"font-size:14.0pt\">Hepatocellular carcinoma</span></span></span></p>"
        },
        {
          "id": 189492,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"IT\" style=\"font-size:14.0pt\">Metastatic infiltrates</span></span></span></p>"
        },
        {
          "id": 189493,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"IT\" style=\"font-size:14.0pt\">Hepatic adenoma</span></span></span></p>"
        },
        {
          "id": 189494,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"IT\" style=\"font-size:14.0pt\">Hemangioma</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A young woman on oral contraceptives presents with right upper quadrant pain. A CT scan of the abdomen is performed, and the image is shown below. What is the most likely diagnosis? </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/06/screenshot-2024-06-06-110359.png\" style=\"height:300px; width:300px\" /></p>",
      "unique_key": "Q3298138",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. C) Hepatic adenoma</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The image given is of hepatic adenoma which is the <strong>most frequent hepatic tumor in young women on oral contraceptive pills</strong>. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Hepatic adenomas are benign liver tumors, predisposed in patients on OCPs and glycogen storage disorders with a predilection for hemorrhage. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">They are enhancing lesions on the arterial phase.</span></strong></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Hepatic adenomas are benign liver tumors that are commonly associated with the use of oral contraceptives in young women. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">These tumors are typically well-circumscribed and can vary in size. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">They often present with right upper quadrant pain or may be discovered incidentally during imaging for other reasons. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The CT scan findings in this patient, combined with her history of oral contraceptive use, strongly suggest a hepatic adenoma.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Hepatocellular Carcinoma:</span></strong><span style=\"font-size:14.0pt\"> Hepatocellular carcinoma (HCC) is a primary malignant tumor of the liver. It is often associated with underlying liver disease such as cirrhosis or chronic hepatitis B and C infections. While HCC can present with a liver mass, it is less likely in a young woman without underlying liver disease or risk factors, and the history of oral contraceptive use points more towards a benign lesion like a hepatic adenoma.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Metastatic Infiltrates:</span></strong><span style=\"font-size:14.0pt\"> Metastatic liver disease refers to the spread of cancer to the liver from other primary sites. It is more common in patients with a known history of malignancy. The patient&#39;s age, absence of known primary cancer, and the association with oral contraceptive use make this diagnosis less likely.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Haemangiomas:</span></strong><span style=\"font-size:14.0pt\"> Hemangiomas are the most common benign liver tumors. They are typically asymptomatic and discovered incidentally. Hemangiomas have characteristic imaging features such as peripheral nodular enhancement with centripetal filling on delayed imaging, which helps differentiate them from hepatic adenomas.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Hepatic adenomas are benign liver tumors frequently associated with oral contraceptive use in young women, presenting as well-circumscribed lesions on imaging studies.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 189493,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        17
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47727,
      "choices": [
        {
          "id": 190519,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Citrus fruit consumption increases the risk of skin cancer.</span></span></span></p>"
        },
        {
          "id": 190520,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Citrus fruit consumption decreases the risk of skin cancer.</span></span></span></p>"
        },
        {
          "id": 190521,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The findings are insufficient to prove a causal link between citrus fruit consumption and skin cancer reduction.</span></span></span></p>"
        },
        {
          "id": 190522,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">A risk ratio close to 1 implies that citrus fruit consumption has no effect on skin cancer risk.</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A population-based study evaluates the effect of consuming citrus fruits on the occurrence of skin cancer. The study results show a risk ratio of 0.84 for skin cancer in individuals who regularly consume citrus fruits compared to those who do not. What conclusion can be drawn from this risk ratio?</span></span></p>",
      "unique_key": "Q6914223",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. </span></strong><strong><span style=\"font-size:14.0pt\">B) Citrus fruit consumption decreases the risk of skin cancer.</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This is correct as the risk ratio of 0.84 indicates that individuals who regularly consume citrus fruits have a reduced incidence of skin cancer compared to those who do not consume them. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This suggests a protective association between citrus fruit intake and the risk of developing skin cancer.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Citrus fruit consumption increases the risk of skin cancer: </span></strong><span style=\"font-size:14.0pt\">&nbsp;Incorrect. A risk ratio below 1 suggests a decrease, not an increase, in risk associated with the exposure.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. The findings are insufficient to prove a causal link between citrus fruit consumption and skin cancer reduction:</span></strong><span style=\"font-size:14.0pt\"> Incorrect. Although causality cannot be definitively established from a single observational study, the risk ratio itself is indicative of a significant association.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D.</span></strong><span style=\"font-size:14.0pt\"> <strong>A risk ratio close to 1 implies that citrus fruit consumption has no effect on skin cancer risk:</strong> Incorrect. While 0.84 is indeed close to 1, it still represents a statistically significant decrease in risk, indicating a protective effect rather than no effect.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/06/screenshot-2024-06-06-152745.png\" style=\"height:456px; width:1000px\" /></p>",
      "correct_choice_id": 190520,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47803,
      "choices": [
        {
          "id": 190815,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Pseudomonas aeruginosa</span></span></span></p>"
        },
        {
          "id": 190816,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Yersinia pestis</span></span></span></p>"
        },
        {
          "id": 190817,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">&nbsp;Bacillus anthracis</span></span></span></p>"
        },
        {
          "id": 190818,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">&nbsp;Francisella tularensis</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 30-year-old farmer presents to the emergency department with a painful lesion on his forearm that developed several days after cleaning out an old barn. The lesion started as a small bump and progressed to look like as shown in the image. The patient reports a mild fever and feeling unwell. Which of the following organisms is the most likely cause of the lesion observed in this patient? </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/07/screenshot-2024-06-07-100626.png\" style=\"height:168px; width:300px\" /></p>",
      "unique_key": "Q4435889",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans.</span></strong><span style=\"font-size:14.0pt\"> <strong>C) Bacillus anthracis</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The patient&#39;s lesion, characterized by a black eschar with a prominent inflammatory ring, is indicative of cutaneous anthrax, caused by Bacillus anthracis. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This presentation is typically referred to as a malignant pustule. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Bacillus anthracis is known to be contracted through contact with contaminated animal products, which fits the patient&#39;s history of exposure in a barn. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Cutaneous anthrax is the most common form of the disease and, while it can be severe, it is often localized if treated promptly.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Additional Information</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/07/screenshot-2024-06-07-100702.png\" style=\"height:182px; width:300px\" /></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Image A and B: Gram-stain of B. anthracis:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">A. Direct smear shows gram-positive, large rectangular bacilli and pus cells; </span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">B. Culture smear-shows gram-positive bacilli with non-bulging spores (bamboo stick appearance)</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Pseudomonas aeruginosa:</span></strong><span style=\"font-size:14.0pt\"> While capable of causing skin infections, typically presents with different clinical features, such as ecthyma gangrenosum in immunocompromised individuals, not the black eschar typical of anthrax.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Yersinia pestis:</span></strong><span style=\"font-size:14.0pt\"> Causes bubonic plague, characterized by swollen and painful lymph nodes, not primarily skin lesions with black eschars.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Francisella tularensis:</span></strong><span style=\"font-size:14.0pt\"> Causes tularemia, which can manifest in ulceroglandular form with skin ulcers and swollen glands, but lacks the black eschar seen in anthrax.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Bacillus anthracis should be suspected in patients presenting with black eschar lesions, especially those with a history of exposure to potentially contaminated animal products. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Early identification and treatment are critical to prevent systemic complications of anthrax.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 190817,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        6
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47666,
      "choices": [
        {
          "id": 190275,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Ancylostoma caninum</span></span></span></p>"
        },
        {
          "id": 190276,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">&nbsp;Capillaria philippinensis</span></span></span></p>"
        },
        {
          "id": 190277,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">&nbsp;Strongyloides stercoralis</span></span></span></p>"
        },
        {
          "id": 190278,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Enterobius vermicularis</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 45-year-old male with a history of chronic urticaria being treated with steroids presents to the emergency department with acute worsening of his respiratory symptoms. He reports a persistent nocturnal cough that has been troubling him for several weeks. Laboratory tests reveal a significant elevation in eosinophils. During a diagnostic bronchoscopy, a bronchoalveolar lavage (BAL) is performed, and the specimen shows the presence of larvae as depicted in the image.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/06/screenshot-2024-06-06-124235.png\" style=\"height:153px; width:300px\" /></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Identify the causative organism based on the BAL findings.</span></span></span></p>",
      "unique_key": "Q8441564",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans.</span></strong><span style=\"font-size:14.0pt\"> <strong>C) Strongyloides stercoralis</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The patient&#39;s clinical presentation, including the use of immunosuppressive therapy (steroids), nocturnal cough, eosinophilia, and the identification of rhabditiform larvae in the BAL, is suggestive of disseminated strongyloidiasis caused by Strongyloides stercoralis.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Strongyloides are ovoviviparous nematodes that typically infect humans through skin contact with contaminated soil. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The larvae migrate to the intestines, where they can mature into adults and perpetuate autoinfection by penetrating intestinal or perianal skin to re-enter the bloodstream, leading to a widespread infection, particularly in immunocompromised hosts. Respiratory symptoms can arise when larvae migrate through the pulmonary capillaries into the alveoli.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Laboratory diagnosis of strongyloidiasis:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul style=\"list-style-type:circle\">\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">ï»¿ï»¿Eosinophilia and raised IgE levels.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">ï»¿ï»¿Microscopic examination of the direct wet mount of the stool demonstrating rhabditiform larvae forms the definitive diagnosis</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">ï»¿ï»¿Stool culture and serological tests are also done</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Treatment: Ivermectin is the preferred agent in the management of strongyloidiasis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Ancylostoma caninum:</span></strong><span style=\"font-size:14.0pt\"> This causes cutaneous larva migrans, often manifesting as creeping eruption due to skin penetration, not typically associated with respiratory symptoms or found in BAL specimens.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Capillaria philippinensis:</span></strong><span style=\"font-size:14.0pt\"> Infection with this organism leads to severe diarrhea and malabsorption; it does not typically present with respiratory symptoms or eosinophilia in BAL.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Enterobius vermicularis:</span></strong><span style=\"font-size:14.0pt\"> Commonly known as pinworm, which primarily causes enteric symptoms like nocturnal itching around the anus, not respiratory symptoms.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Strongyloides stercoralis should be considered in patients with eosinophilia and worsening pulmonary symptoms, especially if immunosuppressed. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Identification of rhabditiform larvae in clinical specimens such as BAL can confirm the diagnosis. Ivermectin is the preferred treatment for strongyloidiasis, addressing both intestinal and disseminated infections effectively.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Autoinfection: - CHEST (Mnemonic)</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Cryptosporidium parvum</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">H. nana larva</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Enterobius vermicularis</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Strongyloides</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Taenia solium</span></span></span></li>\r\n</ol>",
      "correct_choice_id": 190277,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        6
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47697,
      "choices": [
        {
          "id": 190399,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Hemidesmosomes</span></span></span></p>"
        },
        {
          "id": 190400,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Basement membrane antigens</span></span></span></p>"
        },
        {
          "id": 190401,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Desmogleins</span></span></span></p>"
        },
        {
          "id": 190402,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Proteins in dermal papillae</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 58-year-old woman presents with blisters and persistent oral ulcers for the past month. Recently, she developed blisters on her back, most of which burst spontaneously. Physical examination reveals ulcers on her palate and buccal mucosa, and numerous erythematous erosions with a few intact flaccid bullae on her upper back. Gentle pressure on an intact area of skin causes the top layer to slough off. Immunofluorescence examination of a skin biopsy shows an Immunoglobulin-G pattern as seen below. Which of the following is the most likely target of these antibodies? </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/06/screenshot-2024-06-06-132639.png\" style=\"height:339px; width:500px\" /></span></span></p>",
      "unique_key": "Q5110385",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. C) Desmogleins</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This patient&#39;s presentation is indicative of pemphigus vulgaris, an autoimmune blistering disorder. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Key clinical features of pemphigus vulgaris include painful oral ulcers and flaccid bullae on the skin that easily rupture, leading to erosions. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">A critical diagnostic clue is the positive Nikolsky sign, where gentle pressure on the skin causes the epidermis to separate.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The pathophysiology of pemphigus vulgaris involves autoantibodies directed against Desmogleins, which are components of desmosomes. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Desmosomes are structures that provide adhesion between keratinocytes in the epidermis. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The immunoglobulin G (IgG) antibodies in pemphigus vulgaris bind to desmogleins, disrupting cell adhesion and leading to the formation of intraepidermal bullae.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option&nbsp;</span></strong><span style=\"font-size:14pt\"><strong>A.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>Hemidesmosomes</strong>: Hemidesmosomes anchor the basal cells of the epidermis to the basement membrane. Autoantibodies against hemidesmosomes are seen in bullous pemphigoid, not pemphigus vulgaris.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option&nbsp;</span></strong><span style=\"font-size:14pt\"><strong>B.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>Basement membrane antigens</strong>: Antibodies targeting components of the basement membrane are also associated with bullous pemphigoid. In this condition, blisters are typically tense rather than flaccid.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option&nbsp;</span></strong><span style=\"font-size:14pt\"><strong>D.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>Proteins in dermal papillae</strong>: This option is incorrect as antibodies against proteins in the dermal papillae are found in dermatitis herpetiformis, a condition characterized by grouped vesicles and is associated with celiac disease.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Pemphigus vulgaris is characterized by autoantibodies against Desmogleins, leading to flaccid bullae and mucosal involvement. </span></span></span></li>\r\n\t<li><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A positive Nikolsky sign is a key diagnostic feature.</span></span></li>\r\n</ul>",
      "correct_choice_id": 190401,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        18
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47560,
      "choices": [
        {
          "id": 189851,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Phase 1 </span></span></span></p>"
        },
        {
          "id": 189852,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Phase 2 </span></span></span></p>"
        },
        {
          "id": 189853,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Phase 3 </span></span></span></p>"
        },
        {
          "id": 189854,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Phase 4</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A team of clinical researchers is planning a study to determine the effectiveness of a new cardiovascular drug in reducing mortality and morbidity in patients with chronic heart failure. The study aims to establish the drug&#39;s efficacy and safety in a large, diverse population. Based on the phases of clinical trials, which phase would this study most likely represent?</span></span></p>",
      "unique_key": "Q1970234",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans.&nbsp;</span></strong><strong><span style=\"font-size:14.0pt\">C) Phase 3</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Phase 3 of a clinical trial is often referred to as an efficacy trial because it is designed to evaluate the efficacy and safety of the investigational drug or intervention in a larger and more diverse patient population compared to earlier phases. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">These trials typically involve several hundred to several thousand participants and are usually randomized and controlled, often comparing the new intervention against a placebo or an existing standard treatment. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The goal is to confirm the therapeutic benefits observed in Phase 2 trials and to gather sufficient evidence to demonstrate that the drug&#39;s benefits outweigh its risks.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Option A.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>Phase 1:</strong> Trials focus primarily on assessing the safety, tolerability, and pharmacokinetics of a drug in a small group of healthy volunteers or patients, not efficacy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B</span></strong><span style=\"font-size:14.0pt\">.&nbsp; <strong>Phase 2: </strong>&nbsp;Trials aim to evaluate both safety and preliminary efficacy but do so in a relatively smaller patient population and are not definitive efficacy trials.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D</span></strong><span style=\"font-size:14.0pt\">. <strong>Phase 4: </strong>&nbsp;Trials are post-marketing studies that monitor long-term safety and effectiveness in the general population after a drug has been approved for use.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/05/screenshot-2024-06-05-154926.JPG\" style=\"height:376px; width:1000px\" /></span></strong></span></span></p>",
      "correct_choice_id": 189853,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47696,
      "choices": [
        {
          "id": 190395,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Acyl carrier protein</span></span></span></p>"
        },
        {
          "id": 190396,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">LCAT (Lecithin&ndash;cholesterol acyltransferase)</span></span></span></p>"
        },
        {
          "id": 190397,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Cholesterol transporter</span></span></span></p>"
        },
        {
          "id": 190398,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Carnitine</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 45-year-old woman presents to the clinic with a history of muscle weakness and fatigue, particularly after exercise. Laboratory tests reveal elevated levels of muscle enzymes, indicating muscle damage. Further evaluation reveals that she has a metabolic disorder affecting the transport of fatty acids into the mitochondria. Which molecule is primarily responsible for transporting fatty acids across the mitochondrial membrane? </span></span></p>",
      "unique_key": "Q2227731",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans.&nbsp;</span></strong><strong><span style=\"font-size:14.0pt\">D) Carnitine</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The primary molecule responsible for transporting long-chain fatty acids across the mitochondrial membrane is carnitine. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Fatty acids must be transported into the mitochondria for &beta;-oxidation, which is essential for energy production, especially in muscle cells. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Carnitine plays a crucial role in this process by forming acyl-carnitine complexes, which can be shuttled across the inner mitochondrial membrane via the carnitine-acylcarnitine translocase. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Once inside the mitochondria, the fatty acids are released and converted back to their CoA derivatives for &beta;-oxidation. Defects in this transport system can lead to muscle weakness and fatigue due to the impaired ability to utilize fatty acids for energy.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/06/screenshot-2024-06-06-132230.png\" style=\"height:432px; width:500px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Acyl carrier protein:</span></strong><span style=\"font-size:14.0pt\"> This protein is involved in the synthesis of fatty acids in the cytoplasm, not in the transport of fatty acids into the mitochondria. It carries the growing fatty acid chain during the synthesis process.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. LCAT (Lecithin&ndash;cholesterol acyltransferase):</span></strong><span style=\"font-size:14.0pt\"> LCAT is an enzyme involved in the metabolism of lipoproteins in the blood, specifically in the conversion of free cholesterol into cholesteryl ester for transport in high-density lipoproteins (HDL). It does not play a role in the transport of fatty acids into mitochondria.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Cholesterol transporter:</span></strong><span style=\"font-size:14.0pt\"> While cholesterol transporters are involved in the movement of cholesterol within cells and across membranes, they are not involved in the transport of fatty acids into the mitochondria for &beta;-oxidation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Carnitine is essential for the transport of long-chain fatty acids into the mitochondria, where they undergo &beta;-oxidation for energy production. </span></span></span></li>\r\n\t<li><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Defects in carnitine-mediated transport can lead to muscle weakness and fatigue, particularly after exercise, due to the impaired ability to utilize fatty acids for energy.</span></span></li>\r\n</ul>",
      "correct_choice_id": 190398,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        1
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47840,
      "choices": [
        {
          "id": 190959,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">HSV</span></span></span></p>"
        },
        {
          "id": 190960,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Epstein-Barr virus</span></span></span></p>"
        },
        {
          "id": 190961,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Picornavirus</span></span></span></p>"
        },
        {
          "id": 190962,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Parvovirus B19</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A pregnant woman in her first trimester presents to her obstetrician with concerns about an infection she believes she gets from her child (see picture). The mother is concerned about the impact of the infection on her pregnancy. Which viral infection, contracted during early pregnancy, is known to mimic erythroblastosis fetalis? </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/07/screenshot-2024-06-07-112115.png\" style=\"height:402px; width:600px\" /></p>",
      "unique_key": "Q7023634",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. D) Parvovirus B19</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Parvovirus B19 infection can mimic erythroblastosis fetalis, particularly when a pregnant woman is infected during early pregnancy. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This condition is characterized by severe fetal anemia, leading to heart failure and hydrops fetalis, similar to the effects of erythroblastosis fetalis, which is typically caused by blood group incompatibility between the mother and fetus. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Parvovirus B19 is also associated with several other clinical presentations, including erythema infectiosum (fifth disease), transient aplastic crisis, and pure red cell aplasia.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. HSV:</span></strong><span style=\"font-size:14.0pt\"> While HSV can cause serious congenital infections, it does not typically mimic erythroblastosis fetalis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Epstein-Barr virus:</span></strong><span style=\"font-size:14.0pt\"> Known for causing infectious mononucleosis, EBV has not been associated with conditions mimicking erythroblastosis fetalis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Picornavirus:</span></strong><span style=\"font-size:14.0pt\"> This family of viruses, including enteroviruses and rhinoviruses, generally causes respiratory and gastrointestinal symptoms, not conditions that mimic erythroblastosis fetalis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">In pregnant women, Parvovirus B19 infection should be considered if symptoms similar to those of erythroblastosis fetalis are observed, as it can lead to severe fetal anemia and hydrops fetalis. </span></span></span></li>\r\n\t<li><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Proper prenatal care and monitoring are crucial for early detection and management of potential complications from this infection.</span></span></li>\r\n</ul>",
      "correct_choice_id": 190962,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        6
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47810,
      "choices": [
        {
          "id": 190843,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Creatinine</span></span></span></p>"
        },
        {
          "id": 190844,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Inulin</span></span></span></p>"
        },
        {
          "id": 190845,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">PAH&nbsp;(Para-aminohippuric acid)</span></span></span></p>"
        },
        {
          "id": 190846,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Urea</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 61-year-old male with a history of chronic kidney disease is undergoing a renal function evaluation. As part of the assessment, various substances are measured to determine their renal clearance rates. Which of the following substances is expected to have the highest renal clearance rate in this patient?</span></span></p>",
      "unique_key": "Q9126254",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. C) PAH&nbsp;(Para-aminohippuric acid)</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Renal clearance refers to the volume of plasma that is completely cleared of a particular substance by the kidneys per unit time. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The clearance rate of different substances varies depending on their filtration, reabsorption, and secretion in the nephron.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">PAH (Para-aminohippuric acid) has the highest renal clearance rate among the substances listed because it is both freely filtered by the glomerulus and actively secreted by the renal tubules. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Consequently, nearly all of the PAH that enters the kidneys is excreted in the urine. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">PAH clearance is often used to estimate renal plasma flow, as its clearance rate approaches the total renal plasma flow when secreted maximally.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Option A.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>Creatinine:</strong> Creatinine is freely filtered and minimally secreted by the renal tubules. Its clearance rate is used to estimate the glomerular filtration rate (GFR), but it is still lower than that of PAH due to the lack of significant tubular secretion.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Option B.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>Inulin:</strong> Inulin is freely filtered and neither reabsorbed nor secreted, making its clearance rate equivalent to the GFR. However, its clearance rate is lower than that of PAH because it is not secreted by the renal tubules.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Urea:</span></strong><span style=\"font-size:14.0pt\"> Urea is freely filtered by the glomerulus and partially reabsorbed by the renal tubules, resulting in a lower clearance rate compared to inulin, creatinine, and PAH.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">PAH (para-aminohippuric acid) has the highest renal clearance rate because it is both freely filtered and actively secreted by the renal tubules, making it an effective marker for estimating renal plasma flow.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 190845,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        2
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47661,
      "choices": [
        {
          "id": 190255,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"IT\" style=\"font-size:14.0pt\">RNA polymerase</span></span></span></p>"
        },
        {
          "id": 190256,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"IT\" style=\"font-size:14.0pt\">Aminoacyl tRNA synthetase</span></span></span></p>"
        },
        {
          "id": 190257,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"IT\" style=\"font-size:14.0pt\">Leucine zipper</span></span></span></p>"
        },
        {
          "id": 190258,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"IT\" style=\"font-size:14.0pt\">DNA polymerase</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following enzyme is responsible for the proofreading of mRNA during translation?</span></span></p>",
      "unique_key": "Q3406241",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. B)</span></strong><strong><span style=\"font-size:14.0pt\"> Aminoacyl tRNA synthetase</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Aminoacyl tRNA synthetases are the enzymes responsible for attaching the correct amino acid to its corresponding tRNA molecule. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This process includes a crucial proofreading step to ensure high fidelity in protein synthesis. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The enzyme first activates the amino acid and then transfers it to the corresponding tRNA. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">If an incorrect amino acid is attached, the synthetase can hydrolyze the incorrect aminoacyl-tRNA before it is used in translation, thereby ensuring the accuracy of protein synthesis.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. RNA polymerase:</span></strong><span style=\"font-size:14.0pt\"> This enzyme is involved in the transcription of DNA into RNA. It does not play a role in the proofreading of mRNA during translation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Leucine zipper:</span></strong><span style=\"font-size:14.0pt\"> This is a structural motif involved in the dimerization and DNA binding of certain transcription factors. It is not involved in the proofreading process during translation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. DNA polymerase:</span></strong><span style=\"font-size:14.0pt\"> This enzyme is responsible for synthesizing new strands of DNA during DNA replication. It has proofreading capabilities to correct errors during DNA synthesis but is not involved in the translation process.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Aminoacyl tRNA synthetases are crucial for ensuring the accuracy of protein synthesis by proofreading and correcting errors during the attachment of amino acids to their corresponding tRNA molecules.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 190256,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        1
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47834,
      "choices": [
        {
          "id": 190935,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Chemoradiation</span></span></span></p>"
        },
        {
          "id": 190936,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Chemotherapy</span></span></span></p>"
        },
        {
          "id": 190937,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Surgery</span></span></span></p>"
        },
        {
          "id": 190938,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Brachytherapy</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 53-year-old woman comes to the clinic with a complaint of a foul-smelling, bloody vaginal discharge mixed with mucus. Physical examination reveals a necrotic growth in the cervix extending into the lateral parametrium. What is the most appropriate management for this patient? </span></span></p>",
      "unique_key": "Q1291824",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>&nbsp;Ans.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>A) Chemoradiation</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The patient presents with advanced cervical cancer characterized by necrotic growth in the cervix with lateral parametrium involvement. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This stage of cervical cancer often extends beyond the cervix and may involve surrounding tissues, necessitating a multimodal treatment approach. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Lateral parametrium involvement indicate that Cancer is in Stage 2B, for which treatment is Chemoradiation. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Chemoradiation, which combines chemotherapy with radiation therapy, is the standard of care for locally advanced cervical cancer. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Chemotherapy sensitizes the cancer cells to radiation, enhancing the effectiveness of the treatment and improving local control and survival rates.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Staging of CA Cervix</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/07/screenshot-2024-06-07-110730.png\" style=\"height:1164px; width:1000px\" /></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">TREATMENT:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">&bull; Surgery: for early stages like stage 1, stage 2A1</span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">&bull; Radiotherapy: for all patients from Stage 1 to 4</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/07/screenshot-2024-06-07-110901_GERvzvi.png\" style=\"height:483px; width:1000px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Option B.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>Chemotherapy:</strong> While chemotherapy alone can be part of the treatment for cervical cancer, it is typically used in metastatic disease or as a palliative treatment. In cases of locally advanced disease with parametrium involvement, chemoradiation is preferred because it provides better local control and survival benefits compared to chemotherapy alone.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Option C.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>Surgery:</strong> Surgical options, such as radical hysterectomy, are generally reserved for earlier stages of cervical cancer (up to stage IB1). For advanced stages with parametrium involvement, surgery alone is not sufficient and is not typically recommended due to the extent of disease spread and the higher risk of recurrence.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D</span></strong><span style=\"font-size:14.0pt\">.&nbsp;<strong>Brachytherapy:</strong> Brachytherapy, a form of internal radiation, is used as part of the overall radiation treatment but is not sufficient as a standalone therapy for advanced cervical cancer. It is often combined with external beam radiation therapy as part of the chemoradiation regimen.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">For patients with advanced cervical cancer involving the lateral parametrium, chemoradiation is the standard treatment approach, combining the benefits of both chemotherapy and radiation to improve treatment outcomes.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 190935,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47830,
      "choices": [
        {
          "id": 190919,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Rupture of membranes</span></span></span></p>"
        },
        {
          "id": 190920,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Fetal head 5/5 palpable on abdominal examination</span></span></span></p>"
        },
        {
          "id": 190921,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">More than 5 cm cervical dilatation with complete effacement</span></span></span></p>"
        },
        {
          "id": 190922,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Two contractions lasting for 10 seconds in 10 minutes</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 25-year-old primigravida at 40 weeks of gestation presents to the labor and delivery unit with complaints of lower abdominal pain. She reports that she has been experiencing contractions for the past 3 hours. Which of the following findings would confirm that she is in active labor?</span></span></p>",
      "unique_key": "Q2317258",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. C) More than 5 cm cervical dilatation with complete effacement</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Active labor is characterized by regular, painful uterine contractions that result in progressive cervical dilatation and effacement. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The transition from early labor to active labor is typically marked by cervical dilatation of more than 5 cm and complete effacement. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This stage indicates that the labor is progressing and the cervix is opening adequately to allow for the passage of the baby.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Rupture of membranes:</span></strong><span style=\"font-size:14.0pt\"> Rupture of membranes, also known as the breaking of the water, can occur before or during labor but does not alone confirm active labor. It is one of the signs of labor onset but not a definitive indicator of active labor.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Fetal head 5/5 palpable on abdominal examination:</span></strong><span style=\"font-size:14.0pt\"> When the fetal head is 5/5 palpable, it indicates that the head is still high in the pelvis, suggesting that labor may not be very advanced. In active labor, the fetal head is usually lower and engaged in the pelvis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Two contractions lasting for 10 seconds in 10 minutes:</span></strong><span style=\"font-size:14.0pt\"> This pattern of contractions is not sufficient to confirm active labor. Active labor is characterized by more frequent and longer-lasting contractions that are strong enough to cause cervical changes.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Active labor is confirmed by the presence of more than 5 cm cervical dilatation with complete effacement, indicating significant progression of labor and readiness for delivery.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 190921,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47549,
      "choices": [
        {
          "id": 189807,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Spongiosis</span></span></span></p>"
        },
        {
          "id": 189808,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Acantholysis</span></span></span></p>"
        },
        {
          "id": 189809,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Hypergranulosis</span></span></span></p>"
        },
        {
          "id": 189810,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Hyperkeratosis</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 19-year-old obese man presents to the clinic with a progressively darkening rash on the back of his neck over the past six months (see image). The patient has a history of insulin resistance and is at risk for developing type 2 diabetes. A skin biopsy of this lesion is most likely to show which of the following?</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/05/screenshot-2024-06-05-154013.JPG\" style=\"height:317px; width:300px\" /></span></span></p>",
      "unique_key": "Q6894730",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans.&nbsp;</span></strong><strong><span style=\"font-size:14.0pt\">D) Hyperkeratosis</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Acanthosis nigricans is a skin condition often associated with obesity and insulin resistance, characterized by dark, velvety patches of skin, typically in body folds and creases. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The biopsy of these lesions usually reveals hyperkeratosis, which is the thickening of the stratum corneum.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A.</span></strong><span style=\"font-size:14.0pt\"> <strong>Spongiosis:</strong> This indicates intercellular edema in the epidermis, commonly seen in eczema and not characteristic of acanthosis nigricans. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B.</span></strong><span style=\"font-size:14.0pt\"> <strong>Acantholysis:</strong> This is the loss of connections between keratinocytes, often seen in conditions like pemphigus vulgaris, not acanthosis nigricans. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C.</span></strong><span style=\"font-size:14.0pt\"> <strong>Hypergranulosis:</strong> This is the increased thickness of the stratum granulosum, often seen in lichen planus, not in acanthosis nigricans.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Acanthosis nigricans, associated with obesity and insulin resistance, is characterized by hyperkeratosis on biopsy.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 189810,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        18
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47701,
      "choices": [
        {
          "id": 190415,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Bird seed agar</span></span></span></p>"
        },
        {
          "id": 190416,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Brain heart infusion agar</span></span></span></p>"
        },
        {
          "id": 190417,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">CHROMagar</span></span></span></p>"
        },
        {
          "id": 190418,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Sabouraud dextrose agar</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 28-year-old female presents to the clinic with complaints of vaginal discomfort and the presence of thick, white vaginal secretions. She reports no history of similar symptoms and has not used any antibiotics recently. A sample of the discharge is obtained for laboratory analysis to identify the causative agent. Which of the following media is most appropriate for the rapid identification of the likely species causing this patient&rsquo;s symptoms? </span></span></p>",
      "unique_key": "Q4342821",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans.&nbsp;</span></strong><span style=\"font-size:14.0pt\"><strong>C) CHROMagar</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">CHROMagar is particularly useful for the rapid identification of different species of Candida, which are common causes of vaginal candidiasis. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This medium utilizes chromogenic substrates that, when metabolized by the enzymes specific to different Candida species, change color, allowing for easy differentiation. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Candida albicans, for instance, typically produces green colonies on this medium. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The ability of CHROMagar to provide visual differentiation within 1-4 days of incubation makes it a valuable tool in clinical settings for prompt diagnosis and treatment planning.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Bird seed agar:</span></strong><span style=\"font-size:14.0pt\"> Used primarily for the identification of Cryptococcus neoformans, not Candida species.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Brain heart infusion agar:</span></strong><span style=\"font-size:14.0pt\"> An anaerobic medium suitable for the growth of obligate anaerobes. Here, the supplements include Vit. K and hemin</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Sabouraud dextrose agar:</span></strong><span style=\"font-size:14.0pt\"> Candida albicans on SDA shows creamy white colonies; but it lacks the specificity like how CHROMagar differentiate between species based on colony color. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">CHROMagar is the preferred medium for identifying Candida species in clinical specimens due to its rapid and distinct color differentiation of species, crucial for effective treatment of candidiasis.</span></span></span></li>\r\n\t<li><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Diagnosis of Candida </span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/06/screenshot-2024-06-06-135358.png\" style=\"height:220px; width:1000px\" /></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li style=\"list-style-type:none\">\r\n\t<ol style=\"list-style-type:upper-alpha\">\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Candida albicans&mdash;gram-positive oval budding yeast cells with pseudohyphae; </span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Candida albicans on SDA shows creamy white colonies; </span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">CHROMagar showing colonies of various Candida species producing different colors (e.g. light-green color by C. albicans, red arrow); </span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Candida albicans shows positive germ tube test (arrow showing); </span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Candida albicans shows thick walled chlamydospores (arrow showing)</span></span></span></li>\r\n\t</ol>\r\n\t</li>\r\n</ol>",
      "correct_choice_id": 190417,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        6
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47756,
      "choices": [
        {
          "id": 190631,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Extramedullary spinal cord compression</span></span></span></p>"
        },
        {
          "id": 190632,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Amyotrophic lateral sclerosis</span></span></span></p>"
        },
        {
          "id": 190633,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Multiple sclerosis</span></span></span></p>"
        },
        {
          "id": 190634,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Subacute combined degeneration</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 30-year-old woman presents with a history of tingling sensations and needle-like pain in her limbs. She also experiences numbness, episodes of decreased visual acuity, and spastic paralysis. Her symptoms worsen with heat exposure, such as during hot showers. What is the most likely diagnosis? </span></span></p>",
      "unique_key": "Q1869289",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. C) Multiple sclerosis</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Multiple sclerosis (MS) is an autoimmune demyelinating disease of the central nervous system. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Patients with MS commonly present with paresthesia (tingling sensations, pins, and needles), hypesthesia (numbness), optic neuritis (decreased visual acuity and color perception), and unilateral or bilateral limb weakness. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Other symptoms include spastic paralysis, gait disturbances, positive Babinski&#39;s sign, facial weakness, vertigo, hearing loss, bladder dysfunction, Lhermitte&#39;s sign (shooting pain down the back on neck movement), and Uhthoff&#39;s sign (worsening of neurological symptoms with heat exposure, such as hot showers).</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Extramedullary spinal cord compression: </span></strong><span style=\"font-size:14.0pt\">Patients with extramedullary spinal cord compression usually present with back pain aggravated in the supine position, tingling or electric sensation along the back and upper and lower limbs upon flexion or extending the neck. Loss of pain, vibration, and proprioception is common. Extensor plantar reflex may be seen in significant compression, and deep tendon reflexes may be brisk.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Amyotrophic lateral sclerosis:</span></strong><span style=\"font-size:14.0pt\"> Patients with amyotrophic lateral sclerosis (ALS) present with fasciculations, muscle cramps, distal weakness and atrophy, bulbar palsy (dysarthria, dysphagia, respiratory compromise), spasticity, increased reflexes, flexor spasms, and pseudobulbar effects (inappropriate laughing, crying, yawning).</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Subacute combined degeneration:</span></strong><span style=\"font-size:14.0pt\"> Subacute combined degeneration (SACD) is due to vitamin B12 deficiency. Patients with SACD present with loss of vibration sense and proprioception, paresthesia, unsteady gait due to sensory ataxia, loss of deep tendon reflexes, peripheral neuropathy, optic neuropathy (can present as blurring of vision), and psychiatric manifestations such as irritability, severe dementia, or frank psychosis. SACD myelopathy is diffuse rather than focal.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Multiple sclerosis presents with paresthesia, hypesthesia, optic neuritis, limb weakness, spastic paralysis, and symptoms worsened by heat exposure (Uhthoff&#39;s sign).</span></span></p>",
      "correct_choice_id": 190633,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47755,
      "choices": [
        {
          "id": 190627,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Uncomplicated Mitral stenosis</span></span></span></p>"
        },
        {
          "id": 190628,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Mitral valve prolapse</span></span></span></p>"
        },
        {
          "id": 190629,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Aortic stenosis</span></span></span></p>"
        },
        {
          "id": 190630,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Pulmonary regurgitation</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Identify the condition in which this murmur is heard: </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/07/screenshot-2024-06-07-123459.JPG\" style=\"height:110px; width:500px\" /></span></span></p>",
      "unique_key": "Q1488880",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. D) Pulmonary regurgitation</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Pulmonary regurgitation is a condition where the pulmonary valve does not close properly, causing blood to flow back into the right ventricle from the pulmonary artery. This results in an early diastolic murmur best heard over the left upper sternal border. </span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Uncomplicated Mitral stenosis:</span></strong><span style=\"font-size:14.0pt\"> The murmur of mitral stenosis is a mid diastolic rumbling murmur with a presystolic accentuation heard best at the apex with the patient in the left lateral decubitus position.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Mitral valve prolapse:</span></strong><span style=\"font-size:14.0pt\"> It is often associated with a mid-systolic click followed by a late systolic murmur heard best at the apex.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Aortic stenosis:</span></strong><span style=\"font-size:14.0pt\"> This condition produces a systolic ejection murmur, best heard at the right second intercostal space and often radiating to the carotids. The murmur is typically described as a crescendo-decrescendo or diamond-shaped.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Pulmonary regurgitation is identified by a decrescendo diastolic murmur best heard over the left upper sternal border.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 190630,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        11
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47669,
      "choices": [
        {
          "id": 190287,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">She is likely to develop shingles. </span></span></span></p>"
        },
        {
          "id": 190288,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">She is vulnerable to contracting chickenpox. </span></span></span></p>"
        },
        {
          "id": 190289,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">She possesses immunity against chickenpox. </span></span></p>"
        },
        {
          "id": 190290,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">She possesses immunity against shingles.</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 21-year-old female college student is evaluated for potential exposure to chickenpox after a classmate is diagnosed with the disease. She is unsure of her vaccination status and undergoes serologic testing for varicella-zoster virus, which returns negative. What does this imply about her susceptibility to varicella-related conditions? </span></span></p>",
      "unique_key": "Q9773080",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans.&nbsp;</span></strong><strong><span style=\"font-size:14.0pt\">B) She is vulnerable to contracting chickenpox.</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This<strong> </strong>is correct. The negative serologic test indicates the absence of varicella-zoster virus IgG antibodies, meaning she has not been previously exposed to the virus nor has she been vaccinated against it. Consequently, she is susceptible to contracting chickenpox for the first time.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. She is likely to develop shingles: </span></strong><span style=\"font-size:14.0pt\">&nbsp;<strong>Incorrect,</strong> Shingles typically develops in individuals who have had chickenpox in the past as the virus reactivates. A negative antibody test suggests that she has never been infected with the varicella-zoster virus, thus she is not at risk for shingles currently.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Option C.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>She possesses immunity against chickenpox:</strong> <strong>Incorrect, </strong>the negative test result explicitly shows she does not have immunity to chickenpox, as she lacks the necessary antibodies.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Option D.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>She possesses immunity against shingles:</strong> <strong>Incorrect</strong>, without prior infection or vaccination (as evidenced by the absence of antibodies), there is no immunity against shingles either.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span><br />\r\n&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Varicella Zoster immunoglobulin (VZIG):</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Given within 72 hours of exposure</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Dose: 1.25&ndash;5.0 mL intramuscularly</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Reserved for:</span></span></span>\r\n\t<ul>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Immunosuppressed contacts of acute cases</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Newborn contacts</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>",
      "correct_choice_id": 190288,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47828,
      "choices": [
        {
          "id": 190911,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Myringotomy with tympanostomy tube insertion</span></span></span></p>"
        },
        {
          "id": 190912,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Conservative management with topical antibiotics</span></span></p>"
        },
        {
          "id": 190913,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Mastoidectomy with cholesteatoma removal</span></span></span></p>"
        },
        {
          "id": 190914,
          "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Systemic antibiotics and observation</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 25-year-old man presents with a long history of intermittent purulent ear discharge, hearing loss, and occasional vertigo. On otoscopic examination, there is a retraction pocket in the pars flaccida and granulation tissue in the attic region. A CT scan of the temporal bone shows erosion of the ossicles and extension into the mastoid antrum. What is the most appropriate management for this condition? </span></span></p>",
      "unique_key": "Q3889814",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. C) Mastoidectomy with cholesteatoma removal</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This is the appropriate treatment for attico-antral type chronic otitis media. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The presence of a retraction pocket, granulation tissue, ossicular erosion, and extension into the mastoid antrum indicates cholesteatoma, which requires surgical intervention to remove the disease and prevent complications like intracranial spread or hearing loss<strong>.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Myringotomy with tympanostomy tube insertion:&nbsp;</span></strong><span style=\"font-size:14.0pt\">Myringotomy with tympanostomy tube insertion is typically used for acute otitis media or otitis media with effusion. It is not appropriate for attico-antral type of chronic otitis media, which involves cholesteatoma and requires more extensive surgical intervention.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Conservative management with topical antibiotics:&nbsp;</span></strong><span style=\"font-size:14.0pt\">While topical antibiotics can help manage secondary infections, they are not sufficient for treating cholesteatoma, which is the underlying cause in attico-antral type chronic otitis media. Surgical removal of the cholesteatoma is necessary to prevent further complications.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Systemic antibiotics and observation:&nbsp;</span></strong><span style=\"font-size:14.0pt\">Systemic antibiotics may temporarily address secondary bacterial infections but do not treat the underlying cholesteatoma. Observation alone is inadequate for this condition, as it can lead to serious complications if not surgically managed.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Attico-antral type chronic otitis media, characterized by cholesteatoma and erosion of ossicles, requires surgical management with mastoidectomy and cholesteatoma removal to prevent further complications and preserve hearing.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 190913,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        9
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47675,
      "choices": [
        {
          "id": 190311,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Cetirizine</span></span></span></p>"
        },
        {
          "id": 190312,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Promethazine</span></span></span></p>"
        },
        {
          "id": 190313,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Misolastine</span></span></span></p>"
        },
        {
          "id": 190314,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Loratidine</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 35-year-old female planning a cruise vacation seeks medication to prevent motion sickness during her trip. Which of the following drugs is commonly used for the prophylaxis of motion sickness?</span></span></p>",
      "unique_key": "Q2455804",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. </span></strong><strong><span style=\"font-size:14.0pt\">B) Promethazine</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Promethazine</span></strong><span style=\"font-size:14.0pt\"> is an antihistamine with strong antiemetic and anticholinergic properties, making it highly effective for preventing and treating motion sickness. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">It acts on the central nervous system to reduce the symptoms of nausea and vertigo associated with motion.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Cetirizine:</span></strong><span style=\"font-size:14.0pt\"> This is a second-generation antihistamine mainly used for allergy symptoms. It is less sedating and generally not used for motion sickness due to its limited efficacy in this condition.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Misolastine:</span></strong><span style=\"font-size:14.0pt\"> This drug appears to be a misspelling or incorrect reference, as it is not recognized as a standard medication.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Loratadine: </span></strong><span style=\"font-size:14.0pt\">&nbsp;Another second-generation antihistamine primarily used for allergic conditions. Like cetirizine, it does not have significant antiemetic effects and is not suitable for motion sickness prevention.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Promethazine is the drug of choice among the options for the prophylaxis of motion sickness due to its effectiveness in reducing nausea and vertigo symptoms. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This makes it a suitable choice for travelers prone to motion sickness.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 190312,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47489,
      "choices": [
        {
          "id": 189567,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Vitamin B12</span></span></span></p>"
        },
        {
          "id": 189568,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Vitamin B6</span></span></span></p>"
        },
        {
          "id": 189569,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Vitamin B2</span></span></span></p>"
        },
        {
          "id": 189570,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Vitamin B1</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 35-year-old hospital employee presents to the clinic with complaints of tingling and numbness in his hands and feet. He also notes that his scalp has become dry and scaly. He has been undergoing treatment for pulmonary tuberculosis with anti-tubercular therapy (ATT) for the past 4 months. Which vitamin deficiency is most likely causing his symptoms?</span></span></p>",
      "unique_key": "Q5567671",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. </span></strong><span style=\"font-size:14.0pt\">&nbsp;<strong>B) Vitamin B6</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Vitamin B6 (pyridoxine) deficiency is commonly associated with the use of isoniazid, a key drug in the treatment of tuberculosis. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Isoniazid can interfere with the metabolism of vitamin B6, leading to a deficiency. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Symptoms of vitamin B6 deficiency include peripheral neuropathy, which manifests as tingling and numbness in the extremities. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Additionally, a deficiency in vitamin B6 can result in dermatitis, characterized by dry and scaly skin, which explains the patient&#39;s scalp condition.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Vitamin B12:</span></strong><span style=\"font-size:14.0pt\"> Deficiency in vitamin B12 typically leads to megaloblastic anemia and neurological symptoms such as numbness and tingling, but it is less commonly associated with dry and scaly skin. Furthermore, vitamin B12 deficiency is not specifically linked to the treatment of tuberculosis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Vitamin B2:</span></strong><span style=\"font-size:14.0pt\"> Also known as riboflavin, deficiency in vitamin B2 can cause symptoms such as sore throat, redness and swelling of the lining of the mouth and throat, cracks or sores on the outsides of the lips (cheilosis) and at the corners of the mouth (angular stomatitis), inflammation and redness of the tongue (magenta tongue), and a moist, scaly skin inflammation (seborrheic dermatitis). However, it is not typically linked to peripheral neuropathy or tuberculosis treatment.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Vitamin B1:</span></strong><span style=\"font-size:14.0pt\"> Deficiency in vitamin B1 (thiamine) leads to conditions like beriberi and Wernicke-Korsakoff syndrome, which can include symptoms such as peripheral neuropathy, but it is not specifically associated with dry and scaly skin or tuberculosis treatment.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Patients undergoing treatment for tuberculosis with isoniazid are at risk for vitamin B6 deficiency, which can present as peripheral neuropathy and dermatitis.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 189568,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        1
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47477,
      "choices": [
        {
          "id": 189519,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">30:2</span></span></span></p>"
        },
        {
          "id": 189520,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">15:1</span></span></span></p>"
        },
        {
          "id": 189521,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">3:1</span></span></span></p>"
        },
        {
          "id": 189522,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">15:2</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A newborn is brought to the emergency department with respiratory distress and bradycardia. After initiating positive pressure ventilation for 30 seconds, the heart rate remains below 60 beats per minute. What is the ideal ratio of chest compressions to ventilations for this newborn? </span></span></p>",
      "unique_key": "Q3380717",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans.&nbsp;</span></strong><strong><span style=\"font-size:14.0pt\">C) 3:1</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The ratio of compressions to ventilation in the resuscitation of the newborn is 3:1 (90 compressions and 30 breaths in one minute). </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This specific ratio is used for neonatal resuscitation because the primary cause of cardiovascular collapse in newborns is usually a compromise in gas exchange. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Effective resuscitation aims to restore adequate gas exchange and circulation simultaneously.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Option A.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>30:2:</strong> This ratio is commonly used for adult cardiopulmonary resuscitation (CPR) </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. 15:1:</span></strong><span style=\"font-size:14.0pt\"> This ratio is not standard for any age group in CPR guidelines and would not be appropriate for neonatal resuscitation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Option D.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>15: 2:</strong> This ratio is used in pediatrics CPR with 2 rescuers</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">In neonatal resuscitation, the ideal compression-to-ventilation ratio is 3:1. </span></span></span></li>\r\n\t<li><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This is crucial for effectively addressing the primary issue of compromised gas exchange in newborns.</span></span></li>\r\n</ul>",
      "correct_choice_id": 189521,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        13
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47819,
      "choices": [
        {
          "id": 190875,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Good graft uptake</span></span></span></p>"
        },
        {
          "id": 190876,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Reusable donor site</span></span></span></p>"
        },
        {
          "id": 190877,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Less graft contracture</span></span></span></p>"
        },
        {
          "id": 190878,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Large grafts can be harvested</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">All are advantages of split thickness skin grafting except?</span></span></p>",
      "unique_key": "Q7271322",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. C) Less graft contracture</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This is NOT an advantage of split thickness skin grafts. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Contrary to full-thickness skin grafts, split thickness grafts are more prone to secondary contracture due to the lesser amount of dermis taken. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This makes it unsuitable for use over sites where cosmesis is desirable.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Good graft uptake:</span></strong><span style=\"font-size:14.0pt\"> This is an advantage of split thickness skin grafts because they consist of the epidermis and a variable portion of the dermis, allowing for better integration with the recipient site if it&#39;s well-vascularized.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Reusable donor site:</span></strong><span style=\"font-size:14.0pt\"> The donor site from where the split thickness skin graft is taken can heal and be reused for future grafts because it only involves a portion of the dermis, allowing for the possibility of re-harvesting if necessary.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Large grafts can be harvested:</span></strong><span style=\"font-size:14.0pt\"> Because split thickness skin grafts involve less of the dermis, larger areas of skin can be harvested as grafts compared to full-thickness grafts.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Split thickness skin grafts offer several benefits, such as good uptake, the potential to reuse the donor site, and the ability to harvest large grafts. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">However, they are more susceptible to contraction limiting their use in areas of cosmesis, which is not an advantage of this grafting method. </span></span></span></li>\r\n</ul>",
      "correct_choice_id": 190877,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        12
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47881,
      "choices": [
        {
          "id": 191119,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Juvenile nasopharyngeal angiofibroma treated with surgical excision</span></span></span></p>"
        },
        {
          "id": 191120,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Nasopharyngeal carcinoma treated with radiotherapy</span></span></span></p>"
        },
        {
          "id": 191121,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Inverted papilloma treated with endoscopic resection</span></span></span></p>"
        },
        {
          "id": 191122,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Rhinoscleroma treated with antibiotics and surgical debridement</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 15-year-old boy presents with recurrent severe epistaxis and nasal obstruction. On examination, a mass is visualized in the nasopharynx. Imaging confirms a highly vascular tumor extending into the pterygopalatine fossa and infratemporal fossa. Which of the following is the most likely diagnosis and the primary treatment approach? </span></span></p>",
      "unique_key": "Q6567716",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. A) Juvenile nasopharyngeal angiofibroma treated with surgical excision</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Juvenile nasopharyngeal angiofibroma (JNA) is a benign but highly vascular tumor that typically occurs in adolescent males. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">It presents with recurrent severe epistaxis and nasal obstruction. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The tumor is confirmed through imaging, which often shows extension into the pterygopalatine and infratemporal fossae. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The primary treatment is surgical excision, often preceded by preoperative embolization to reduce intraoperative bleeding.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Option</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>B. Nasopharyngeal carcinoma treated with radiotherapy: </strong>Nasopharyngeal carcinoma is a malignant tumor usually seen in adults and associated with Epstein-Barr virus (EBV) infection. It typically presents with nasal obstruction, epistaxis, and neck masses. Treatment primarily involves radiotherapy, not surgical excision.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Option</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>C. Inverted papilloma treated with endoscopic resection:</strong> Inverted papilloma is a benign tumor of the nasal cavity and paranasal sinuses. It presents with unilateral nasal obstruction and possibly epistaxis. Treatment is endoscopic resection, but it does not typically involve the extensive vascular nature or extension seen in JNA.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Option</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>D. Rhinoscleroma treated with antibiotics and surgical debridement:</strong> Rhinoscleroma is a chronic granulomatous disease caused by Klebsiella rhinoscleromatis. It presents with nasal obstruction, crusting, and sometimes epistaxis. Treatment involves antibiotics and surgical debridement. The presentation and imaging characteristics are distinct from JNA.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Juvenile nasopharyngeal angiofibroma, a benign but highly vascular tumor in adolescent males, presents with recurrent severe epistaxis and nasal obstruction, and is primarily treated with surgical excision, often preceded by preoperative embolization.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 191119,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        9
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47717,
      "choices": [
        {
          "id": 190479,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Weight loss &gt; 10% of birth weight</span></span></span></p>"
        },
        {
          "id": 190480,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Sleeping for 2-3 hours after breast feeding</span></span></span></p>"
        },
        {
          "id": 190481,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Inconsolable crying </span></span></span></p>"
        },
        {
          "id": 190482,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Decreased urine output (&lt; 5-7 times/ day)&nbsp;&nbsp;&nbsp;&nbsp;</span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Indicators of inadequate breastfeeding in newborn are all except:</span></span></p>",
      "unique_key": "Q6827789",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Ans. B) Sleeping for 2-3 hours after breast feeding </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">This is the correct option. A baby should sleep for 2-3 hours after breast feeding. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">This is an indicator of adequate breast feeding.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Other Option:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Option A. Weight loss &gt; 10% of birth weight:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"> Weight loss greater than 10% of birth weight is a clear indicator of inadequate breastfeeding in a neonate. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Option C. Inconsolable crying:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"> Inconsolable crying and increased hunger are signs that the baby might not be getting enough milk. This could be due to insufficient milk production or poor breastfeeding techniques.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Option D. Decreased urine output (&lt; 5-7 times/day):</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"> Decreased urine output, defined as urinating less than 5-7 times per day, is a significant indicator of inadequate breastfeeding. It suggests that the baby is not receiving sufficient fluids.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">&bull; Indicators of inadequate breastfeeding include weight loss greater than 7-10% of birth weight, delayed passage of stools (less than 4 times/day), decreased urine output (urinating less than 5-7 times/day), hypernatremic dehydration and inconsolable crying.</span></span></span></p>",
      "correct_choice_id": 190480,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        13
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47888,
      "choices": [
        {
          "id": 191147,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">2 hours</span></span></span></p>"
        },
        {
          "id": 191148,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">4 hours</span></span></span></p>"
        },
        {
          "id": 191149,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">6 hours</span></span></span></p>"
        },
        {
          "id": 191150,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">8 hours</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Dr. Sara, Epidemiologist is preparing for a community vaccination drive in a rural region with a high incidence of Japanese Encephalitis (JE). As part of the preparations, she conducts a training session for the healthcare team on the proper handling and administration of the JE vaccine. She emphasizes the importance of maintaining the vaccine&#39;s efficacy post-reconstitution. Dr. Sara asks her team how long the reconstituted JE vaccine can be safely stored and used during the drive. </span></span></span></p>\r\n\r\n<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">What is the maximum time that the reconstituted JE vaccine should be kept before it must be discarded? </span></span></p>",
      "unique_key": "Q2444154",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans.&nbsp;</span></strong><strong><span style=\"font-size:14.0pt\">B) 4 hours</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">This is correct</span></strong><span style=\"font-size:14.0pt\">. The reconstituted Japanese Encephalitis (JE) vaccine should be used within 4 hours of preparation. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This timeframe ensures the vaccine&#39;s efficacy and safety, as the stability of the active components can be compromised beyond this period.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/07/screenshot-2024-06-07-145504.png\" style=\"height:568px; width:500px\" /></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">In endemic areas, JE vaccine is given to all children aged 1-15 years age</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">JE vaccine is not used below the age of 6 months</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Cell culture based Live attenuated freeze dried vaccine (SA-14-14-2 strain):</span></span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Diluent - phosphate buffer saline (PBS);&nbsp; </span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Dose under NIS &ndash; 0.5 ml subcutaneous in left upper arm @ 9 m &amp; 16-24 m under NIS [upto 15 years]</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>",
      "correct_choice_id": 191148,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47763,
      "choices": [
        {
          "id": 190659,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Wolff-Parkinson-White (WPW) Syndrome</span></span></span></p>"
        },
        {
          "id": 190660,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Long QT Syndrome</span></span></span></p>"
        },
        {
          "id": 190661,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Brugada Syndrome</span></span></span></p>"
        },
        {
          "id": 190662,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Atrial Fibrillation</span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 15-year-old boy presents with episodes of palpitations and dizziness. His ECG is shown below. Identify the most likely diagnosis:</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/06/screenshot-2024-06-06-165110.JPG\" style=\"height:191px; width:400px\" /></span></span></p>",
      "unique_key": "Q5295421",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Ans. A)&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Wolff-Parkinson-White (WPW) Syndrome</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">WPW syndrome is characterized by the presence of a delta wave on the ECG, which represents early ventricular depolarization due to an accessory pathway. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">It is also associated with a short PR interval and a wide QRS complex. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Patients with WPW syndrome can present with palpitations, dizziness, and sometimes syncope due to supraventricular tachycardia (SVT).</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Option B. Long QT Syndrome:&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Long QT syndrome is characterized by a prolonged QT interval on the ECG, which can lead to torsades de pointes and sudden cardiac death. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Option C. Brugada Syndrome:&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Brugada syndrome is identified by a characteristic pattern on the ECG, including coved-type ST-segment elevation in leads V1-V3. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Option D. Atrial Fibrillation:&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Atrial fibrillation is characterized by an irregularly irregular rhythm without distinct P waves on the ECG</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">WPW syndrome is diagnosed by the presence of a delta wave, short PR interval, and wide QRS complex on an ECG. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">It is crucial to identify this condition as it predisposes patients to tachyarrhythmias.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 190659,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        11
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47745,
      "choices": [
        {
          "id": 190587,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Adenolymphoma </span></span></span></p>"
        },
        {
          "id": 190588,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Adenoid cystic carcinoma </span></span></span></p>"
        },
        {
          "id": 190589,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Acinic cell tumour </span></span></span></p>"
        },
        {
          "id": 190590,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Pleomorphic adenoma </span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 62 years old man presented to the surgery OPD with swelling below the left ear since 8 months. The swelling is insidious in onset, gradually increasing in size. There is history of 20 packs per/year of smoking. On examination, a firm, non-tender swelling is noted. A parotid gland tumour is suspected. The tumor shows hot spot on nuclear imaging. Which of the following is the most likely diagnosis? </span></span></p>",
      "unique_key": "Q9307692",
      "difficulty_level": "difficult",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. A) Adenolymphoma </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Adenolymphoma</span><strong> </strong><span style=\"font-size:14.0pt\">also known as Warthin&#39;s tumor, it is a benign salivary gland neoplasm that commonly presents in the fifth to seventh decade and has a strong association with smoking. It is characterized by oncocytic epithelial cells and a lymphoid stroma. Warthin&#39;s tumor is the only salivary gland neoplasm that consistently takes up Tc 99m pertechnetate, appearing as a hot spot on the scan, making it the most likely diagnosis for this patient.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Adenoid cystic carcinoma: </span></strong><span style=\"font-size:14.0pt\">&nbsp;This is a malignant salivary gland tumor that most commonly affects the minor salivary glands, particularly the hard palate. It typically does not demonstrate a hot spot on Tc 99m pertechnetate scans.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Acinic cell tumour: </span></strong><span style=\"font-size:14.0pt\">&nbsp;This is a malignant tumor that arises from the acinar cells of the salivary glands, usually the parotid gland. It is typically slow-growing but does not show a hot spot on Tc 99m pertechnetate scans.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Pleomorphic adenoma: </span></strong><span style=\"font-size:14.0pt\">&nbsp;This is a type of salivary gland tumor that seen in 30-60-year age group, without any association with smoking.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Adenolymphoma (Warthin&#39;s tumor) is the most likely diagnosis in a patient with a smoking history and a firm, non-tender swelling in front of the ear, especially when a Tc 99m pertechnetate scan shows a hot spot, indicative of the high mitochondrial content of oncocytes.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 190587,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        12
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47558,
      "choices": [
        {
          "id": 189843,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Drug C is a competitive antagonist. </span></span></span></p>"
        },
        {
          "id": 189844,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Drug C is more potent than Drug A. </span></span></span></p>"
        },
        {
          "id": 189845,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Drug B is more potent than Drug A. </span></span></span></p>"
        },
        {
          "id": 189846,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Drug B is a competitive antagonist.</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 42-year-old male patient presents with moderate hypertension and is prescribed multiple antihypertensive medications. After the initial treatment, the physician needs to decide whether to intensify the treatment with a new drug. The dose-response curves for various drugs are reviewed to assess their efficacy and potency. Which statement correctly interprets the dose-response curve characteristics of the medications shown in the graph?</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/05/screenshot-2024-06-05-162514.JPG\" style=\"height:199px; width:300px\" /></span></span></p>",
      "unique_key": "Q7269461",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans.&nbsp;</span></strong><strong><span style=\"font-size:14.0pt\">D) Drug B is a competitive antagonist.</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">In the graph:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Potency and Efficacy</span></strong><span style=\"font-size:14.0pt\">: Potency refers to the amount of drug needed to produce an effect, and efficacy refers to the maximum effect a drug can produce. The graph shows that Drug B and Drug A achieve the same maximum effect, indicating similar efficacy. Potency is suggested by the leftward position of the dose-response curve; Drug A&#39;s curve is more leftward than Drug B, indicating that Drug A is more potent.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Type of Inhibition</span></strong><span style=\"font-size:14.0pt\">: Drug B causes a rightward shift in the dose-response curve of Drug A without decreasing the maximum effect, which is characteristic of competitive antagonists. They compete with the agonist (Drug A) for the same binding site but do not affect the maximum effect of the agonist. Drug C causes a downward shift in the dose-response curve, indicating a decrease in efficacy, characteristic of non-competitive antagonists, which bind to a different site and reduce the maximum possible effect of the agonist.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Option A.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>Drug C is a competitive antagonist: </strong>&nbsp;Incorrect because Drug C does not shift the dose-response curve of Drug A to the right, which is required for a competitive antagonist.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B</span></strong><span style=\"font-size:14.0pt\">. <strong>Drug C is more potent than Drug A:</strong> Incorrect because Drug C&#39;s curve is to the right of Drug A, indicating it is less potent, not more potent.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C</span></strong><span style=\"font-size:14.0pt\">. <strong>Drug B is more potent than Drug A</strong>: Incorrect because Drug B&#39;s curve is to the right of Drug A&#39;s curve, indicating Drug A is more potent than Drug B.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Drug B acts as a competitive antagonist, shifting the dose-response curve rightward without affecting the maximum efficacy, while Drug C, showing reduced efficacy and no shift in potency, is a non-competitive antagonist. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Remember the rule: leftward and upward shifts in dose-response curves suggest increased potency and efficacy, respectively.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 189846,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        4
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47687,
      "choices": [
        {
          "id": 190359,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Laparoscopic cholecystectomy</span></span></span></p>"
        },
        {
          "id": 190360,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Conservative management</span></span></span></p>"
        },
        {
          "id": 190361,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Medical dissolution therapy</span></span></span></p>"
        },
        {
          "id": 190362,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">ERCP and stone removal</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 52-year-old woman was undergoing a routine check-up when the radiologist noticed gallstones on USG. However, the patient says that there have been no complaints so far and she is asymptomatic. The stone measures 4cms. What will be your treatment of choice?</span></span></p>",
      "unique_key": "Q4440967",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans.&nbsp; A) Laparoscopic cholecystectomy</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This is usually the treatment of choice for symptomatic gallstones. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">However, prophylactic cholecystectomy may be recommended for asymptomatic gallstones in certain situations, such as when the stones are larger than 3 cm, which can increase the risk of gallbladder cancer, particularly in certain ethnic groups or geographical locations with a high prevalence of gallbladder cancer.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Conservative Management: </span></strong><span style=\"font-size:14.0pt\">For patients with asymptomatic gallstones, conservative management is often the initial approach. Intervention is generally not recommended unless the patient becomes symptomatic or develops complications.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Medical Dissolution Therapy: </span></strong><span style=\"font-size:14.0pt\">This treatment option involves the use of oral bile acids to dissolve cholesterol gallstones. It is typically reserved for patients who cannot undergo surgery, but the stones must be cholesterol-based, and the process is slow and has a high recurrence rate. It is not typically used for stones as large as 4 cm.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. ERCP and Stone Removal: </span></strong><span style=\"font-size:14.0pt\">ERCP (Endoscopic Retrograde Cholangiopancreatography) is generally not used for stones in the gallbladder itself but is a treatment option for stones in the common bile duct.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">For a patient with asymptomatic gallstones measuring 4 cm, the treatment of choice is generally conservative management, but prophylactic laparoscopic cholecystectomy may be considered due to the increased risk of complications associated with larger stones. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Medical dissolution therapy is not typically effective for large stones, and ERCP is not indicated unless there is choledocholithiasis.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 190359,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        12
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47833,
      "choices": [
        {
          "id": 190931,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">P. falciparum</span></span></span></p>"
        },
        {
          "id": 190932,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">P. malariae</span></span></span></p>"
        },
        {
          "id": 190933,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">P. ovale</span></span></span></p>"
        },
        {
          "id": 190934,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">P. vivax</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 32-year-old female, recently returned from a trip to sub-Saharan Africa, presents to the emergency department with a high fever, chills, and severe headaches. A blood smear is taken as part of the diagnostic workup due to her travel history and symptoms suggestive of malaria. Which of the following is the most likely causative agent of her illness based on the diagnosis of malaria made through examination of the peripheral smear shown? </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/07/screenshot-2024-06-07-110622.png\" style=\"height:285px; width:600px\" /></p>",
      "unique_key": "Q7715011",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Ans.&nbsp;</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>A) P. falciparum</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The peripheral blood smear image demonstrates ring forms within erythrocytes, characterized by the presence of double chromatin dots, resembling stereo headphones, which is distinctive of P. falciparum. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This species can cause severe malaria and is known for its capability to infect a larger number of erythrocytes, including those of any age, which might explain the observation of multiple rings within a single erythrocyte. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">These rings are typically small and delicate, often adhering to the erythrocyte membrane, creating what is described as an &#39;accol&eacute;&#39; appearance.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. P. malariae:</span></strong><span style=\"font-size:14.0pt\"> The parasites of P. malariae typically form larger and more compact ring forms in older erythrocytes and do not show the double chromatin feature.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. P. ovale:</span></strong><span style=\"font-size:14.0pt\"> Characterized by oval or fimbriated erythrocytes, with infected cells often showing enlargement and distinct Sch&uuml;ffner&#39;s stippling, not typically showing multiple ring forms per cell.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. P. vivax:</span></strong><span style=\"font-size:14.0pt\"> While this species also shows enlargement of infected erythrocytes and Sch&uuml;ffner&#39;s stippling, the rings do not usually exhibit the &#39;double chromatin&#39; appearance and are generally fewer in number per cell compared to P. falciparum.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">P. falciparum infection is identified by distinctive double chromatin dots within ring forms in erythrocytes, often with multiple infections per cell, indicative of the species&#39; high virulence and severity potential. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Prompt diagnosis and treatment are crucial to manage and mitigate severe complications associated with this malaria species.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Morphological forms of malaria parasites &ndash; </span></span></strong></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/07/screenshot-2024-06-07-110800.png\" style=\"height:624px; width:600px\" /></span></span></strong></p>",
      "correct_choice_id": 190931,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        6
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47808,
      "choices": [
        {
          "id": 190835,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Metformin</span></span></span></p>"
        },
        {
          "id": 190836,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Repaglinide</span></span></span></p>"
        },
        {
          "id": 190837,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Pramlintide</span></span></span></p>"
        },
        {
          "id": 190838,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Sitagliptin</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following medications can be effectively used to treat both type 1 and type 2 diabetes mellitus?</span></span></p>",
      "unique_key": "Q2767004",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. </span></strong><strong><span style=\"font-size:14.0pt\">C) Pramlintide</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Pramlintide</span></strong><span style=\"font-size:14.0pt\"> is an adjunct treatment for patients with both type 1 and type 2 diabetes. It is a synthetic analogue of amylin, a hormone that is co-secreted with insulin by pancreatic beta cells. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Pramlintide aids in glycemic control by slowing gastric emptying, suppressing glucagon secretion postprandially, and enhancing satiety. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This multifaceted approach makes it suitable for use in both types of diabetes to control postprandial glucose spikes.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Metformin</span></strong><strong><span style=\"font-size:14.0pt\">:</span></strong><span style=\"font-size:14.0pt\"> Primarily indicated for type 2 diabetes, it is used to decrease hepatic glucose production and improve insulin sensitivity but is not typically prescribed for type 1 diabetes.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Repaglinide</span></strong><strong><span style=\"font-size:14.0pt\">: </span></strong><span style=\"font-size:14.0pt\">Targets postprandial blood glucose levels by stimulating insulin release from pancreatic beta cells, mainly used in type 2 diabetes.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Sitagliptin</span></strong><strong><span style=\"font-size:14.0pt\">: </span></strong><span style=\"font-size:14.0pt\">&nbsp;A DPP-4 inhibitor that enhances the incretin system, increasing insulin release in response to meals. It is effective in type 2 diabetes but does not address the insulin deficiency found in type 1 diabetes.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Pramlintide provides a unique therapeutic benefit for patients managing both type 1 and type 2 diabetes, particularly for those struggling with postprandial glucose control, making it a valuable addition to insulin therapy.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 190837,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47922,
      "choices": [
        {
          "id": 191283,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Mild COPD</span></span></span></p>"
        },
        {
          "id": 191284,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Moderate COPD</span></span></span></p>"
        },
        {
          "id": 191285,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Severe COPD</span></span></span></p>"
        },
        {
          "id": 191286,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Very severe COPD</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient presents with spirometry results showing an FEV1/FVC ratio of less than 0.7 after salbutamol nebulization and an FEV1 of 44% of the predicted value. According to the GOLD criteria, how should this patient&#39;s COPD be classified?<strong> </strong></span></span></p>",
      "unique_key": "Q8337889",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>C) Severe COPD</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Severe COPD is identified by an FEV1/FVC ratio of less than 0.7 and an FEV1 between 30% and 49% of the predicted value. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The patient&rsquo;s spirometry results match this category, confirming severe COPD.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Mild COPD:</span></strong><span style=\"font-size:14.0pt\"> According to the GOLD criteria, mild COPD is classified as FEV1/FVC &lt;0.7 and FEV1 &ge;80% predicted. The given patient&#39;s FEV1 is significantly below 80%, ruling out this option.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Moderate COPD:</span></strong><span style=\"font-size:14.0pt\"> Moderate COPD is defined by FEV1/FVC &lt;0.7 and FEV1 between 50% and 79% of the predicted value. The patient&rsquo;s FEV1 is below 50%, making this classification incorrect.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Very severe COPD:</span></strong><span style=\"font-size:14.0pt\"> Very severe COPD is characterized by an FEV1/FVC ratio of less than 0.7 and an FEV1 of less than 30% of the predicted value. The patient&#39;s FEV1 is higher than 30%, so this category does not apply.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The Global Initiative for Chronic Obstructive Lung Disease (GOLD) criteria classify COPD severity based on spirometry results: Mild (Stage I) FEV1 &ge;80%, Moderate (Stage II) FEV1 50-79%, Severe (Stage III) FEV1 30-49%, and Very Severe (Stage IV) FEV1 &lt;30%. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Recognizing these stages helps guide treatment and management strategies.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 191285,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47813,
      "choices": [
        {
          "id": 190851,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Fungiform papillae</span></span></span></p>"
        },
        {
          "id": 190852,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Circumvallate&nbsp;papillae</span></span></span></p>"
        },
        {
          "id": 190853,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Filiform papillae</span></span></span></p>"
        },
        {
          "id": 190854,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Foliate papillae</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 28-year-old woman presents to the clinic with complaints of a loss of taste sensation. She has been experiencing this issue for the past month. As part of the diagnostic workup, a biopsy of her tongue was performed, and the histological section is shown below. Identify the type of papillae from the given histological section: </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/07/screenshot-2024-06-07-102740_uKsFRO5.png\" style=\"height:384px; width:400px\" /></p>",
      "unique_key": "Q2916654",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. B) Circumvallate papillae</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">The histological section shows large, round structures with a central taste bud-rich area, which are characteristic of circumvallate papillae. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">These papillae are located at the back of the tongue and are surrounded by a trench-like structure. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">They contain numerous taste buds that are involved in the sensation of taste. Circumvallate papillae are distinct due to their large size and the presence of von Ebner&#39;s glands at their base, which secrete a serous fluid that helps in taste sensation.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Fungiform Papillae:</span></strong><span style=\"font-size:14.0pt\"> These papillae are smaller, mushroom-shaped structures located mainly on the tip and sides of the tongue. They contain fewer taste buds compared to circumvallate papillae and do not have the large trench-like structures seen in the image.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Filiform Papillae:</span></strong><span style=\"font-size:14.0pt\"> These are the most numerous papillae on the tongue and are slender, conical, and do not contain taste buds. They are primarily involved in the mechanical aspect of moving food around the mouth and do not resemble the structure shown in the histological section.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Foliate Papillae:</span></strong><span style=\"font-size:14.0pt\"> These papillae are located on the lateral aspects of the tongue and are characterized by multiple parallel ridges. They contain taste buds but their structure is different from the circumvallate papillae shown in the image.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Circumvallate papillae are large, round papillae located at the back of the tongue, characterized by a central area rich in taste buds and surrounded by a trench-like structure, distinguishing them from other types of papillae on the tongue.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 190852,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        3
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47712,
      "choices": [
        {
          "id": 190459,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Strontium ranelate</span></span></span></p>"
        },
        {
          "id": 190460,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Ibandronate</span></span></span></p>"
        },
        {
          "id": 190461,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Teriparatide</span></span></span></p>"
        },
        {
          "id": 190462,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Calcitonin</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In the management of osteoporosis, a 60-year-old female patient is considering medication options that affect both bone formation and resorption. Which of the following medications is known to influence both decreased bone resorption and increased bone formation? </span></span></p>",
      "unique_key": "Q4822560",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans.&nbsp;</span></strong><strong><span style=\"font-size:14.0pt\">A) Strontium ranelate</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Strontium ranelate</span></strong><span style=\"font-size:14.0pt\"> is unique among osteoporosis treatments as it has a dual mode of action: it simultaneously decreases bone resorption and increases bone formation. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This dual activity helps to rebalance the bone remodeling process, which is crucial in the treatment of osteoporosis to both reduce the risk of fractures and promote bone health.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Ibandronate</span></strong><span style=\"font-size:14.0pt\">: This is a bisphosphonate that primarily reduces bone resorption. It binds to bone minerals and inhibits osteoclast-mediated bone resorption, but it does not promote bone formation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Teriparatide</span></strong><span style=\"font-size:14.0pt\">: An analog of parathyroid hormone, teriparatide primarily stimulates bone formation. It activates osteoblasts, which are bone-forming cells, but does not have a direct effect on reducing bone resorption.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Calcitonin</span></strong><span style=\"font-size:14.0pt\">: This hormone helps reduce bone resorption. It is used in osteoporosis treatment to slow down the bone loss but does not have a significant effect on increasing bone formation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Strontium ranelate offers a comprehensive approach to managing osteoporosis by both reducing bone resorption and enhancing bone formation, making it a valuable treatment option for patients needing intervention on both fronts of bone remodeling.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 190459,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47824,
      "choices": [
        {
          "id": 190895,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Systemic lupus erythematosus (SLE)</span></span></span></p>"
        },
        {
          "id": 190896,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Henoch-Sch&ouml;nlein purpura (HSP)</span></span></span></p>"
        },
        {
          "id": 190897,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Immune thrombocytopenic purpura (ITP)</span></span></span></p>"
        },
        {
          "id": 190898,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Polyarteritis Nodosa (PAN)</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 10-year-old boy presents with swollen knee joints and non-blanching rashes on his legs as seen in the picture. Urine examination reveals haematuria +++ and proteinuria +. Platelet levels are normal. What is the most likely diagnosis? </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/07/screenshot-2024-06-07-104616.png\" style=\"height:186px; width:300px\" /></p>",
      "unique_key": "Q3836610",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. B) Henoch-Sch&ouml;nlein purpura (HSP)</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">In the given clinical scenario, the boy exhibits typical signs and symptoms of Henoch-Sch&ouml;nlein purpura (HSP). </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">HSP is a type of small vessel vasculitis that commonly affects children. It is characterized by the presence of a purpuric rash, as well as arthritis and abdominal pain. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Additionally, approximately 50% of patients with HSP develop renal complications that can range from asymptomatic microscopic hematuria to severe, progressive glomerulonephritis.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Systemic lupus erythematosus (SLE):</span></strong><span style=\"font-size:14.0pt\"> SLE can cause a wide variety of symptoms including a characteristic malar rash, arthritis, and renal involvement (such as proteinuria and hematuria). However, the typical non-blanching rash and specific association with recent upper respiratory infections point more towards HSP in this case.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Immune thrombocytopenic purpura (ITP):</span></strong><span style=\"font-size:14.0pt\"> ITP is characterized by isolated thrombocytopenia with petechiae or purpura, but it does not typically cause renal involvement like hematuria or proteinuria. Moreover, the platelet levels in this boy are normal, which is not consistent with ITP.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Polyarteritis Nodosa (PAN):</span></strong><span style=\"font-size:14.0pt\"> PAN is a medium vessel vasculitis that can cause systemic symptoms such as fever, abdominal pain, and skin changes like livedo reticularis. However, it is less common in children and does not typically present with the classic purpuric rash and joint involvement seen in HSP.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Henoch-Sch&ouml;nlein purpura (HSP) is a small vessel vasculitis commonly affecting children, characterized by purpuric rash, arthritis, abdominal pain, and renal involvement such as hematuria and proteinuria. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Diagnosis is clinical, supported by typical findings and normal platelet levels.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 190896,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        13
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47581,
      "choices": [
        {
          "id": 189935,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Auriculotemporal nerve</span></span></span></p>"
        },
        {
          "id": 189936,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Greater auricular nerve</span></span></span></p>"
        },
        {
          "id": 189937,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Lesser occipital nerve</span></span></span></p>"
        },
        {
          "id": 189938,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Vagus nerve</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 35-year-old man presents to the clinic with pain in his right ear. On examination, there is no visible infection or trauma. The patient mentions that the pain sometimes radiates to his jaw and neck. Which of the following nerves is most likely responsible for the pain in the ear?</span></span></p>",
      "unique_key": "Q9964996",
      "difficulty_level": "difficult",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. A) Auriculotemporal nerve</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The auriculotemporal nerve, a branch of the mandibular division of the trigeminal nerve (CN V3), supplies sensation to the anterior and superior parts of the auricle and the external acoustic meatus. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">It is commonly involved in referred pain to the ear from the temporomandibular joint (TMJ), explaining why the patient experiences pain radiating to the jaw and neck.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"margin-left:24px\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Option:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Greater auricular nerve:</span></strong><span style=\"font-size:14.0pt\"> The greater auricular nerve is derived from the cervical plexus (C2 and C3). It provides sensation to the skin over the parotid gland, mastoid process, and part of the auricle. While it supplies part of the ear, it is less likely to be associated with pain radiating to the jaw and neck.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Lesser occipital nerve:</span></strong><span style=\"font-size:14.0pt\"> The lesser occipital nerve also originates from the cervical plexus (C2). It supplies the skin on the posterolateral aspect of the head and neck, but it does not significantly contribute to the innervation of the ear. Therefore, it is unlikely to be the source of ear pain.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Vagus nerve:</span></strong><span style=\"font-size:14.0pt\"> The vagus nerve (CN X) supplies the auricular branch (Arnold&#39;s nerve), which innervates posterior part of the external auditory canal and the concha of the auricle. However, involvement of the vagus nerve typically presents with symptoms like cough or gag reflex rather than isolated ear pain radiating to the jaw and neck.</span></span></span></p>\r\n\r\n<p style=\"margin-left:24px\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The auriculotemporal nerve, a branch of the mandibular division of the trigeminal nerve (CN V3), is responsible for supplying sensation to the anterior and superior parts of the auricle and the external acoustic meatus, and can cause referred pain to the ear from the temporomandibular joint (TMJ).</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 189935,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        9
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47858,
      "choices": [
        {
          "id": 191027,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Tree in bud appearance</span></span></span></p>"
        },
        {
          "id": 191028,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Crazy paving appearance</span></span></span></p>"
        },
        {
          "id": 191029,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Signet ring appearance</span></span></span></p>"
        },
        {
          "id": 191030,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Traction bronchiectasis with lung fibrosis</span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 55-year-old patient with a chronic cough and recurrent respiratory infections undergoes a CT scan of the chest to evaluate for bronchiectasis. Which of the following CT findings is least likely to be associated with bronchiectasis?<strong> </strong></span></span></p>",
      "unique_key": "Q5323279",
      "difficulty_level": "intermediate",
      "solution": "<div class=\"WordSection1\">\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Ans. B) Crazy paving appearance</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">&quot;Crazy paving appearance&quot;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"> on a CT scan refers to the presence of thickened interlobular septa and intralobular lines superimposed on a background of ground-glass opacity, creating a pattern reminiscent of irregularly laid paving stones. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">This finding is more commonly associated with other lung conditions such as pulmonary alveolar proteinosis, acute interstitial pneumonia, and certain types of infections or non-infectious pneumonitis. It is not typically associated with bronchiectasis.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/07/screenshot-2024-06-07-123655.png\" style=\"height:235px; width:400px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Crazy paving appearance</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/07/screenshot-2024-06-07-123702.png\" style=\"height:241px; width:400px\" /></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Crazy paving</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">The other CT findings are more characteristic of bronchiectasis:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Option A. Tree in bud appearance:&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">This pattern is seen in bronchiectasis and represents dilated bronchioles filled with mucus or inflammatory material, often seen in endobronchial spread of infection.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/07/screenshot-2024-06-07-123712.png\" style=\"height:321px; width:400px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Option C. Signet ring appearance:&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">This is a classic finding in bronchiectasis and is seen when the diameter of the bronchus is larger than that of the accompanying pulmonary artery.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/07/screenshot-2024-06-07-123718.png\" style=\"height:402px; width:400px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Option D. Traction bronchiectasis with lung fibrosis:&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Traction bronchiectasis occurs in the setting of lung fibrosis, where the scarring pulls the bronchial walls open, causing dilation. It can be seen in association with bronchiectasis, especially when there is underlying lung damage or fibrosis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/07/screenshot-2024-06-07-123727.png\" style=\"height:386px; width:400px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">The crazy paving pattern on CT is not typically associated with bronchiectasis. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">It suggests other lung pathologies like pulmonary alveolar proteinosis or acute interstitial pneumonia. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Classic CT findings in bronchiectasis include the tree in bud appearance and the signet ring appearance. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Traction bronchiectasis can occur in the context of lung fibrosis.</span></span></span></li>\r\n</ul>\r\n</div>\r\n\r\n<div style=\"page-break-after:always\"><span style=\"display:none\">&nbsp;</span></div>",
      "correct_choice_id": 191028,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47693,
      "choices": [
        {
          "id": 190383,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Inhibition of angiogenesis</span></span></span></p>"
        },
        {
          "id": 190384,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Promotion of cell proliferation</span></span></span></p>"
        },
        {
          "id": 190385,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Activation of cell cycle arrest</span></span></span></p>"
        },
        {
          "id": 190386,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Stimulation of apoptosis</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 32-year-old man presents to the emergency department with persistent abdominal pain and diarrhea. Imaging studies reveal a mass in the pancreas, and subsequent biopsy confirms pancreatic adenocarcinoma. Genetic analysis shows a mutation in the KRAS proto-oncogene. What is the primary effect of this KRAS mutation in pancreatic adenocarcinoma?</span></span></p>",
      "unique_key": "Q2467725",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. B) Promotion of cell proliferation</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The KRAS proto-oncogene encodes a protein involved in regulating cell division, differentiation, and apoptosis. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Mutations in KRAS lead to its constitutive activation, resulting in continuous signaling for cell proliferation. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This unchecked cell growth is a key factor in the development and progression of pancreatic adenocarcinoma. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The mutated KRAS protein activates downstream pathways, such as the MAPK/ERK pathway, which promotes cellular proliferation and tumorigenesis.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Inhibition of Angiogenesis:</span></strong><span style=\"font-size:14.0pt\"> KRAS mutations primarily drive cell proliferation rather than inhibiting angiogenesis. While KRAS can influence angiogenesis indirectly by promoting the production of growth factors, its main role in cancer is to promote cell growth and division.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Activation of Cell Cycle Arrest:</span></strong><span style=\"font-size:14.0pt\"> KRAS mutations result in the opposite effect; they prevent cell cycle arrest and promote continuous cell cycle progression, leading to uncontrolled cell division.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Stimulation of Apoptosis:</span></strong><span style=\"font-size:14.0pt\"> KRAS mutations do not stimulate apoptosis. Instead, they typically inhibit apoptotic pathways, allowing cancer cells to survive and proliferate.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Mutations in the KRAS proto-oncogene lead to the promotion of cell proliferation by constitutively activating signaling pathways that drive cell growth and division, which is a critical mechanism in the development of pancreatic adenocarcinoma.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 190384,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        5
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47474,
      "choices": [
        {
          "id": 189507,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">MDR test for tuberculosis</span></span></span></p>"
        },
        {
          "id": 189508,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Biopsy to rule out squamous cell cancer of lung</span></span></span></p>"
        },
        {
          "id": 189509,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">ANCA for diagnosis of vasculitis</span></span></span></p>"
        },
        {
          "id": 189510,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Culture for fungal infection</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 50-year-old man presents with a history of chronic sinusitis and ulcerative lesions in the nasopharynx. He also reports hemoptysis and has nodular lesions with cavitation in the lungs, as well as recent onset of renal dysfunction. What is the most important investigation to establish the diagnosis in this patient? </span></span></p>",
      "unique_key": "Q8106284",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. C) ANCA for diagnosis of vasculitis</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The patient&rsquo;s presentation of chronic sinusitis, ulcerative nasopharyngeal lesions, pulmonary nodules with cavitation, and renal dysfunction is highly indicative of Granulomatosis with Polyangiitis (GPA), formerly known as Wegener&#39;s granulomatosis. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">GPA is a form of systemic vasculitis that commonly involves the upper respiratory tract, lungs, and kidneys. Anti-neutrophil cytoplasmic antibodies (ANCA), particularly cytoplasmic ANCA (c-ANCA) targeting proteinase-3, are highly specific for GPA. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Testing for ANCA is crucial for the diagnosis and helps distinguish GPA from other conditions with similar presentations.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. MDR Test for Tuberculosis:</span></strong><span style=\"font-size:14.0pt\"> While tuberculosis can present with lung cavitations and sometimes renal involvement, it does not typically present with chronic sinusitis and nasopharyngeal ulcers. The specific combination of symptoms in this patient is more suggestive of GPA than tuberculosis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Biopsy to Rule Out Squamous Cell Cancer of Lung:</span></strong><span style=\"font-size:14.0pt\"> Although lung cancer can present with cavitary lung lesions, it is less likely to cause chronic sinusitis, nasopharyngeal ulcers, and renal failure. The clinical presentation strongly suggests a systemic vasculitis rather than malignancy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Culture for Fungal Infection:</span></strong><span style=\"font-size:14.0pt\"> Fungal infections can cause cavitary lung lesions, but the combination of chronic sinusitis, nasopharyngeal ulcers, and renal dysfunction is more indicative of a vasculitic process like GPA rather than a fungal infection.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In a patient with chronic sinusitis, ulcerative nasopharyngeal lesions, cavitary lung nodules, and renal dysfunction, ANCA testing is essential for diagnosing Granulomatosis with Polyangiitis (GPA), a form of vasculitis that affects these organ systems.</span></span></li>\r\n</ul>",
      "correct_choice_id": 189509,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        5
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47714,
      "choices": [
        {
          "id": 190467,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">50 mmol/L</span></span></span></p>"
        },
        {
          "id": 190468,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">75 mmol/L</span></span></span></p>"
        },
        {
          "id": 190469,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">90 mmol/L</span></span></span></p>"
        },
        {
          "id": 190470,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">100 mmol/L</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 2-year-old child is brought to the outpatient department with symptoms of dehydration due to acute diarrhea. The doctor prescribes reduced-osmolarity oral rehydration solution (ORS). What is the sodium composition in the reduced-osmolarity ORS recommended for this child?</span></span></p>",
      "unique_key": "Q3684208",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. </span></strong><strong><span style=\"font-size:14.0pt\">B) 75 mmol/L</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The sodium composition in the reduced-osmolarity oral rehydration solution (ORS) is 75 mmol/L. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This composition helps in effectively treating dehydration caused by diarrhea while minimizing the risk of hypernatremia and improving water absorption.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Note :</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/08/screenshot-2024-06-08-174434.JPG\" style=\"height:247px; width:868px\" /></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The sodium composition in reduced-osmolarity ORS is 75 mmol/L. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This formulation is designed to optimize rehydration while minimizing the risk of electrolyte imbalances, particularly hypernatremia.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 190468,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        13
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47566,
      "choices": [
        {
          "id": 189875,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Less negative</span></span></span></p>"
        },
        {
          "id": 189876,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">No change</span></span></span></p>"
        },
        {
          "id": 189877,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">First becomes more positive, then negative</span></span></span></p>"
        },
        {
          "id": 189878,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Becomes more negative</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 34-year-old man was rushed to the emergency department after a severe crush injury to his leg sustained in a workplace accident. He has significant muscle damage and laboratory tests reveal a serum potassium (K+) level of 5.5 mEq/L. Which of the following changes is most likely to occur to the resting membrane potential in this patient?</span></span></p>",
      "unique_key": "Q7692078",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans.&nbsp;</span></strong><strong><span style=\"font-size:14.0pt\">A) Less negative</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">An elevated serum potassium level, known as hyperkalemia, affects the resting membrane potential of cells. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Normally, the resting membrane potential is maintained by the difference in potassium concentration inside and outside the cell. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">When extracellular potassium levels increase, the gradient across the cell membrane decreases, leading to a less negative (more depolarized) resting membrane potential. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This change can increase the excitability of neurons and muscle cells, potentially leading to arrhythmias or other complications.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Option B.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>No change:</strong> This option is incorrect because an increase in serum potassium concentration will definitely affect the resting membrane potential by making it less negative. The resting membrane potential is sensitive to changes in extracellular potassium levels.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Option C.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>First becomes more positive, then negative:</strong> This sequence does not accurately describe the typical response to hyperkalemia. While severe hyperkalemia can eventually lead to cellular dysfunction and potentially reverse the effects, the initial and primary change in resting membrane potential due to increased serum potassium is a more positive value.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Option D.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>Becomes more negative:</strong> This is incorrect because an increased serum potassium level would reduce the potassium gradient across the cell membrane, leading to a less negative resting membrane potential. A more negative resting membrane potential would occur with hypokalemia, not hyperkalemia.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Hyperkalemia results in a less negative resting membrane potential due to the decreased potassium gradient across the cell membrane, leading to increased cell excitability.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 189875,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        2
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47584,
      "choices": [
        {
          "id": 189947,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Asking the patient to perform the Valsalva maneuver and see if the pessary is in place</span></span></span></p>"
        },
        {
          "id": 189948,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Seeing if the patient feels any discomfort, which means that the pessary is retained</span></span></span></p>"
        },
        {
          "id": 189949,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">&nbsp;Being able to admit two fingers between the ring and the pessary</span></span></span></p>"
        },
        {
          "id": 189950,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">&nbsp;Asking the patient to void and see if the pessary is in place</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 62-year-old woman presents with symptoms of pelvic organ prolapse. After fitting her with a pessary, what is the first step to check if the pessary is adequately retained?</span></span></p>",
      "unique_key": "Q2071461",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. A) Asking the patient to perform the Valsalva maneuver and see if the pessary is in place</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The Valsalva maneuver increases intra-abdominal pressure, which can simulate the forces that might dislodge the pessary during normal daily activities. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">If the pessary stays in place during the Valsalva maneuver, it is likely to be adequately retained.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Seeing if the patient feels any discomfort, which means that the pessary is retained:</span></strong><span style=\"font-size:14.0pt\"> While discomfort might indicate that the pessary is too large or incorrectly positioned, the absence of discomfort does not necessarily mean that the pessary is adequately retained. Comfort is important, but it is not the primary method to check retention.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Being able to admit two fingers between the ring and the pessary:</span></strong><span style=\"font-size:14.0pt\"> This is not a standard method to check for adequate retention of a pessary. Proper fitting involves ensuring the pessary is comfortably positioned without significant gaps that would allow for easy displacement.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Asking the patient to void and see if the pessary is in place:</span></strong><span style=\"font-size:14.0pt\"> Voiding can help assess if the pessary is causing any obstruction or discomfort during urination, but it is not the first step to check for adequate retention.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The first step to check if a pessary is adequately retained after fitting is to ask the patient to perform the Valsalva maneuver. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This maneuver increases intra-abdominal pressure, which helps determine if the pessary remains in place under stress conditions.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 189947,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47877,
      "choices": [
        {
          "id": 191103,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:14.0pt\">Alcohol Withdrawal Delirium&nbsp; </span></span></span></p>"
        },
        {
          "id": 191104,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:14.0pt\">Wernicke&#39;s encephalopathy&nbsp; </span></span></span></p>"
        },
        {
          "id": 191105,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:14.0pt\">Acute and Transient Psychotic Disorder&nbsp; </span></span></span></p>"
        },
        {
          "id": 191106,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:14.0pt\">Alcohol-induced psychosis</span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 45-year-old man presents to the emergency department with a history of chronic alcohol use. He has abstained from alcohol for three days and is now experiencing irritability, disorientation, paranoid delusions, agitation, visual hallucinations, and altered sensorium. His vital signs are notable for tachycardia and hypertension. On physical examination, he is tremulous and diaphoretic. What is the most likely diagnosis? </span></span></p>",
      "unique_key": "Q3672622",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:14.0pt\">Ans. A) Alcohol Withdrawal Delirium</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:14.0pt\">The patient&rsquo;s symptoms&mdash;irritability, disorientation, paranoid delusions, agitation, visual hallucinations, altered sensorium, tachycardia, hypertension, tremors, and diaphoresis&mdash;are consistent with Alcohol Withdrawal Delirium (also known as delirium tremens).</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:14.0pt\">These symptoms typically occur after abrupt cessation of heavy, chronic alcohol use and are severe manifestations of alcohol withdrawal.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:14.0pt\">Option B. Wernicke&#39;s encephalopathy:</span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:14.0pt\"> This condition is characterized by confusion, ophthalmoplegia, and ataxia, resulting from thiamine deficiency due to chronic alcohol use. The absence of these specific symptoms makes it less likely.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:14.0pt\">Option C. Acute and Transient Psychotic Disorder:</span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:14.0pt\"> This involves sudden onset of psychotic symptoms, but without the history of chronic alcohol use and withdrawal context. The patient&#39;s symptoms align more with withdrawal.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:14.0pt\">Option D. Alcohol-induced psychosis:</span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:14.0pt\"> This condition can present with psychotic symptoms, but it occurs while the person is still consuming alcohol, not after a period of abstinence. The overall clinical picture fits better with Alcohol Withdrawal Delirium.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:14.0pt\">Delirium Tremens (DTs) (alcohol withdrawal delirium) is a medical emergency and if untreated the mortality rate is around 20%. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:14.0pt\">The symptoms and signs include disturbances of consciousness, disorientation to time, place, and person, hallucination (most commonly visual), coarse tremors, and autonomic hyperactivity. </span></span></span></li>\r\n\t<li><span dir=\"ltr\" lang=\"EN\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It usually occurs after 48-72 hours of the last alcohol intake or reduction in the amount of alcohol use. </span></span></li>\r\n</ul>",
      "correct_choice_id": 191103,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        16
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47878,
      "choices": [
        {
          "id": 191107,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Minimal Change Disease</span></span></span></p>"
        },
        {
          "id": 191108,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Post-Streptococcal Glomerulonephritis</span></span></span></p>"
        },
        {
          "id": 191109,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">IgA Nephropathy</span></span></span></p>"
        },
        {
          "id": 191110,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Nephrotic Syndrome</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 7-year-old girl presents to the emergency department with facial swelling and decreased urine output. Her parents report that she had a sore throat and fever about two weeks ago. On physical examination, she has periorbital edema and elevated blood pressure. Urinalysis shows cola-colored urine and RBC casts. Laboratory tests reveal low C3 levels. What is the most likely diagnosis? </span></span></p>",
      "unique_key": "Q7468443",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans.&nbsp;</span></strong><strong><span style=\"font-size:14.0pt\">B) Post-Streptococcal Glomerulonephritis</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Post-streptococcal glomerulonephritis (PSGN) typically presents with hematuria (cola-colored urine), oliguria, facial swelling (periorbital edema), and hypertension. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">It usually follows a streptococcal throat or skin infection by 1-3 weeks and is associated with low C3 levels and the presence of RBC casts in urine.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Minimal Change Disease:</span></strong><span style=\"font-size:14.0pt\"> Minimal change disease typically presents with nephrotic syndrome, characterized by severe proteinuria, hypoalbuminemia, and edema. It does not commonly present with hematuria, cola-colored urine, or a history of recent infection.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. IgA Nephropathy:</span></strong><span style=\"font-size:14.0pt\"> IgA nephropathy often presents with recurrent episodes of hematuria, typically following mucosal infections, such as those of the upper respiratory tract, but the hematuria usually coincides with the infection rather than following it by weeks. Normal C3 levels are usually found.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Nephrotic Syndrome:</span></strong><span style=\"font-size:14.0pt\"> Nephrotic syndrome presents with severe proteinuria, hypoalbuminemia, hyperlipidemia, and generalized edema. It does not typically present with hematuria or low C3 levels.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Post-streptococcal glomerulonephritis (PSGN) is often preceded by a streptococcal infection, such as a sore throat or impetigo.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Key features of PSGN include hematuria (cola-colored urine), oliguria, periorbital edema, hypertension, low C3 levels, and RBC casts in the urine.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 191108,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        13
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47873,
      "choices": [
        {
          "id": 191087,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Isomorphic RBCs</span></span></span></p>"
        },
        {
          "id": 191088,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">RBC casts</span></span></span></p>"
        },
        {
          "id": 191089,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Nephrotic range proteinuria</span></span></span></p>"
        },
        {
          "id": 191090,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Eosinophiluria</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient presents with hematuria and hypercalciuria. Urine analysis is performed. Which of the following findings is most likely to be revealed? </span></span></p>",
      "unique_key": "Q9667312",
      "difficulty_level": "difficult",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. A) Isomorphic RBCs</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Hematuria in the context of hypercalciuria is often due to conditions such as nephrolithiasis (kidney stones) or hypercalciuria-associated damage to the renal tubules. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">In these conditions, the red blood cells (RBCs) found in the urine are typically isomorphic, meaning they have a uniform appearance. This contrasts with glomerular causes of hematuria, where RBCs are dysmorphic due to passage through the glomerular basement membrane.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. RBC casts:</span></strong><span style=\"font-size:14.0pt\"> RBC casts are typically indicative of glomerulonephritis or other glomerular diseases. The presence of casts suggests that the RBCs originate from the glomeruli. Given the context of hypercalciuria and likely nephrolithiasis, RBC casts are less likely.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Nephrotic range proteinuria:</span></strong><span style=\"font-size:14.0pt\"> Nephrotic range proteinuria (defined as protein excretion of &gt;3.5 grams per day) is associated with nephrotic syndrome, which includes conditions like minimal change disease, focal segmental glomerulosclerosis, and membranous nephropathy. It is not typically associated with hypercalciuria and nephrolithiasis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Eosinophiluria:</span></strong><span style=\"font-size:14.0pt\"> Eosinophiluria is typically associated with allergic interstitial nephritis or certain types of vasculitis. It is not a common finding in hypercalciuria or nephrolithiasis-related hematuria.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational objective:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">In a patient with hematuria and hypercalciuria, urine analysis is most likely to reveal isomorphic RBCs, which are typically associated with conditions like nephrolithiasis or hypercalciuria-induced renal damage. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This contrasts with RBC casts, which suggest a glomerular origin for the hematuria.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 191087,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        5
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47831,
      "choices": [
        {
          "id": 190923,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Misoprostol and Medroxyprogesterone</span></span></span></p>"
        },
        {
          "id": 190924,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Misoprostol and Mifepristone</span></span></span></p>"
        },
        {
          "id": 190925,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Mifepristone and Methotrexate</span></span></span></p>"
        },
        {
          "id": 190926,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Mifepristone and Medroxyprogesterone</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 19-year-old woman presents at 7 weeks of gestation and expresses her desire to terminate the pregnancy. Which of the following combinations of drugs is used for medical termination of pregnancy in this patient?</span></span></p>",
      "unique_key": "Q2225239",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. B) Misoprostol and Mifepristone</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Mifepristone 200mg is administered orally on day 1. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The minimum recommended interval between mifepristone &amp; misoprostol is 24 hours.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Clinical confirmation of MTP is done on day 14.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The combination of Misoprostol and Mifepristone is the most commonly used regimen for medical termination of pregnancy up to 10 weeks of gestation. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Mifepristone is an antiprogestin that blocks the effects of progesterone, a hormone necessary for pregnancy maintenance, leading to detachment of the pregnancy. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Misoprostol is a prostaglandin analog that induces uterine contractions to expel the pregnancy. This combination is highly effective and is the standard regimen for early medical abortion.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Misoprostol and Medroxyprogesterone:</span></strong><span style=\"font-size:14.0pt\"> Medroxyprogesterone is a synthetic progestin, not used for medical termination of pregnancy. It is commonly used for hormone replacement therapy or as a contraceptive, but it does not aid in the termination process.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Mifepristone and Methotrexate:</span></strong><span style=\"font-size:14.0pt\"> While Methotrexate can be used in combination with Misoprostol for medical termination, it is less common than the Mifepristone and Misoprostol regimen. Methotrexate is a folic acid antagonist that disrupts cell division, but it is not the preferred method due to its slower action and higher risk of side effects.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Mifepristone and Medroxyprogesterone:</span></strong><span style=\"font-size:14.0pt\"> Medroxyprogesterone does not have a role in the medical termination of pregnancy. The combination of Mifepristone and Misoprostol is preferred for its effectiveness and safety profile.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The combination of Misoprostol and Mifepristone is the standard and most effective regimen for medical termination of pregnancy up to 10 weeks of gestation.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 190924,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47854,
      "choices": [
        {
          "id": 191011,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Vasopressin is the vasopressor of choice</span></span></span></p>"
        },
        {
          "id": 191012,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Empirical broad-spectrum antibiotics should be initiated within 1 hour of recognition.</span></span></span></p>"
        },
        {
          "id": 191013,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Target a mean arterial pressure (MAP) of at least 65 mmHg.</span></span></span></p>"
        },
        {
          "id": 191014,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Low molecular weight heparin is recommended for prophylaxis against venous thromboembolism.</span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 65-year-old male patient with a history of COPD has been admitted for septic shock. Which of the following statements regarding the management of this patient is incorrect?</span></span></p>",
      "unique_key": "Q4414891",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Ans. A) </span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Vasopressin is the vasopressor of choice</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">This statement is incorrect. The first-line vasopressor recommended for septic shock is norepinephrine, not vasopressin. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Vasopressin may be added to norepinephrine to raise mean arterial pressure (MAP) or reduce norepinephrine dosage, but it is not used as the primary vasopressor.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14pt\"><strong>Option B.</strong>&nbsp;</span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><strong>Empirical broad-spectrum antibiotics should be initiated within 1 hour of recognition</strong>: This statement is correct. Early initiation of broad-spectrum antibiotics is critical in the management of septic shock to cover a wide range of potential pathogens and improve patient outcomes. This should be done as soon as septic shock is recognized, ideally within the first hour.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14pt\"><strong>Option C.</strong>&nbsp;</span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><strong>Target a mean arterial pressure (MAP) of at least 65 mmHg</strong>: This statement is correct. The target MAP for patients with septic shock is at least 65 mmHg to ensure adequate tissue perfusion and oxygenation. Maintaining this target helps prevent organ dysfunction and supports overall patient stabilization.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14pt\"><strong>Option D.</strong>&nbsp;</span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><strong>Low molecular weight heparin is recommended for prophylaxis against venous thromboembolism</strong>: This statement is correct. Patients with septic shock are at increased risk for venous thromboembolism (VTE) due to immobility and the hypercoagulable state induced by sepsis. Prophylactic anticoagulation with low molecular weight heparin (LMWH) is recommended to prevent VTE.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">In the management of septic shock, norepinephrine is the first-line vasopressor, not vasopressin. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Early administration of broad-spectrum antibiotics, targeting a MAP of at least 65 mmHg, and prophylaxis against venous thromboembolism with low molecular weight heparin are key components of effective treatment.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 191011,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47486,
      "choices": [
        {
          "id": 189555,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">1-a, 2-b, 3-c, 4-d</span></span></span></p>"
        },
        {
          "id": 189556,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">1-d, 2-a, 3-b 4-c</span></span></span></p>"
        },
        {
          "id": 189557,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">1-d, 2-a, 3-c, 4-b</span></span></span></p>"
        },
        {
          "id": 189558,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">1-d, 2-c, 3-a, 4-b</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Match the following: Monitors (Column A) and their common sites of monitoring (Column B):&nbsp;</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Column A</span></strong></span></span></p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Invasive blood pressure monitoring</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Neuromuscular blockade monitoring</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Central venous cannulation</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Noninvasive blood pressure monitoring</span></span></span></li>\r\n</ol>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Column B</span></strong></span></span></p>\r\n\r\n<ol style=\"list-style-type:lower-alpha\">\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Ulnar nerve</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Brachial artery</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Right internal jugular vein</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Radial artery </span></span></span></li>\r\n</ol>",
      "unique_key": "Q2546415",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Ans. C) 1-d, 2-a, 3-c, 4-b</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">&nbsp;Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">1-d - Invasive blood pressure monitoring is commonly performed via the radial artery. </span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">2-a - Neuromuscular blockade monitoring is often assessed at the ulnar nerve. </span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">3-c Central venous cannulation is typically done via the right internal jugular vein. </span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">4-b- Non-invasive blood pressure monitoring is most commonly performed using the brachial artery.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Invasive blood pressure is typically monitored through the radial artery, neuromuscular blockade through the ulnar nerve, central venous cannulation via the right internal jugular vein, and non-invasive blood pressure through the brachial artery.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 189557,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        19
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47702,
      "choices": [
        {
          "id": 190419,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Conservative</span></span></span></p>"
        },
        {
          "id": 190420,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Tendon transfer</span></span></span></p>"
        },
        {
          "id": 190421,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Shoulder Arthroplasty</span></span></span></p>"
        },
        {
          "id": 190422,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Reverse Shoulder Arthroplasty</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 70-year-old male has come with massive retracted, chronic, irreparable rotator cuff tear. What will be best line of management? </span></span></p>",
      "unique_key": "Q8193175",
      "difficulty_level": "difficult",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. D) Reverse Shoulder Arthroplasty</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Reverse shoulder arthroplasty (RSA) is a specialized type of shoulder replacement surgery designed for patients with massive, irreparable rotator cuff tears and associated shoulder dysfunction. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">In RSA, the normal configuration of the shoulder joint is reversed, with the glenoid component placed on the humerus and the humeral component placed on the scapula.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/06/screenshot-2024-06-06-135748.png\" style=\"height:300px; width:500px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Conventional shoulder arthroplasty VS Reverse shoulder arthroplasty</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Reverse shoulder arthroplasty is considered the treatment of choice for patients with massive retracted, chronic, irreparable rotator cuff tears who have failed conservative management and are not candidates for tendon transfer or traditional shoulder arthroplasty. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">RSA relies on the deltoid muscle to provide stability and function, bypassing the need for intact rotator cuff tendons.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options</span></strong><span style=\"font-size:14.0pt\">: </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Conservative: </span></strong><span style=\"font-size:14.0pt\">Conservative management typically involves non-surgical interventions aimed at managing symptoms and optimizing function without surgical intervention. This may include physical therapy, activity modification, pain management, and possibly corticosteroid injections. Conservative management may be considered in patients who are not surgical candidates due to medical comorbidities, patient preference, or when the tear is not causing significant pain or functional impairment. However, in cases of massive retracted, chronic, irreparable rotator cuff tears, conservative management alone is unlikely to provide satisfactory long-term outcomes, especially in patients experiencing severe pain or functional limitations.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Tendon Transfer: </span></strong><span style=\"font-size:14.0pt\">Tendon transfer surgery involves transferring a healthy tendon from one area of the body to replace a damaged or deficient tendon in another area. In the context of a massive irreparable rotator cuff tear, tendon transfer procedures may involve using intact tendons from nearby muscles to restore shoulder function and stability. Tendon transfer surgery may be considered in cases of irreparable rotator cuff tears, particularly when the tear is not too severe or retracted, and there is sufficient muscle function and tendon quality to support the transfer. However, in cases of massive retracted tears with significant muscle atrophy and tendon degeneration, tendon transfer may not be feasible or may provide suboptimal outcomes.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Shoulder Arthroplasty: </span></strong><span style=\"font-size:14.0pt\">Shoulder arthroplasty, or shoulder replacement surgery, involves replacing all or part of the damaged shoulder joint with artificial components made of metal, plastic, or ceramic. This can include total shoulder arthroplasty (TSA), which replaces both the humeral head and the glenoid, or partial shoulder arthroplasty (hemiarthroplasty), which replaces only the humeral head. Shoulder arthroplasty may be considered in patients with irreparable rotator cuff tears who have intact glenoid anatomy and preserved joint function. However, in cases of massive retracted tears with severe rotator cuff deficiency, traditional shoulder arthroplasty may not be suitable due to the inability of the remaining musculature to provide adequate stability and function.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In case of a massive, chronic, retracted and an irreparable rotator cuff tear, reverse shoulder arthroplasty is the treatment line of choice because this surgical technique relies on the deltoid muscle for the stability of the joint and not on the rotator cuff. </span></span></li>\r\n</ul>",
      "correct_choice_id": 190422,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        15
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47856,
      "choices": [
        {
          "id": 191019,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Superior longitudinal fasciculus</span></span></span></p>"
        },
        {
          "id": 191020,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Anterior commissure</span></span></span></p>"
        },
        {
          "id": 191021,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Arcuate fasciculus</span></span></span></p>"
        },
        {
          "id": 191022,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Inferior occipitofrontal fasciculus</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 45-year-old man presents to the OPD with a sudden-onset speech disorder. Neurological evaluation reveals that he has difficulty repeating spoken words, but his language comprehension and production are intact. MRI reveals a lesion in the left hemisphere involving the superior temporal gyrus and the posterior part of the left frontal lobe. Which of the following white matter tracts is most likely affected in this patient? </span></span></p>",
      "unique_key": "Q9239661",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans.&nbsp;</span></strong><strong><span style=\"font-size:14.0pt\">C) Arcuate fasciculus</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The arcuate fasciculus is a critical white matter tract that connects Wernicke&#39;s area (located in the superior temporal gyrus) with Broca&#39;s area (located in the posterior part of the left frontal lobe). </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This connection is essential for the coordination of language comprehension and production. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Damage to the arcuate fasciculus results in conduction aphasia, characterized by difficulty in repeating spoken words while maintaining intact language comprehension and production. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This specific impairment occurs because the arcuate fasciculus is responsible for transmitting information between these two key language areas.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Option A.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>Superior longitudinal fasciculus:</strong> Although this tract connects various parts of the brain, it does not specifically link Wernicke&#39;s and Broca&#39;s areas and is not primarily involved in the direct transfer of language-related information.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Option B.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>Anterior commissure:</strong> This tract connects the two cerebral hemispheres but is mainly associated with olfactory and some interhemispheric visual functions, not directly with language processing.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14pt\"><strong>Option D.</strong>&nbsp;</span><span style=\"font-size:14.0pt\"><strong>Inferior occipitofrontal fasciculus:</strong> This white matter tract connects the occipital and frontal lobes, playing a role in visual processing and integration rather than in language.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The arcuate fasciculus is the white matter tract that connects Wernicke&#39;s area and Broca&#39;s area, facilitating the coordination between language comprehension and production. </span></span></span></li>\r\n\t<li><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lesions in this tract lead to conduction aphasia, which is characterized by impaired repetition of spoken words despite intact comprehension and production.</span></span></li>\r\n</ul>",
      "correct_choice_id": 191021,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        2
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47832,
      "choices": [
        {
          "id": 190927,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Barberio test</span></span></span></p>"
        },
        {
          "id": 190928,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Florence test</span></span></span></p>"
        },
        {
          "id": 190929,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Takayama test</span></span></span></p>"
        },
        {
          "id": 190930,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Teichmann test</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 23-year-old woman presents to a medical facility following an alleged sexual assault. The medical officer collects a specimen from the perianal area for analysis to confirm the presence of seminal fluid, which is crucial for the investigation. The specimen is subjected to a test that results in the formation of yellow needle shaped crystals, indicative of a specific component of seminal fluid. Which test was most likely performed? </span></span></p>",
      "unique_key": "Q5195512",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans.&nbsp;</span></strong><strong><span style=\"font-size:14.0pt\">A) Barberio test</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Barberio&rsquo;s test &ndash;&nbsp;</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Reagent: Picric Acid.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Component of semen detected: Spermine (secreted from prostate gland) Shape of crystals: Yellow needle shaped crystals of spermine picrate.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/07/screenshot-2024-06-07-105923.png\" style=\"height:358px; width:500px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options &nbsp;</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Florence test:&nbsp;</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Reagent: </span></span></span><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">KI + I<sub>2</sub> + H<sub>2</sub>O</span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Component of semen detected: Coline (secreted from seminal vesicles)</span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Shape of crystals: Dark Brown rhombic crystals of choline iodide (resemble hemin but larger than hemin crystals)</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/07/screenshot-2024-06-07-110109_i4970lJ.png\" style=\"height:392px; width:600px\" /></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option C. Hemochromogen (Takayama) test:</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Reagent: NaOH + pyridine + glucose</span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Pink feathery crystals of hemochromogen (reduced alkaline hematin)</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/07/screenshot-2024-06-07-110224.png\" style=\"height:422px; width:600px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Hemin (Teichmann&rsquo;s) test:</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Reagent: NaCl + acetic acid</span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Brownish-black rhombic crystals of hematin chloride</span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Negative in old stains or washed or treated with chemicals</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/07/screenshot-2024-06-07-110321.png\" style=\"height:436px; width:600px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective -</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Microchemical tests for Semen:</span></strong><span style=\"font-size:14.0pt\"> Florence and Barberio test (Both are presumptive tests)</span></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Florence test&mdash;For choline (dark brown rhombic crystals)</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Barberio test&mdash; detects spermine (yellow needle-shaped rhombic crystals)</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Microchemical tests for Blood:</span></strong><span style=\"font-size:14.0pt\"> Teichmann&rsquo;s and Takayama test (Both are confirmatory tests)</span></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Teichmann&rsquo;s - Brownish-black rhombic crystals of hematin chloride</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Takayama test - Pink feathery crystals of hemochromogen (reduced alkaline hematin)</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 190927,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "subjects_id": [
        10
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47582,
      "choices": [
        {
          "id": 189939,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"IT\" style=\"font-size:14.0pt\">Endometrial carcinoma</span></span></span></p>"
        },
        {
          "id": 189940,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"IT\" style=\"font-size:14.0pt\">Adenomyosis</span></span></span></p>"
        },
        {
          "id": 189941,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"IT\" style=\"font-size:14.0pt\">Leiomyoma</span></span></span></p>"
        },
        {
          "id": 189942,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"IT\" style=\"font-size:14.0pt\">Endometrial polyp</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 55-year-old woman presents with abnormal uterine bleeding. After a thorough evaluation, a hysterectomy is performed. The specimen retrieved is shown below. What is the most likely diagnosis?</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/05/screenshot-2024-06-05-155900.JPG\" style=\"height:397px; width:300px\" /></span></span></p>",
      "unique_key": "Q5332691",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. C) Leiomyoma</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The image shows a well-circumscribed, whorled mass within the uterine wall, characteristic of leiomyoma. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Leiomyomas can cause abnormal uterine bleeding, pelvic pain, and pressure symptoms.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Leiomyomas, also known as fibroids, are benign smooth muscle tumors of the uterus. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">They are the most common uterine neoplasms and are often found in women of reproductive age, though they can persist into menopause. </span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Endometrial carcinoma:</span></strong><span style=\"font-size:14.0pt\"> Endometrial carcinoma usually presents with irregular, friable, and often hemorrhagic areas within the endometrial cavity. The gross appearance is typically not nodular like that seen with leiomyomas.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Adenomyosis:</span></strong><span style=\"font-size:14.0pt\"> Adenomyosis involves the presence of endometrial glands and stroma within the myometrium, leading to a diffusely enlarged uterus with a trabeculated or spongy appearance. It does not present with distinct nodules as seen in leiomyomas.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Endometrial polyp:</span></strong><span style=\"font-size:14.0pt\"> Endometrial polyps are localized overgrowths of the endometrial tissue and appear as soft, fleshy masses within the uterine cavity. They do not have the firm, nodular appearance seen in the provided specimen.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Leiomyomas are the most common benign tumors of the uterus and typically present with abnormal uterine bleeding and a characteristic whorled pattern on gross pathology. </span></span></span></li>\r\n</ul>",
      "correct_choice_id": 189941,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        14
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47741,
      "choices": [
        {
          "id": 190571,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Complement levels (C3, C4)</span></span></span></p>"
        },
        {
          "id": 190572,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Anti-double stranded DNA (Anti-dsDNA) </span></span></span></p>"
        },
        {
          "id": 190573,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Anti-Smith (Anti-Sm) </span></span></span></p>"
        },
        {
          "id": 190574,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Rheumatoid factor (RF) </span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 24-year-old woman presents with fever, oral ulcers, and a rash as shown in the image. She also reports photosensitivity and joint pain. Which of the following investigations would be <strong>LEAST</strong> likely to help in establishing the diagnosis?</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/06/screenshot-2024-06-06-154605.png\" style=\"height:378px; width:300px\" /></span></span></p>",
      "unique_key": "Q5799098",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Ans. </span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">D) Rheumatoid Factor</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">The clinical presentation of fever, oral ulcers, a rash (likely a malar or butterfly rash), photosensitivity, and joint pain suggests a diagnosis of systemic lupus erythematosus (SLE). SLE is an autoimmune disease characterized by a wide range of symptoms and multisystem involvement. The following investigations are commonly used to establish a diagnosis of SLE:</span></span></span></li>\r\n</ul>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Complement levels (C3, C4)</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"> - Complement levels are often measured in patients with suspected SLE. Low levels of C3 and C4 are indicative of disease activity and immune complex deposition, which are common in SLE.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Anti-double stranded DNA (Anti-dsDNA)</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"> - Anti-dsDNA antibodies are highly specific for SLE and are commonly used in the diagnosis and monitoring of disease activity.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Anti-Smith (Anti-Sm)</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"> - Anti-Sm antibodies are another highly specific marker for SLE, though they are less commonly found than anti-dsDNA antibodies.</span></span></span></li>\r\n</ol>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Rheumatoid factor (RF)</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"> is an antibody that is primarily associated with rheumatoid arthritis (RA) and is not commonly used in the diagnosis of SLE. While RF can be present in a small percentage of SLE patients, it is not a primary diagnostic test for SLE.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Option&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14pt\"><strong>A.</strong>&nbsp;</span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><strong>Complement levels (C3, C4)</strong>: Complement levels (C3 and C4) are often low in active SLE due to their consumption in immune complex-mediated inflammation. Thus, measuring these levels is helpful in diagnosing SLE.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Option&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14pt\"><strong>B.</strong>&nbsp;</span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><strong>Anti-double stranded DNA (Anti-dsDNA)</strong>: Anti-dsDNA antibodies are highly specific for SLE and are a key marker in its diagnosis. These antibodies also correlate with disease activity, particularly with renal involvement.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14pt\"><strong>Option C.</strong>&nbsp;</span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\"><strong>Anti-Smith (Anti-Sm)</strong>: Anti-Sm antibodies are highly specific for SLE and, while not as commonly found as anti-dsDNA antibodies, their presence is highly indicative of SLE.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Rheumatoid factor (RF) is primarily associated with rheumatoid arthritis and is not commonly used in the diagnosis of systemic lupus erythematosus (SLE). </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">In contrast, complement levels (C3, C4), anti-double stranded DNA (Anti-dsDNA), and anti-Smith (Anti-Sm) antibodies are valuable investigations for diagnosing SLE.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 190574,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        11
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47671,
      "choices": [
        {
          "id": 190295,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Trichuris trichiura</span></span></span></p>"
        },
        {
          "id": 190296,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Ancylostoma duodenale</span></span></span></p>"
        },
        {
          "id": 190297,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">&nbsp;Necator americanus</span></span></span></p>"
        },
        {
          "id": 190298,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">&nbsp;Ascaris lumbricoides</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 6-year-old child from a rural farming community presents to the pediatric clinic with complaints of intermittent abdominal pain, diarrhea, and noticeable weight loss over the past few months. His family uses untreated well water and often plays in the surrounding fields. A stool sample is collected and analyzed under microscopy, revealing eggs as shown in the image.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/06/screenshot-2024-06-06-125414.png\" style=\"height:297px; width:300px\" /></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Which helminthic infection, commonly transmitted by soil, is characterized by the egg in the stool as shown in the above image?</span></span></span></p>",
      "unique_key": "Q2636925",
      "difficulty_level": "beginner",
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. A) Trichuris trichiura</span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The image displays the distinctive egg of Trichuris trichiura, also known as the whipworm. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">These eggs are notable for their barrel shape with bipolar mucus plugs and an unsegmented ovum. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The outer shell is triple-layered, with the external layer often appearing brown due to staining. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">These eggs are typically passed in an unembryonated state in the stool and are diagnostic of whipworm infection. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Transmission occurs through soil contaminated with human feces, highlighting the importance of sanitation and hygiene.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Options B. Ancylostoma duodenale and C. Necator americanus &ndash; </span></strong><span style=\"font-size:14.0pt\">The eggs are<strong> </strong>Oval shaped, Non-bile stained, colorless; Surrounded by thin, hyaline shell; Clear space between the egg shell and ovum. Egg is segmented with four blastomeres. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Eggs of both Ancylostoma duodenale and Necator americanus are morphologically indistinguishable; hence stool culture is done for species identification. Both are differentiated by their filariform larva grown in culture.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/06/screenshot-2024-06-06-125555.png\" style=\"height:235px; width:500px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Ascaris lumbricoides:</span></strong><span style=\"font-size:14.0pt\"> The eggs of Ascaris lumbricoides are larger and surrounded by a thick mammillated, albuminous coat; Crescentic space at poles; Bile stained; Floats in saturated salt solution</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/06/screenshot-2024-06-06-125635.png\" style=\"height:286px; width:500px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Trichuris trichiura infection is diagnosed by the identification of its characteristic eggs in stool samples. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The condition can range from asymptomatic to severe, with symptoms including abdominal pain, diarrhea, and potential growth retardation in chronic cases. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Treatment involves anti-helminthic medications like mebendazole or albendazole.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 190295,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "subjects_id": [
        6
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}